data_2eqy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eqy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.78 0.324 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -70.71 -50.39 36.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -44.67 -35.98 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -80.28 -46.97 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.3 mt -55.0 -39.15 68.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -44.74 -65.59 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 74.1 t80 -49.66 -68.04 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.426 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 72.5 mt -37.05 -52.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CD ' ' A' ' 109' ' ' LYS . 22.1 t70 -49.77 -53.41 25.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -56.1 -59.64 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.426 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.0 tt -57.06 -25.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.2 -41.82 60.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -56.3 -34.08 66.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.37 -31.12 72.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' LEU . 14.5 m95 -88.13 -54.3 4.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -26.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 111' ' ' TRP . 54.7 mt -69.81 -48.82 57.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.443 ' OE1' ' C ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -68.08 -36.71 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 115.41 33.45 1.6 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -120.05 145.33 46.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.846 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 m -89.31 128.84 35.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.2 120.31 27.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -142.33 124.29 15.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CG2' ' HD2' ' A' ' 121' ' ' PRO . 21.0 mm -81.1 138.46 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 120' ' ' ILE . 53.9 Cg_endo -69.77 179.48 3.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.562 ' CD2' HD13 ' A' ' 127' ' ' ILE . 56.9 m80 -115.8 107.02 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.562 HG12 ' CE1' ' A' ' 161' ' ' PHE . 53.3 t -93.14 110.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 57.65 48.29 14.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 60.21 31.59 20.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -148.42 123.36 10.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.562 HD13 ' CD2' ' A' ' 122' ' ' HIS . 19.9 mm -54.75 131.68 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.437 ' CD2' ' CD2' ' A' ' 174' ' ' HIS . 58.8 tp -92.39 103.62 16.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.14 91.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.46 ' CD1' HD13 ' A' ' 120' ' ' ILE . 64.4 mt -43.17 -59.5 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' LEU . 45.9 t80 -35.31 -69.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 133' ' ' LEU . 40.8 mt-30 -54.89 -57.27 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 171' ' ' ILE . 16.6 tp -34.09 -71.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -51.2 -45.91 62.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -49.17 -58.64 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.94 -46.26 60.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.8 t -49.07 -55.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.85 75.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.0 -38.04 89.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.91 -19.79 60.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 157.38 -59.44 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 148.76 171.32 17.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.07 -46.0 91.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.84 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.52 -66.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 141' ' ' GLY . 4.6 p -49.9 -54.47 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 57.4 t -51.43 -49.09 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.2 m -58.25 -45.41 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -57.49 -49.04 77.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.9 m-20 -97.36 18.4 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 35.36 51.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -86.47 41.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.613 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 43.4 m95 -84.26 -36.36 22.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 m -49.7 -43.7 47.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -54.45 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.23 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.7 -53.51 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 92.4 m -57.83 -43.79 86.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -61.07 -22.83 64.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 93.3 mmm -82.45 9.24 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.82 -10.11 74.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.543 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 123' ' ' VAL . 13.6 m-85 -72.26 157.11 38.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.0 61.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 85.64 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.677 2.252 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.34 -130.49 3.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.44 -46.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.61 -58.98 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -54.9 -31.08 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.16 19.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 t -70.13 -25.65 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -58.49 -48.09 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.613 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 34.7 mm -47.1 -52.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -59.63 -57.47 12.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.14 -57.69 7.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.437 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 82.1 m-70 -40.34 -37.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.6 OUTLIER -77.07 -42.31 38.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -76.81 -9.23 58.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -101.46 -32.23 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.29 -51.1 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 19.5 mt -83.93 21.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.45 -60.25 2.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 0.0 110.888 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.1 Cg_endo -69.72 -50.68 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -40.78 -47.9 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.26 -27.21 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.2 tt -61.52 -29.45 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -95.3 -45.59 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.1 mt -48.94 -39.97 28.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.795 0.331 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -65.57 -62.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.527 HG22 ' CE2' ' A' ' 131' ' ' PHE . 9.7 p -63.24 -20.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -75.02 -49.06 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.99 -37.44 47.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -39.96 -62.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -53.31 -57.69 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.5 mt -44.07 -31.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.8 -40.78 22.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -68.0 -26.17 65.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.567 HD12 ' CD1' ' A' ' 182' ' ' TYR . 4.6 tp -92.88 -31.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.54 -45.33 46.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 29.5 pttt -48.72 -39.78 26.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 6.2 m-85 -56.67 -38.04 71.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.559 ' CD1' HD13 ' A' ' 118' ' ' LEU . 66.4 m95 -72.32 -49.48 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -43.57 -56.05 3.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 109' ' ' LYS . 5.0 mp -47.39 -42.33 21.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -68.15 -31.91 71.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.16 33.86 3.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -138.55 138.26 37.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.971 0.415 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -86.18 137.31 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' A' ' 111' ' ' TRP . 7.0 tt -89.79 128.88 36.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -114.99 120.48 40.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.03 129.73 93.95 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.62 0.724 . . . . 0.0 111.11 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.15 57.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.267 . . . . 0.0 112.301 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.455 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 11.1 m170 -123.61 108.86 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 72.2 t -96.55 140.29 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 41.63 43.24 2.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 60.16 41.82 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -152.99 156.41 38.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 15.3 mm -69.75 137.34 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 174' ' ' HIS . 15.8 tp -107.47 98.78 8.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -72.29 105.09 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.2 -57.35 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 99' ' ' VAL . 7.6 t80 -38.78 -48.37 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -73.44 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 24.6 tp -38.12 -67.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -47.46 -57.49 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -41.51 -56.67 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.0 mt -51.61 -44.34 62.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.26 -51.3 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.21 85.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.67 -42.89 97.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -73.07 -22.01 60.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.411 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 158.76 -58.21 0.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.442 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 141.67 170.11 12.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' ' HG2' ' A' ' 172' ' ' ARG . 30.3 t80 -57.31 -41.76 80.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.847 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.15 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.411 HG12 ' C ' ' A' ' 141' ' ' GLY . 2.8 p -55.54 -52.01 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 95.3 t -56.72 -66.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 14.2 t -51.25 -36.24 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -58.8 -50.99 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.09 25.62 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 38.38 39.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -85.46 46.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.532 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 45.4 m95 -88.96 -42.68 11.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.2 m -40.92 -50.73 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -50.69 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.2 mt -45.16 -62.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.5 -56.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.7 m -55.29 -41.46 72.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -53.65 -44.99 70.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.0 mmm -59.43 -18.82 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.28 -14.53 12.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 19.4 m-85 -66.5 164.63 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 144.14 75.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 111.069 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 96.19 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.2 13.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -36.65 10.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.741 0.305 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -55.97 10.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.1 p -64.44 -38.18 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -50.2 -47.56 41.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -76.7 -33.52 58.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.67 -51.98 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.532 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 6.8 mm -40.98 -55.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.437 ' HG2' ' CE2' ' A' ' 143' ' ' PHE . 21.2 mtm105 -57.38 -56.09 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.04 -44.96 26.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.534 ' CD2' HD23 ' A' ' 128' ' ' LEU . 60.9 m-70 -53.39 -38.42 63.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -76.8 -32.27 57.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -86.33 -9.34 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -101.69 -29.59 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.92 -52.28 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 13.1 mt -84.15 24.16 0.98 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.483 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.53 -60.25 2.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.65 0.738 . . . . 0.0 110.912 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.73 -50.0 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.665 2.243 . . . . 0.0 112.397 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.567 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.0 t80 -42.61 -56.12 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.49 -52.49 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.95 -33.5 4.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -75.11 -55.55 5.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.84 -46.33 64.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.4 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.744 0.307 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -64.19 -52.44 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 100' ' ' LYS . 8.7 p -55.64 -44.88 78.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' N ' ' CG1' ' A' ' 99' ' ' VAL . 81.0 mttt -60.57 -46.78 88.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ASN . 35.2 mt -57.21 -50.25 73.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' LEU . 57.3 t-20 -37.56 -61.95 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 105' ' ' ASP . 31.4 t80 -57.97 -65.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 58.1 mt -38.23 -27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.9 t70 -80.77 -48.95 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 103' ' ' PHE . 12.3 mm100 -64.13 -21.33 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.4 tt -91.55 -39.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.6 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 55.4 pttt -56.93 -44.24 82.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.434 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 5.5 m-85 -50.04 -33.06 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.495 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 60.7 m95 -79.16 -49.47 12.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -45.4 -40.14 7.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.37 -45.25 88.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -65.44 -33.06 75.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.56 40.83 1.69 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -144.06 147.49 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -87.45 146.6 25.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 118' ' ' LEU . 5.3 tt -96.29 115.98 28.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' N ' HD23 ' A' ' 118' ' ' LEU . 22.7 ttpt -107.27 124.08 49.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.72 125.44 90.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 160.75 48.55 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -125.37 109.12 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.15 121.64 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 56.11 45.6 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.411 ' HB3' ' NH1' ' A' ' 125' ' ' ARG . 6.3 mtp-105 58.37 41.29 23.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -145.78 153.36 40.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -76.95 113.57 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.24 108.6 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.944 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.63 88.86 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' PHE . 41.3 mt -39.19 -64.6 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.4 t80 -37.32 -66.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 38.1 tt0 -50.42 -60.65 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 132' ' ' GLN . 7.9 tp -36.45 -70.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.2 -47.49 46.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -49.5 -54.4 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -52.38 -49.31 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.4 t -48.24 -48.84 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.99 90.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.19 -32.12 69.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.05 -12.85 58.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.417 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 153.08 -61.7 0.38 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.92 170.58 18.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 34.2 t80 -60.13 -35.83 76.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 0.0 110.926 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.44 -66.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.417 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.7 p -49.95 -49.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 150' ' ' ARG . 53.2 t -61.89 -62.63 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 52.2 t -46.34 -46.13 18.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -63.35 -55.46 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 14.93 2.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.4 OUTLIER 39.64 52.12 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 9.0 mtpm? -94.22 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.499 ' CZ3' HG23 ' A' ' 171' ' ' ILE . 89.7 m95 -81.81 -40.67 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 98.9 m -42.31 -51.25 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -49.59 -68.28 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 151' ' ' LYS . 5.3 mp -43.13 -65.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.11 -51.29 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.6 m -54.66 -53.02 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -54.08 -27.4 32.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -78.72 10.27 3.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.3 75.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -70.5 157.03 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.65 80.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.521 0.677 . . . . 0.0 111.142 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.224 . . . . 0.0 112.324 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -141.74 -169.18 11.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -93.93 -47.66 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.72 -58.22 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' A' ' 170' ' ' HIS . 11.5 p -60.23 -31.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.25 -49.84 62.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.9 t -74.31 -34.08 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 3.8 m-70 -50.74 -53.78 28.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.499 HG23 ' CZ3' ' A' ' 152' ' ' TRP . 32.4 mm -38.78 -48.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -65.14 -52.84 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 176' ' ' GLU . . . -53.16 -57.31 15.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -43.38 -30.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -79.47 -37.99 35.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' GLY . 7.3 mt-10 -77.97 -10.3 59.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 177' ' ' ARG . 1.2 mpt_? -98.16 -34.03 10.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.1 mt -119.52 -48.34 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 175' ' ' TYR . 7.7 mt -83.47 21.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -70.98 -60.1 3.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.76 -49.08 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.32 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.428 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 6.1 t80 -44.61 -56.65 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.98 -38.84 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.424 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 52.0 tp -58.13 -23.19 54.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -98.13 -43.1 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -53.16 -44.6 67.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.332 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -56.54 -57.84 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 100' ' ' LYS . 9.8 p -71.17 -31.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' N ' HG12 ' A' ' 99' ' ' VAL . 18.2 mmmt -54.8 -49.67 70.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 102' ' ' ASN . 81.5 mt -77.31 -48.16 18.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 101' ' ' LEU . 5.4 t-20 -37.33 -63.25 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.25 -64.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.3 mt -45.08 -26.07 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.17 -40.34 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -74.69 -24.38 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 182' ' ' TYR . 9.1 tp -87.39 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.15 80.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.463 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 61.0 pttt -49.05 -45.0 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.433 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 56.5 t80 -52.49 -41.63 63.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.502 ' CD1' HD12 ' A' ' 118' ' ' LEU . 53.6 m95 -68.09 -48.25 66.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.19 -45.39 16.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 109' ' ' LYS . 5.5 mp -51.44 -37.06 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -78.26 -23.16 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 27.36 9.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -129.91 136.43 49.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.79 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -82.11 145.22 30.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.502 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.6 tt -90.79 117.15 29.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -109.57 114.65 28.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mm -70.47 126.56 92.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.56 10.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.38 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -122.58 121.0 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.22 127.96 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 54.17 42.48 31.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 58.87 45.15 15.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -157.07 153.86 28.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.12 105.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.565 HD23 ' CD2' ' A' ' 174' ' ' HIS . 49.4 tp -65.6 116.6 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -80.41 108.21 13.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.07 -52.19 51.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CD2' ' N ' ' A' ' 132' ' ' GLN . 6.8 t80 -48.27 -66.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 59.3 tt0 -54.77 -47.96 73.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 tp -50.08 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -48.98 -43.6 40.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -51.03 -53.38 34.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 66.1 mt -56.14 -46.29 79.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.1 t -48.57 -49.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.87 79.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.23 -42.59 79.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -72.97 -14.58 61.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 153.97 -61.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 148.82 168.79 14.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.26 -42.15 81.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.28 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.428 HG12 ' C ' ' A' ' 141' ' ' GLY . 4.2 p -52.49 -40.96 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 72.6 t -69.9 -26.38 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.9 m -78.82 -32.64 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 8.1 pttp -81.35 -45.3 16.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 150' ' ' ARG . 5.8 m-20 -89.43 20.15 4.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.474 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 31.41 47.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -87.97 37.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.594 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 24.6 m95 -85.36 -42.27 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m -52.02 -53.27 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -46.71 -53.89 10.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 156' ' ' ALA . 28.4 mt -58.9 -68.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.116 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -34.32 -49.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -58.88 -49.22 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -50.17 -49.13 53.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 22.9 mtp -47.93 -27.19 2.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.5 -7.55 10.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -77.43 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.32 145.11 55.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.542 0.686 . . . . 0.0 111.142 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 93.32 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 166' ' ' ALA . . . -146.91 135.32 5.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.455 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -43.78 -23.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.401 ' N ' ' C ' ' A' ' 164' ' ' GLY . . . -61.01 -59.09 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 168' ' ' GLY . 7.3 p -67.57 -40.68 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -50.94 -41.44 45.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.3 m -83.33 -31.6 26.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.1 m-70 -54.69 -40.0 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.594 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 49.9 mm -50.51 -61.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.081 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.69 -52.68 63.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.69 -43.02 37.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.565 ' CD2' HD23 ' A' ' 128' ' ' LEU . 60.9 m-70 -56.83 -39.81 74.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.8 OUTLIER -75.23 -39.98 59.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -76.29 -9.44 58.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -104.04 -29.72 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.1 mt -119.25 -52.47 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.555 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 29.2 mt -82.94 18.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -69.95 -60.22 3.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.632 0.73 . . . . 0.0 110.909 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -41.78 4.01 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 107' ' ' ILE . 16.5 t80 -45.31 -51.68 10.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.72 -42.85 21.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.4 tp -50.82 -31.28 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -90.53 -54.08 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -42.18 -51.82 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -60.9 -56.18 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -44.34 -35.6 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 60.9 mttt -78.44 -54.88 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 102' ' ' ASN . 72.9 mt -46.06 -48.42 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 101' ' ' LEU . 25.6 t-20 -36.41 -65.55 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 106' ' ' GLN . 55.5 t80 -55.05 -68.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 36.6 mt -36.68 -30.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' PHE . 10.1 t70 -79.48 -45.78 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.3 mm-40 -67.04 -17.98 65.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.6 tt -96.86 -34.98 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.83 -42.32 81.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.092 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 110' ' ' TYR . 49.4 pttt -54.44 -46.37 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' N ' ' CG ' ' A' ' 109' ' ' LYS . 7.5 m-85 -47.97 -36.48 12.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.547 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 80.6 m95 -74.63 -49.33 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -43.21 -54.0 4.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.7 mm? -45.64 -40.69 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.21 -44.54 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 35.87 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -138.14 120.12 15.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.936 0.398 . . . . 0.0 110.883 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 t -65.16 147.46 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.0 tt -110.37 110.28 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -103.91 140.38 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.29 122.99 73.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.13 11.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -122.22 125.27 45.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.7 t -112.94 134.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 46.76 42.32 11.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 57.75 45.6 18.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -163.89 130.71 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mm -46.5 133.05 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.98 104.6 16.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -72.5 98.62 2.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.81 -57.06 14.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.57 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 44.7 t80 -42.26 -65.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -56.01 -53.67 54.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.7 tp -46.94 -70.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -42.91 -48.66 5.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -48.6 -56.17 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.59 -40.26 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.04 -54.74 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.99 70.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -63.86 -37.66 88.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -81.14 -19.12 44.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.441 ' C ' ' CG1' ' A' ' 145' ' ' VAL . . . 159.55 -57.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.508 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.75 160.5 9.11 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 175' ' ' TYR . 2.4 t80 -53.69 -33.62 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.23 -66.26 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 141' ' ' GLY . 2.7 p -52.11 -31.07 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.5 t -76.1 -54.58 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 38.6 t -57.88 -49.8 75.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 9.3 ptmt -51.76 -42.95 62.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 148' ' ' LYS . 16.3 t0 -90.42 0.89 57.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 52.22 50.79 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -102.84 35.41 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.528 ' CZ3' HG23 ' A' ' 171' ' ' ILE . 12.0 m95 -71.73 -31.76 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.3 m -53.75 -62.67 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.154 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -39.32 -58.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 22.2 mt -55.43 -64.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.19 -44.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.1 m -62.42 -47.69 83.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -51.8 -45.9 64.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.1 -27.21 52.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.07 -7.69 9.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -73.29 135.67 44.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.56 142.7 21.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.538 0.685 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 125.69 12.45 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.4 -144.78 4.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -121.36 -29.72 4.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.27 -57.96 10.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 168' ' ' GLY . 9.2 p -58.72 -44.88 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -49.48 -40.38 31.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.49 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -79.75 -28.72 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.1 m-70 -57.83 -51.64 68.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.528 HG23 ' CZ3' ' A' ' 152' ' ' TRP . 4.5 mm -46.77 -58.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -50.69 -54.04 26.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -53.62 -52.08 44.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 90.8 m-70 -44.46 -33.96 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CD1' ' CE2' ' A' ' 143' ' ' PHE . 1.0 OUTLIER -79.4 -36.1 39.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -83.57 -9.07 59.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -101.94 -31.45 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.13 -50.35 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 175' ' ' TYR . 15.8 mt -83.22 18.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.509 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.82 -58.85 4.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.71 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.547 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 54.2 Cg_endo -69.74 -50.83 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.377 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -42.75 -41.64 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.37 -64.55 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.9 mp -40.35 -36.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -70.57 -51.96 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.9 mt -46.9 -44.81 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -47.36 -51.58 19.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.54 HG21 ' CZ ' ' A' ' 131' ' ' PHE . 7.8 p -47.08 -35.84 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 7.3 mtmp? -73.09 -49.2 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.76 -38.26 81.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.26 -53.63 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -58.61 -48.39 81.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.46 -36.72 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.5 -42.02 68.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -65.82 -52.74 48.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 182' ' ' TYR . 2.8 tp -55.16 -49.35 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.17 70.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -43.71 -52.34 6.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.98 -42.96 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.429 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 51.6 m95 -71.72 -48.64 45.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -44.53 -50.59 9.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mt -54.39 -43.86 71.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.13 -38.44 88.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.86 34.8 1.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -140.64 130.08 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 p -67.18 140.16 57.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -111.76 149.02 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -169.98 141.2 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CD1' HD13 ' A' ' 130' ' ' LEU . 10.1 mm -75.26 131.51 78.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.602 0.715 . . . . 0.0 111.17 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.31 24.85 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' CD2' HD12 ' A' ' 127' ' ' ILE . 32.8 m80 -100.46 116.74 33.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.41 120.54 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.147 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 61.82 43.73 9.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 58.11 42.16 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -170.25 133.19 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.538 HD12 ' CD2' ' A' ' 122' ' ' HIS . 17.0 mm -46.99 148.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' A' ' 120' ' ' ILE . 9.4 tp -116.86 111.41 19.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.8 106.31 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 120' ' ' ILE . 64.8 mt -60.36 -50.63 72.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 54.3 t80 -44.38 -56.5 4.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -63.2 -56.03 20.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.464 ' CD2' HG23 ' A' ' 171' ' ' ILE . 6.6 tp -40.79 -70.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -43.54 -48.39 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -50.53 -50.43 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.11 -38.15 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.4 t -58.53 -59.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.54 60.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -60.77 -37.24 81.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -79.49 -13.4 59.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.425 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 151.55 -62.71 0.39 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 162.17 169.22 25.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -61.25 -37.05 81.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.72 -66.34 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 2.5 p -43.15 -30.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 150' ' ' ARG . 20.2 t -80.43 -50.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.5 p -57.78 -38.43 75.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -78.01 -28.27 49.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.16 2.2 45.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmm180 53.69 31.04 12.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -83.53 43.11 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.532 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 11.1 m95 -86.4 -44.97 11.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 m -47.85 -49.62 28.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -49.15 -55.36 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 14.9 mt -57.34 -60.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.64 -48.13 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -50.76 -43.7 58.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.9 mtp -58.31 -21.0 47.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.68 2.11 24.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -78.97 177.46 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.88 142.91 34.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.595 0.712 . . . . 0.0 111.095 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 122.98 9.64 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.39 -166.63 32.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -104.7 -20.87 13.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.72 -59.1 4.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 168' ' ' GLY . 7.1 p -61.79 -30.75 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.448 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -58.63 -49.29 78.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.8 m -75.43 -27.38 58.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.6 m-70 -58.22 -54.22 49.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.532 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 5.4 mm -37.97 -64.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -52.04 -50.61 61.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -52.55 -44.38 59.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.75 -31.53 70.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -84.17 -22.87 30.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -90.63 -10.77 42.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.15 -25.21 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.7 mt -119.35 -52.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.26 28.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.499 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.26 -62.73 0.79 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.67 0.748 . . . . 0.0 110.905 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.76 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.508 ' CD1' HD11 ' A' ' 107' ' ' ILE . 7.3 t80 -40.56 -44.22 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 175' ' ' TYR . 8.3 m120 -72.06 -43.38 64.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.3 mt -56.78 -54.96 40.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.46 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 182' ' ' TYR . 34.5 mt -50.11 -48.11 53.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.795 0.331 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.6 -40.08 94.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.95 -26.29 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 50.8 mtpt -80.05 -37.49 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.7 -44.85 69.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -39.32 -58.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.85 -62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 37.4 mt -42.15 -37.75 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.49 -54.84 30.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -57.03 -54.55 45.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 7.9 tt -60.91 -35.27 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.81 91.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -56.66 -29.09 61.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 181' ' ' PRO . 42.2 t80 -71.22 -32.83 69.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.531 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 56.7 m95 -85.26 -53.24 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -42.44 -39.42 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -62.09 -47.74 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -60.45 -39.74 88.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.36 35.49 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.438 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.5 m -141.26 119.29 11.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 110.885 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.6 m -62.78 128.7 37.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.419 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 6.0 tt -78.11 128.55 33.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -126.17 142.24 51.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -84.17 130.43 54.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.68 0.753 . . . . 0.0 111.109 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 159.21 54.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -119.1 118.08 30.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' LYS . 90.2 t -110.67 143.95 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' VAL . 77.0 mm-40 37.79 42.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? 59.06 42.81 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 123' ' ' VAL . 40.7 mttm -147.96 141.87 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.76 100.66 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.31 94.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.33 100.67 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.28 -52.32 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 4.2 t80 -41.92 -59.14 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.4 tp60 -67.51 -54.05 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.448 ' CD1' ' CG2' ' A' ' 171' ' ' ILE . 9.9 tp -37.93 -72.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 134' ' ' ASN . 3.3 t-20 -48.61 -47.08 40.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -47.73 -48.12 29.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.474 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 90.7 t -53.23 -48.85 54.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.05 85.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.81 -36.94 80.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.71 -18.89 50.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.438 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 158.34 -59.04 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.71 173.86 24.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.787 ' CZ ' ' CD1' ' A' ' 175' ' ' TYR . 48.0 t80 -64.63 -37.26 86.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.62 -66.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG11 ' C ' ' A' ' 141' ' ' GLY . 4.7 p -45.99 -44.85 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.54 -68.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 51.7 t -42.26 -45.72 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -57.67 -55.43 34.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.452 ' CB ' ' HG3' ' A' ' 151' ' ' LYS . 17.3 m-20 -84.46 24.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 149' ' ' ASP . 29.2 mmt180 34.38 37.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 25.2 mtpp -79.74 44.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.683 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 10.3 m95 -90.04 -49.76 6.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.9 m -37.0 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -57.61 -69.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.433 HD13 ' CE3' ' A' ' 152' ' ' TRP . 26.2 mt -45.43 -58.75 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.82 -56.23 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.3 m -51.31 -50.07 60.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -55.83 -27.86 53.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.0 mmm -79.69 12.23 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.75 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -65.07 171.61 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.94 144.09 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 86.7 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.82 -158.78 7.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -103.71 -39.46 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -48.26 -59.15 3.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.124 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 168' ' ' GLY . 13.0 p -63.89 -37.43 79.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -54.25 -58.38 13.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.1 m -65.19 -31.51 72.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 3.5 m-70 -52.73 -57.57 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.683 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 26.0 mm -41.69 -46.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.47 ' HB2' ' NE1' ' A' ' 152' ' ' TRP . 1.3 tmt_? -59.64 -51.27 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.62 -44.2 97.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.9 -22.64 10.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.787 ' CD1' ' CZ ' ' A' ' 143' ' ' PHE . 0.5 OUTLIER -91.46 -21.35 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -90.98 -11.41 39.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -105.01 -25.44 12.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 mt -119.82 -52.52 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.0 mt -83.21 19.11 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.55 -60.12 2.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.897 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.531 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.2 Cg_endo -69.8 -46.48 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.345 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.9 t80 -38.55 -56.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -75.18 -34.57 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.99 -28.23 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -88.28 -54.99 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.9 mt -44.37 -44.64 8.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.801 0.334 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -61.95 -44.0 97.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.441 ' CG1' ' HD2' ' A' ' 100' ' ' LYS . 9.7 p -52.1 -37.96 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.099 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HD2' ' CG1' ' A' ' 99' ' ' VAL . 1.4 mptt -71.72 -58.45 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.5 mt -50.67 -39.84 51.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.74 -63.69 0.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -51.33 -67.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 39.6 mt -38.21 -40.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.66 -53.06 61.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -56.68 -51.69 67.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.56 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.9 tt -59.63 -45.49 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -55.76 -48.2 75.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -40.6 -57.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -43.56 -48.94 7.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 35.8 m95 -66.6 -53.46 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -40.93 -51.23 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.02 -48.27 67.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -64.54 -37.66 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.65 37.99 1.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.8 p -131.8 141.2 49.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 m -85.76 134.45 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 4.5 tt -94.38 111.18 22.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -118.79 115.3 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.423 ' CD1' HD11 ' A' ' 130' ' ' LEU . 40.5 mm -62.72 129.7 93.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.63 0.729 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 157.32 60.72 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -98.85 120.85 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 55.3 46.47 23.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 56.52 32.54 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -141.91 134.26 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.68 99.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -66.36 104.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.35 116.74 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 120' ' ' ILE . 34.7 mt -66.94 -57.0 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.552 ' CE1' ' HG3' ' A' ' 135' ' ' LYS . 2.7 t80 -50.88 -54.57 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.69 -44.48 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 171' ' ' ILE . 13.7 tp -47.91 -72.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -50.21 -39.15 43.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.552 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -54.04 -55.04 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.432 ' CG2' HG21 ' A' ' 155' ' ' ILE . 69.6 t -53.52 -50.04 51.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.36 92.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.56 -42.09 98.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -67.57 -17.89 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.415 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 156.58 -56.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.48 166.59 12.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.45 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 143' ' ' PHE . 2.7 t80 -59.63 -42.48 92.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.11 -64.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG13 ' C ' ' A' ' 141' ' ' GLY . 2.3 p -48.64 -44.9 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 150' ' ' ARG . 28.9 t -63.8 -64.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 20.3 m -49.11 -36.64 19.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -66.35 -51.09 60.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -95.37 18.32 12.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 146' ' ' VAL . 13.5 mmt85 45.38 51.86 9.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -86.55 24.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.563 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -68.46 -40.04 81.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.5 m -54.73 -39.44 68.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' N ' ' HE3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -63.8 -33.6 76.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.48 ' N ' HD13 ' A' ' 155' ' ' ILE . 1.9 mm -73.37 -61.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -44.87 -51.95 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 m -59.98 -51.15 70.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -52.97 -45.08 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 32.4 mtp -58.41 -15.92 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.09 -7.62 27.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 171.24 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.1 31.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.593 0.711 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 109.65 2.38 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.4 -147.48 4.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -115.7 -37.0 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -59.48 -58.22 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 168' ' ' GLY . 8.2 p -57.96 -41.34 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.462 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -48.69 -52.65 19.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -77.85 -27.02 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 2.8 m-70 -53.47 -46.93 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.563 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 46.7 mm -46.3 -43.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -71.35 -63.25 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.51 -51.62 7.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -46.68 -40.44 13.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -67.33 -45.33 76.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -76.41 -9.34 58.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -97.25 -35.55 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.6 mt -119.87 -48.32 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 175' ' ' TYR . 10.8 mt -83.5 21.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.513 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -71.73 -60.24 2.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 53.7 Cg_endo -69.75 -50.68 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.709 2.273 . . . . 0.0 112.353 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 4.1 t80 -44.63 -52.71 7.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.19 -51.24 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -49.32 -44.18 44.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.61 -57.42 5.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.6 mt -38.28 -50.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.807 0.337 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -69.56 -34.51 74.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 131' ' ' PHE . 7.1 p -73.84 -33.78 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 40.5 mtmt -68.54 -52.42 32.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.47 -40.69 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -48.36 -52.35 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 104' ' ' LEU . 3.9 t80 -58.95 -61.3 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 103' ' ' PHE . 16.5 mt -49.37 -20.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.69 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.13 -31.91 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 182' ' ' TYR . 5.5 tt -81.59 -39.23 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.56 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -42.55 -58.01 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -38.89 -42.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 43.0 m95 -73.97 -49.1 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -42.75 -43.44 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -61.48 -47.54 85.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -64.9 -28.2 69.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.92 40.68 3.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -136.66 127.24 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 110.853 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.6 m -77.81 128.37 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 4.2 tt -89.92 108.0 19.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -106.09 128.23 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.6 mm -63.58 127.29 91.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 161.97 43.91 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.313 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -118.1 115.44 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.816 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.563 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 77.1 t -102.4 124.29 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 51.52 51.16 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 55.62 35.27 24.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -144.83 142.89 30.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.53 107.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.4 tp -71.55 114.77 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.74 89.06 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' PHE . 23.1 mt -44.28 -63.47 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CD2' ' HG2' ' A' ' 100' ' ' LYS . 17.0 t80 -34.91 -67.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.456 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 17.1 tt0 -53.97 -56.8 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.6 tp -43.93 -71.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -45.6 -57.46 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -41.56 -47.55 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.928 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -46.65 87.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -50.71 -46.79 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.16 95.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.6 -45.04 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -67.56 -18.16 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 155.28 -60.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.36 165.36 12.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.492 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -55.85 -35.12 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.884 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -66.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.418 HG12 ' C ' ' A' ' 141' ' ' GLY . 2.6 p -51.88 -37.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 150' ' ' ARG . 51.0 t -72.06 -64.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 9.8 t -52.24 -32.22 35.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -73.55 -49.42 26.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -91.54 15.22 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 45.81 55.03 7.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.16 36.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.509 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 42.4 m95 -84.69 -46.89 11.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.8 m -43.96 -54.57 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -48.58 -63.05 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ALA . 20.4 mt -54.27 -63.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.22 -47.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.6 m -62.75 -45.43 92.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -51.28 -51.12 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.2 mmm -50.08 -25.08 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.87 -8.14 10.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.563 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 26.0 m-85 -72.27 146.55 47.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.45 142.99 98.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 122.8 9.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.716 2.277 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.67 -134.89 1.78 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -127.81 -34.8 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.68 -58.65 7.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.17 -30.93 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -58.91 12.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -67.16 -25.97 66.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.2 m-70 -58.32 -59.54 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.509 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 24.8 mm -37.83 -63.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -52.21 -56.86 11.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.14 -52.99 9.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -49.27 -35.65 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -82.27 -22.72 35.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.67 -13.06 40.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -105.25 -22.79 12.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.7 mt -119.98 -52.61 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 175' ' ' TYR . 5.4 mp -87.01 25.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -76.5 -63.64 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -48.28 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.694 2.262 . . . . 0.0 112.356 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' A' ' 107' ' ' ILE . 6.1 t80 -40.12 -48.21 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.34 -34.2 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.0 tt -56.57 -40.66 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -84.8 -56.65 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.9 mt -40.61 -36.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.733 0.301 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -55.21 -46.31 75.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.54 -31.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 45.1 mtmt -73.41 -47.15 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -66.6 -44.08 83.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -42.7 -44.52 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -68.18 -44.74 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.465 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.9 mt -63.27 -26.94 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -76.91 -51.04 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -62.02 -32.82 73.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.8 tt -79.68 -42.43 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.83 -47.51 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -28.15 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -70.21 -30.39 67.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.509 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 79.0 m95 -87.07 -49.4 7.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -47.6 -21.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.57 -45.22 46.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -70.07 -37.98 75.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.97 36.49 1.23 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.455 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.4 t -137.9 111.26 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.789 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 p -58.05 147.12 30.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 111' ' ' TRP . 5.6 tt -98.07 108.03 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -96.34 132.82 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -87.06 121.02 71.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.62 0.724 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 149.73 67.43 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.94 111.59 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.42 124.95 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 51.43 44.79 28.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.3 30.37 19.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -139.33 150.23 45.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.1 mm -75.01 129.95 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.6 tp -91.59 107.97 19.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.79 82.44 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 131' ' ' PHE . 60.1 mt -40.05 -59.9 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CD2' ' HG2' ' A' ' 100' ' ' LYS . 31.1 t80 -34.91 -67.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 0.9 OUTLIER -58.81 -54.83 42.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.48 ' CD1' ' CG2' ' A' ' 171' ' ' ILE . 4.3 tp -35.47 -71.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -49.37 -53.81 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -40.06 -56.9 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.417 ' CD1' ' NE2' ' A' ' 132' ' ' GLN . 12.4 mt -54.6 -48.11 72.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -46.54 -49.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.07 86.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.48 -37.26 86.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -79.89 -14.35 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.446 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 153.18 -62.73 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 154.54 165.28 13.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 3.1 t80 -55.47 -38.83 69.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.6 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 141' ' ' GLY . 4.1 p -48.37 -46.0 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.05 -69.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 47.1 t -40.32 -42.45 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.32 -51.34 63.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' ARG . 12.3 m-20 -84.81 25.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 34.49 41.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -86.07 40.59 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.533 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 23.3 m95 -86.11 -46.91 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -38.88 -44.72 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -63.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.31 -57.87 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' CB ' HG21 ' A' ' 167' ' ' VAL . . . -45.45 -50.04 12.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 m -64.25 -37.9 89.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -65.35 -27.5 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 mtp -75.36 -3.24 32.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.81 54.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.73 166.85 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.93 144.62 79.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.558 0.694 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 85.73 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.729 2.286 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.38 169.76 26.3 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.03 -34.55 64.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.78 0.324 . . . . 0.0 110.882 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.66 -58.83 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 168' ' ' GLY . 12.7 p -67.06 -44.12 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -45.5 -48.89 11.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 m -75.49 -36.08 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.834 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.4 m-70 -49.18 -39.0 27.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.533 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 37.0 mm -57.33 -59.42 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -50.83 -61.19 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -44.91 -48.67 9.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 32.1 m-70 -50.55 -44.83 56.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -43.54 90.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -80.01 -9.03 59.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 173' ' ' GLY . 23.1 mmt180 -99.1 -30.37 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.36 -51.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.16 26.58 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.54 -60.05 2.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.892 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.509 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.74 -48.18 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -44.25 -41.41 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -71.28 -38.52 71.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 69.4 mt -57.57 -36.31 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.86 -41.72 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.2 mt -61.87 -32.62 73.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -66.04 -57.55 7.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 131' ' ' PHE . 1.5 p -65.76 -39.78 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -53.38 -54.78 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.66 -39.27 84.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -50.64 -50.71 53.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' A' ' 107' ' ' ILE . 52.3 t80 -60.01 -64.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.6 mt -41.17 -35.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -70.13 -57.99 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -55.13 -50.65 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.463 HD11 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 tt -63.73 -37.03 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.72 76.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -45.76 -56.07 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -39.58 -40.67 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -76.4 -50.66 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -41.87 -38.12 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 113' ' ' LEU . 10.4 mp -57.24 -44.45 83.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -73.72 -36.68 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 111.55 30.1 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -116.97 139.57 50.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 m -84.9 129.4 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.497 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.3 tt -93.62 119.5 32.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.451 ' N ' HD23 ' A' ' 118' ' ' LEU . 25.7 tptt -133.19 142.99 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.55 122.45 82.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -177.21 1.78 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.679 2.252 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.442 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 25.1 m80 -126.21 126.04 43.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.1 t -112.67 128.53 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.8 42.39 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 61.06 27.88 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -145.03 128.49 16.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.442 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 4.8 mm -40.92 146.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 16.3 tp -120.27 89.71 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -56.22 103.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' PHE . 81.3 mt -58.13 -63.09 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 5.7 t80 -37.79 -62.21 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -54.82 -59.15 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.425 ' CD1' HG21 ' A' ' 171' ' ' ILE . 13.7 tp -38.15 -72.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -47.28 -46.36 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -58.48 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.62 -42.42 62.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.49 -50.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.49 75.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.41 -41.76 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -72.69 -12.03 60.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 150.97 -59.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 146.88 176.11 20.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.21 -36.7 84.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.7 -66.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.068 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.75 -47.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 152' ' ' TRP . 72.9 t -60.14 -43.72 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.4 m -67.7 -33.46 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -70.97 -49.85 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.03 10.84 39.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmt85 46.41 52.25 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -81.92 40.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.598 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 72.6 m95 -87.04 -45.22 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.1 m -41.43 -49.21 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -56.81 -59.28 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 156' ' ' ALA . 14.2 mt -51.8 -72.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.15 -51.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.0 m -60.35 -41.98 94.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 155' ' ' ILE . 37.7 mttp -62.56 -22.65 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.4 mmm -81.67 7.31 12.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.19 -15.45 62.37 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -69.62 162.29 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -80.13 143.95 57.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.726 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 84.42 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.12 -138.63 4.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -124.21 -48.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.85 -57.56 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.127 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 168' ' ' GLY . 5.4 p -58.39 -39.17 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -52.0 -48.21 52.54 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.517 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.1 m -72.86 -32.04 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.443 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 6.4 m-70 -54.66 -53.9 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.598 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 45.0 mm -43.25 -51.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.519 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 28.3 mtm180 -56.91 -62.32 1.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -43.8 -51.87 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.467 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 96.6 m-70 -50.58 -41.38 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.3 OUTLIER -71.22 -45.74 62.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.61 -9.15 58.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 173' ' ' GLY . 38.1 mtm180 -105.12 -28.94 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.9 mt -116.43 -52.63 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.456 ' CD1' HD12 ' A' ' 107' ' ' ILE . 1.5 mm? -92.84 35.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.546 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -75.39 -62.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.859 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.82 -49.23 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.322 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -42.11 -55.83 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.46 -46.68 75.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt -51.67 -37.08 49.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.1 -54.09 12.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 42.3 mt -49.83 -36.47 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -57.78 -51.62 68.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.435 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 14.6 p -53.45 -24.99 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 47.6 mttp -81.01 -53.02 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.91 -44.92 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -39.0 -64.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -51.73 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.431 HD21 ' CD1' ' A' ' 120' ' ' ILE . 38.5 mt -39.72 -39.52 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.5 -53.87 50.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -54.26 -59.97 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.8 -45.36 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.93 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' TRP . 4.5 mmmm -55.97 -60.26 3.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -38.54 -26.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.527 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 88.7 m95 -87.97 -45.72 9.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 109' ' ' LYS . 5.6 pt-20 -49.61 -18.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -78.9 -35.34 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -81.25 -28.74 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.32 34.55 3.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 m -135.17 112.25 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.849 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -58.39 143.38 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 119' ' ' LYS . 2.0 tm? -105.92 157.87 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' N ' ' CD1' ' A' ' 118' ' ' LEU . 14.7 ttmm -171.99 155.51 3.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.431 ' CD1' HD21 ' A' ' 104' ' ' LEU . 28.6 mm -89.26 129.69 46.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.694 0.759 . . . . 0.0 111.121 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -179.29 2.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 39.4 m80 -119.77 129.28 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 161' ' ' PHE . 93.0 t -115.09 109.08 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 61.65 51.25 4.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 56.71 31.64 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -148.77 126.1 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 32.4 mm -48.16 145.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.6 tp -110.31 91.85 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.7 83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 mt -40.12 -57.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.49 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 23.9 t80 -39.72 -52.28 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 133' ' ' LEU . 32.0 tp60 -70.35 -58.36 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 132' ' ' GLN . 7.4 tp -35.68 -71.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -47.34 -57.44 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -42.09 -55.46 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.97 -45.09 60.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 64.8 t -52.82 -55.08 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.03 -41.04 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.94 -37.69 88.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.09 -27.5 63.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.511 ' C ' ' CG1' ' A' ' 145' ' ' VAL . . . 169.1 -52.0 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 131.41 150.45 6.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -41.7 -36.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.15 -66.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.511 ' CG1' ' C ' ' A' ' 141' ' ' GLY . 5.0 p -61.81 -54.99 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.199 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.407 ' H ' ' CG1' ' A' ' 145' ' ' VAL . 72.3 t -46.77 -57.93 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.1 t -57.62 -43.76 84.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -54.52 -53.73 50.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 150' ' ' ARG . 2.2 m-20 -90.02 18.39 5.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 149' ' ' ASP . 1.1 mpp_? 37.62 48.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -86.87 40.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.558 ' CZ3' HG23 ' A' ' 171' ' ' ILE . 34.1 m95 -81.21 -50.54 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.8 m -39.03 -50.73 1.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -50.72 -61.03 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 19.0 mt -49.14 -67.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' A' ' 167' ' ' VAL . . . -40.14 -49.73 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.4 m -63.17 -36.91 85.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.63 -22.04 65.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 75.5 mmm -83.67 5.3 25.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.55 -1.36 66.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 123' ' ' VAL . 5.4 m-85 -80.26 156.93 26.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.57 143.72 85.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.2 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.92 -168.58 11.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -97.73 -32.11 11.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 110.955 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.65 -59.09 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.455 HG22 ' CB ' ' A' ' 156' ' ' ALA . 11.6 p -59.19 -32.1 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -58.25 -43.54 95.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -82.22 -23.65 35.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.5 -47.27 84.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.558 HG23 ' CZ3' ' A' ' 152' ' ' TRP . 30.0 mm -43.62 -50.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -63.88 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.44 -45.3 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.44 -46.44 66.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -69.18 -23.71 63.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -90.28 -9.33 48.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -104.96 -28.58 11.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.1 -51.4 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.32 15.57 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.56 -58.85 4.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.723 . . . . 0.0 110.874 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.527 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 54.0 Cg_endo -69.72 -50.87 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.379 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -48.34 -49.61 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 185' ' ' PHE . 7.9 t-20 -65.5 -68.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.2 mp -39.06 -27.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 183' ' ' ASN . 82.1 t80 -82.08 -63.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.8 mt -43.81 -48.03 8.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.4 mtt-85 -64.69 -61.68 2.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.88 -35.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.562 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 46.3 mtpt -70.59 -53.73 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 mt -53.74 -39.16 65.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -46.36 -51.9 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.67 -65.76 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.5 mt -45.24 -24.94 0.31 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -82.69 -48.11 11.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -67.22 -26.0 66.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 6.0 tt -85.08 -42.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.19 -41.57 73.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -55.67 -28.49 55.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 3.7 t80 -69.8 -29.41 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.505 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 77.0 m95 -81.56 -49.52 10.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -44.28 -40.94 5.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.67 -40.05 68.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -76.58 -39.62 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.29 32.69 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 m -134.82 103.89 5.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 p -53.64 141.3 26.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 tt -86.32 125.43 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -118.94 125.06 48.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.02 129.44 61.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.722 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.34 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.42 ' NE2' ' CD1' ' A' ' 127' ' ' ILE . 26.3 m80 -120.61 114.51 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.8 t -100.12 119.11 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 56.35 51.13 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 52.64 35.59 18.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -150.28 140.4 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' ' NE2' ' A' ' 122' ' ' HIS . 15.9 mm -60.81 144.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.91 104.21 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.93 113.32 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.39 -61.06 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 100' ' ' LYS . 33.8 t80 -39.97 -55.32 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -66.87 -51.06 59.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.65 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -49.26 -46.35 46.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -49.52 -52.13 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.69 -49.05 74.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.2 t -47.35 -54.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.66 70.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -54.92 -39.28 68.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.99 -14.77 61.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 152.85 -61.92 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.484 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 160.04 173.51 28.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.475 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.94 -46.19 90.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.38 -66.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 5.7 p -44.32 -37.04 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 37.5 t -72.89 -49.34 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 148' ' ' LYS . 5.8 p -58.15 -45.87 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 147' ' ' CYS . 31.3 tttm -68.27 -33.4 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.54 4.45 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 146' ' ' VAL . 15.6 mmm180 47.12 37.88 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 19.3 mtpp -83.42 36.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.638 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 51.9 m95 -81.5 -44.21 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.1 m -43.39 -47.16 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -51.89 -61.63 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 151' ' ' LYS . 5.3 mp -55.73 -55.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.87 -53.61 2.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -47.4 86.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -45.19 -49.23 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -60.78 -25.81 66.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.97 -2.93 14.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -74.54 138.61 43.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.27 144.14 16.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.545 0.688 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 85.03 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.353 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.22 169.13 24.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.489 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -74.6 -38.28 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.73 -59.11 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 168' ' ' GLY . 7.4 p -61.32 -37.25 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.47 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -53.4 -49.33 57.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.4 t -73.67 -31.11 63.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.442 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.7 m-70 -54.7 -47.23 73.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.638 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 20.7 mm -46.2 -49.75 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.574 ' NH2' ' CD1' ' A' ' 152' ' ' TRP . 16.9 ttm105 -61.86 -61.66 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.31 -46.56 11.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 80.1 m-70 -49.34 -43.26 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.0 t80 -68.01 -41.45 82.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.65 -9.26 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -100.13 -32.12 11.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.0 mt -119.75 -49.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.169 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 11.8 mt -82.52 18.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.08 -60.24 2.93 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.739 . . . . 0.0 110.885 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.505 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.9 Cg_endo -69.75 -47.54 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -49.41 -49.41 45.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -80.69 -38.0 29.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 14.9 tp -55.62 -26.23 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.12 -51.89 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.3 mt -45.37 -53.72 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 102' ' ' ASN . 5.0 tpt85 -66.59 -57.68 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.29 -22.99 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -77.88 -60.66 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.75 -34.8 78.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 30.9 m-20 -44.22 -58.26 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -55.21 -59.97 4.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -42.5 -43.11 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.86 -40.54 95.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -64.9 -51.38 62.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.505 ' CD1' ' CG ' ' A' ' 182' ' ' TYR . 2.1 tp -61.46 -37.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.12 88.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -53.06 -36.63 60.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.13 -37.35 87.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -80.17 -59.87 2.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -38.99 -40.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -59.12 -53.03 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -61.36 -35.37 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.84 39.87 1.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -136.21 123.08 21.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.1 m -70.41 129.45 39.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.39 125.22 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -121.81 125.37 46.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -70.9 131.65 87.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.162 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 158.69 56.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -115.69 126.37 54.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.18 112.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 57.8 49.91 11.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 125' ' ' ARG . 26.2 mtm105 54.48 35.97 24.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.82 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -145.32 125.11 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.24 127.43 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.092 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.1 115.04 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.51 102.63 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.49 -51.94 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -43.53 -53.27 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 133' ' ' LEU . 43.3 tt0 -70.4 -60.51 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 171' ' ' ILE . 13.3 tp -35.19 -69.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -47.93 -47.61 32.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 139' ' ' GLU . 22.8 tptt -47.67 -54.21 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.28 -40.87 74.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -53.27 -47.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.77 81.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 2.3 mp0 -66.59 -38.02 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -75.19 -21.41 58.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 159.34 -58.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 152.55 169.63 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.503 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -61.03 -39.09 88.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.69 -66.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.429 HG12 ' C ' ' A' ' 141' ' ' GLY . 5.0 p -48.05 -42.99 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 54.5 t -65.03 -70.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.3 t -44.61 -50.04 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -48.87 -55.41 11.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.81 14.78 5.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 42.85 54.34 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -98.25 41.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.566 ' CZ3' HG22 ' A' ' 171' ' ' ILE . 22.6 m95 -79.75 -40.84 27.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -46.35 -56.51 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -45.07 -53.34 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' ALA . 19.9 mt -64.09 -62.8 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -38.09 -49.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 m -63.27 -47.75 81.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -48.35 -41.15 27.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.4 mtp -67.45 -28.52 67.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -2.06 10.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -80.52 129.64 34.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -44.58 143.04 2.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.558 0.694 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.11 137.04 5.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -44.61 -26.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.23 -59.11 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 168' ' ' GLY . 10.8 p -67.82 -36.35 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -55.51 -44.95 85.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.445 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -78.64 -32.37 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -53.18 -50.57 64.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.566 HG22 ' CZ3' ' A' ' 152' ' ' TRP . 21.8 mm -40.31 -61.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -54.39 -54.96 33.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -47.9 -47.0 25.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -51.21 -42.89 61.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.5 t80 -68.08 -40.75 82.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -78.04 -9.24 59.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -103.7 -28.18 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mt -120.11 -52.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 8.4 mt -88.58 28.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.58 -60.37 2.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.668 0.747 . . . . 0.0 110.864 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.3 Cg_endo -69.66 -48.12 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.676 2.251 . . . . 0.0 112.383 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CG ' ' CD1' ' A' ' 107' ' ' ILE . 6.3 t80 -39.25 -46.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.38 -51.78 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 83.8 mt -45.35 -37.47 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.32 -55.31 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.2 mt -47.32 -46.51 25.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.466 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 42.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.781 0.324 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -67.47 -45.59 75.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 100' ' ' LYS . 11.5 p -65.63 -24.98 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' CE ' ' HA ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.46 -41.77 21.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.18 -44.52 88.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -43.83 -60.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 106' ' ' GLN . 45.9 t80 -61.17 -63.64 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 98.7 mt -38.4 -32.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 103' ' ' PHE . 7.5 t70 -77.63 -46.35 22.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 103' ' ' PHE . 91.9 mt-30 -64.17 -23.52 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 182' ' ' TYR . 2.2 tp -92.02 -36.6 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.07 62.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 13.6 ptmt -57.76 -43.67 85.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 33.1 t80 -55.41 -28.19 52.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.556 ' CD1' HD13 ' A' ' 118' ' ' LEU . 68.5 m95 -81.08 -48.81 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.97 -57.09 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -47.36 -36.37 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -73.62 -32.92 64.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.63 34.46 3.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.3 t -139.02 123.24 18.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 110.865 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -68.85 148.95 49.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 111' ' ' TRP . 6.8 tt -105.79 143.75 33.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' N ' HD21 ' A' ' 118' ' ' LEU . 24.3 ttmt -156.42 120.46 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.41 HD12 ' CD1' ' A' ' 130' ' ' LEU . 34.6 mm -84.18 131.94 49.34 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG2' ' CE1' ' A' ' 174' ' ' HIS . 53.3 Cg_endo -69.84 153.77 68.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 0.0 112.294 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -86.36 109.68 19.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.9 t -96.69 123.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 49.6 53.75 12.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 54.8 27.85 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -154.38 123.85 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.15 127.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.433 HD21 ' CD2' ' A' ' 133' ' ' LEU . 10.7 tp -82.35 107.76 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.72 117.2 17.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.41 ' CD1' HD12 ' A' ' 120' ' ' ILE . 17.5 mt -65.16 -49.59 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CD2' ' HG3' ' A' ' 100' ' ' LYS . 35.7 t80 -42.62 -57.34 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -72.99 -48.14 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CD2' HD21 ' A' ' 128' ' ' LEU . 32.0 tp -44.43 -71.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' VAL . 57.5 t-20 -47.99 -66.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 134' ' ' ASN . 35.9 tttp -35.65 -54.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.51 -41.67 63.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 134' ' ' ASN . 94.6 t -58.07 -48.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.3 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -73.69 -35.11 65.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -77.92 -16.64 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 159.75 -57.53 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.31 175.81 22.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.79 -33.17 73.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.78 -65.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.409 HG12 ' C ' ' A' ' 141' ' ' GLY . 2.1 p -48.05 -42.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 150' ' ' ARG . 67.5 t -70.51 -67.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 48.6 t -45.51 -34.2 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -77.02 -49.23 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 150' ' ' ARG . 37.6 m-20 -89.22 21.18 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 149' ' ' ASP . 2.5 mmp_? 35.72 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -89.37 17.4 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.519 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 62.6 m95 -63.69 -45.99 87.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.2 m -41.69 -58.49 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -47.54 -58.43 4.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.8 mt -51.2 -66.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.1 m -54.9 -46.37 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -60.57 -26.8 67.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 82.1 mmm -78.56 2.19 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.99 63.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.15 166.71 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.12 145.16 52.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.602 0.715 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 85.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.98 -176.54 14.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.37 -25.26 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.778 0.323 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.17 -58.39 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.1 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.5 -38.65 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.82 -41.61 76.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.4 t -79.22 -29.57 42.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -57.99 -47.68 82.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.519 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 6.3 mm -45.05 -55.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -59.29 -63.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.92 -47.69 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.418 ' CE1' ' HG2' ' A' ' 121' ' ' PRO . 57.7 m-70 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -66.76 -30.85 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -85.04 -9.23 58.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -101.7 -31.31 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.09 -51.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 175' ' ' TYR . 16.4 mt -83.12 20.03 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.83 -60.26 2.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.82 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.551 ' CE2' HD12 ' A' ' 186' ' ' LEU . 10.0 t80 -40.05 -51.1 2.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.02 -41.29 95.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.4 -43.95 79.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -71.31 -59.19 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.551 HD12 ' CE2' ' A' ' 182' ' ' TYR . 67.7 mt -38.4 -49.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.743 0.306 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -67.05 -62.41 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.38 -35.38 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 62.6 mttm -71.26 -61.28 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.08 -40.46 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -51.76 -53.52 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -57.98 -65.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 44.2 mt -44.47 -35.38 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.67 -52.82 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -56.73 -52.59 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 3.8 tt -63.23 -32.14 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.43 93.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 111' ' ' TRP . 3.0 mmmm -54.46 -58.62 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -38.79 -25.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 109' ' ' LYS . 63.5 m95 -90.86 -51.11 5.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.63 -20.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' N ' HD21 ' A' ' 113' ' ' LEU . 1.5 mm? -79.17 -46.62 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -69.21 -1.66 8.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.12 43.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.7 p -128.98 129.04 44.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 110.802 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.4 114.74 25.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.13 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 tt -50.31 137.12 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.65 115.14 61.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 165.66 30.19 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 12.0 m170 -117.66 132.5 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.09 124.99 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.177 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 59.72 39.25 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.41 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 6.7 mmp_? 63.38 35.17 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -145.32 162.93 36.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.54 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 44.7 mm -82.69 102.99 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' A' ' 174' ' ' HIS . 47.2 tp -66.8 93.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.47 106.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.9 -46.43 90.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 131' ' ' PHE . 4.3 t80 -53.5 -56.12 19.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.19 -41.27 94.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 HD13 ' CG2' ' A' ' 171' ' ' ILE . 4.1 tp -49.63 -72.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -51.63 -32.23 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -62.07 -50.79 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 136' ' ' LEU . 3.6 mm? -59.2 -41.6 88.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.18 -55.51 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -54.04 -41.59 68.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.55 -40.99 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.45 -17.06 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 157.1 -59.09 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 144.18 170.33 13.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.472 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.58 -36.68 72.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -65.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 141' ' ' GLY . 4.0 p -56.62 -54.92 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 85.2 t -51.4 -62.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.3 t -53.92 -40.86 67.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.2 tptp -53.88 -48.92 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.32 11.87 37.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 49.4 44.9 23.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -84.98 50.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.551 ' CZ3' HG22 ' A' ' 171' ' ' ILE . 81.4 m95 -86.85 -51.23 6.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.0 m -39.4 -67.36 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -37.74 -53.94 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' ALA . 23.3 mt -58.78 -65.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.72 -46.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 m -68.08 -45.35 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -57.14 -29.44 63.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mmm -70.3 -17.22 63.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.65 1.71 11.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -90.02 172.38 8.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.21 145.92 43.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 88.46 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.266 . . . . 0.0 112.366 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.98 131.08 4.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -42.74 -25.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.26 -59.18 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 168' ' ' GLY . 12.5 p -64.85 -32.99 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -54.5 -48.3 65.68 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -77.05 -32.4 56.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -51.71 -51.07 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.551 HG22 ' CZ3' ' A' ' 152' ' ' TRP . 50.4 mm -42.16 -62.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -51.88 -53.43 40.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.41 -42.69 34.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.54 ' CD2' HD23 ' A' ' 128' ' ' LEU . 93.1 m-70 -60.52 -36.9 79.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 110.84 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.463 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.2 t80 -78.82 -30.2 45.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.56 -9.25 56.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 177' ' ' ARG . 13.3 mtp-105 -104.82 -28.43 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.98 -52.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 28.8 mt -85.2 21.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -71.65 -60.08 2.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 0.0 110.881 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.73 -49.65 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.383 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.5 t80 -45.07 -54.12 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -77.21 -37.93 52.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 40.9 tp -62.14 -19.59 63.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -98.0 -50.59 4.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -48.34 -45.12 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 12.9 ttp-105 -45.74 -59.09 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.41 -34.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HA ' ' CE2' ' A' ' 131' ' ' PHE . 53.1 mtpt -82.86 -58.82 2.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.0 mt -45.56 -36.98 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -50.5 -57.44 8.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 6.2 t80 -58.27 -58.91 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.9 mt -46.71 -37.95 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.32 -57.5 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -48.32 -56.0 9.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.555 HD12 ' CD1' ' A' ' 182' ' ' TYR . 1.7 tp -55.59 -40.1 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.18 91.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.01 -36.81 30.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -63.4 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.46 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 27.0 m95 -83.34 -59.24 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -38.31 -36.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.462 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 33.4 mt -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.47 -36.36 82.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.86 39.94 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -132.7 118.08 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.8 m -64.88 129.62 40.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 118' ' ' LEU . 6.8 tt -79.97 122.15 26.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -116.15 141.66 47.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 mm -85.52 127.38 63.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.621 0.724 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 168.01 22.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.362 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -127.61 125.49 40.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 56.0 t -113.41 131.78 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 51.06 37.61 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? 64.16 54.5 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -164.37 164.02 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -73.45 127.56 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.02 98.69 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 129' ' ' ASP . 43.0 t0 -70.8 117.12 11.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.4 mt -72.36 -63.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' HA ' ' A' ' 100' ' ' LYS . 16.2 t80 -38.68 -61.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -57.46 -58.42 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tp -41.23 -67.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -50.59 -49.28 56.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -46.17 -54.35 8.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.64 -43.3 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 64.6 t -51.17 -48.81 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.48 91.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.26 -41.14 88.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.01 -22.35 58.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.438 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 161.63 -57.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 146.15 177.47 20.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.45 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 11.1 t80 -66.61 -36.63 83.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.61 -66.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG12 ' C ' ' A' ' 141' ' ' GLY . 4.2 p -50.6 -51.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 98.4 t -59.04 -68.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 35.5 t -44.73 -38.09 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -66.59 -45.42 79.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.2 m-20 -93.34 24.07 4.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 149' ' ' ASP . 3.0 mpt_? 35.02 45.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -93.36 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.555 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 30.6 m95 -84.8 -48.67 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 152' ' ' TRP . 38.7 m -37.04 -53.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -46.43 -68.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 156' ' ' ALA . 24.0 mt -45.31 -65.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.91 -50.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.8 m -54.3 -53.31 55.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -47.47 -49.57 25.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.4 mmm -50.12 -28.15 6.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.24 -4.04 10.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 36.7 m-85 -81.07 167.69 19.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 143.29 60.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 104.49 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.62 -159.48 9.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -101.0 -36.85 8.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.321 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -52.82 -58.48 6.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.52 -36.97 78.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.6 90.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 t -77.22 -28.76 53.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -58.34 -50.77 72.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.555 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 50.6 mm -40.4 -60.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -56.51 -53.58 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.38 -43.27 34.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -55.85 -39.86 72.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 2.6 t80 -67.77 -39.17 84.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -80.96 -9.21 59.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -97.2 -33.35 11.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.01 -51.39 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 175' ' ' TYR . 12.6 mt -84.53 28.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.53 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -72.28 -60.4 2.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.875 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.75 -33.7 16.1 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.369 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.555 ' CD1' HD12 ' A' ' 107' ' ' ILE . 4.4 t80 -47.89 -60.91 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -72.4 -34.85 68.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.08 -48.8 70.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -73.67 -58.55 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.7 mt -41.83 -43.56 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.959 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -69.6 -42.28 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.444 HG21 ' CZ ' ' A' ' 131' ' ' PHE . 7.2 p -62.2 -34.41 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.88 -53.55 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.1 mt -60.36 -46.01 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -46.64 -59.47 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 104' ' ' LEU . 71.7 t80 -49.25 -68.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 70.7 mt -37.03 -37.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.37 -57.92 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -52.29 -51.46 58.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.446 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.7 tt -58.05 -36.78 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.85 -50.99 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -47.71 -38.77 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -58.57 -38.58 78.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -82.06 -53.49 6.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -41.58 -50.13 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.33 -44.31 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -73.31 -36.81 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.18 40.71 0.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.9 m -131.88 126.68 34.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -74.51 128.28 35.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.426 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 4.1 tt -91.22 118.32 30.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -128.59 136.84 51.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mm -67.47 124.5 89.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 111.108 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.547 ' HB2' ' CE1' ' A' ' 174' ' ' HIS . 53.9 Cg_endo -69.76 167.17 25.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.696 2.264 . . . . 0.0 112.311 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -123.89 119.92 31.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.67 136.51 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 45.17 39.84 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 61.48 44.82 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -155.04 142.33 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.06 118.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 174' ' ' HIS . 22.1 tp -94.8 103.9 15.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.938 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.1 104.03 5.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.9 mt -64.67 -46.64 81.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 58.6 t80 -48.12 -61.06 2.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.456 ' O ' ' CG ' ' A' ' 136' ' ' LEU . 7.1 mm100 -65.7 -39.5 91.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.6 tp -52.66 -71.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -53.57 -62.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -42.31 -50.81 4.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.456 ' CG ' ' O ' ' A' ' 132' ' ' GLN . 24.8 mt -56.1 -42.87 77.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.8 -48.04 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.73 75.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.9 -44.9 94.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.35 -27.57 67.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.439 ' C ' ' CG1' ' A' ' 145' ' ' VAL . . . 165.65 -54.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.49 163.48 9.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -57.17 -29.29 63.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.34 -66.3 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.069 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.439 ' CG1' ' C ' ' A' ' 141' ' ' GLY . 3.6 p -55.01 -39.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.04 -56.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.0 t -56.29 -41.95 76.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -55.61 -49.77 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.34 4.12 53.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.73 40.43 31.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -89.38 46.79 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.554 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 72.6 m95 -89.08 -41.65 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.4 m -42.9 -52.72 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -54.01 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.4 mt -60.35 -60.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -43.72 -47.6 7.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.6 m -62.51 -46.21 89.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -51.78 -52.77 46.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 30.5 mtp -46.6 -28.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.33 -3.99 10.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.481 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.36 172.03 13.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.08 142.09 51.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 90.02 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.324 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.01 178.97 21.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -83.0 -32.38 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.58 55.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.9 p -63.59 -38.57 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.438 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -53.33 -45.96 64.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.1 m -75.43 -32.87 60.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -56.25 -49.71 73.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.554 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 9.7 mm -44.23 -55.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.8 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.53 -56.69 9.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 25.3 m-70 -49.32 -35.6 18.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.6 OUTLIER -75.99 -44.54 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.0 -9.9 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -105.27 -28.62 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.4 mt -116.72 -52.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.45 33.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.507 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.63 -63.88 0.52 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.39 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.7 t80 -37.74 -36.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -82.55 -53.8 5.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -55.7 -20.36 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -90.6 -52.08 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 182' ' ' TYR . 27.4 mt -47.98 -46.03 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.745 0.307 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -71.26 -59.01 3.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.54 HG21 ' CE2' ' A' ' 131' ' ' PHE . 7.6 p -56.87 -39.07 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 31.0 mttm -65.56 -54.37 28.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.47 -56.75 18.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.963 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -38.42 -58.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 12.1 t80 -50.17 -57.36 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 41.0 mt -52.18 -27.98 16.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.2 -53.71 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -56.32 -49.87 73.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.45 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 4.8 tt -57.49 -42.07 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.72 82.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -48.87 -37.36 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.528 ' OH ' ' CE1' ' A' ' 185' ' ' PHE . 5.6 m-85 -59.18 -43.98 92.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.426 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 73.2 m95 -68.97 -51.7 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -42.09 -50.3 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.3 mt -47.96 -42.0 26.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.92 -36.21 64.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.3 30.05 2.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.44 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.3 m -128.83 138.07 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.811 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -86.96 132.85 33.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.31 118.75 25.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -112.54 125.0 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.79 119.61 75.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 154.47 67.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.471 ' CE1' HD11 ' A' ' 127' ' ' ILE . 5.5 m170 -111.2 123.36 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.59 121.47 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.07 48.57 6.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 126' ' ' LYS . 12.1 mpt_? 54.14 46.8 24.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 125' ' ' ARG . 34.8 mtmm -164.52 142.18 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.471 HD11 ' CE1' ' A' ' 122' ' ' HIS . 21.0 mm -56.88 144.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.431 ' N ' HG23 ' A' ' 127' ' ' ILE . 20.1 tp -109.07 120.09 41.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.43 95.37 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 131' ' ' PHE . 55.9 mt -57.3 -63.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 99' ' ' VAL . 10.5 t80 -34.76 -58.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 133' ' ' LEU . 10.8 tp60 -62.41 -62.61 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 171' ' ' ILE . 7.9 tp -35.08 -66.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -45.86 -56.22 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.45 -52.51 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.28 -41.97 66.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.14 -45.89 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.73 -34.99 79.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -68.01 -31.59 71.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -82.93 -16.1 48.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 155.15 -60.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 153.43 172.76 21.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.72 -40.42 95.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.16 -66.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.432 HG12 ' C ' ' A' ' 141' ' ' GLY . 5.2 p -48.61 -43.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 44.8 t -62.83 -62.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 8.7 m -49.89 -46.02 51.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 148' ' ' LYS . 4.7 tmtt? -53.5 -60.15 3.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 150' ' ' ARG . 18.1 m-20 -84.47 25.87 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 149' ' ' ASP . 21.2 mmt180 34.49 38.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.403 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 41.1 mtpt -76.9 47.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.541 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 13.6 m95 -91.03 -48.73 6.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.5 m -39.07 -51.25 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -48.55 -64.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LYS . 18.8 mt -52.92 -62.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.43 -49.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.6 m -65.23 -38.67 91.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 155' ' ' ILE . 24.3 mmtt -53.64 -47.14 70.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.0 mtp -65.13 -19.97 66.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.44 3.56 25.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.455 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CB ' HG23 ' A' ' 167' ' ' VAL . 27.8 m-85 -83.56 128.17 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -47.4 143.87 5.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.545 0.688 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.08 4.86 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 171.35 41.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -79.17 -14.66 58.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.21 -56.84 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 168' ' ' GLY . 7.5 p -64.69 -37.34 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.463 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -55.98 -46.73 83.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.9 t -76.0 -28.31 57.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -58.33 -49.21 77.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.541 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 5.7 mm -44.5 -60.09 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -57.05 -55.9 28.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.41 -44.87 16.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -49.14 -46.73 45.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -38.54 91.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -80.56 -9.18 59.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -99.91 -31.73 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.0 mt -119.74 -50.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.66 22.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -72.48 -60.62 2.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -48.03 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.99 -44.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.01 -58.07 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -42.09 -35.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.528 ' CE1' ' OH ' ' A' ' 110' ' ' TYR . 12.1 t80 -73.2 -49.5 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.1 mt -56.65 -35.68 68.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.832 0.349 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -41.35 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.422 HG23 ' CZ ' ' A' ' 131' ' ' PHE . 8.4 p -64.54 -30.56 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -79.0 -51.51 9.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.89 -47.75 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -42.78 -53.2 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -51.84 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.0 mt -42.75 -36.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.59 -59.19 3.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -52.87 -54.14 38.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.1 -33.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.55 -54.37 47.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.466 ' N ' ' HE2' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -42.84 -54.85 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -42.76 -38.12 2.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.537 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 66.7 m95 -83.56 -47.82 10.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -46.52 -44.38 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.82 -42.59 89.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -68.43 -37.67 80.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.8 40.46 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.9 p -142.8 106.15 4.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.912 0.387 . . . . 0.0 110.818 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.7 p -50.58 147.11 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.51 111.95 24.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -110.03 140.6 43.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.91 131.89 45.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.163 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 170.97 15.33 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -127.62 111.13 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.6 t -104.47 123.55 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 60.74 41.86 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 57.64 40.89 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -153.69 149.31 27.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.38 135.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.0 tp -103.47 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.91 97.71 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' PHE . 51.7 mt -55.43 -62.84 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' LEU . 88.7 t80 -34.79 -54.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 133' ' ' LEU . 4.7 tp60 -64.94 -62.91 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 132' ' ' GLN . 14.4 tp -34.39 -69.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -50.33 -51.27 46.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -46.27 -51.55 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.01 -50.17 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.5 t -47.64 -50.7 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.26 -45.86 83.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.55 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -76.56 -22.7 53.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 159.2 -58.55 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 151.93 170.76 18.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.518 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -60.52 -40.79 92.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.89 -66.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 141' ' ' GLY . 5.3 p -49.13 -43.37 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 69.2 t -67.62 -66.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 52.7 t -44.57 -48.1 10.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -56.79 -57.82 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.99 19.56 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 38.86 48.67 1.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -84.51 38.49 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.559 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 80.7 m95 -84.01 -44.97 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -41.28 -50.71 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -49.38 -55.15 13.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' ALA . 4.6 mp -60.3 -64.49 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.48 -49.97 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.4 m -61.41 -47.55 85.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -50.09 -41.88 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 31.6 mtp -68.15 -28.0 66.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -1.67 10.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.468 ' CB ' HG23 ' A' ' 167' ' ' VAL . 19.6 m-85 -81.37 128.02 33.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -46.4 141.61 4.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.56 0.695 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.39 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 0.0 112.37 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.17 132.32 5.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -37.36 -33.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -53.2 -58.75 5.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.468 HG23 ' CB ' ' A' ' 161' ' ' PHE . 8.6 p -64.77 -32.57 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.461 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -56.24 -45.0 89.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.9 m -77.49 -35.3 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -51.89 -48.09 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.559 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 5.0 mm -45.89 -55.72 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' C ' ' OE1' ' A' ' 176' ' ' GLU . 41.2 mtp180 -55.38 -57.88 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.81 -42.29 7.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -59.6 -39.95 85.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -72.2 -39.12 68.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.408 ' OE1' ' C ' ' A' ' 172' ' ' ARG . 10.1 mp0 -81.89 -9.24 59.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.76 -30.84 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.98 -50.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.2 mt -84.04 23.36 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.485 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.61 -60.34 2.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.537 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.8 Cg_endo -69.74 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.28 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.535 ' CD2' HD13 ' A' ' 186' ' ' LEU . 5.8 t80 -42.08 -54.4 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -77.25 -42.16 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.1 tp -55.28 -27.01 43.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -97.1 -54.16 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 182' ' ' TYR . 28.0 mt -41.95 -44.36 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.6 m -88.84 100.34 13.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 t -116.21 114.23 24.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.76 59.75 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.474 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 83.1 p -109.92 161.61 15.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 0.0 110.847 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.8 t -171.35 144.75 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.29 42.01 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.81 155.83 15.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 149.59 45.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -128.96 -58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -82.25 -36.43 27.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -70.71 -50.39 36.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -44.67 -35.98 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -80.28 -46.97 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.3 mt -55.0 -39.15 68.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -44.74 -65.59 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 74.1 t80 -49.66 -68.04 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.426 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 72.5 mt -37.05 -52.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CD ' ' A' ' 109' ' ' LYS . 22.1 t70 -49.77 -53.41 25.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -56.1 -59.64 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.426 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.0 tt -57.06 -25.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.2 -41.82 60.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -56.3 -34.08 66.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.37 -31.12 72.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' LEU . 14.5 m95 -88.13 -54.3 4.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -26.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 111' ' ' TRP . 54.7 mt -69.81 -48.82 57.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.443 ' OE1' ' C ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -68.08 -36.71 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 115.41 33.45 1.6 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -120.05 145.33 46.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.846 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 m -89.31 128.84 35.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.2 120.31 27.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -142.33 124.29 15.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CG2' ' HD2' ' A' ' 121' ' ' PRO . 21.0 mm -81.1 138.46 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 120' ' ' ILE . 53.9 Cg_endo -69.77 179.48 3.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.562 ' CD2' HD13 ' A' ' 127' ' ' ILE . 56.9 m80 -115.8 107.02 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.562 HG12 ' CE1' ' A' ' 161' ' ' PHE . 53.3 t -93.14 110.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 57.65 48.29 14.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 60.21 31.59 20.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -148.42 123.36 10.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.562 HD13 ' CD2' ' A' ' 122' ' ' HIS . 19.9 mm -54.75 131.68 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.437 ' CD2' ' CD2' ' A' ' 174' ' ' HIS . 58.8 tp -92.39 103.62 16.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.14 91.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.46 ' CD1' HD13 ' A' ' 120' ' ' ILE . 64.4 mt -43.17 -59.5 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' LEU . 45.9 t80 -35.31 -69.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 133' ' ' LEU . 40.8 mt-30 -54.89 -57.27 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 171' ' ' ILE . 16.6 tp -34.09 -71.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -51.2 -45.91 62.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -49.17 -58.64 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.94 -46.26 60.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.8 t -49.07 -55.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.85 75.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.0 -38.04 89.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.91 -19.79 60.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 157.38 -59.44 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 148.76 171.32 17.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.07 -46.0 91.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.84 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.52 -66.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 141' ' ' GLY . 4.6 p -49.9 -54.47 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 57.4 t -51.43 -49.09 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.2 m -58.25 -45.41 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -57.49 -49.04 77.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.9 m-20 -97.36 18.4 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 35.36 51.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -86.47 41.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.613 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 43.4 m95 -84.26 -36.36 22.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 m -49.7 -43.7 47.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -54.45 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.23 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.7 -53.51 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 92.4 m -57.83 -43.79 86.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -61.07 -22.83 64.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 93.3 mmm -82.45 9.24 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.82 -10.11 74.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.543 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 123' ' ' VAL . 13.6 m-85 -72.26 157.11 38.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.0 61.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 85.64 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.677 2.252 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.34 -130.49 3.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.44 -46.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.61 -58.98 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -54.9 -31.08 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.16 19.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 t -70.13 -25.65 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -58.49 -48.09 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.613 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 34.7 mm -47.1 -52.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -59.63 -57.47 12.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.14 -57.69 7.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.437 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 82.1 m-70 -40.34 -37.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.6 OUTLIER -77.07 -42.31 38.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -76.81 -9.23 58.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -101.46 -32.23 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.29 -51.1 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 19.5 mt -83.93 21.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.45 -60.25 2.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 0.0 110.888 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.1 Cg_endo -69.72 -50.68 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -40.78 -47.9 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.26 -27.21 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.2 tt -61.52 -29.45 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -95.3 -45.59 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.1 mt -48.94 -39.97 28.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 79.7 p -62.84 -49.55 74.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.52 -49.67 0.85 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.15 101.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.5 t -50.39 -35.94 30.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -47.41 -55.78 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -45.2 101.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.82 164.02 32.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.55 119.41 14.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -66.41 120.12 12.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.469 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 14.1 ttpp -86.83 139.96 33.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.569 0.7 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 54.1 Cg_endo -69.74 -179.69 3.08 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 0.0 112.325 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 199' ' ' LEU . 88.4 m-20 -122.77 99.53 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 198' ' ' ASN . 4.6 pp -34.39 142.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 85.2 m -99.84 132.42 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.4 m -107.58 158.7 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -136.82 146.28 45.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 204' ' ' LYS . 97.8 m -130.8 138.57 49.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.41 ' N ' HG23 ' A' ' 203' ' ' THR . 22.0 ttmt -117.96 152.24 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.83 131.13 16.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 207' ' ' GLU . 2.5 pptp? -110.46 175.71 5.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.401 ' N ' ' HD2' ' A' ' 206' ' ' LYS . 2.3 pm0 -147.4 156.64 43.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 6.7 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -48.33 160.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 110.833 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -81.32 162.11 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.843 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.53 -99.1 1.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -105.06 168.67 8.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.873 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -134.14 -51.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 46.17 49.71 13.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -104.04 172.71 6.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 -33.79 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 16.4 tt0 -71.75 -29.46 64.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -59.15 -29.24 67.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.118 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -65.57 -62.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.527 HG22 ' CE2' ' A' ' 131' ' ' PHE . 9.7 p -63.24 -20.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 96' ' ' GLN . 22.4 mmtt -75.02 -49.06 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.99 -37.44 47.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -39.96 -62.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -53.31 -57.69 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.5 mt -44.07 -31.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.8 -40.78 22.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -68.0 -26.17 65.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.567 HD12 ' CD1' ' A' ' 182' ' ' TYR . 4.6 tp -92.88 -31.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.54 -45.33 46.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 29.5 pttt -48.72 -39.78 26.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 6.2 m-85 -56.67 -38.04 71.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.559 ' CD1' HD13 ' A' ' 118' ' ' LEU . 66.4 m95 -72.32 -49.48 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -43.57 -56.05 3.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 109' ' ' LYS . 5.0 mp -47.39 -42.33 21.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -68.15 -31.91 71.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.16 33.86 3.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -138.55 138.26 37.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.971 0.415 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -86.18 137.31 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' A' ' 111' ' ' TRP . 7.0 tt -89.79 128.88 36.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -114.99 120.48 40.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.03 129.73 93.95 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.62 0.724 . . . . 0.0 111.11 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.15 57.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.267 . . . . 0.0 112.301 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.455 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 11.1 m170 -123.61 108.86 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 72.2 t -96.55 140.29 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 41.63 43.24 2.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 60.16 41.82 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -152.99 156.41 38.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 15.3 mm -69.75 137.34 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 174' ' ' HIS . 15.8 tp -107.47 98.78 8.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -72.29 105.09 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.2 -57.35 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 99' ' ' VAL . 7.6 t80 -38.78 -48.37 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -73.44 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 24.6 tp -38.12 -67.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -47.46 -57.49 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -41.51 -56.67 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.0 mt -51.61 -44.34 62.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.26 -51.3 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.21 85.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.67 -42.89 97.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -73.07 -22.01 60.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 158.76 -58.21 0.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.442 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 141.67 170.11 12.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' ' HG2' ' A' ' 172' ' ' ARG . 30.3 t80 -57.31 -41.76 80.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.847 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.15 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.411 HG12 ' C ' ' A' ' 141' ' ' GLY . 2.8 p -55.54 -52.01 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 95.3 t -56.72 -66.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 14.2 t -51.25 -36.24 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -58.8 -50.99 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.09 25.62 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 38.38 39.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -85.46 46.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.532 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 45.4 m95 -88.96 -42.68 11.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.2 m -40.92 -50.73 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -50.69 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.2 mt -45.16 -62.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.5 -56.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.7 m -55.29 -41.46 72.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -53.65 -44.99 70.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.0 mmm -59.43 -18.82 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.28 -14.53 12.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 19.4 m-85 -66.5 164.63 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 144.14 75.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 111.069 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 96.19 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.2 13.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -36.65 10.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.741 0.305 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -55.97 10.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.1 p -64.44 -38.18 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -50.2 -47.56 41.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -76.7 -33.52 58.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.67 -51.98 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.532 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 6.8 mm -40.98 -55.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.437 ' HG2' ' CE2' ' A' ' 143' ' ' PHE . 21.2 mtm105 -57.38 -56.09 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.04 -44.96 26.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.534 ' CD2' HD23 ' A' ' 128' ' ' LEU . 60.9 m-70 -53.39 -38.42 63.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -76.8 -32.27 57.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -86.33 -9.34 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -101.69 -29.59 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.92 -52.28 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 13.1 mt -84.15 24.16 0.98 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.483 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.53 -60.25 2.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.65 0.738 . . . . 0.0 110.912 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.73 -50.0 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.665 2.243 . . . . 0.0 112.397 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.567 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.0 t80 -42.61 -56.12 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.49 -52.49 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.95 -33.5 4.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -75.11 -55.55 5.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.84 -46.33 64.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 188' ' ' GLY . 25.4 p -88.02 -0.88 57.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' SER . . . -34.45 114.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -111.45 113.92 26.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.0 p -51.42 -43.25 61.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.73 -46.23 40.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.28 92.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.8 t -81.11 168.13 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.47 120.48 14.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -88.5 114.08 24.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 149.07 53.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 159.92 51.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.656 2.238 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.51 45.06 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 13.3 mt -132.71 119.86 20.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.1 m -117.24 94.57 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.1 m -91.22 134.95 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -93.81 153.04 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -116.2 123.45 47.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -57.24 165.69 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 206' ' ' LYS . 2.9 p30 -131.3 147.06 52.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.869 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 205' ' ' ASP . 30.9 tttt -36.34 141.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -127.71 172.72 10.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.3 t -115.67 103.45 10.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 t -119.27 157.7 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.09 -107.2 0.86 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 84.8 p -123.27 40.16 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 110.869 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.3 m -139.31 154.65 47.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.83 129.35 18.59 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -96.17 34.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.17 82.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -69.7 -20.49 63.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -87.94 -36.02 17.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.142 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -64.19 -52.44 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 100' ' ' LYS . 8.7 p -55.64 -44.88 78.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' N ' ' CG1' ' A' ' 99' ' ' VAL . 81.0 mttt -60.57 -46.78 88.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ASN . 35.2 mt -57.21 -50.25 73.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' LEU . 57.3 t-20 -37.56 -61.95 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 105' ' ' ASP . 31.4 t80 -57.97 -65.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 58.1 mt -38.23 -27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.9 t70 -80.77 -48.95 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 103' ' ' PHE . 12.3 mm100 -64.13 -21.33 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.4 tt -91.55 -39.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.6 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 55.4 pttt -56.93 -44.24 82.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 5.5 m-85 -50.04 -33.06 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.495 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 60.7 m95 -79.16 -49.47 12.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -45.4 -40.14 7.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.37 -45.25 88.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -65.44 -33.06 75.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.56 40.83 1.69 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -144.06 147.49 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -87.45 146.6 25.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 118' ' ' LEU . 5.3 tt -96.29 115.98 28.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' N ' HD23 ' A' ' 118' ' ' LEU . 22.7 ttpt -107.27 124.08 49.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.72 125.44 90.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 160.75 48.55 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -125.37 109.12 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.15 121.64 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 56.11 45.6 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.411 ' HB3' ' NH1' ' A' ' 125' ' ' ARG . 6.3 mtp-105 58.37 41.29 23.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -145.78 153.36 40.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -76.95 113.57 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.24 108.6 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.944 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.63 88.86 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' PHE . 41.3 mt -39.19 -64.6 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.4 t80 -37.32 -66.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 38.1 tt0 -50.42 -60.65 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 132' ' ' GLN . 7.9 tp -36.45 -70.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.2 -47.49 46.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -49.5 -54.4 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -52.38 -49.31 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.4 t -48.24 -48.84 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.99 90.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.19 -32.12 69.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.05 -12.85 58.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.417 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 153.08 -61.7 0.38 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.92 170.58 18.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 34.2 t80 -60.13 -35.83 76.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 0.0 110.926 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.44 -66.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.417 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.7 p -49.95 -49.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 150' ' ' ARG . 53.2 t -61.89 -62.63 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 52.2 t -46.34 -46.13 18.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -63.35 -55.46 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 14.93 2.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.4 OUTLIER 39.64 52.12 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 9.0 mtpm? -94.22 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.499 ' CZ3' HG23 ' A' ' 171' ' ' ILE . 89.7 m95 -81.81 -40.67 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 98.9 m -42.31 -51.25 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -49.59 -68.28 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 151' ' ' LYS . 5.3 mp -43.13 -65.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.11 -51.29 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.6 m -54.66 -53.02 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -54.08 -27.4 32.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -78.72 10.27 3.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.3 75.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -70.5 157.03 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.65 80.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.521 0.677 . . . . 0.0 111.142 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.224 . . . . 0.0 112.324 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -141.74 -169.18 11.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -93.93 -47.66 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.72 -58.22 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' A' ' 170' ' ' HIS . 11.5 p -60.23 -31.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.25 -49.84 62.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.9 t -74.31 -34.08 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 3.8 m-70 -50.74 -53.78 28.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.499 HG23 ' CZ3' ' A' ' 152' ' ' TRP . 32.4 mm -38.78 -48.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -65.14 -52.84 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 176' ' ' GLU . . . -53.16 -57.31 15.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -43.38 -30.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -79.47 -37.99 35.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' GLY . 7.3 mt-10 -77.97 -10.3 59.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 177' ' ' ARG . 1.2 mpt_? -98.16 -34.03 10.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.1 mt -119.52 -48.34 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 175' ' ' TYR . 7.7 mt -83.47 21.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -70.98 -60.1 3.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.76 -49.08 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.32 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.428 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 6.1 t80 -44.61 -56.65 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.98 -38.84 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.424 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 52.0 tp -58.13 -23.19 54.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -98.13 -43.1 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -53.16 -44.6 67.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 m -69.18 -47.17 65.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.06 142.11 3.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -126.24 160.32 30.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.0 m -92.51 -44.91 8.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.9 mp -51.98 -46.64 64.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -50.7 140.53 14.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.7 p -69.21 174.14 4.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 194' ' ' LEU . 4.2 mm? -70.08 136.94 50.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.962 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -110.93 149.42 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -52.66 146.33 18.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.541 0.686 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -4.28 13.7 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.322 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.87 134.69 57.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -146.46 125.63 12.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 106.4 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.9 p -124.03 128.48 49.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -72.39 82.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.5 m -131.74 104.93 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -72.08 162.97 28.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.895 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.46 127.34 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -118.92 162.84 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 208' ' ' TYR . 12.0 tt0 -58.94 159.01 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 207' ' ' GLU . 77.9 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.3 m -83.88 172.26 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.2 t -125.68 -42.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.39 -104.51 0.73 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 90.4 p -153.32 168.75 24.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.924 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -137.11 145.95 44.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.835 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -130.4 -110.37 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -123.77 149.28 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.96 133.46 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 97' ' ' THR . 22.9 mp0 -69.1 -60.18 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 96' ' ' GLN . 3.7 t -34.16 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 96' ' ' GLN . 28.4 mmt180 -56.54 -57.84 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 100' ' ' LYS . 9.8 p -71.17 -31.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' N ' HG12 ' A' ' 99' ' ' VAL . 18.2 mmmt -54.8 -49.67 70.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 102' ' ' ASN . 81.5 mt -77.31 -48.16 18.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 101' ' ' LEU . 5.4 t-20 -37.33 -63.25 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.25 -64.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.3 mt -45.08 -26.07 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.17 -40.34 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -74.69 -24.38 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 182' ' ' TYR . 9.1 tp -87.39 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.15 80.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.463 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 61.0 pttt -49.05 -45.0 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 56.5 t80 -52.49 -41.63 63.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.502 ' CD1' HD12 ' A' ' 118' ' ' LEU . 53.6 m95 -68.09 -48.25 66.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.19 -45.39 16.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 109' ' ' LYS . 5.5 mp -51.44 -37.06 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -78.26 -23.16 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 27.36 9.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -129.91 136.43 49.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.79 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -82.11 145.22 30.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.502 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.6 tt -90.79 117.15 29.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -109.57 114.65 28.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mm -70.47 126.56 92.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.56 10.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.38 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -122.58 121.0 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.22 127.96 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 54.17 42.48 31.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 58.87 45.15 15.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -157.07 153.86 28.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.12 105.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.565 HD23 ' CD2' ' A' ' 174' ' ' HIS . 49.4 tp -65.6 116.6 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -80.41 108.21 13.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.07 -52.19 51.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CD2' ' N ' ' A' ' 132' ' ' GLN . 6.8 t80 -48.27 -66.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 59.3 tt0 -54.77 -47.96 73.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 tp -50.08 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -48.98 -43.6 40.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -51.03 -53.38 34.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 66.1 mt -56.14 -46.29 79.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.1 t -48.57 -49.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.87 79.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.23 -42.59 79.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -72.97 -14.58 61.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 153.97 -61.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 148.82 168.79 14.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.26 -42.15 81.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.28 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.428 HG12 ' C ' ' A' ' 141' ' ' GLY . 4.2 p -52.49 -40.96 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 72.6 t -69.9 -26.38 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.9 m -78.82 -32.64 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 8.1 pttp -81.35 -45.3 16.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 150' ' ' ARG . 5.8 m-20 -89.43 20.15 4.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 31.41 47.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -87.97 37.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.594 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 24.6 m95 -85.36 -42.27 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m -52.02 -53.27 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -46.71 -53.89 10.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 156' ' ' ALA . 28.4 mt -58.9 -68.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.116 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -34.32 -49.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -58.88 -49.22 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -50.17 -49.13 53.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 22.9 mtp -47.93 -27.19 2.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.5 -7.55 10.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -77.43 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.32 145.11 55.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.542 0.686 . . . . 0.0 111.142 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 93.32 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.401 ' C ' ' N ' ' A' ' 166' ' ' ALA . . . -146.91 135.32 5.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.455 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -43.78 -23.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.401 ' N ' ' C ' ' A' ' 164' ' ' GLY . . . -61.01 -59.09 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 168' ' ' GLY . 7.3 p -67.57 -40.68 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -50.94 -41.44 45.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.3 m -83.33 -31.6 26.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.1 m-70 -54.69 -40.0 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.594 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 49.9 mm -50.51 -61.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.081 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.69 -52.68 63.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.69 -43.02 37.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.565 ' CD2' HD23 ' A' ' 128' ' ' LEU . 60.9 m-70 -56.83 -39.81 74.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.8 OUTLIER -75.23 -39.98 59.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -76.29 -9.44 58.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -104.04 -29.72 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.1 mt -119.25 -52.47 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.555 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 29.2 mt -82.94 18.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -69.95 -60.22 3.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.632 0.73 . . . . 0.0 110.909 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -41.78 4.01 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 107' ' ' ILE . 16.5 t80 -45.31 -51.68 10.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.72 -42.85 21.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.4 tp -50.82 -31.28 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -90.53 -54.08 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -42.18 -51.82 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.8 m -63.99 -40.6 96.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -43.4 -82.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.498 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -123.65 115.19 21.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 5.3 p -95.33 -21.9 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.17 2.2 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -134.42 84.55 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.7 m -146.47 179.61 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.41 160.11 41.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -132.96 130.55 39.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -89.17 141.99 29.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 129.36 17.5 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.342 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.9 125.14 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.59 108.15 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.7 p -115.2 163.48 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.0 m -129.72 122.33 28.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 98' ' ' ARG . 2.2 p-10 -120.23 114.76 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.7 p -109.53 -29.69 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 108.77 20.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.5 -24.92 66.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -149.75 116.95 6.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.9 -25.42 42.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 36.9 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.1 p -170.34 145.14 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.896 0.379 . . . . 0.0 110.834 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.1 t -131.32 176.28 8.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.89 -114.55 4.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' SER . 77.6 p -131.85 40.92 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 91' ' ' SER . 1.3 t -37.06 120.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.67 -156.33 23.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.45 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -56.86 169.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.35 156.31 38.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.6 -35.04 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 t -85.26 -38.34 19.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -60.9 -56.18 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -44.34 -35.6 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 60.9 mttt -78.44 -54.88 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 102' ' ' ASN . 72.9 mt -46.06 -48.42 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 101' ' ' LEU . 25.6 t-20 -36.41 -65.55 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 106' ' ' GLN . 55.5 t80 -55.05 -68.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 36.6 mt -36.68 -30.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' PHE . 10.1 t70 -79.48 -45.78 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.3 mm-40 -67.04 -17.98 65.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.6 tt -96.86 -34.98 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.83 -42.32 81.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.092 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 110' ' ' TYR . 49.4 pttt -54.44 -46.37 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' N ' ' CG ' ' A' ' 109' ' ' LYS . 7.5 m-85 -47.97 -36.48 12.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.547 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 80.6 m95 -74.63 -49.33 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -43.21 -54.0 4.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.46 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.7 mm? -45.64 -40.69 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.21 -44.54 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 35.87 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -138.14 120.12 15.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.936 0.398 . . . . 0.0 110.883 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 t -65.16 147.46 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.0 tt -110.37 110.28 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -103.91 140.38 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.29 122.99 73.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.13 11.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -122.22 125.27 45.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.7 t -112.94 134.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 46.76 42.32 11.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 57.75 45.6 18.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -163.89 130.71 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mm -46.5 133.05 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.98 104.6 16.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -72.5 98.62 2.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.81 -57.06 14.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.57 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 44.7 t80 -42.26 -65.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -56.01 -53.67 54.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.7 tp -46.94 -70.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -42.91 -48.66 5.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -48.6 -56.17 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.59 -40.26 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.04 -54.74 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.99 70.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -63.86 -37.66 88.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -81.14 -19.12 44.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.441 ' C ' ' CG1' ' A' ' 145' ' ' VAL . . . 159.55 -57.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.508 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.75 160.5 9.11 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 175' ' ' TYR . 2.4 t80 -53.69 -33.62 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.23 -66.26 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 141' ' ' GLY . 2.7 p -52.11 -31.07 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.5 t -76.1 -54.58 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 38.6 t -57.88 -49.8 75.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 9.3 ptmt -51.76 -42.95 62.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 148' ' ' LYS . 16.3 t0 -90.42 0.89 57.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 52.22 50.79 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -102.84 35.41 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.528 ' CZ3' HG23 ' A' ' 171' ' ' ILE . 12.0 m95 -71.73 -31.76 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.3 m -53.75 -62.67 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.154 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -39.32 -58.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 22.2 mt -55.43 -64.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.19 -44.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.1 m -62.42 -47.69 83.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -51.8 -45.9 64.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.1 -27.21 52.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.07 -7.69 9.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -73.29 135.67 44.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.56 142.7 21.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.538 0.685 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 125.69 12.45 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.4 -144.78 4.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -121.36 -29.72 4.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.27 -57.96 10.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 168' ' ' GLY . 9.2 p -58.72 -44.88 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -49.48 -40.38 31.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.49 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -79.75 -28.72 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.1 m-70 -57.83 -51.64 68.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.528 HG23 ' CZ3' ' A' ' 152' ' ' TRP . 4.5 mm -46.77 -58.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -50.69 -54.04 26.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -53.62 -52.08 44.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 90.8 m-70 -44.46 -33.96 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CD1' ' CE2' ' A' ' 143' ' ' PHE . 1.0 OUTLIER -79.4 -36.1 39.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -83.57 -9.07 59.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -101.94 -31.45 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.13 -50.35 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 175' ' ' TYR . 15.8 mt -83.22 18.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.509 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.82 -58.85 4.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.71 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.547 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 54.2 Cg_endo -69.74 -50.83 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.377 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -42.75 -41.64 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.37 -64.55 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.9 mp -40.35 -36.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -70.57 -51.96 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.9 mt -46.9 -44.81 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 m -66.07 -43.19 88.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.15 144.18 3.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.49 173.36 6.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.879 0.371 . . . . 0.0 110.837 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.2 p -83.14 -6.04 59.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.73 -27.85 20.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.24 -46.23 62.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.1 m -104.99 167.29 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.84 114.39 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -147.36 151.63 36.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.417 ' N ' ' HD2' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -127.17 143.38 46.86 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.903 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 112.62 3.14 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -66.73 169.19 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.14 140.01 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 76.4 p -125.09 142.83 51.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 7.9 t -83.46 137.37 33.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -114.73 122.87 47.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.2 m -74.15 124.08 25.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.27 148.55 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -120.83 -20.17 7.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -93.24 110.65 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -66.37 96.45 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.824 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p 37.85 41.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -67.62 151.48 47.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.76 65.75 0.26 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -66.15 123.11 19.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.4 t 61.15 43.22 11.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.37 -47.99 3.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.46 139.14 40.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.343 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.97 152.85 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -104.74 -36.38 7.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 p -86.05 -54.19 4.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -47.36 -51.58 19.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.54 HG21 ' CZ ' ' A' ' 131' ' ' PHE . 7.8 p -47.08 -35.84 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.543 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 7.3 mtmp? -73.09 -49.2 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.76 -38.26 81.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.26 -53.63 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -58.61 -48.39 81.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.46 -36.72 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.5 -42.02 68.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -65.82 -52.74 48.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 182' ' ' TYR . 2.8 tp -55.16 -49.35 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.26 -49.17 70.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -43.71 -52.34 6.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.98 -42.96 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.429 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 51.6 m95 -71.72 -48.64 45.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -44.53 -50.59 9.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mt -54.39 -43.86 71.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.13 -38.44 88.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.86 34.8 1.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -140.64 130.08 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 p -67.18 140.16 57.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -111.76 149.02 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -169.98 141.2 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CD1' HD13 ' A' ' 130' ' ' LEU . 10.1 mm -75.26 131.51 78.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.602 0.715 . . . . 0.0 111.17 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.31 24.85 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.538 ' CD2' HD12 ' A' ' 127' ' ' ILE . 32.8 m80 -100.46 116.74 33.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.41 120.54 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.147 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 61.82 43.73 9.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 58.11 42.16 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -170.25 133.19 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.538 HD12 ' CD2' ' A' ' 122' ' ' HIS . 17.0 mm -46.99 148.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' A' ' 120' ' ' ILE . 9.4 tp -116.86 111.41 19.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.8 106.31 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 120' ' ' ILE . 64.8 mt -60.36 -50.63 72.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 54.3 t80 -44.38 -56.5 4.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -63.2 -56.03 20.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.464 ' CD2' HG23 ' A' ' 171' ' ' ILE . 6.6 tp -40.79 -70.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -43.54 -48.39 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -50.53 -50.43 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.11 -38.15 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.4 t -58.53 -59.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.54 60.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -60.77 -37.24 81.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -79.49 -13.4 59.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.425 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 151.55 -62.71 0.39 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 162.17 169.22 25.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -61.25 -37.05 81.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.72 -66.34 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 2.5 p -43.15 -30.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 150' ' ' ARG . 20.2 t -80.43 -50.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.5 p -57.78 -38.43 75.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -78.01 -28.27 49.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.16 2.2 45.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmm180 53.69 31.04 12.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -83.53 43.11 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.532 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 11.1 m95 -86.4 -44.97 11.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 m -47.85 -49.62 28.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -49.15 -55.36 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 14.9 mt -57.34 -60.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.64 -48.13 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -50.76 -43.7 58.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.9 mtp -58.31 -21.0 47.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.68 2.11 24.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -78.97 177.46 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.88 142.91 34.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.595 0.712 . . . . 0.0 111.095 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 122.98 9.64 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.39 -166.63 32.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -104.7 -20.87 13.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.72 -59.1 4.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 168' ' ' GLY . 7.1 p -61.79 -30.75 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.448 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -58.63 -49.29 78.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.8 m -75.43 -27.38 58.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.6 m-70 -58.22 -54.22 49.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.532 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 5.4 mm -37.97 -64.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -52.04 -50.61 61.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -52.55 -44.38 59.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.75 -31.53 70.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -84.17 -22.87 30.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -90.63 -10.77 42.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.15 -25.21 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.7 mt -119.35 -52.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.26 28.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.499 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.26 -62.73 0.79 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.67 0.748 . . . . 0.0 110.905 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.76 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.508 ' CD1' HD11 ' A' ' 107' ' ' ILE . 7.3 t80 -40.56 -44.22 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 175' ' ' TYR . 8.3 m120 -72.06 -43.38 64.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.3 mt -56.78 -54.96 40.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 189' ' ' ASP . 27.0 t80 -59.46 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 182' ' ' TYR . 34.5 mt -50.11 -48.11 53.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.1 t -55.5 -46.89 76.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.31 124.17 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 185' ' ' PHE . 11.9 t70 -106.85 80.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.331 . . . . 0.0 110.903 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.4 t -84.45 -46.97 11.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 192' ' ' ARG . 1.7 pt? -43.34 -34.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.43 ' N ' ' HG ' ' A' ' 191' ' ' LEU . 1.8 mpt_? -140.22 132.66 28.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 88.2 m -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.9 107.9 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -97.07 94.18 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -127.26 142.66 44.56 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 102.08 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -89.09 163.09 15.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.439 ' N ' HD22 ' A' ' 199' ' ' LEU . 0.9 OUTLIER -146.08 175.31 10.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 86.7 m -144.21 127.62 16.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 t -116.65 154.38 30.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -129.3 164.7 22.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 t -149.24 156.98 42.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 134.03 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.88 172.1 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.65 136.13 33.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -105.06 -48.25 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.846 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -114.04 120.08 39.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.7 t -108.36 108.4 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.2 119.49 1.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -80.24 158.19 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -142.16 159.46 42.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.67 -123.83 1.05 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.52 167.32 17.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.419 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . . . -95.01 -43.6 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 95' ' ' ALA . 2.9 mp0 -81.13 46.14 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.0 m -83.95 -40.67 18.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.6 -40.08 94.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.95 -26.29 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 50.8 mtpt -80.05 -37.49 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.7 -44.85 69.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -39.32 -58.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.85 -62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 37.4 mt -42.15 -37.75 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.49 -54.84 30.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -57.03 -54.55 45.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 7.9 tt -60.91 -35.27 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.81 91.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -56.66 -29.09 61.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 181' ' ' PRO . 42.2 t80 -71.22 -32.83 69.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.531 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 56.7 m95 -85.26 -53.24 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -42.44 -39.42 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -62.09 -47.74 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -60.45 -39.74 88.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.36 35.49 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.438 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.5 m -141.26 119.29 11.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 110.885 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.6 m -62.78 128.7 37.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.419 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 6.0 tt -78.11 128.55 33.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -126.17 142.24 51.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -84.17 130.43 54.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.68 0.753 . . . . 0.0 111.109 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 159.21 54.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -119.1 118.08 30.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' LYS . 90.2 t -110.67 143.95 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' VAL . 77.0 mm-40 37.79 42.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? 59.06 42.81 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 123' ' ' VAL . 40.7 mttm -147.96 141.87 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.76 100.66 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.31 94.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.33 100.67 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.28 -52.32 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 4.2 t80 -41.92 -59.14 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.4 tp60 -67.51 -54.05 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' CD1' ' CG2' ' A' ' 171' ' ' ILE . 9.9 tp -37.93 -72.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 134' ' ' ASN . 3.3 t-20 -48.61 -47.08 40.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -47.73 -48.12 29.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.474 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 90.7 t -53.23 -48.85 54.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.05 85.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.81 -36.94 80.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.71 -18.89 50.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.438 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 158.34 -59.04 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.71 173.86 24.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.787 ' CZ ' ' CD1' ' A' ' 175' ' ' TYR . 48.0 t80 -64.63 -37.26 86.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.62 -66.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG11 ' C ' ' A' ' 141' ' ' GLY . 4.7 p -45.99 -44.85 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.54 -68.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 51.7 t -42.26 -45.72 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -57.67 -55.43 34.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.452 ' CB ' ' HG3' ' A' ' 151' ' ' LYS . 17.3 m-20 -84.46 24.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 149' ' ' ASP . 29.2 mmt180 34.38 37.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 25.2 mtpp -79.74 44.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.683 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 10.3 m95 -90.04 -49.76 6.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.9 m -37.0 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -57.61 -69.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.433 HD13 ' CE3' ' A' ' 152' ' ' TRP . 26.2 mt -45.43 -58.75 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.82 -56.23 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.3 m -51.31 -50.07 60.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -55.83 -27.86 53.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.0 mmm -79.69 12.23 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.75 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -65.07 171.61 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.94 144.09 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 86.7 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.82 -158.78 7.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -103.71 -39.46 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -48.26 -59.15 3.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.124 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 168' ' ' GLY . 13.0 p -63.89 -37.43 79.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -54.25 -58.38 13.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.1 m -65.19 -31.51 72.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 3.5 m-70 -52.73 -57.57 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.683 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 26.0 mm -41.69 -46.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.47 ' HB2' ' NE1' ' A' ' 152' ' ' TRP . 1.3 tmt_? -59.64 -51.27 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.62 -44.2 97.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.9 -22.64 10.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.787 ' CD1' ' CZ ' ' A' ' 143' ' ' PHE . 0.5 OUTLIER -91.46 -21.35 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -90.98 -11.41 39.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -105.01 -25.44 12.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 mt -119.82 -52.52 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.0 mt -83.21 19.11 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.55 -60.12 2.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.897 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.531 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.2 Cg_endo -69.8 -46.48 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.345 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.9 t80 -38.55 -56.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -75.18 -34.57 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.99 -28.23 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -88.28 -54.99 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.9 mt -44.37 -44.64 8.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.9 p -68.15 -46.17 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.61 42.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -88.97 46.18 1.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 m -46.26 -32.56 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 192' ' ' ARG . 3.9 mp -47.71 -53.04 16.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -36.91 113.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 m -148.41 175.11 11.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.68 98.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -60.85 103.81 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 140.97 23.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.609 0.718 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 175.64 7.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.249 . . . . 0.0 112.362 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -138.27 176.56 8.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 199' ' ' LEU . 3.4 pp -107.51 165.14 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t -127.04 165.11 20.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 88.6 p -95.93 173.07 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.04 178.93 4.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -132.79 132.99 42.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.446 ' N ' ' HE3' ' A' ' 204' ' ' LYS . 0.3 OUTLIER -72.4 -176.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -131.18 175.52 9.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -86.14 143.11 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -107.93 -37.41 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.439 ' N ' ' HG2' ' A' ' 207' ' ' GLU . 2.2 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -119.42 118.94 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 t -125.46 143.98 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.08 168.57 53.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -154.33 129.01 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.9 p -78.79 119.93 22.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.38 -137.21 6.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.78 126.15 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.83 108.16 8.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -118.39 -41.44 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -90.92 -30.74 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -61.95 -44.0 97.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.441 ' CG1' ' HD2' ' A' ' 100' ' ' LYS . 9.7 p -52.1 -37.96 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.099 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HD2' ' CG1' ' A' ' 99' ' ' VAL . 1.4 mptt -71.72 -58.45 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.5 mt -50.67 -39.84 51.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.74 -63.69 0.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -51.33 -67.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 39.6 mt -38.21 -40.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.66 -53.06 61.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -56.68 -51.69 67.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.56 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.9 tt -59.63 -45.49 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -55.76 -48.2 75.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -40.6 -57.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -43.56 -48.94 7.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 35.8 m95 -66.6 -53.46 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -40.93 -51.23 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.02 -48.27 67.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -64.54 -37.66 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.65 37.99 1.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.8 p -131.8 141.2 49.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 m -85.76 134.45 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 4.5 tt -94.38 111.18 22.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -118.79 115.3 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.423 ' CD1' HD11 ' A' ' 130' ' ' LEU . 40.5 mm -62.72 129.7 93.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.63 0.729 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 157.32 60.72 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -98.85 120.85 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 55.3 46.47 23.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 56.52 32.54 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -141.91 134.26 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.68 99.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -66.36 104.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.35 116.74 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 120' ' ' ILE . 34.7 mt -66.94 -57.0 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.552 ' CE1' ' HG3' ' A' ' 135' ' ' LYS . 2.7 t80 -50.88 -54.57 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.69 -44.48 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 171' ' ' ILE . 13.7 tp -47.91 -72.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -50.21 -39.15 43.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.552 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -54.04 -55.04 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' CG2' HG21 ' A' ' 155' ' ' ILE . 69.6 t -53.52 -50.04 51.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.36 92.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.56 -42.09 98.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -67.57 -17.89 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.415 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 156.58 -56.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.48 166.59 12.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.45 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 143' ' ' PHE . 2.7 t80 -59.63 -42.48 92.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.11 -64.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG13 ' C ' ' A' ' 141' ' ' GLY . 2.3 p -48.64 -44.9 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 150' ' ' ARG . 28.9 t -63.8 -64.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 20.3 m -49.11 -36.64 19.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -66.35 -51.09 60.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -95.37 18.32 12.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 146' ' ' VAL . 13.5 mmt85 45.38 51.86 9.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -86.55 24.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.563 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -68.46 -40.04 81.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.5 m -54.73 -39.44 68.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' N ' ' HE3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -63.8 -33.6 76.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.48 ' N ' HD13 ' A' ' 155' ' ' ILE . 1.9 mm -73.37 -61.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -44.87 -51.95 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 m -59.98 -51.15 70.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -52.97 -45.08 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 32.4 mtp -58.41 -15.92 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.09 -7.62 27.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 171.24 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.1 31.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.593 0.711 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 109.65 2.38 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.4 -147.48 4.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -115.7 -37.0 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -59.48 -58.22 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 168' ' ' GLY . 8.2 p -57.96 -41.34 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.462 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -48.69 -52.65 19.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -77.85 -27.02 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 2.8 m-70 -53.47 -46.93 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.563 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 46.7 mm -46.3 -43.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.1 mmm-85 -71.35 -63.25 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.51 -51.62 7.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -46.68 -40.44 13.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -67.33 -45.33 76.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -76.41 -9.34 58.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -97.25 -35.55 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.6 mt -119.87 -48.32 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 175' ' ' TYR . 10.8 mt -83.5 21.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.513 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -71.73 -60.24 2.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 53.7 Cg_endo -69.75 -50.68 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.709 2.273 . . . . 0.0 112.353 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 4.1 t80 -44.63 -52.71 7.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.19 -51.24 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -49.32 -44.18 44.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 188' ' ' GLY . 8.7 t80 -69.61 -57.42 5.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.6 mt -38.28 -50.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 m -66.18 -38.84 89.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 129.39 177.53 14.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -139.65 152.08 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 110.818 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.7 p -97.97 -61.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.826 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -49.26 -20.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.3 p -71.4 168.61 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 117.5 11.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 165.11 13.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -75.48 143.94 76.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 133.88 26.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.698 2.266 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.15 115.68 30.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.5 mt -62.03 102.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 90.3 m -126.16 128.81 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.0 p -49.33 165.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.76 175.1 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 97.3 m -120.9 149.28 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -124.89 128.7 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -90.91 162.91 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -143.79 111.83 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.27 -178.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 58.0 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.932 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -72.49 165.24 25.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -123.22 172.19 8.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.87 156.82 23.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -101.39 106.32 17.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -44.49 143.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.19 -141.21 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.31 117.31 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 131.32 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -121.05 43.23 2.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -90.23 -32.01 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.121 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -69.56 -34.51 74.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 131' ' ' PHE . 7.1 p -73.84 -33.78 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 40.5 mtmt -68.54 -52.42 32.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.47 -40.69 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -48.36 -52.35 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 104' ' ' LEU . 3.9 t80 -58.95 -61.3 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 103' ' ' PHE . 16.5 mt -49.37 -20.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.69 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.13 -31.91 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 182' ' ' TYR . 5.5 tt -81.59 -39.23 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.56 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -42.55 -58.01 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -38.89 -42.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 43.0 m95 -73.97 -49.1 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -42.75 -43.44 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -61.48 -47.54 85.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -64.9 -28.2 69.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.92 40.68 3.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -136.66 127.24 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 110.853 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.6 m -77.81 128.37 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 4.2 tt -89.92 108.0 19.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -106.09 128.23 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.6 mm -63.58 127.29 91.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 161.97 43.91 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.313 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -118.1 115.44 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.816 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.563 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 77.1 t -102.4 124.29 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 51.52 51.16 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 55.62 35.27 24.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -144.83 142.89 30.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.53 107.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.4 tp -71.55 114.77 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.74 89.06 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' PHE . 23.1 mt -44.28 -63.47 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CD2' ' HG2' ' A' ' 100' ' ' LYS . 17.0 t80 -34.91 -67.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.456 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 17.1 tt0 -53.97 -56.8 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 22.6 tp -43.93 -71.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -45.6 -57.46 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -41.56 -47.55 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.928 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -46.65 87.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -50.71 -46.79 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.16 95.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.6 -45.04 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -67.56 -18.16 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 155.28 -60.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.36 165.36 12.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.492 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -55.85 -35.12 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.884 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -66.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.418 HG12 ' C ' ' A' ' 141' ' ' GLY . 2.6 p -51.88 -37.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 150' ' ' ARG . 51.0 t -72.06 -64.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 9.8 t -52.24 -32.22 35.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -73.55 -49.42 26.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -91.54 15.22 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 45.81 55.03 7.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.16 36.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.509 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 42.4 m95 -84.69 -46.89 11.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.8 m -43.96 -54.57 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -48.58 -63.05 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ALA . 20.4 mt -54.27 -63.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.22 -47.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.6 m -62.75 -45.43 92.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -51.28 -51.12 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.2 mmm -50.08 -25.08 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.87 -8.14 10.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.563 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 26.0 m-85 -72.27 146.55 47.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.45 142.99 98.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 122.8 9.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.716 2.277 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.67 -134.89 1.78 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -127.81 -34.8 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.68 -58.65 7.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.17 -30.93 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -58.91 12.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -67.16 -25.97 66.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.2 m-70 -58.32 -59.54 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.509 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 24.8 mm -37.83 -63.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -52.21 -56.86 11.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.14 -52.99 9.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -49.27 -35.65 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -82.27 -22.72 35.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.67 -13.06 40.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -105.25 -22.79 12.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.7 mt -119.98 -52.61 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 175' ' ' TYR . 5.4 mp -87.01 25.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -76.5 -63.64 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -48.28 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.694 2.262 . . . . 0.0 112.356 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' A' ' 107' ' ' ILE . 6.1 t80 -40.12 -48.21 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.34 -34.2 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.0 tt -56.57 -40.66 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -84.8 -56.65 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.9 mt -40.61 -36.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 m -89.29 -45.48 9.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.12 124.63 2.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.04 136.85 41.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.3 t -98.56 -18.43 18.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 -38.04 12.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -63.51 112.45 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 76.4 m -43.4 91.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 192' ' ' ARG . 1.1 pp -150.12 116.66 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.5 135.07 54.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -87.49 143.14 33.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 147.84 63.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.664 2.243 . . . . 0.0 112.366 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 198' ' ' ASN . 11.2 p-10 -53.39 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.4 mt -133.25 169.35 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 46.1 p -68.81 106.97 2.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -136.92 167.18 21.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -119.45 151.02 39.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.9 p -124.19 175.13 7.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -146.39 105.31 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.03 169.62 11.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 207' ' ' GLU . 7.1 tmtt? -135.05 145.57 48.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -132.47 175.68 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 207' ' ' GLU . 21.4 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 m -143.75 139.89 29.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -139.71 169.65 17.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.0 -137.67 5.52 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.5 m -76.29 121.47 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.893 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -93.27 81.57 4.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.88 -47.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -148.49 114.37 5.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.13 40.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -115.04 38.91 3.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.4 m -83.54 -42.33 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -55.21 -46.31 75.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.54 -31.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 45.1 mtmt -73.41 -47.15 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -66.6 -44.08 83.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -42.7 -44.52 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -68.18 -44.74 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.465 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.9 mt -63.27 -26.94 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -76.91 -51.04 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -62.02 -32.82 73.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.8 tt -79.68 -42.43 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.83 -47.51 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -28.15 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -70.21 -30.39 67.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.509 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 79.0 m95 -87.07 -49.4 7.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -47.6 -21.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.57 -45.22 46.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -70.07 -37.98 75.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.97 36.49 1.23 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.455 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.4 t -137.9 111.26 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.789 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 p -58.05 147.12 30.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 111' ' ' TRP . 5.6 tt -98.07 108.03 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -96.34 132.82 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -87.06 121.02 71.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.62 0.724 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 149.73 67.43 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.94 111.59 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.42 124.95 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 51.43 44.79 28.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.3 30.37 19.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -139.33 150.23 45.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.1 mm -75.01 129.95 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.6 tp -91.59 107.97 19.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.79 82.44 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 131' ' ' PHE . 60.1 mt -40.05 -59.9 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CD2' ' HG2' ' A' ' 100' ' ' LYS . 31.1 t80 -34.91 -67.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 0.9 OUTLIER -58.81 -54.83 42.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.48 ' CD1' ' CG2' ' A' ' 171' ' ' ILE . 4.3 tp -35.47 -71.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -49.37 -53.81 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -40.06 -56.9 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.417 ' CD1' ' NE2' ' A' ' 132' ' ' GLN . 12.4 mt -54.6 -48.11 72.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -46.54 -49.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.07 86.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.48 -37.26 86.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -79.89 -14.35 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.446 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 153.18 -62.73 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 154.54 165.28 13.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 3.1 t80 -55.47 -38.83 69.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.6 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 141' ' ' GLY . 4.1 p -48.37 -46.0 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.05 -69.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 47.1 t -40.32 -42.45 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.32 -51.34 63.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' ARG . 12.3 m-20 -84.81 25.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 34.49 41.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -86.07 40.59 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.533 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 23.3 m95 -86.11 -46.91 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -38.88 -44.72 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -63.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.31 -57.87 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' CB ' HG21 ' A' ' 167' ' ' VAL . . . -45.45 -50.04 12.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 m -64.25 -37.9 89.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -65.35 -27.5 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 mtp -75.36 -3.24 32.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.81 54.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.73 166.85 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.93 144.62 79.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.558 0.694 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 85.73 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.729 2.286 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.38 169.76 26.3 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.03 -34.55 64.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.78 0.324 . . . . 0.0 110.882 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.66 -58.83 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 168' ' ' GLY . 12.7 p -67.06 -44.12 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -45.5 -48.89 11.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 m -75.49 -36.08 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.834 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.4 m-70 -49.18 -39.0 27.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.533 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 37.0 mm -57.33 -59.42 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -50.83 -61.19 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -44.91 -48.67 9.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 32.1 m-70 -50.55 -44.83 56.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -43.54 90.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -80.01 -9.03 59.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 173' ' ' GLY . 23.1 mmt180 -99.1 -30.37 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.36 -51.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.16 26.58 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.54 -60.05 2.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.892 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.509 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.74 -48.18 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -44.25 -41.41 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -71.28 -38.52 71.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 69.4 mt -57.57 -36.31 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.86 -41.72 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.2 mt -61.87 -32.62 73.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.9 t -81.63 9.25 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.58 -132.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.57 74.57 10.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 97.2 p -97.86 -22.97 16.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.484 ' CD2' ' C ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -87.48 -0.66 57.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.422 ' CZ ' HD23 ' A' ' 194' ' ' LEU . 7.0 mmm180 -77.85 109.22 11.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.0 -40.1 65.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.01 22.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -46.4 173.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -51.43 145.29 14.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.598 0.713 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 141.55 45.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.27 157.05 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 1.6 mm? -84.75 90.48 7.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.7 p -131.59 111.1 11.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 t -113.59 107.08 15.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.52 113.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.3 p -92.78 85.27 5.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -105.75 142.24 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.54 138.38 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -93.53 120.62 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -120.84 120.81 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -38.93 109.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.0 t -131.15 127.06 37.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.55 -148.66 5.66 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 m -127.9 159.66 34.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 p -50.89 173.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.33 -162.78 22.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.56 -23.51 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.8 141.75 46.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 98' ' ' ARG . 15.3 pt20 -119.63 -46.53 2.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 96' ' ' GLN . 98.9 m -33.79 -34.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 96' ' ' GLN . 6.7 ptm180 -66.04 -57.55 7.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 131' ' ' PHE . 1.5 p -65.76 -39.78 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -53.38 -54.78 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.66 -39.27 84.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -50.64 -50.71 53.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' A' ' 107' ' ' ILE . 52.3 t80 -60.01 -64.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.6 mt -41.17 -35.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -70.13 -57.99 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -55.13 -50.65 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.463 HD11 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 tt -63.73 -37.03 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.72 76.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -45.76 -56.07 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -39.58 -40.67 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -76.4 -50.66 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -41.87 -38.12 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 113' ' ' LEU . 10.4 mp -57.24 -44.45 83.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -73.72 -36.68 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 111.55 30.1 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -116.97 139.57 50.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 m -84.9 129.4 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.497 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.3 tt -93.62 119.5 32.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.451 ' N ' HD23 ' A' ' 118' ' ' LEU . 25.7 tptt -133.19 142.99 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.55 122.45 82.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -177.21 1.78 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.679 2.252 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.442 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 25.1 m80 -126.21 126.04 43.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.1 t -112.67 128.53 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.8 42.39 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 61.06 27.88 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -145.03 128.49 16.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.442 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 4.8 mm -40.92 146.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 16.3 tp -120.27 89.71 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -56.22 103.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' PHE . 81.3 mt -58.13 -63.09 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 5.7 t80 -37.79 -62.21 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -54.82 -59.15 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.425 ' CD1' HG21 ' A' ' 171' ' ' ILE . 13.7 tp -38.15 -72.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -47.28 -46.36 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -58.48 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.62 -42.42 62.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.49 -50.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.49 75.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.41 -41.76 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -72.69 -12.03 60.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 150.97 -59.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 146.88 176.11 20.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.21 -36.7 84.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.7 -66.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.068 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.75 -47.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 152' ' ' TRP . 72.9 t -60.14 -43.72 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.4 m -67.7 -33.46 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -70.97 -49.85 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.03 10.84 39.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmt85 46.41 52.25 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -81.92 40.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.598 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 72.6 m95 -87.04 -45.22 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.1 m -41.43 -49.21 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -56.81 -59.28 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 156' ' ' ALA . 14.2 mt -51.8 -72.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.15 -51.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.0 m -60.35 -41.98 94.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 155' ' ' ILE . 37.7 mttp -62.56 -22.65 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.4 mmm -81.67 7.31 12.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.19 -15.45 62.37 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -69.62 162.29 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -80.13 143.95 57.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.726 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 84.42 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.12 -138.63 4.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -124.21 -48.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.85 -57.56 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.127 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 168' ' ' GLY . 5.4 p -58.39 -39.17 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -52.0 -48.21 52.54 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.517 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.1 m -72.86 -32.04 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.443 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 6.4 m-70 -54.66 -53.9 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.598 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 45.0 mm -43.25 -51.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.519 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 28.3 mtm180 -56.91 -62.32 1.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -43.8 -51.87 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.467 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 96.6 m-70 -50.58 -41.38 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.3 OUTLIER -71.22 -45.74 62.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.61 -9.15 58.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 173' ' ' GLY . 38.1 mtm180 -105.12 -28.94 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.9 mt -116.43 -52.63 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.456 ' CD1' HD12 ' A' ' 107' ' ' ILE . 1.5 mm? -92.84 35.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.546 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -75.39 -62.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.859 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.82 -49.23 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.322 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -42.11 -55.83 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.46 -46.68 75.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt -51.67 -37.08 49.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.1 -54.09 12.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 42.3 mt -49.83 -36.47 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.5 t -78.26 -48.02 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -171.48 -140.35 3.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.44 163.67 14.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.353 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.0 t -99.06 -45.51 5.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 192' ' ' ARG . 3.1 pp -49.96 -44.23 50.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.909 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -35.3 117.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.8 t -50.57 166.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.64 149.11 44.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -86.53 156.48 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -37.37 141.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -177.34 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -120.78 160.65 22.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -61.88 152.33 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.7 p -53.91 144.24 19.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 67.2 m -99.38 101.94 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.0 120.07 34.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.0 m -114.02 95.82 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -61.84 172.1 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 205' ' ' ASP . 7.0 p-10 -89.01 98.2 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 207' ' ' GLU . 72.1 tttt -75.13 126.69 31.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 206' ' ' LYS . 6.7 tp10 -37.22 114.3 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.827 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 m -64.7 -48.87 73.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.0 p -173.6 150.33 1.75 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.38 72.1 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.521 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 p -43.05 116.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -170.14 155.1 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.51 160.38 8.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.518 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -91.33 124.49 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.75 149.94 10.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.43 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.1 pp0? -124.12 -21.03 5.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.8 m -87.79 -44.61 10.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -57.78 -51.62 68.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.435 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 14.6 p -53.45 -24.99 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 47.6 mttp -81.01 -53.02 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.91 -44.92 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -39.0 -64.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -51.73 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.431 HD21 ' CD1' ' A' ' 120' ' ' ILE . 38.5 mt -39.72 -39.52 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.5 -53.87 50.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -54.26 -59.97 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.8 -45.36 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.93 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' TRP . 4.5 mmmm -55.97 -60.26 3.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -38.54 -26.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.527 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 88.7 m95 -87.97 -45.72 9.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 109' ' ' LYS . 5.6 pt-20 -49.61 -18.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -78.9 -35.34 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -81.25 -28.74 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.32 34.55 3.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 m -135.17 112.25 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.849 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -58.39 143.38 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 119' ' ' LYS . 2.0 tm? -105.92 157.87 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' N ' ' CD1' ' A' ' 118' ' ' LEU . 14.7 ttmm -171.99 155.51 3.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.431 ' CD1' HD21 ' A' ' 104' ' ' LEU . 28.6 mm -89.26 129.69 46.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.694 0.759 . . . . 0.0 111.121 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -179.29 2.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 39.4 m80 -119.77 129.28 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 161' ' ' PHE . 93.0 t -115.09 109.08 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 61.65 51.25 4.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 56.71 31.64 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -148.77 126.1 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 32.4 mm -48.16 145.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.6 tp -110.31 91.85 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.7 83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 mt -40.12 -57.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.49 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 23.9 t80 -39.72 -52.28 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 133' ' ' LEU . 32.0 tp60 -70.35 -58.36 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 132' ' ' GLN . 7.4 tp -35.68 -71.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -47.34 -57.44 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -42.09 -55.46 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.97 -45.09 60.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 64.8 t -52.82 -55.08 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.03 -41.04 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.94 -37.69 88.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.09 -27.5 63.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.511 ' C ' ' CG1' ' A' ' 145' ' ' VAL . . . 169.1 -52.0 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 131.41 150.45 6.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -41.7 -36.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.15 -66.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.511 ' CG1' ' C ' ' A' ' 141' ' ' GLY . 5.0 p -61.81 -54.99 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.199 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.407 ' H ' ' CG1' ' A' ' 145' ' ' VAL . 72.3 t -46.77 -57.93 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.1 t -57.62 -43.76 84.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -54.52 -53.73 50.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 150' ' ' ARG . 2.2 m-20 -90.02 18.39 5.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 149' ' ' ASP . 1.1 mpp_? 37.62 48.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -86.87 40.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.558 ' CZ3' HG23 ' A' ' 171' ' ' ILE . 34.1 m95 -81.21 -50.54 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.8 m -39.03 -50.73 1.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -50.72 -61.03 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 19.0 mt -49.14 -67.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' A' ' 167' ' ' VAL . . . -40.14 -49.73 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.4 m -63.17 -36.91 85.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.63 -22.04 65.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 75.5 mmm -83.67 5.3 25.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.55 -1.36 66.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 123' ' ' VAL . 5.4 m-85 -80.26 156.93 26.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.57 143.72 85.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.2 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.92 -168.58 11.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -97.73 -32.11 11.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 110.955 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.65 -59.09 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.455 HG22 ' CB ' ' A' ' 156' ' ' ALA . 11.6 p -59.19 -32.1 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -58.25 -43.54 95.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -82.22 -23.65 35.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.5 -47.27 84.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.558 HG23 ' CZ3' ' A' ' 152' ' ' TRP . 30.0 mm -43.62 -50.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -63.88 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.44 -45.3 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.44 -46.44 66.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -69.18 -23.71 63.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -90.28 -9.33 48.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -104.96 -28.58 11.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.1 -51.4 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.32 15.57 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.56 -58.85 4.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.723 . . . . 0.0 110.874 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.527 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 54.0 Cg_endo -69.72 -50.87 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.379 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -48.34 -49.61 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 185' ' ' PHE . 7.9 t-20 -65.5 -68.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.2 mp -39.06 -27.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 183' ' ' ASN . 82.1 t80 -82.08 -63.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.8 mt -43.81 -48.03 8.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 t -79.23 -44.35 21.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -51.72 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -47.01 109.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.9 m -98.07 -58.46 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -77.34 -0.06 24.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.463 ' N ' HD11 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -119.81 86.66 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.25 157.74 46.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -47.02 147.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -82.79 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 148.61 45.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 137.73 36.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -48.27 159.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.01 175.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 31.0 p -131.2 164.44 25.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.4 m -131.56 177.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -108.29 174.29 5.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.887 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 75.9 p -125.37 164.47 20.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -127.83 177.91 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.04 154.57 45.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -136.29 172.19 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -110.32 172.43 6.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 20.7 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -76.86 118.13 19.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 135.79 36.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.23 115.17 4.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -70.77 -22.13 62.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.884 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.2 p -91.73 125.97 36.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.55 47.52 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -99.92 86.35 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.16 145.98 26.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -78.67 -42.71 27.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.5 p -60.4 -38.1 82.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.4 mtt-85 -64.69 -61.68 2.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.88 -35.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.562 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 46.3 mtpt -70.59 -53.73 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 mt -53.74 -39.16 65.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -46.36 -51.9 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.67 -65.76 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.5 mt -45.24 -24.94 0.31 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -82.69 -48.11 11.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -67.22 -26.0 66.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 6.0 tt -85.08 -42.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.19 -41.57 73.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -55.67 -28.49 55.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 3.7 t80 -69.8 -29.41 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.505 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 77.0 m95 -81.56 -49.52 10.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -44.28 -40.94 5.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.67 -40.05 68.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -76.58 -39.62 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.29 32.69 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 m -134.82 103.89 5.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 p -53.64 141.3 26.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 tt -86.32 125.43 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -118.94 125.06 48.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.02 129.44 61.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.722 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.34 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.42 ' NE2' ' CD1' ' A' ' 127' ' ' ILE . 26.3 m80 -120.61 114.51 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.8 t -100.12 119.11 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 56.35 51.13 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 52.64 35.59 18.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -150.28 140.4 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' ' NE2' ' A' ' 122' ' ' HIS . 15.9 mm -60.81 144.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.91 104.21 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.93 113.32 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.39 -61.06 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 100' ' ' LYS . 33.8 t80 -39.97 -55.32 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -66.87 -51.06 59.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.65 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -49.26 -46.35 46.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -49.52 -52.13 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.69 -49.05 74.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.2 t -47.35 -54.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.66 70.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -54.92 -39.28 68.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.99 -14.77 61.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 152.85 -61.92 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.484 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 160.04 173.51 28.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.475 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.94 -46.19 90.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.38 -66.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 5.7 p -44.32 -37.04 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 37.5 t -72.89 -49.34 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 148' ' ' LYS . 5.8 p -58.15 -45.87 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 147' ' ' CYS . 31.3 tttm -68.27 -33.4 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.54 4.45 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 146' ' ' VAL . 15.6 mmm180 47.12 37.88 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 19.3 mtpp -83.42 36.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.638 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 51.9 m95 -81.5 -44.21 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.1 m -43.39 -47.16 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -51.89 -61.63 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 151' ' ' LYS . 5.3 mp -55.73 -55.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.87 -53.61 2.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -47.4 86.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -45.19 -49.23 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -60.78 -25.81 66.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.97 -2.93 14.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -74.54 138.61 43.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.27 144.14 16.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.545 0.688 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 85.03 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.353 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.22 169.13 24.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.489 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -74.6 -38.28 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.73 -59.11 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 168' ' ' GLY . 7.4 p -61.32 -37.25 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.47 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -53.4 -49.33 57.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.4 t -73.67 -31.11 63.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.442 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.7 m-70 -54.7 -47.23 73.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.638 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 20.7 mm -46.2 -49.75 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.574 ' NH2' ' CD1' ' A' ' 152' ' ' TRP . 16.9 ttm105 -61.86 -61.66 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.31 -46.56 11.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 80.1 m-70 -49.34 -43.26 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.0 t80 -68.01 -41.45 82.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.65 -9.26 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -100.13 -32.12 11.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.0 mt -119.75 -49.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.169 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 11.8 mt -82.52 18.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.08 -60.24 2.93 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.739 . . . . 0.0 110.885 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.505 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.9 Cg_endo -69.75 -47.54 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -49.41 -49.41 45.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -80.69 -38.0 29.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 14.9 tp -55.62 -26.23 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.12 -51.89 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.3 mt -45.37 -53.72 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t -60.68 -46.02 91.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.07 75.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -117.1 82.83 1.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -93.01 -50.22 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -46.73 -41.25 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 130.18 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.8 p -69.78 152.69 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -57.72 142.65 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -149.33 140.93 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.36 131.45 23.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 0.0 110.908 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 138.87 38.91 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 0.0 112.35 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -107.96 112.33 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 199' ' ' LEU . 5.7 tt -125.1 154.28 41.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 82.2 p -120.11 146.65 45.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.1 m -135.96 130.47 33.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -111.11 42.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 75.2 p -87.8 116.24 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -39.35 114.64 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -48.63 163.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 206' ' ' LYS . 6.5 tmtm? -95.31 134.72 37.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -140.86 168.7 19.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.9 p -122.13 166.0 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -43.7 -58.49 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.2 -152.28 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.457 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 m -163.69 121.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 110.86 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.1 p -44.69 109.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.7 64.02 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.472 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -63.43 -48.79 76.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.868 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.95 91.42 3.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -82.49 -60.8 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 p -40.64 -30.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 102' ' ' ASN . 5.0 tpt85 -66.59 -57.68 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.29 -22.99 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -77.88 -60.66 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.75 -34.8 78.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 30.9 m-20 -44.22 -58.26 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -55.21 -59.97 4.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -42.5 -43.11 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.86 -40.54 95.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -64.9 -51.38 62.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.505 ' CD1' ' CG ' ' A' ' 182' ' ' TYR . 2.1 tp -61.46 -37.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.12 88.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -53.06 -36.63 60.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.13 -37.35 87.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -80.17 -59.87 2.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -38.99 -40.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -59.12 -53.03 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -61.36 -35.37 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.84 39.87 1.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -136.21 123.08 21.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.1 m -70.41 129.45 39.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.39 125.22 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -121.81 125.37 46.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -70.9 131.65 87.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.162 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 158.69 56.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -115.69 126.37 54.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.18 112.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 57.8 49.91 11.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 125' ' ' ARG . 26.2 mtm105 54.48 35.97 24.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.82 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -145.32 125.11 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.24 127.43 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.092 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.1 115.04 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.51 102.63 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.49 -51.94 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -43.53 -53.27 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 133' ' ' LEU . 43.3 tt0 -70.4 -60.51 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 171' ' ' ILE . 13.3 tp -35.19 -69.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -47.93 -47.61 32.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 139' ' ' GLU . 22.8 tptt -47.67 -54.21 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.28 -40.87 74.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -53.27 -47.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.77 81.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 2.3 mp0 -66.59 -38.02 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -75.19 -21.41 58.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 159.34 -58.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 152.55 169.63 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.503 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -61.03 -39.09 88.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.69 -66.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.429 HG12 ' C ' ' A' ' 141' ' ' GLY . 5.0 p -48.05 -42.99 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 54.5 t -65.03 -70.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.3 t -44.61 -50.04 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -48.87 -55.41 11.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.81 14.78 5.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 42.85 54.34 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -98.25 41.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.566 ' CZ3' HG22 ' A' ' 171' ' ' ILE . 22.6 m95 -79.75 -40.84 27.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -46.35 -56.51 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -45.07 -53.34 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' ALA . 19.9 mt -64.09 -62.8 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -38.09 -49.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 m -63.27 -47.75 81.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -48.35 -41.15 27.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.4 mtp -67.45 -28.52 67.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -2.06 10.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -80.52 129.64 34.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -44.58 143.04 2.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.558 0.694 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.11 137.04 5.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -44.61 -26.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.23 -59.11 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 168' ' ' GLY . 10.8 p -67.82 -36.35 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -55.51 -44.95 85.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.445 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -78.64 -32.37 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -53.18 -50.57 64.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.566 HG22 ' CZ3' ' A' ' 152' ' ' TRP . 21.8 mm -40.31 -61.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -54.39 -54.96 33.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -47.9 -47.0 25.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -51.21 -42.89 61.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.5 t80 -68.08 -40.75 82.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -78.04 -9.24 59.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -103.7 -28.18 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mt -120.11 -52.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 8.4 mt -88.58 28.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.58 -60.37 2.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.668 0.747 . . . . 0.0 110.864 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.3 Cg_endo -69.66 -48.12 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.676 2.251 . . . . 0.0 112.383 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CG ' ' CD1' ' A' ' 107' ' ' ILE . 6.3 t80 -39.25 -46.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.38 -51.78 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 83.8 mt -45.35 -37.47 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.32 -55.31 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.2 mt -47.32 -46.51 25.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.5 m -59.63 -46.78 87.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -58.91 92.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.8 119.23 9.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 97.7 p -88.77 -27.98 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 192' ' ' ARG . 1.3 pt? -80.65 -38.69 28.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 192' ' ' ARG . 1.1 mmp_? -62.72 134.16 55.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.18 148.93 41.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 tp -55.96 125.3 20.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -135.15 137.54 42.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.457 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -142.46 137.73 15.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.943 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.457 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 53.5 Cg_endo -69.76 160.26 50.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -133.69 106.91 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.51 166.69 14.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 23.4 m -131.38 103.61 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.7 p -64.08 107.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -54.82 107.71 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.9 p -52.33 166.19 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -73.85 96.73 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 170.2 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.38 138.59 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -42.99 -46.13 5.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 32.0 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.843 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.6 t -86.05 151.95 23.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.803 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 p -84.31 -45.19 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.86 138.86 6.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 t -47.46 137.49 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -100.25 87.1 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 53.51 -171.07 0.77 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.48 165.28 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.98 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.402 ' C ' ' N ' ' A' ' 98' ' ' ARG . 68.4 mt-30 -111.6 -44.98 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.466 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 42.5 p -45.3 -21.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' GLN . 23.4 ttt180 -67.47 -45.59 75.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 100' ' ' LYS . 11.5 p -65.63 -24.98 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' CE ' ' HA ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.46 -41.77 21.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.18 -44.52 88.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -43.83 -60.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 106' ' ' GLN . 45.9 t80 -61.17 -63.64 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 98.7 mt -38.4 -32.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 103' ' ' PHE . 7.5 t70 -77.63 -46.35 22.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 103' ' ' PHE . 91.9 mt-30 -64.17 -23.52 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 182' ' ' TYR . 2.2 tp -92.02 -36.6 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.07 62.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 13.6 ptmt -57.76 -43.67 85.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 33.1 t80 -55.41 -28.19 52.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.556 ' CD1' HD13 ' A' ' 118' ' ' LEU . 68.5 m95 -81.08 -48.81 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.97 -57.09 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -47.36 -36.37 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -73.62 -32.92 64.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.63 34.46 3.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.3 t -139.02 123.24 18.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 110.865 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -68.85 148.95 49.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 111' ' ' TRP . 6.8 tt -105.79 143.75 33.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' N ' HD21 ' A' ' 118' ' ' LEU . 24.3 ttmt -156.42 120.46 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.41 HD12 ' CD1' ' A' ' 130' ' ' LEU . 34.6 mm -84.18 131.94 49.34 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG2' ' CE1' ' A' ' 174' ' ' HIS . 53.3 Cg_endo -69.84 153.77 68.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 0.0 112.294 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -86.36 109.68 19.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.9 t -96.69 123.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 49.6 53.75 12.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 54.8 27.85 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -154.38 123.85 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.15 127.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.433 HD21 ' CD2' ' A' ' 133' ' ' LEU . 10.7 tp -82.35 107.76 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.72 117.2 17.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.41 ' CD1' HD12 ' A' ' 120' ' ' ILE . 17.5 mt -65.16 -49.59 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CD2' ' HG3' ' A' ' 100' ' ' LYS . 35.7 t80 -42.62 -57.34 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -72.99 -48.14 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CD2' HD21 ' A' ' 128' ' ' LEU . 32.0 tp -44.43 -71.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' VAL . 57.5 t-20 -47.99 -66.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 134' ' ' ASN . 35.9 tttp -35.65 -54.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.51 -41.67 63.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 134' ' ' ASN . 94.6 t -58.07 -48.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.3 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -73.69 -35.11 65.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -77.92 -16.64 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 159.75 -57.53 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.31 175.81 22.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.79 -33.17 73.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.78 -65.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.409 HG12 ' C ' ' A' ' 141' ' ' GLY . 2.1 p -48.05 -42.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 150' ' ' ARG . 67.5 t -70.51 -67.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 48.6 t -45.51 -34.2 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -77.02 -49.23 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 150' ' ' ARG . 37.6 m-20 -89.22 21.18 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 149' ' ' ASP . 2.5 mmp_? 35.72 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -89.37 17.4 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.519 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 62.6 m95 -63.69 -45.99 87.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.2 m -41.69 -58.49 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -47.54 -58.43 4.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.8 mt -51.2 -66.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.1 m -54.9 -46.37 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -60.57 -26.8 67.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 82.1 mmm -78.56 2.19 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.99 63.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.15 166.71 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.12 145.16 52.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.602 0.715 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 85.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.98 -176.54 14.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.37 -25.26 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.778 0.323 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.17 -58.39 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.1 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.5 -38.65 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.82 -41.61 76.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.4 t -79.22 -29.57 42.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -57.99 -47.68 82.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.519 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 6.3 mm -45.05 -55.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -59.29 -63.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.92 -47.69 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.418 ' CE1' ' HG2' ' A' ' 121' ' ' PRO . 57.7 m-70 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -66.76 -30.85 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -85.04 -9.23 58.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -101.7 -31.31 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.09 -51.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 175' ' ' TYR . 16.4 mt -83.12 20.03 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.83 -60.26 2.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.82 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.551 ' CE2' HD12 ' A' ' 186' ' ' LEU . 10.0 t80 -40.05 -51.1 2.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.02 -41.29 95.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.4 -43.95 79.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -71.31 -59.19 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.551 HD12 ' CE2' ' A' ' 182' ' ' TYR . 67.7 mt -38.4 -49.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -43.91 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.92 66.93 1.54 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -139.04 128.18 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.363 . . . . 0.0 110.82 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -81.28 -52.77 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.1 pp -48.35 -36.7 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -46.67 -33.56 4.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.81 157.9 5.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.06 144.56 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -102.54 169.9 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -128.78 136.8 29.71 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.538 0.685 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -171.2 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.338 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -116.18 179.42 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -150.48 159.56 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.539 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 12.9 t -148.62 169.3 20.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.0 t -72.26 152.15 42.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.49 115.16 17.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 65.8 p -136.07 167.76 20.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -43.44 122.42 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -116.47 179.99 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -50.98 122.01 6.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.13 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.858 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.7 p -75.14 -45.9 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -116.44 121.71 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.13 -128.28 5.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.53 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 t -139.3 176.84 8.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 m -148.81 173.73 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.48 175.6 14.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.461 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -62.67 103.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.65 -176.58 3.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -97.97 -25.11 15.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.8 t -62.34 -33.97 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -67.05 -62.41 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.38 -35.38 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 62.6 mttm -71.26 -61.28 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.08 -40.46 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -51.76 -53.52 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -57.98 -65.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 44.2 mt -44.47 -35.38 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.67 -52.82 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -56.73 -52.59 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 3.8 tt -63.23 -32.14 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.43 93.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 111' ' ' TRP . 3.0 mmmm -54.46 -58.62 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -38.79 -25.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 109' ' ' LYS . 63.5 m95 -90.86 -51.11 5.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.63 -20.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' N ' HD21 ' A' ' 113' ' ' LEU . 1.5 mm? -79.17 -46.62 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -69.21 -1.66 8.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.12 43.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.7 p -128.98 129.04 44.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 110.802 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.4 114.74 25.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.13 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 tt -50.31 137.12 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.65 115.14 61.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 165.66 30.19 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 12.0 m170 -117.66 132.5 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.09 124.99 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.177 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 59.72 39.25 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.41 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 6.7 mmp_? 63.38 35.17 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -145.32 162.93 36.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.54 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 44.7 mm -82.69 102.99 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' A' ' 174' ' ' HIS . 47.2 tp -66.8 93.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.47 106.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.9 -46.43 90.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 131' ' ' PHE . 4.3 t80 -53.5 -56.12 19.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.19 -41.27 94.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 HD13 ' CG2' ' A' ' 171' ' ' ILE . 4.1 tp -49.63 -72.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -51.63 -32.23 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -62.07 -50.79 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 136' ' ' LEU . 3.6 mm? -59.2 -41.6 88.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -56.18 -55.51 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -54.04 -41.59 68.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.55 -40.99 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.45 -17.06 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 157.1 -59.09 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 144.18 170.33 13.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.472 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.58 -36.68 72.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -65.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 141' ' ' GLY . 4.0 p -56.62 -54.92 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 85.2 t -51.4 -62.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.3 t -53.92 -40.86 67.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.2 tptp -53.88 -48.92 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.32 11.87 37.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 49.4 44.9 23.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -84.98 50.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.551 ' CZ3' HG22 ' A' ' 171' ' ' ILE . 81.4 m95 -86.85 -51.23 6.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.0 m -39.4 -67.36 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -37.74 -53.94 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' ALA . 23.3 mt -58.78 -65.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.72 -46.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 m -68.08 -45.35 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -57.14 -29.44 63.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mmm -70.3 -17.22 63.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.65 1.71 11.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -90.02 172.38 8.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.21 145.92 43.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 88.46 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.266 . . . . 0.0 112.366 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.98 131.08 4.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -42.74 -25.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.26 -59.18 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 168' ' ' GLY . 12.5 p -64.85 -32.99 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -54.5 -48.3 65.68 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -77.05 -32.4 56.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -51.71 -51.07 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.551 HG22 ' CZ3' ' A' ' 152' ' ' TRP . 50.4 mm -42.16 -62.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -51.88 -53.43 40.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.41 -42.69 34.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.54 ' CD2' HD23 ' A' ' 128' ' ' LEU . 93.1 m-70 -60.52 -36.9 79.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 110.84 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.463 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.2 t80 -78.82 -30.2 45.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.56 -9.25 56.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 177' ' ' ARG . 13.3 mtp-105 -104.82 -28.43 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.98 -52.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 28.8 mt -85.2 21.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -71.65 -60.08 2.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 0.0 110.881 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.73 -49.65 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.383 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.5 t80 -45.07 -54.12 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -77.21 -37.93 52.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 40.9 tp -62.14 -19.59 63.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -98.0 -50.59 4.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -48.34 -45.12 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m -56.58 -45.7 81.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 175.55 177.07 44.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -97.6 74.33 2.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.1 p -96.62 -17.68 20.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -80.55 3.25 22.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.401 ' N ' HD13 ' A' ' 191' ' ' LEU . 28.3 mmt180 -69.01 96.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 17.2 p -40.22 154.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.1 tp -38.74 119.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -78.39 163.07 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -43.89 156.09 0.31 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.588 0.708 . . . . 0.0 110.894 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 86.72 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 0.0 112.312 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.92 170.48 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.51 76.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.5 p -137.63 154.96 49.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.0 t -68.19 78.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -104.89 103.31 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.2 m -67.83 146.47 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 204' ' ' LYS . 0.0 OUTLIER -128.04 102.81 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.35 102.62 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -71.79 158.14 36.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -91.99 -44.24 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 39.4 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.1 m -65.78 168.59 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -149.73 156.74 42.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.3 112.12 4.02 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 m -57.09 -61.17 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.7 m -104.8 169.83 8.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.24 117.15 5.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -106.97 41.29 1.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.842 0.353 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.53 -45.88 12.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -121.7 62.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.6 m -92.2 -67.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 12.9 ttp-105 -45.74 -59.09 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.41 -34.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HA ' ' CE2' ' A' ' 131' ' ' PHE . 53.1 mtpt -82.86 -58.82 2.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.0 mt -45.56 -36.98 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -50.5 -57.44 8.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 6.2 t80 -58.27 -58.91 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.9 mt -46.71 -37.95 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.32 -57.5 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -48.32 -56.0 9.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.555 HD12 ' CD1' ' A' ' 182' ' ' TYR . 1.7 tp -55.59 -40.1 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.18 91.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.01 -36.81 30.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -63.4 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.46 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 27.0 m95 -83.34 -59.24 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -38.31 -36.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.462 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 33.4 mt -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.47 -36.36 82.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.86 39.94 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -132.7 118.08 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.8 m -64.88 129.62 40.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 118' ' ' LEU . 6.8 tt -79.97 122.15 26.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -116.15 141.66 47.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 mm -85.52 127.38 63.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.621 0.724 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 168.01 22.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.362 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -127.61 125.49 40.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.559 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 56.0 t -113.41 131.78 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 51.06 37.61 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? 64.16 54.5 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -164.37 164.02 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -73.45 127.56 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.02 98.69 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 129' ' ' ASP . 43.0 t0 -70.8 117.12 11.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.4 mt -72.36 -63.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' HA ' ' A' ' 100' ' ' LYS . 16.2 t80 -38.68 -61.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -57.46 -58.42 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tp -41.23 -67.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -50.59 -49.28 56.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -46.17 -54.35 8.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.64 -43.3 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 64.6 t -51.17 -48.81 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.48 91.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.26 -41.14 88.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.01 -22.35 58.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.438 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 161.63 -57.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 146.15 177.47 20.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.45 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 11.1 t80 -66.61 -36.63 83.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.61 -66.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG12 ' C ' ' A' ' 141' ' ' GLY . 4.2 p -50.6 -51.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 98.4 t -59.04 -68.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 35.5 t -44.73 -38.09 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -66.59 -45.42 79.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.2 m-20 -93.34 24.07 4.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 149' ' ' ASP . 3.0 mpt_? 35.02 45.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -93.36 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.555 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 30.6 m95 -84.8 -48.67 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 152' ' ' TRP . 38.7 m -37.04 -53.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -46.43 -68.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 156' ' ' ALA . 24.0 mt -45.31 -65.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.91 -50.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.8 m -54.3 -53.31 55.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -47.47 -49.57 25.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.4 mmm -50.12 -28.15 6.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.24 -4.04 10.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 36.7 m-85 -81.07 167.69 19.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 143.29 60.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 104.49 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.62 -159.48 9.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -101.0 -36.85 8.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.321 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -52.82 -58.48 6.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.52 -36.97 78.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.6 90.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 t -77.22 -28.76 53.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -58.34 -50.77 72.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.555 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 50.6 mm -40.4 -60.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -56.51 -53.58 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.38 -43.27 34.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -55.85 -39.86 72.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 2.6 t80 -67.77 -39.17 84.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -80.96 -9.21 59.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -97.2 -33.35 11.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.01 -51.39 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 175' ' ' TYR . 12.6 mt -84.53 28.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.53 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -72.28 -60.4 2.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.875 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.75 -33.7 16.1 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.369 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.555 ' CD1' HD12 ' A' ' 107' ' ' ILE . 4.4 t80 -47.89 -60.91 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -72.4 -34.85 68.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.08 -48.8 70.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -73.67 -58.55 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.7 mt -41.83 -43.56 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 t -60.54 -46.63 89.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.86 123.56 0.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.74 133.41 8.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.9 m -45.36 -30.02 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 28.3 mt -50.47 -51.51 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -53.77 152.71 5.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.461 ' N ' ' HD3' ' A' ' 192' ' ' ARG . 4.2 m -109.93 149.15 30.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.77 125.37 24.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -116.03 41.28 2.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.54 132.15 13.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 115.05 3.91 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 0.0 112.347 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -150.02 157.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 198' ' ' ASN . 23.1 tp -36.31 119.61 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 40.2 p -46.72 142.03 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 7.7 t -50.9 158.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -83.39 150.41 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.2 t -114.59 156.91 23.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -95.7 130.59 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -134.71 152.27 51.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -105.55 130.38 53.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.3 154.67 17.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 57.6 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -109.24 127.79 54.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.84 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -159.68 152.31 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.22 -99.43 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -129.17 152.11 49.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.873 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -54.47 -48.85 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.01 136.31 6.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -86.96 39.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.92 176.82 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -110.68 42.2 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.3 t -88.82 -34.0 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -69.6 -42.28 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.444 HG21 ' CZ ' ' A' ' 131' ' ' PHE . 7.2 p -62.2 -34.41 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.88 -53.55 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.1 mt -60.36 -46.01 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -46.64 -59.47 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 104' ' ' LEU . 71.7 t80 -49.25 -68.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 70.7 mt -37.03 -37.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.37 -57.92 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -52.29 -51.46 58.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.446 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.7 tt -58.05 -36.78 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.85 -50.99 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -47.71 -38.77 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -58.57 -38.58 78.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -82.06 -53.49 6.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -41.58 -50.13 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.33 -44.31 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -73.31 -36.81 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.18 40.71 0.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.9 m -131.88 126.68 34.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -74.51 128.28 35.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.426 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 4.1 tt -91.22 118.32 30.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -128.59 136.84 51.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mm -67.47 124.5 89.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 111.108 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.547 ' HB2' ' CE1' ' A' ' 174' ' ' HIS . 53.9 Cg_endo -69.76 167.17 25.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.696 2.264 . . . . 0.0 112.311 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -123.89 119.92 31.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.67 136.51 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 45.17 39.84 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 61.48 44.82 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -155.04 142.33 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.06 118.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 174' ' ' HIS . 22.1 tp -94.8 103.9 15.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.938 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.1 104.03 5.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.9 mt -64.67 -46.64 81.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 58.6 t80 -48.12 -61.06 2.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.456 ' O ' ' CG ' ' A' ' 136' ' ' LEU . 7.1 mm100 -65.7 -39.5 91.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.6 tp -52.66 -71.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -53.57 -62.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -42.31 -50.81 4.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.456 ' CG ' ' O ' ' A' ' 132' ' ' GLN . 24.8 mt -56.1 -42.87 77.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.8 -48.04 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.73 75.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.9 -44.9 94.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.35 -27.57 67.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.439 ' C ' ' CG1' ' A' ' 145' ' ' VAL . . . 165.65 -54.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.49 163.48 9.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -57.17 -29.29 63.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.34 -66.3 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.069 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.439 ' CG1' ' C ' ' A' ' 141' ' ' GLY . 3.6 p -55.01 -39.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.4 t -68.04 -56.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.0 t -56.29 -41.95 76.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -55.61 -49.77 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.34 4.12 53.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.73 40.43 31.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -89.38 46.79 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.554 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 72.6 m95 -89.08 -41.65 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.4 m -42.9 -52.72 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -54.01 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.4 mt -60.35 -60.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -43.72 -47.6 7.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.6 m -62.51 -46.21 89.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -51.78 -52.77 46.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 30.5 mtp -46.6 -28.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.33 -3.99 10.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.481 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.36 172.03 13.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.08 142.09 51.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 90.02 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.324 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.01 178.97 21.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -83.0 -32.38 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.58 55.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.9 p -63.59 -38.57 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.438 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -53.33 -45.96 64.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.1 m -75.43 -32.87 60.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -56.25 -49.71 73.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.554 ' CG2' ' CZ3' ' A' ' 152' ' ' TRP . 9.7 mm -44.23 -55.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.8 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.53 -56.69 9.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 25.3 m-70 -49.32 -35.6 18.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.6 OUTLIER -75.99 -44.54 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.0 -9.9 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -105.27 -28.62 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.4 mt -116.72 -52.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.45 33.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.507 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.63 -63.88 0.52 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.39 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.7 t80 -37.74 -36.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -82.55 -53.8 5.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -55.7 -20.36 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -90.6 -52.08 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 182' ' ' TYR . 27.4 mt -47.98 -46.03 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 m -76.93 -48.47 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.92 64.3 3.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.445 ' HB2' ' CG ' ' A' ' 192' ' ' ARG . 15.9 p-10 -105.74 107.13 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.0 m -97.83 -52.13 3.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.54 -18.56 1.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.445 ' CG ' ' HB2' ' A' ' 189' ' ' ASP . 36.5 ptt180 -133.39 169.04 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.99 157.87 16.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.483 ' C ' ' CD1' ' A' ' 194' ' ' LEU . 0.9 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -111.63 108.17 17.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -79.47 143.46 59.65 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.57 0.7 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 89.06 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.69 2.26 . . . . 0.0 112.301 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -71.44 72.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.535 ' CD2' ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -79.39 166.77 21.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.41 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 2.3 p -142.36 148.78 38.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 36.0 p -110.33 88.92 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.846 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.61 106.01 11.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -96.9 132.83 42.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 204' ' ' LYS . 0.0 OUTLIER -98.46 143.14 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -145.36 151.07 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -111.23 139.08 46.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.66 127.42 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -129.89 149.71 51.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.857 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 t -138.74 119.81 14.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.57 57.8 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -61.16 161.35 8.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -107.68 178.38 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.09 -111.06 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.13 137.53 37.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 126.25 30.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -108.31 -45.49 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 p -59.73 -30.54 68.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -71.26 -59.01 3.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.54 HG21 ' CE2' ' A' ' 131' ' ' PHE . 7.6 p -56.87 -39.07 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 31.0 mttm -65.56 -54.37 28.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.47 -56.75 18.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.963 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -38.42 -58.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 12.1 t80 -50.17 -57.36 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 41.0 mt -52.18 -27.98 16.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.2 -53.71 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -56.32 -49.87 73.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.45 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 4.8 tt -57.49 -42.07 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.72 82.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -48.87 -37.36 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.528 ' OH ' ' CE1' ' A' ' 185' ' ' PHE . 5.6 m-85 -59.18 -43.98 92.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.426 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 73.2 m95 -68.97 -51.7 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -42.09 -50.3 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.3 mt -47.96 -42.0 26.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.92 -36.21 64.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.3 30.05 2.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.44 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.3 m -128.83 138.07 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.811 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -86.96 132.85 33.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.31 118.75 25.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -112.54 125.0 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.79 119.61 75.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 154.47 67.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.471 ' CE1' HD11 ' A' ' 127' ' ' ILE . 5.5 m170 -111.2 123.36 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.59 121.47 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.07 48.57 6.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 126' ' ' LYS . 12.1 mpt_? 54.14 46.8 24.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 125' ' ' ARG . 34.8 mtmm -164.52 142.18 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.471 HD11 ' CE1' ' A' ' 122' ' ' HIS . 21.0 mm -56.88 144.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.431 ' N ' HG23 ' A' ' 127' ' ' ILE . 20.1 tp -109.07 120.09 41.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.43 95.37 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 131' ' ' PHE . 55.9 mt -57.3 -63.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 99' ' ' VAL . 10.5 t80 -34.76 -58.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 133' ' ' LEU . 10.8 tp60 -62.41 -62.61 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 171' ' ' ILE . 7.9 tp -35.08 -66.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -45.86 -56.22 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.45 -52.51 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.28 -41.97 66.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.14 -45.89 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.73 -34.99 79.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -68.01 -31.59 71.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -82.93 -16.1 48.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 145' ' ' VAL . . . 155.15 -60.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 153.43 172.76 21.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.72 -40.42 95.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.16 -66.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.432 HG12 ' C ' ' A' ' 141' ' ' GLY . 5.2 p -48.61 -43.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 44.8 t -62.83 -62.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 8.7 m -49.89 -46.02 51.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 148' ' ' LYS . 4.7 tmtt? -53.5 -60.15 3.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 150' ' ' ARG . 18.1 m-20 -84.47 25.87 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 149' ' ' ASP . 21.2 mmt180 34.49 38.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.403 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 41.1 mtpt -76.9 47.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.541 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 13.6 m95 -91.03 -48.73 6.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.5 m -39.07 -51.25 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -48.55 -64.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LYS . 18.8 mt -52.92 -62.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.43 -49.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.6 m -65.23 -38.67 91.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 155' ' ' ILE . 24.3 mmtt -53.64 -47.14 70.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.0 mtp -65.13 -19.97 66.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.44 3.56 25.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.455 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CB ' HG23 ' A' ' 167' ' ' VAL . 27.8 m-85 -83.56 128.17 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -47.4 143.87 5.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.545 0.688 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.08 4.86 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 171.35 41.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -79.17 -14.66 58.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.21 -56.84 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 168' ' ' GLY . 7.5 p -64.69 -37.34 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.463 ' N ' HG11 ' A' ' 167' ' ' VAL . . . -55.98 -46.73 83.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.9 t -76.0 -28.31 57.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -58.33 -49.21 77.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.541 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 5.7 mm -44.5 -60.09 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -57.05 -55.9 28.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.41 -44.87 16.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -49.14 -46.73 45.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.78 -38.54 91.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -80.56 -9.18 59.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -99.91 -31.73 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.0 mt -119.74 -50.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.66 22.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -72.48 -60.62 2.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -48.03 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.99 -44.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.01 -58.07 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -42.09 -35.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.528 ' CE1' ' OH ' ' A' ' 110' ' ' TYR . 12.1 t80 -73.2 -49.5 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.1 mt -56.65 -35.68 68.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.0 t -79.47 -45.41 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.63 -145.28 4.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.521 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -124.86 151.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.1 m -48.98 -42.27 37.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 192' ' ' ARG . 4.6 mm? -45.07 -43.35 9.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -35.91 141.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.7 m -132.66 161.4 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.402 HD21 ' C ' ' A' ' 194' ' ' LEU . 7.0 tt -112.04 122.64 48.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -43.97 105.4 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.457 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -41.24 137.06 1.66 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.925 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.457 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 53.6 Cg_endo -69.76 138.17 37.2 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -76.44 156.49 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.27 145.99 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 70.3 p -97.73 164.88 12.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.0 p -111.58 87.54 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.81 149.51 43.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 73.1 m -132.23 103.31 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.16 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -42.9 132.19 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.61 132.8 38.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -97.67 85.09 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -98.52 152.78 19.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.823 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.4 m -86.2 131.59 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t -72.02 171.96 10.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.63 57.71 4.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -130.4 93.86 3.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -53.3 146.69 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.26 74.32 0.87 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.08 132.35 56.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.78 -53.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.32 45.08 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.0 t -90.01 -26.7 20.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -41.35 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.422 HG23 ' CZ ' ' A' ' 131' ' ' PHE . 8.4 p -64.54 -30.56 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -79.0 -51.51 9.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.89 -47.75 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -42.78 -53.2 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -51.84 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.0 mt -42.75 -36.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.59 -59.19 3.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -52.87 -54.14 38.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.1 -33.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.55 -54.37 47.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' N ' ' HE2' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -42.84 -54.85 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -42.76 -38.12 2.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.537 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 66.7 m95 -83.56 -47.82 10.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -46.52 -44.38 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.82 -42.59 89.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -68.43 -37.67 80.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.8 40.46 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.9 p -142.8 106.15 4.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.912 0.387 . . . . 0.0 110.818 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.7 p -50.58 147.11 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.51 111.95 24.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -110.03 140.6 43.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.91 131.89 45.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.163 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 170.97 15.33 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -127.62 111.13 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.6 t -104.47 123.55 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 60.74 41.86 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 57.64 40.89 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -153.69 149.31 27.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.38 135.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.0 tp -103.47 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.91 97.71 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' PHE . 51.7 mt -55.43 -62.84 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' LEU . 88.7 t80 -34.79 -54.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 133' ' ' LEU . 4.7 tp60 -64.94 -62.91 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 132' ' ' GLN . 14.4 tp -34.39 -69.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -50.33 -51.27 46.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -46.27 -51.55 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.01 -50.17 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.5 t -47.64 -50.7 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.26 -45.86 83.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.55 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -76.56 -22.7 53.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 145' ' ' VAL . . . 159.2 -58.55 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 146' ' ' VAL . . . 151.93 170.76 18.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.518 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -60.52 -40.79 92.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.89 -66.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 141' ' ' GLY . 5.3 p -49.13 -43.37 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 142' ' ' GLY . 69.2 t -67.62 -66.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 52.7 t -44.57 -48.1 10.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -56.79 -57.82 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.99 19.56 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 38.86 48.67 1.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -84.51 38.49 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.559 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 80.7 m95 -84.01 -44.97 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -41.28 -50.71 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -49.38 -55.15 13.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' ALA . 4.6 mp -60.3 -64.49 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.48 -49.97 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.4 m -61.41 -47.55 85.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -50.09 -41.88 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 31.6 mtp -68.15 -28.0 66.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -1.67 10.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.468 ' CB ' HG23 ' A' ' 167' ' ' VAL . 19.6 m-85 -81.37 128.02 33.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -46.4 141.61 4.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.56 0.695 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.39 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 0.0 112.37 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.17 132.32 5.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -37.36 -33.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -53.2 -58.75 5.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.468 HG23 ' CB ' ' A' ' 161' ' ' PHE . 8.6 p -64.77 -32.57 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.461 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -56.24 -45.0 89.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.9 m -77.49 -35.3 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -51.89 -48.09 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.559 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 5.0 mm -45.89 -55.72 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' C ' ' OE1' ' A' ' 176' ' ' GLU . 41.2 mtp180 -55.38 -57.88 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.81 -42.29 7.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -59.6 -39.95 85.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -72.2 -39.12 68.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.408 ' OE1' ' C ' ' A' ' 172' ' ' ARG . 10.1 mp0 -81.89 -9.24 59.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.76 -30.84 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.98 -50.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.2 mt -84.04 23.36 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.485 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.61 -60.34 2.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.537 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.8 Cg_endo -69.74 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.28 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.535 ' CD2' HD13 ' A' ' 186' ' ' LEU . 5.8 t80 -42.08 -54.4 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -77.25 -42.16 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.1 tp -55.28 -27.01 43.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -97.1 -54.16 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 182' ' ' TYR . 28.0 mt -41.95 -44.36 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.4 t -54.16 -47.29 72.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 189' ' ' ASP . . . -71.04 102.09 1.03 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 188' ' ' GLY . 1.1 m-20 -34.44 109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.848 0.356 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 87.8 p -46.07 -34.42 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.87 -43.49 38.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -47.4 -27.62 1.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 10.5 t -134.87 53.48 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.9 tp -133.04 100.36 4.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.15 34.19 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -125.37 122.36 25.05 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.602 0.715 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 136.04 31.99 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.4 176.18 5.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.44 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 55.3 m -69.85 144.18 52.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.5 m -142.78 169.33 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -82.02 125.56 30.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.5 p -101.95 128.58 48.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -57.24 143.35 39.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -120.48 143.55 48.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.05 126.31 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -123.83 -44.79 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.78 0.324 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -70.71 -50.39 36.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -44.67 -35.98 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -80.28 -46.97 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.3 mt -55.0 -39.15 68.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -44.74 -65.59 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 74.1 t80 -49.66 -68.04 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.436 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 72.5 mt -37.05 -52.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CD ' ' A' ' 109' ' ' LYS . 22.1 t70 -49.77 -53.41 25.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -56.1 -59.64 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.436 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.0 tt -57.06 -25.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -74.2 -41.82 60.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -56.3 -34.08 66.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.37 -31.12 72.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' LEU . 14.5 m95 -88.13 -54.3 4.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -26.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 111' ' ' TRP . 54.7 mt -69.81 -48.82 57.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.443 ' OE1' ' C ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -68.08 -36.71 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 115.41 33.45 1.6 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -120.05 145.33 46.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.846 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 m -89.31 128.84 35.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -86.2 120.31 27.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 118' ' ' LEU . 16.3 tptp -142.33 124.29 15.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.0 mm -81.1 138.46 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.9 Cg_endo -69.77 179.48 3.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 127' ' ' ILE . 56.9 m80 -115.8 107.02 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.505 HG12 ' CE1' ' A' ' 161' ' ' PHE . 53.3 t -93.14 110.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 57.65 48.29 14.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 60.21 31.59 20.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -148.42 123.36 10.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 122' ' ' HIS . 19.9 mm -54.75 131.68 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.618 ' O ' HG21 ' A' ' 120' ' ' ILE . 58.8 tp -92.39 103.62 16.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.14 91.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 131' ' ' PHE . 64.4 mt -43.17 -59.5 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' LEU . 45.9 t80 -35.31 -69.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 133' ' ' LEU . 40.8 mt-30 -54.89 -57.27 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.996 HD11 HG23 ' A' ' 171' ' ' ILE . 16.6 tp -34.09 -71.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -51.2 -45.91 62.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -49.17 -58.64 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.94 -46.26 60.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.8 t -49.07 -55.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.85 75.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.0 -38.04 89.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.91 -19.79 60.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 157.38 -59.44 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.76 171.32 17.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.07 -46.0 91.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.84 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.52 -66.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.6 p -49.9 -54.47 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 142' ' ' GLY . 57.4 t -51.43 -49.09 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.2 m -58.25 -45.41 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -57.49 -49.04 77.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.9 m-20 -97.36 18.4 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 35.36 51.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -86.47 41.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.85 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 43.4 m95 -84.26 -36.36 22.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 m -49.7 -43.7 47.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -54.45 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.583 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.7 mp -55.23 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -38.7 -53.51 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 92.4 m -57.83 -43.79 86.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -61.07 -22.83 64.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 93.3 mmm -82.45 9.24 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.82 -10.11 74.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.543 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.505 ' CE1' HG12 ' A' ' 123' ' ' VAL . 13.6 m-85 -72.26 157.11 38.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.0 61.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 85.64 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.677 2.252 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.34 -130.49 3.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.44 -46.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.61 -58.98 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.534 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.2 p -54.9 -31.08 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.16 19.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 t -70.13 -25.65 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -58.49 -48.09 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.996 HG23 HD11 ' A' ' 133' ' ' LEU . 34.7 mm -47.1 -52.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -59.63 -57.47 12.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.14 -57.69 7.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -40.34 -37.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.6 OUTLIER -77.07 -42.31 38.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -76.81 -9.23 58.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -101.46 -32.23 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.29 -51.1 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 19.5 mt -83.93 21.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.45 -60.25 2.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 0.0 110.888 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.1 Cg_endo -69.72 -50.68 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -40.78 -47.9 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.26 -27.21 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 184' ' ' LEU . 2.2 tt -61.52 -29.45 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -95.3 -45.59 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.1 mt -48.94 -39.97 28.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.795 0.331 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -65.57 -62.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' A' ' 131' ' ' PHE . 9.7 p -63.24 -20.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -75.02 -49.06 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 104' ' ' LEU . 71.7 mt -77.99 -37.44 47.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -39.96 -62.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.66 ' O ' HG22 ' A' ' 107' ' ' ILE . 46.0 t80 -53.31 -57.69 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 101' ' ' LEU . 43.5 mt -44.07 -31.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.8 -40.78 22.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -68.0 -26.17 65.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.6 tp -92.88 -31.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.54 -45.33 46.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 113' ' ' LEU . 29.5 pttt -48.72 -39.78 26.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 6.2 m-85 -56.67 -38.04 71.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 66.4 m95 -72.32 -49.48 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -43.57 -56.05 3.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.0 mp -47.39 -42.33 21.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -68.15 -31.91 71.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.16 33.86 3.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -138.55 138.26 37.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.971 0.415 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -86.18 137.31 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 7.0 tt -89.79 128.88 36.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.3 tptm -114.99 120.48 40.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.03 129.73 93.95 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.62 0.724 . . . . 0.0 111.11 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.15 57.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.267 . . . . 0.0 112.301 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 1.6 m80 -123.61 108.86 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 72.2 t -96.55 140.29 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 41.63 43.24 2.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 60.16 41.82 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -152.99 156.41 38.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.513 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 15.3 mm -69.75 137.34 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.75 HD11 HD22 ' A' ' 133' ' ' LEU . 15.8 tp -107.47 98.78 8.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -72.29 105.09 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.2 -57.35 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CE2' HG22 ' A' ' 99' ' ' VAL . 7.6 t80 -38.78 -48.37 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -73.44 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.75 HD22 HD11 ' A' ' 128' ' ' LEU . 24.6 tp -38.12 -67.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -47.46 -57.49 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -41.51 -56.67 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.0 mt -51.61 -44.34 62.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 133' ' ' LEU . 59.2 t -52.26 -51.3 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.21 85.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.67 -42.89 97.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -73.07 -22.01 60.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 158.76 -58.21 0.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 141.67 170.11 12.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CE2' ' HG2' ' A' ' 172' ' ' ARG . 30.3 t80 -57.31 -41.76 80.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.847 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.15 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.8 p -55.54 -52.01 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 142' ' ' GLY . 95.3 t -56.72 -66.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 14.2 t -51.25 -36.24 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -58.8 -50.99 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.09 25.62 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 38.38 39.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -85.46 46.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.865 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 45.4 m95 -88.96 -42.68 11.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.2 m -40.92 -50.73 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -50.69 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.2 mt -45.16 -62.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.5 -56.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.7 m -55.29 -41.46 72.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -53.65 -44.99 70.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.0 mmm -59.43 -18.82 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.28 -14.53 12.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 19.4 m-85 -66.5 164.63 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 144.14 75.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 111.069 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 96.19 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.2 13.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -36.65 10.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.741 0.305 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -55.97 10.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.44 -38.18 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.2 -47.56 41.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -76.7 -33.52 58.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.67 -51.98 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.865 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 6.8 mm -40.98 -55.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HG2' ' CE2' ' A' ' 143' ' ' PHE . 21.2 mtm105 -57.38 -56.09 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.04 -44.96 26.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.425 ' CD2' HD22 ' A' ' 128' ' ' LEU . 60.9 m-70 -53.39 -38.42 63.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -76.8 -32.27 57.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -86.33 -9.34 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -101.69 -29.59 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.92 -52.28 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 13.1 mt -84.15 24.16 0.98 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.53 -60.25 2.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.65 0.738 . . . . 0.0 110.912 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.73 -50.0 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.665 2.243 . . . . 0.0 112.397 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.0 t80 -42.61 -56.12 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.49 -52.49 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.95 -33.5 4.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -75.11 -55.55 5.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.84 -46.33 64.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.4 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.744 0.307 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -64.19 -52.44 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 100' ' ' LYS . 8.7 p -55.64 -44.88 78.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 99' ' ' VAL . 81.0 mttt -60.57 -46.78 88.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ASN . 35.2 mt -57.21 -50.25 73.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' LEU . 57.3 t-20 -37.56 -61.95 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 105' ' ' ASP . 31.4 t80 -57.97 -65.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 58.1 mt -38.23 -27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.9 t70 -80.77 -48.95 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 103' ' ' PHE . 12.3 mm100 -64.13 -21.33 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.4 tt -91.55 -39.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -67.16 -41.6 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 55.4 pttt -56.93 -44.24 82.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 5.5 m-85 -50.04 -33.06 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.52 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 60.7 m95 -79.16 -49.47 12.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -45.4 -40.14 7.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.37 -45.25 88.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -65.44 -33.06 75.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.56 40.83 1.69 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -144.06 147.49 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -87.45 146.6 25.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -96.29 115.98 28.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 118' ' ' LEU . 22.7 ttpt -107.27 124.08 49.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.72 125.44 90.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 160.75 48.55 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -125.37 109.12 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.15 121.64 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 56.11 45.6 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' NH1' ' A' ' 125' ' ' ARG . 6.3 mtp-105 58.37 41.29 23.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -145.78 153.36 40.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -76.95 113.57 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.24 108.6 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.944 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.63 88.86 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' PHE . 41.3 mt -39.19 -64.6 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.4 t80 -37.32 -66.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 38.1 tt0 -50.42 -60.65 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -36.45 -70.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.2 -47.49 46.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -49.5 -54.4 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -52.38 -49.31 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 155' ' ' ILE . 97.4 t -48.24 -48.84 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.99 90.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.19 -32.12 69.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.05 -12.85 58.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.08 -61.7 0.38 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.92 170.58 18.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 34.2 t80 -60.13 -35.83 76.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 0.0 110.926 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.44 -66.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.7 p -49.95 -49.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 145' ' ' VAL . 53.2 t -61.89 -62.63 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 52.2 t -46.34 -46.13 18.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -63.35 -55.46 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 14.93 2.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.4 OUTLIER 39.64 52.12 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 9.0 mtpm? -94.22 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.496 ' CE3' HG21 ' A' ' 171' ' ' ILE . 89.7 m95 -81.81 -40.67 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 98.9 m -42.31 -51.25 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -49.59 -68.28 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -43.13 -65.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.11 -51.29 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.6 m -54.66 -53.02 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -54.08 -27.4 32.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -78.72 10.27 3.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.3 75.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -70.5 157.03 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.65 80.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.521 0.677 . . . . 0.0 111.142 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.224 . . . . 0.0 112.324 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -141.74 -169.18 11.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -93.93 -47.66 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.72 -58.22 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HA ' ' CD2' ' A' ' 170' ' ' HIS . 11.5 p -60.23 -31.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.25 -49.84 62.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.9 t -74.31 -34.08 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.446 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 3.8 m-70 -50.74 -53.78 28.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.684 HG23 HD11 ' A' ' 133' ' ' LEU . 32.4 mm -38.78 -48.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -65.14 -52.84 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 176' ' ' GLU . . . -53.16 -57.31 15.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -43.38 -30.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.599 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -79.47 -37.99 35.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' GLY . 7.3 mt-10 -77.97 -10.3 59.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 177' ' ' ARG . 1.2 mpt_? -98.16 -34.03 10.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.1 mt -119.52 -48.34 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 175' ' ' TYR . 7.7 mt -83.47 21.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -70.98 -60.1 3.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.52 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.76 -49.08 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.32 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 6.1 t80 -44.61 -56.65 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.98 -38.84 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.424 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 52.0 tp -58.13 -23.19 54.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -98.13 -43.1 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -53.16 -44.6 67.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.905 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.332 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -56.54 -57.84 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.17 -31.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -54.8 -49.67 70.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 102' ' ' ASN . 81.5 mt -77.31 -48.16 18.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 101' ' ' LEU . 5.4 t-20 -37.33 -63.25 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.25 -64.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.453 ' HA ' HG22 ' A' ' 107' ' ' ILE . 28.3 mt -45.08 -26.07 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.17 -40.34 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -74.69 -24.38 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 182' ' ' TYR . 9.1 tp -87.39 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -65.69 -46.15 80.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.651 ' O ' HD12 ' A' ' 113' ' ' LEU . 61.0 pttt -49.05 -45.0 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.446 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 56.5 t80 -52.49 -41.63 63.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.864 ' CD1' HD12 ' A' ' 118' ' ' LEU . 53.6 m95 -68.09 -48.25 66.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.19 -45.39 16.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.5 mp -51.44 -37.06 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -78.26 -23.16 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 27.36 9.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -129.91 136.43 49.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.79 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -82.11 145.22 30.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.6 tt -90.79 117.15 29.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -109.57 114.65 28.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mm -70.47 126.56 92.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.56 10.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.38 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -122.58 121.0 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 128' ' ' LEU . 97.4 t -110.22 127.96 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 54.17 42.48 31.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 58.87 45.15 15.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -157.07 153.86 28.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.12 105.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.533 ' CD2' ' CD2' ' A' ' 174' ' ' HIS . 49.4 tp -65.6 116.6 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -80.41 108.21 13.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.07 -52.19 51.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CD2' ' N ' ' A' ' 132' ' ' GLN . 6.8 t80 -48.27 -66.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 59.3 tt0 -54.77 -47.96 73.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 171' ' ' ILE . 5.8 tp -50.08 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -48.98 -43.6 40.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -51.03 -53.38 34.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 66.1 mt -56.14 -46.29 79.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.1 t -48.57 -49.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.87 79.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.23 -42.59 79.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -72.97 -14.58 61.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.97 -61.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.82 168.79 14.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.26 -42.15 81.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.28 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.447 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -52.49 -40.96 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.6 t -69.9 -26.38 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.9 m -78.82 -32.64 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 8.1 pttp -81.35 -45.3 16.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 150' ' ' ARG . 5.8 m-20 -89.43 20.15 4.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.474 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 31.41 47.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -87.97 37.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 24.6 m95 -85.36 -42.27 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m -52.02 -53.27 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -46.71 -53.89 10.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 156' ' ' ALA . 28.4 mt -58.9 -68.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.116 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -34.32 -49.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -58.88 -49.22 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -50.17 -49.13 53.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 22.9 mtp -47.93 -27.19 2.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.5 -7.55 10.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -77.43 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.32 145.11 55.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.542 0.686 . . . . 0.0 111.142 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 93.32 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -146.91 135.32 5.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.455 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -43.78 -23.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.401 ' N ' ' C ' ' A' ' 164' ' ' GLY . . . -61.01 -59.09 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.53 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.3 p -67.57 -40.68 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.94 -41.44 45.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.3 m -83.33 -31.6 26.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.1 m-70 -54.69 -40.0 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.791 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 49.9 mm -50.51 -61.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.081 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.69 -52.68 63.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.69 -43.02 37.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.533 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 60.9 m-70 -56.83 -39.81 74.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.8 OUTLIER -75.23 -39.98 59.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -76.29 -9.44 58.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -104.04 -29.72 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.1 mt -119.25 -52.47 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 29.2 mt -82.94 18.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -69.95 -60.22 3.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.632 0.73 . . . . 0.0 110.909 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -41.78 4.01 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.576 ' CD1' HD12 ' A' ' 107' ' ' ILE . 16.5 t80 -45.31 -51.68 10.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.72 -42.85 21.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 47.4 tp -50.82 -31.28 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -90.53 -54.08 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -42.18 -51.82 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.889 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -60.9 -56.18 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.614 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.1 p -44.34 -35.6 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 60.9 mttt -78.44 -54.88 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 102' ' ' ASN . 72.9 mt -46.06 -48.42 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 101' ' ' LEU . 25.6 t-20 -36.41 -65.55 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 106' ' ' GLN . 55.5 t80 -55.05 -68.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.468 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 36.6 mt -36.68 -30.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' PHE . 10.1 t70 -79.48 -45.78 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.3 mm-40 -67.04 -17.98 65.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.6 tt -96.86 -34.98 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.83 -42.32 81.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.092 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' O ' HD23 ' A' ' 113' ' ' LEU . 49.4 pttt -54.44 -46.37 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' N ' ' CG ' ' A' ' 109' ' ' LYS . 7.5 m-85 -47.97 -36.48 12.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.848 ' CD1' HD12 ' A' ' 118' ' ' LEU . 80.6 m95 -74.63 -49.33 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -43.21 -54.0 4.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 109' ' ' LYS . 2.7 mm? -45.64 -40.69 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.21 -44.54 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 35.87 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -138.14 120.12 15.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.936 0.398 . . . . 0.0 110.883 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 t -65.16 147.46 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.848 HD12 ' CD1' ' A' ' 111' ' ' TRP . 4.0 tt -110.37 110.28 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -103.91 140.38 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.29 122.99 73.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.13 11.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -122.22 125.27 45.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.7 t -112.94 134.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 46.76 42.32 11.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 57.75 45.6 18.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -163.89 130.71 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mm -46.5 133.05 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 133' ' ' LEU . 25.8 tp -94.98 104.6 16.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -72.5 98.62 2.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.81 -57.06 14.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.614 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 44.7 t80 -42.26 -65.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -56.01 -53.67 54.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 128' ' ' LEU . 20.7 tp -46.94 -70.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -42.91 -48.66 5.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -48.6 -56.17 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.59 -40.26 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 155' ' ' ILE . 46.6 t -55.04 -54.74 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.99 70.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -63.86 -37.66 88.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -81.14 -19.12 44.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.458 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.55 -57.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.508 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.75 160.5 9.11 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 175' ' ' TYR . 2.4 t80 -53.69 -33.62 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.23 -66.26 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.7 p -52.11 -31.07 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.5 t -76.1 -54.58 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 38.6 t -57.88 -49.8 75.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 9.3 ptmt -51.76 -42.95 62.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 148' ' ' LYS . 16.3 t0 -90.42 0.89 57.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 52.22 50.79 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -102.84 35.41 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -71.73 -31.76 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.3 m -53.75 -62.67 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.154 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -39.32 -58.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 137' ' ' VAL . 22.2 mt -55.43 -64.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.441 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -39.19 -44.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.1 m -62.42 -47.69 83.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -51.8 -45.9 64.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.1 -27.21 52.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.07 -7.69 9.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -73.29 135.67 44.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.56 142.7 21.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.538 0.685 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 125.69 12.45 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.4 -144.78 4.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -121.36 -29.72 4.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.27 -57.96 10.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 168' ' ' GLY . 9.2 p -58.72 -44.88 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -49.48 -40.38 31.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.49 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -79.75 -28.72 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.1 m-70 -57.83 -51.64 68.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 133' ' ' LEU . 4.5 mm -46.77 -58.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -50.69 -54.04 26.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -53.62 -52.08 44.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 90.8 m-70 -44.46 -33.96 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CD1' ' CE2' ' A' ' 143' ' ' PHE . 1.0 OUTLIER -79.4 -36.1 39.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -83.57 -9.07 59.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -101.94 -31.45 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.13 -50.35 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 175' ' ' TYR . 15.8 mt -83.22 18.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.517 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.82 -58.85 4.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.71 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.57 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 54.2 Cg_endo -69.74 -50.83 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.377 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -42.75 -41.64 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.37 -64.55 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 180' ' ' ASN . 6.9 mp -40.35 -36.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -70.57 -51.96 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.9 mt -46.9 -44.81 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -47.36 -51.58 19.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.8 p -47.08 -35.84 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.553 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 7.3 mtmp? -73.09 -49.2 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.76 -38.26 81.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.26 -53.63 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 107' ' ' ILE . 50.1 t80 -58.61 -48.39 81.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.46 -36.72 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.5 -42.02 68.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -65.82 -52.74 48.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 103' ' ' PHE . 2.8 tp -55.16 -49.35 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -54.26 -49.17 70.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -43.71 -52.34 6.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.98 -42.96 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.455 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 51.6 m95 -71.72 -48.64 45.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -44.53 -50.59 9.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mt -54.39 -43.86 71.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.13 -38.44 88.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.86 34.8 1.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -140.64 130.08 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 p -67.18 140.16 57.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -111.76 149.02 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.915 ' H ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -169.98 141.2 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 128' ' ' LEU . 10.1 mm -75.26 131.51 78.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.602 0.715 . . . . 0.0 111.17 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.31 24.85 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.541 ' CE1' HD11 ' A' ' 127' ' ' ILE . 32.8 m80 -100.46 116.74 33.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 128' ' ' LEU . 88.2 t -108.41 120.54 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 61.82 43.73 9.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 58.11 42.16 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -170.25 133.19 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.541 HD11 ' CE1' ' A' ' 122' ' ' HIS . 17.0 mm -46.99 148.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.66 ' O ' HG21 ' A' ' 120' ' ' ILE . 9.4 tp -116.86 111.41 19.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.8 106.31 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.36 -50.63 72.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 54.3 t80 -44.38 -56.5 4.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -63.2 -56.03 20.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 171' ' ' ILE . 6.6 tp -40.79 -70.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -43.54 -48.39 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -50.53 -50.43 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.448 ' HB3' HG23 ' A' ' 155' ' ' ILE . 4.1 mm? -57.11 -38.15 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.707 HG22 HD13 ' A' ' 155' ' ' ILE . 46.4 t -58.53 -59.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.54 60.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -60.77 -37.24 81.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -79.49 -13.4 59.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 151.55 -62.71 0.39 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 162.17 169.22 25.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -61.25 -37.05 81.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.72 -66.34 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 2.5 p -43.15 -30.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 150' ' ' ARG . 20.2 t -80.43 -50.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.5 p -57.78 -38.43 75.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -78.01 -28.27 49.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.16 2.2 45.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmm180 53.69 31.04 12.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 146' ' ' VAL . 40.9 mtmt -83.53 43.11 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -86.4 -44.97 11.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 m -47.85 -49.62 28.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -49.15 -55.36 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.707 HD13 HG22 ' A' ' 137' ' ' VAL . 14.9 mt -57.34 -60.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.429 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -41.64 -48.13 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -50.76 -43.7 58.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.9 mtp -58.31 -21.0 47.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.68 2.11 24.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -78.97 177.46 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.88 142.91 34.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.595 0.712 . . . . 0.0 111.095 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 122.98 9.64 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.39 -166.63 32.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -104.7 -20.87 13.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.72 -59.1 4.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.429 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.1 p -61.79 -30.75 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.63 -49.29 78.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.8 m -75.43 -27.38 58.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.6 m-70 -58.22 -54.22 49.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.856 HG23 HD21 ' A' ' 133' ' ' LEU . 5.4 mm -37.97 -64.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -52.04 -50.61 61.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -52.55 -44.38 59.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.75 -31.53 70.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -84.17 -22.87 30.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -90.63 -10.77 42.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.15 -25.21 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.7 mt -119.35 -52.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.26 28.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.499 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.26 -62.73 0.79 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.67 0.748 . . . . 0.0 110.905 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.76 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 107' ' ' ILE . 7.3 t80 -40.56 -44.22 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 175' ' ' TYR . 8.3 m120 -72.06 -43.38 64.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 181' ' ' PRO . 43.3 mt -56.78 -54.96 40.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.46 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.5 mt -50.11 -48.11 53.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.795 0.331 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.6 -40.08 94.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.95 -26.29 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 50.8 mtpt -80.05 -37.49 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.7 -44.85 69.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -39.32 -58.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 107' ' ' ILE . 79.2 t80 -55.85 -62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 37.4 mt -42.15 -37.75 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.49 -54.84 30.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -57.03 -54.55 45.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 103' ' ' PHE . 7.9 tt -60.91 -35.27 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -65.79 -41.81 91.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' O ' HD12 ' A' ' 113' ' ' LEU . 47.0 mttt -56.66 -29.09 61.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 181' ' ' PRO . 42.2 t80 -71.22 -32.83 69.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.668 ' HD1' HD12 ' A' ' 118' ' ' LEU . 56.7 m95 -85.26 -53.24 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -42.44 -39.42 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 109' ' ' LYS . 15.9 mt -62.09 -47.74 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -60.45 -39.74 88.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.36 35.49 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.438 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.5 m -141.26 119.29 11.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 110.885 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.6 m -62.78 128.7 37.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.0 tt -78.11 128.55 33.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.647 ' N ' HD23 ' A' ' 118' ' ' LEU . 10.8 ttmm -126.17 142.24 51.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -84.17 130.43 54.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.68 0.753 . . . . 0.0 111.109 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 159.21 54.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -119.1 118.08 30.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' LYS . 90.2 t -110.67 143.95 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' VAL . 77.0 mm-40 37.79 42.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? 59.06 42.81 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 123' ' ' VAL . 40.7 mttm -147.96 141.87 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.76 100.66 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 133' ' ' LEU . 53.5 tp -67.31 94.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.33 100.67 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.28 -52.32 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 4.2 t80 -41.92 -59.14 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.4 tp60 -67.51 -54.05 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.938 HD11 ' CG2' ' A' ' 171' ' ' ILE . 9.9 tp -37.93 -72.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 134' ' ' ASN . 3.3 t-20 -48.61 -47.08 40.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -47.73 -48.12 29.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 132' ' ' GLN . 11.2 mp -63.24 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.23 -48.85 54.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.05 85.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.81 -36.94 80.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.71 -18.89 50.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 158.34 -59.04 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 154.71 173.86 24.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.787 ' CZ ' ' CD1' ' A' ' 175' ' ' TYR . 48.0 t80 -64.63 -37.26 86.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.62 -66.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.7 p -45.99 -44.85 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' GLY . 50.3 t -65.54 -68.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 51.7 t -42.26 -45.72 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -57.67 -55.43 34.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 151' ' ' LYS . 17.3 m-20 -84.46 24.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 149' ' ' ASP . 29.2 mmt180 34.38 37.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 25.2 mtpp -79.74 44.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.766 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -90.04 -49.76 6.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.9 m -37.0 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -57.61 -69.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.2 mt -45.43 -58.75 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.82 -56.23 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.3 m -51.31 -50.07 60.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.462 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -55.83 -27.86 53.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.0 mmm -79.69 12.23 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.75 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CB ' HG21 ' A' ' 167' ' ' VAL . 24.2 m-85 -65.07 171.61 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.94 144.09 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 86.7 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.82 -158.78 7.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -103.71 -39.46 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -48.26 -59.15 3.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.124 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 161' ' ' PHE . 13.0 p -63.89 -37.43 79.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.25 -58.38 13.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.1 m -65.19 -31.51 72.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 3.5 m-70 -52.73 -57.57 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 133' ' ' LEU . 26.0 mm -41.69 -46.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.461 ' HB2' ' NE1' ' A' ' 152' ' ' TRP . 1.3 tmt_? -59.64 -51.27 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.62 -44.2 97.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.9 -22.64 10.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.787 ' CD1' ' CZ ' ' A' ' 143' ' ' PHE . 0.5 OUTLIER -91.46 -21.35 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -90.98 -11.41 39.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -105.01 -25.44 12.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 mt -119.82 -52.52 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.0 mt -83.21 19.11 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.55 -60.12 2.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.897 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.558 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.2 Cg_endo -69.8 -46.48 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.345 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.9 t80 -38.55 -56.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -75.18 -34.57 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.99 -28.23 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -88.28 -54.99 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.9 mt -44.37 -44.64 8.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.801 0.334 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -61.95 -44.0 97.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.582 HG13 ' HD2' ' A' ' 100' ' ' LYS . 9.7 p -52.1 -37.96 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.099 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.582 ' HD2' HG13 ' A' ' 99' ' ' VAL . 1.4 mptt -71.72 -58.45 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.5 mt -50.67 -39.84 51.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.74 -63.69 0.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -51.33 -67.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 39.6 mt -38.21 -40.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.66 -53.06 61.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -56.68 -51.69 67.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.9 tt -59.63 -45.49 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -55.76 -48.2 75.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -40.6 -57.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -43.56 -48.94 7.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.516 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 35.8 m95 -66.6 -53.46 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -40.93 -51.23 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.02 -48.27 67.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -64.54 -37.66 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.65 37.99 1.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.8 p -131.8 141.2 49.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 m -85.76 134.45 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.5 tt -94.38 111.18 22.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.419 ' N ' HD23 ' A' ' 118' ' ' LEU . 4.4 tppp? -118.79 115.3 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 mm -62.72 129.7 93.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.63 0.729 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 157.32 60.72 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.48 HG21 HD22 ' A' ' 128' ' ' LEU . 45.0 t -98.85 120.85 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 55.3 46.47 23.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 56.52 32.54 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -141.91 134.26 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.68 99.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 123' ' ' VAL . 14.7 tp -66.36 104.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.35 116.74 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.7 mt -66.94 -57.0 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 135' ' ' LYS . 2.7 t80 -50.88 -54.57 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.69 -44.48 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -47.91 -72.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.21 -39.15 43.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -54.04 -55.04 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.48 ' CG2' HG21 ' A' ' 155' ' ' ILE . 69.6 t -53.52 -50.04 51.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.36 92.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.56 -42.09 98.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -67.57 -17.89 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.537 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 156.58 -56.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.48 166.59 12.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.45 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 143' ' ' PHE . 2.7 t80 -59.63 -42.48 92.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.11 -64.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.3 p -48.64 -44.9 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 151' ' ' LYS . 28.9 t -63.8 -64.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 20.3 m -49.11 -36.64 19.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -66.35 -51.09 60.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -95.37 18.32 12.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 146' ' ' VAL . 13.5 mmt85 45.38 51.86 9.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.621 ' HB2' HG22 ' A' ' 146' ' ' VAL . 4.2 mmmm -86.55 24.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.671 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -68.46 -40.04 81.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.5 m -54.73 -39.44 68.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.468 ' N ' ' HE3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -63.8 -33.6 76.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.526 ' N ' HD13 ' A' ' 155' ' ' ILE . 1.9 mm -73.37 -61.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -44.87 -51.95 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 m -59.98 -51.15 70.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -52.97 -45.08 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.424 ' SD ' HD13 ' A' ' 133' ' ' LEU . 32.4 mtp -58.41 -15.92 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.09 -7.62 27.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 171.24 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.1 31.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.593 0.711 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 109.65 2.38 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.4 -147.48 4.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -115.7 -37.0 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -59.48 -58.22 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.2 p -57.96 -41.34 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -48.69 -52.65 19.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -77.85 -27.02 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 2.8 m-70 -53.47 -46.93 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 133' ' ' LEU . 46.7 mm -46.3 -43.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.407 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 23.1 mmm-85 -71.35 -63.25 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.51 -51.62 7.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -46.68 -40.44 13.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.542 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -67.33 -45.33 76.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -76.41 -9.34 58.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -97.25 -35.55 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.6 mt -119.87 -48.32 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 175' ' ' TYR . 10.8 mt -83.5 21.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.73 -60.24 2.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.516 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 53.7 Cg_endo -69.75 -50.68 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.709 2.273 . . . . 0.0 112.353 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 4.1 t80 -44.63 -52.71 7.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.19 -51.24 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -49.32 -44.18 44.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.61 -57.42 5.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.6 mt -38.28 -50.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.807 0.337 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -69.56 -34.51 74.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 131' ' ' PHE . 7.1 p -73.84 -33.78 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 40.5 mtmt -68.54 -52.42 32.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.47 -40.69 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -48.36 -52.35 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 104' ' ' LEU . 3.9 t80 -58.95 -61.3 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 16.5 mt -49.37 -20.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.69 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 107' ' ' ILE . 7.1 pt20 -53.13 -31.91 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.48 HD12 ' CD2' ' A' ' 182' ' ' TYR . 5.5 tt -81.59 -39.23 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.56 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -42.55 -58.01 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -38.89 -42.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.472 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 43.0 m95 -73.97 -49.1 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -42.75 -43.44 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -61.48 -47.54 85.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -64.9 -28.2 69.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.92 40.68 3.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -136.66 127.24 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 110.853 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.6 m -77.81 128.37 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.2 tt -89.92 108.0 19.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -106.09 128.23 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.6 mm -63.58 127.29 91.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 174' ' ' HIS . 53.1 Cg_endo -69.82 161.97 43.91 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.313 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -118.1 115.44 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.816 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 77.1 t -102.4 124.29 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 51.52 51.16 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 55.62 35.27 24.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -144.83 142.89 30.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.53 107.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 1.044 HD11 HD22 ' A' ' 133' ' ' LEU . 19.4 tp -71.55 114.77 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.74 89.06 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' PHE . 23.1 mt -44.28 -63.47 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 99' ' ' VAL . 17.0 t80 -34.91 -67.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.456 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 17.1 tt0 -53.97 -56.8 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 128' ' ' LEU . 22.6 tp -43.93 -71.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -45.6 -57.46 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -41.56 -47.55 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.928 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -46.65 87.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -50.71 -46.79 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.16 95.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.6 -45.04 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -67.56 -18.16 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.458 ' CA ' HG11 ' A' ' 145' ' ' VAL . . . 155.28 -60.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 149.36 165.36 12.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.492 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -55.85 -35.12 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.884 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -66.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' CA ' ' A' ' 141' ' ' GLY . 2.6 p -51.88 -37.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 151' ' ' LYS . 51.0 t -72.06 -64.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 9.8 t -52.24 -32.22 35.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -73.55 -49.42 26.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -91.54 15.22 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 45.81 55.03 7.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -96.16 36.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.509 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 42.4 m95 -84.69 -46.89 11.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.8 m -43.96 -54.57 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -48.58 -63.05 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ALA . 20.4 mt -54.27 -63.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.22 -47.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.6 m -62.75 -45.43 92.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -51.28 -51.12 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.2 mmm -50.08 -25.08 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.87 -8.14 10.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 26.0 m-85 -72.27 146.55 47.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.45 142.99 98.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 122.8 9.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.716 2.277 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.67 -134.89 1.78 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -127.81 -34.8 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.68 -58.65 7.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.17 -30.93 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -58.91 12.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -67.16 -25.97 66.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.2 m-70 -58.32 -59.54 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 133' ' ' LEU . 24.8 mm -37.83 -63.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -52.21 -56.86 11.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.14 -52.99 9.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 70.9 m-70 -49.27 -35.65 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -82.27 -22.72 35.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.67 -13.06 40.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -105.25 -22.79 12.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.7 mt -119.98 -52.61 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 175' ' ' TYR . 5.4 mp -87.01 25.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.5 -63.64 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -48.28 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.694 2.262 . . . . 0.0 112.356 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 107' ' ' ILE . 6.1 t80 -40.12 -48.21 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.34 -34.2 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 184' ' ' LEU . 4.0 tt -56.57 -40.66 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -84.8 -56.65 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.9 mt -40.61 -36.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.733 0.301 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -55.21 -46.31 75.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.47 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 6.0 p -58.54 -31.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 45.1 mtmt -73.41 -47.15 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -66.6 -44.08 83.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -42.7 -44.52 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.8 t80 -68.18 -44.74 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.476 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.9 mt -63.27 -26.94 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -76.91 -51.04 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -62.02 -32.82 73.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 103' ' ' PHE . 5.8 tt -79.68 -42.43 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -66.83 -47.51 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -28.15 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -70.21 -30.39 67.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.781 ' HD1' HD12 ' A' ' 118' ' ' LEU . 79.0 m95 -87.07 -49.4 7.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -47.6 -21.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.57 -45.22 46.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -70.07 -37.98 75.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.97 36.49 1.23 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.455 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.4 t -137.9 111.26 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.789 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 p -58.05 147.12 30.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.781 HD12 ' HD1' ' A' ' 111' ' ' TRP . 5.6 tt -98.07 108.03 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -96.34 132.82 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -87.06 121.02 71.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.62 0.724 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 149.73 67.43 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.94 111.59 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 167' ' ' VAL . 96.8 t -97.42 124.95 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 51.43 44.79 28.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.3 30.37 19.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -139.33 150.23 45.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.1 mm -75.01 129.95 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.6 tp -91.59 107.97 19.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.79 82.44 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 131' ' ' PHE . 60.1 mt -40.05 -59.9 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 31.1 t80 -34.91 -67.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.63 ' OE1' HD12 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -58.81 -54.83 42.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.927 HD11 ' CG2' ' A' ' 171' ' ' ILE . 4.3 tp -35.47 -71.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -49.37 -53.81 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -40.06 -56.9 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.63 HD12 ' OE1' ' A' ' 132' ' ' GLN . 12.4 mt -54.6 -48.11 72.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 HD13 ' A' ' 155' ' ' ILE . 93.3 t -46.54 -49.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.07 86.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.48 -37.26 86.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -79.89 -14.35 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.48 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.18 -62.73 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 154.54 165.28 13.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 3.1 t80 -55.47 -38.83 69.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.6 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.48 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.1 p -48.37 -46.0 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 151' ' ' LYS . 54.3 t -67.05 -69.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 47.1 t -40.32 -42.45 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.32 -51.34 63.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' ARG . 12.3 m-20 -84.81 25.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 34.49 41.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 146' ' ' VAL . 29.6 mtpt -86.07 40.59 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.584 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 23.3 m95 -86.11 -46.91 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -38.88 -44.72 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -63.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 137' ' ' VAL . 20.0 mt -52.31 -57.87 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -45.45 -50.04 12.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 m -64.25 -37.9 89.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -65.35 -27.5 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.47 ' HG2' HE22 ' A' ' 132' ' ' GLN . 17.7 mtp -75.36 -3.24 32.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.81 54.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.73 166.85 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.93 144.62 79.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.558 0.694 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 85.73 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.729 2.286 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.38 169.76 26.3 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.03 -34.55 64.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.78 0.324 . . . . 0.0 110.882 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.66 -58.83 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 168' ' ' GLY . 12.7 p -67.06 -44.12 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -45.5 -48.89 11.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 m -75.49 -36.08 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.834 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -49.18 -39.0 27.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.927 ' CG2' HD11 ' A' ' 133' ' ' LEU . 37.0 mm -57.33 -59.42 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -50.83 -61.19 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -44.91 -48.67 9.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -50.55 -44.83 56.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -43.54 90.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -80.01 -9.03 59.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 173' ' ' GLY . 23.1 mmt180 -99.1 -30.37 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.36 -51.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.16 26.58 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.54 -60.05 2.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.892 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.724 ' HA ' HD12 ' A' ' 184' ' ' LEU . 53.6 Cg_endo -69.74 -48.18 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 186' ' ' LEU . 6.2 t80 -44.25 -41.41 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -71.28 -38.52 71.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 181' ' ' PRO . 69.4 mt -57.57 -36.31 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.86 -41.72 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.465 HD11 ' CE2' ' A' ' 182' ' ' TYR . 79.2 mt -61.87 -32.62 73.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -66.04 -57.55 7.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.76 -39.78 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -53.38 -54.78 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.66 -39.27 84.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -50.64 -50.71 53.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 107' ' ' ILE . 52.3 t80 -60.01 -64.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 58.6 mt -41.17 -35.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -70.13 -57.99 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -55.13 -50.65 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.3 tt -63.73 -37.03 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -59.64 -49.72 76.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' HD13 ' A' ' 113' ' ' LEU . 37.6 mttp -45.76 -56.07 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -39.58 -40.67 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -76.4 -50.66 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -41.87 -38.12 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 109' ' ' LYS . 10.4 mp -57.24 -44.45 83.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -73.72 -36.68 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 111.55 30.1 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -116.97 139.57 50.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 m -84.9 129.4 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 119' ' ' LYS . 2.3 tt -93.62 119.5 32.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.699 ' N ' HD23 ' A' ' 118' ' ' LEU . 25.7 tptt -133.19 142.99 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.55 122.45 82.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -177.21 1.78 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.679 2.252 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CE1' HD13 ' A' ' 127' ' ' ILE . 25.1 m80 -126.21 126.04 43.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 128' ' ' LEU . 93.1 t -112.67 128.53 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.8 42.39 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 61.06 27.88 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -145.03 128.49 16.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 122' ' ' HIS . 4.8 mm -40.92 146.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 133' ' ' LEU . 16.3 tp -120.27 89.71 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -56.22 103.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 178' ' ' ILE . 81.3 mt -58.13 -63.09 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' LEU . 5.7 t80 -37.79 -62.21 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -54.82 -59.15 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.964 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -38.15 -72.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -47.28 -46.36 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -58.48 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.62 -42.42 62.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.493 HG22 HD13 ' A' ' 155' ' ' ILE . 60.9 t -52.49 -50.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.49 75.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.41 -41.76 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -72.69 -12.03 60.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 150.97 -59.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.88 176.11 20.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.21 -36.7 84.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.7 -66.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.068 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.3 p -50.75 -47.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.9 t -60.14 -43.72 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.4 m -67.7 -33.46 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -70.97 -49.85 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.03 10.84 39.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmt85 46.41 52.25 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -81.92 40.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -87.04 -45.22 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.1 m -41.43 -49.21 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -56.81 -59.28 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 137' ' ' VAL . 14.2 mt -51.8 -72.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.621 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.15 -51.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.0 m -60.35 -41.98 94.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 155' ' ' ILE . 37.7 mttp -62.56 -22.65 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.4 mmm -81.67 7.31 12.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.19 -15.45 62.37 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -69.62 162.29 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -80.13 143.95 57.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.726 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 84.42 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.12 -138.63 4.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -124.21 -48.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.85 -57.56 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.127 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.621 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 5.4 p -58.39 -39.17 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.0 -48.21 52.54 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.1 m -72.86 -32.04 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.443 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 6.4 m-70 -54.66 -53.9 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.964 HG23 HD11 ' A' ' 133' ' ' LEU . 45.0 mm -43.25 -51.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 28.3 mtm180 -56.91 -62.32 1.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -43.8 -51.87 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.467 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 96.6 m-70 -50.58 -41.38 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.3 OUTLIER -71.22 -45.74 62.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.61 -9.15 58.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 173' ' ' GLY . 38.1 mtm180 -105.12 -28.94 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.619 HG22 HD13 ' A' ' 179' ' ' LEU . 39.9 mt -116.43 -52.63 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.619 HD13 HG22 ' A' ' 178' ' ' ILE . 1.5 mm? -92.84 35.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.488 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.39 -62.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.859 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.82 -49.23 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.322 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.4 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 5.0 t80 -42.11 -55.83 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.46 -46.68 75.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt -51.67 -37.08 49.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.1 -54.09 12.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 42.3 mt -49.83 -36.47 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -57.78 -51.62 68.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.6 p -53.45 -24.99 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 47.6 mttp -81.01 -53.02 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.91 -44.92 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -39.0 -64.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -51.73 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.874 HD22 HD11 ' A' ' 120' ' ' ILE . 38.5 mt -39.72 -39.52 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.5 -53.87 50.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -54.26 -59.97 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 104' ' ' LEU . 2.9 tt -48.8 -45.36 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.93 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' TRP . 4.5 mmmm -55.97 -60.26 3.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -38.54 -26.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.56 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 88.7 m95 -87.97 -45.72 9.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' A' ' 113' ' ' LEU . 5.6 pt-20 -49.61 -18.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.441 HD12 ' HG2' ' A' ' 112' ' ' GLU . 6.5 mp -78.9 -35.34 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -81.25 -28.74 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.32 34.55 3.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 m -135.17 112.25 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.849 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -58.39 143.38 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.96 HD13 ' N ' ' A' ' 119' ' ' LYS . 2.0 tm? -105.92 157.87 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 118' ' ' LEU . 14.7 ttmm -171.99 155.51 3.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.874 HD11 HD22 ' A' ' 104' ' ' LEU . 28.6 mm -89.26 129.69 46.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.694 0.759 . . . . 0.0 111.121 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HG3' ' CD2' ' A' ' 174' ' ' HIS . 53.1 Cg_endo -69.81 -179.29 2.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 39.4 m80 -119.77 129.28 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 128' ' ' LEU . 93.0 t -115.09 109.08 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 61.65 51.25 4.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 56.71 31.64 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -148.77 126.1 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 32.4 mm -48.16 145.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 HD22 ' A' ' 133' ' ' LEU . 22.6 tp -110.31 91.85 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.7 83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 mt -40.12 -57.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 23.9 t80 -39.72 -52.28 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 133' ' ' LEU . 32.0 tp60 -70.35 -58.36 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.978 HD22 HD11 ' A' ' 128' ' ' LEU . 7.4 tp -35.68 -71.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -47.34 -57.44 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -42.09 -55.46 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.97 -45.09 60.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.782 HG22 HD13 ' A' ' 155' ' ' ILE . 64.8 t -52.82 -55.08 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.03 -41.04 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.94 -37.69 88.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.09 -27.5 63.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 169.1 -52.0 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 131.41 150.45 6.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -41.7 -36.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.15 -66.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.0 p -61.81 -54.99 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.199 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 142' ' ' GLY . 72.3 t -46.77 -57.93 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.1 t -57.62 -43.76 84.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -54.52 -53.73 50.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 150' ' ' ARG . 2.2 m-20 -90.02 18.39 5.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 149' ' ' ASP . 1.1 mpp_? 37.62 48.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -86.87 40.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 34.1 m95 -81.21 -50.54 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.8 m -39.03 -50.73 1.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -50.72 -61.03 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.782 HD13 HG22 ' A' ' 137' ' ' VAL . 19.0 mt -49.14 -67.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -40.14 -49.73 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.4 m -63.17 -36.91 85.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.63 -22.04 65.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 75.5 mmm -83.67 5.3 25.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.55 -1.36 66.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.26 156.93 26.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.57 143.72 85.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.2 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.92 -168.58 11.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -97.73 -32.11 11.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 110.955 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.65 -59.09 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.493 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 11.6 p -59.19 -32.1 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.54 95.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -82.22 -23.65 35.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.5 -47.27 84.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 133' ' ' LEU . 30.0 mm -43.62 -50.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -63.88 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.44 -45.3 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.411 ' CD2' ' HG3' ' A' ' 121' ' ' PRO . 4.5 m170 -52.44 -46.44 66.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -69.18 -23.71 63.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -90.28 -9.33 48.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -104.96 -28.58 11.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.1 -51.4 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 175' ' ' TYR . 12.5 mt -83.32 15.57 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.514 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.56 -58.85 4.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.723 . . . . 0.0 110.874 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.56 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 54.0 Cg_endo -69.72 -50.87 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.379 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.461 ' CE2' HD11 ' A' ' 186' ' ' LEU . 8.0 t80 -48.34 -49.61 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 185' ' ' PHE . 1.1 t30 -65.5 -68.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.2 mp -39.06 -27.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 183' ' ' ASN . 82.1 t80 -82.08 -63.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 182' ' ' TYR . 71.8 mt -43.81 -48.03 8.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.4 mtt-85 -64.69 -61.68 2.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.88 -35.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.573 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 46.3 mtpt -70.59 -53.73 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 mt -53.74 -39.16 65.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -46.36 -51.9 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' ILE . 38.0 t80 -58.67 -65.76 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.474 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.5 mt -45.24 -24.94 0.31 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -82.69 -48.11 11.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -67.22 -26.0 66.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.0 tt -85.08 -42.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -70.19 -41.57 73.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -55.67 -28.49 55.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 3.7 t80 -69.8 -29.41 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.809 ' CD1' HD12 ' A' ' 118' ' ' LEU . 77.0 m95 -81.56 -49.52 10.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -44.28 -40.94 5.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.67 -40.05 68.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -76.58 -39.62 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.29 32.69 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 m -134.82 103.89 5.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 p -53.64 141.3 26.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.1 tt -86.32 125.43 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -118.94 125.06 48.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.02 129.44 61.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.722 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.34 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.42 ' NE2' ' CD1' ' A' ' 127' ' ' ILE . 26.3 m80 -120.61 114.51 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.8 t -100.12 119.11 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 56.35 51.13 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 52.64 35.59 18.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -150.28 140.4 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' ' NE2' ' A' ' 122' ' ' HIS . 15.9 mm -60.81 144.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 133' ' ' LEU . 22.1 tp -106.91 104.21 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' HE1' ' A' ' 159' ' ' MET . 5.8 t70 -71.93 113.32 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.39 -61.06 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 100' ' ' LYS . 33.8 t80 -39.97 -55.32 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.87 -51.06 59.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 128' ' ' LEU . 34.9 tp -50.65 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -49.26 -46.35 46.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -49.52 -52.13 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.69 -49.05 74.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 146' ' ' VAL . 98.2 t -47.35 -54.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.66 70.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -54.92 -39.28 68.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.99 -14.77 61.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.407 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 152.85 -61.92 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 160.04 173.51 28.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.475 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.94 -46.19 90.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.38 -66.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 5.7 p -44.32 -37.04 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 142' ' ' GLY . 37.5 t -72.89 -49.34 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 148' ' ' LYS . 5.8 p -58.15 -45.87 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 147' ' ' CYS . 31.3 tttm -68.27 -33.4 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.54 4.45 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 146' ' ' VAL . 15.6 mmm180 47.12 37.88 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 19.3 mtpp -83.42 36.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 51.9 m95 -81.5 -44.21 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.1 m -43.39 -47.16 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -51.89 -61.63 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -55.73 -55.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.87 -53.61 2.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -47.4 86.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -45.19 -49.23 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.419 ' HE1' ' O ' ' A' ' 129' ' ' ASP . 92.0 mmm -60.78 -25.81 66.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.97 -2.93 14.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -74.54 138.61 43.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.27 144.14 16.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.545 0.688 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 85.03 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.353 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.22 169.13 24.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.489 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -74.6 -38.28 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.73 -59.11 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.32 -37.25 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.4 -49.33 57.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.4 t -73.67 -31.11 63.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.442 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.7 m-70 -54.7 -47.23 73.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 20.7 mm -46.2 -49.75 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.574 ' NH2' ' CD1' ' A' ' 152' ' ' TRP . 16.9 ttm105 -61.86 -61.66 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.31 -46.56 11.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 80.1 m-70 -49.34 -43.26 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.0 t80 -68.01 -41.45 82.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.65 -9.26 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -100.13 -32.12 11.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.0 mt -119.75 -49.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.169 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 11.8 mt -82.52 18.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.08 -60.24 2.93 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.739 . . . . 0.0 110.885 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.526 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.9 Cg_endo -69.75 -47.54 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -49.41 -49.41 45.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -80.69 -38.0 29.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 14.9 tp -55.62 -26.23 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.12 -51.89 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.3 mt -45.37 -53.72 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 102' ' ' ASN . 5.0 tpt85 -66.59 -57.68 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.29 -22.99 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -77.88 -60.66 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HA ' HD12 ' A' ' 104' ' ' LEU . 73.4 mt -63.75 -34.8 78.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 30.9 m-20 -44.22 -58.26 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -55.21 -59.97 4.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 101' ' ' LEU . 27.8 mt -42.5 -43.11 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.86 -40.54 95.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -64.9 -51.38 62.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.714 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.1 tp -61.46 -37.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.12 88.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -53.06 -36.63 60.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.13 -37.35 87.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.578 ' HD1' HD12 ' A' ' 118' ' ' LEU . 39.1 m95 -80.17 -59.87 2.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -38.99 -40.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -59.12 -53.03 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -61.36 -35.37 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.84 39.87 1.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -136.21 123.08 21.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.1 m -70.41 129.45 39.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.578 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.9 tt -84.39 125.22 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.46 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.1 ttmm -121.81 125.37 46.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.6 mm -70.9 131.65 87.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.162 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.6 Cg_endo -69.75 158.69 56.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -115.69 126.37 54.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.18 112.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 57.8 49.91 11.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 125' ' ' ARG . 26.2 mtm105 54.48 35.97 24.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.82 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -145.32 125.11 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.24 127.43 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.092 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.1 115.04 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.51 102.63 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.49 -51.94 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -43.53 -53.27 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 133' ' ' LEU . 43.3 tt0 -70.4 -60.51 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 171' ' ' ILE . 13.3 tp -35.19 -69.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -47.93 -47.61 32.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 139' ' ' GLU . 22.8 tptt -47.67 -54.21 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 132' ' ' GLN . 9.3 mp -56.28 -40.87 74.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 155' ' ' ILE . 63.9 t -53.27 -47.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.77 81.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 2.3 mp0 -66.59 -38.02 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -75.19 -21.41 58.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.34 -58.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 152.55 169.63 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.503 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -61.03 -39.09 88.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.69 -66.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.437 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.0 p -48.05 -42.99 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 142' ' ' GLY . 54.5 t -65.03 -70.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.3 t -44.61 -50.04 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -48.87 -55.41 11.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.81 14.78 5.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 42.85 54.34 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -98.25 41.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -79.75 -40.84 27.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -46.35 -56.51 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -45.07 -53.34 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 137' ' ' VAL . 19.9 mt -64.09 -62.8 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -38.09 -49.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 m -63.27 -47.75 81.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -48.35 -41.15 27.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.4 mtp -67.45 -28.52 67.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -2.06 10.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.576 ' CB ' HG21 ' A' ' 167' ' ' VAL . 21.2 m-85 -80.52 129.64 34.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -44.58 143.04 2.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.558 0.694 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -152.11 137.04 5.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -44.61 -26.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.23 -59.11 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 161' ' ' PHE . 10.8 p -67.82 -36.35 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.51 -44.95 85.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -78.64 -32.37 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -53.18 -50.57 64.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.641 HG23 HD21 ' A' ' 133' ' ' LEU . 21.8 mm -40.31 -61.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -54.39 -54.96 33.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -47.9 -47.0 25.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -51.21 -42.89 61.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.5 t80 -68.08 -40.75 82.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -78.04 -9.24 59.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -103.7 -28.18 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mt -120.11 -52.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 8.4 mt -88.58 28.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.58 -60.37 2.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.668 0.747 . . . . 0.0 110.864 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 184' ' ' LEU . 54.3 Cg_endo -69.66 -48.12 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.676 2.251 . . . . 0.0 112.383 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.714 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.3 t80 -39.25 -46.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.38 -51.78 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 181' ' ' PRO . 83.8 mt -45.35 -37.47 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.32 -55.31 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.2 mt -47.32 -46.51 25.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.487 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 42.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.781 0.324 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -67.47 -45.59 75.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.63 -24.98 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CE ' ' HA ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.46 -41.77 21.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.18 -44.52 88.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -43.83 -60.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 106' ' ' GLN . 45.9 t80 -61.17 -63.64 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 98.7 mt -38.4 -32.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 103' ' ' PHE . 7.5 t70 -77.63 -46.35 22.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 103' ' ' PHE . 91.9 mt-30 -64.17 -23.52 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.2 tp -92.02 -36.6 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.07 62.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 13.6 ptmt -57.76 -43.67 85.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.438 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 33.1 t80 -55.41 -28.19 52.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 68.5 m95 -81.08 -48.81 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.97 -57.09 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -47.36 -36.37 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -73.62 -32.92 64.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.63 34.46 3.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.3 t -139.02 123.24 18.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 110.865 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -68.85 148.95 49.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.8 tt -105.79 143.75 33.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.79 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.3 ttmt -156.42 120.46 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 178' ' ' ILE . 34.6 mm -84.18 131.94 49.34 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.3 Cg_endo -69.84 153.77 68.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 0.0 112.294 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -86.36 109.68 19.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.9 t -96.69 123.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 49.6 53.75 12.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 54.8 27.85 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -154.38 123.85 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.15 127.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.743 HD21 HD22 ' A' ' 133' ' ' LEU . 10.7 tp -82.35 107.76 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.72 117.2 17.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 120' ' ' ILE . 17.5 mt -65.16 -49.59 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CD2' ' HG3' ' A' ' 100' ' ' LYS . 35.7 t80 -42.62 -57.34 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -72.99 -48.14 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.991 HD11 HG23 ' A' ' 171' ' ' ILE . 32.0 tp -44.43 -71.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' VAL . 57.5 t-20 -47.99 -66.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 134' ' ' ASN . 35.9 tttp -35.65 -54.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.51 -41.67 63.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 155' ' ' ILE . 94.6 t -58.07 -48.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.3 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -73.69 -35.11 65.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -77.92 -16.64 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.413 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.75 -57.53 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 150.31 175.81 22.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.443 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.79 -33.17 73.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.78 -65.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.413 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.1 p -48.05 -42.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 151' ' ' LYS . 67.5 t -70.51 -67.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 48.6 t -45.51 -34.2 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -77.02 -49.23 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 150' ' ' ARG . 37.6 m-20 -89.22 21.18 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 149' ' ' ASP . 2.5 mmp_? 35.72 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 146' ' ' VAL . 15.6 mmmt -89.37 17.4 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 62.6 m95 -63.69 -45.99 87.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.2 m -41.69 -58.49 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -47.54 -58.43 4.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.699 HD13 HG22 ' A' ' 137' ' ' VAL . 17.8 mt -51.2 -66.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.1 m -54.9 -46.37 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -60.57 -26.8 67.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 82.1 mmm -78.56 2.19 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.99 63.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.15 166.71 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.12 145.16 52.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.602 0.715 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 85.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.98 -176.54 14.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.37 -25.26 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.778 0.323 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.17 -58.39 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.1 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.5 -38.65 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.82 -41.61 76.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.4 t -79.22 -29.57 42.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -57.99 -47.68 82.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.991 HG23 HD11 ' A' ' 133' ' ' LEU . 6.3 mm -45.05 -55.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -59.29 -63.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.92 -47.69 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -66.76 -30.85 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -85.04 -9.23 58.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -101.7 -31.31 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.463 HD13 ' CD1' ' A' ' 120' ' ' ILE . 23.9 mt -120.09 -51.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 175' ' ' TYR . 16.4 mt -83.12 20.03 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.83 -60.26 2.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.82 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 107' ' ' ILE . 10.0 t80 -40.05 -51.1 2.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.02 -41.29 95.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 184' ' ' LEU . 6.7 tt -56.4 -43.95 79.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -71.31 -59.19 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 182' ' ' TYR . 67.7 mt -38.4 -49.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.743 0.306 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -67.05 -62.41 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.38 -35.38 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 62.6 mttm -71.26 -61.28 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.08 -40.46 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -51.76 -53.52 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -57.98 -65.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 44.2 mt -44.47 -35.38 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.67 -52.82 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -56.73 -52.59 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.571 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 3.8 tt -63.23 -32.14 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.43 93.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 111' ' ' TRP . 3.0 mmmm -54.46 -58.62 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -38.79 -25.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 109' ' ' LYS . 63.5 m95 -90.86 -51.11 5.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.556 ' HG3' HD22 ' A' ' 113' ' ' LEU . 5.4 pt-20 -46.63 -20.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.556 HD22 ' HG3' ' A' ' 112' ' ' GLU . 1.5 mm? -79.17 -46.62 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -69.21 -1.66 8.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.12 43.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.7 p -128.98 129.04 44.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 110.802 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.4 114.74 25.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.13 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.767 HD23 ' N ' ' A' ' 119' ' ' LYS . 5.2 tt -50.31 137.12 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.767 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.65 115.14 61.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 165.66 30.19 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 1.5 m80 -117.66 132.5 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 128' ' ' LEU . 55.0 t -123.09 124.99 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 59.72 39.25 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 6.7 mmp_? 63.38 35.17 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -145.32 162.93 36.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.557 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 44.7 mm -82.69 102.99 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.615 HD11 HD22 ' A' ' 133' ' ' LEU . 47.2 tp -66.8 93.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.47 106.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.9 -46.43 90.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 131' ' ' PHE . 4.3 t80 -53.5 -56.12 19.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.462 ' O ' HD23 ' A' ' 136' ' ' LEU . 10.1 tt0 -65.19 -41.27 94.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 171' ' ' ILE . 4.1 tp -49.63 -72.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -51.63 -32.23 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -62.07 -50.79 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 155' ' ' ILE . 3.6 mm? -59.2 -41.6 88.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 146' ' ' VAL . 63.2 t -56.18 -55.51 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -54.04 -41.59 68.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.55 -40.99 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.45 -17.06 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.639 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 157.1 -59.09 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.632 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 144.18 170.33 13.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.472 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.58 -36.68 72.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -65.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.639 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.0 p -56.62 -54.92 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 142' ' ' GLY . 85.2 t -51.4 -62.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.3 t -53.92 -40.86 67.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.2 tptp -53.88 -48.92 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.32 11.87 37.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 49.4 44.9 23.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' ILE . 55.9 mttm -84.98 50.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.459 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 81.4 m95 -86.85 -51.23 6.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.0 m -39.4 -67.36 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -37.74 -53.94 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 151' ' ' LYS . 23.3 mt -58.78 -65.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.62 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.72 -46.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 m -68.08 -45.35 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -57.14 -29.44 63.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mmm -70.3 -17.22 63.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.65 1.71 11.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -90.02 172.38 8.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.21 145.92 43.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 88.46 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.266 . . . . 0.0 112.366 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -144.98 131.08 4.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.485 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -42.74 -25.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.26 -59.18 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.62 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.5 p -64.85 -32.99 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.68 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -77.05 -32.4 56.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -51.71 -51.07 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mm -42.16 -62.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -51.88 -53.43 40.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.41 -42.69 34.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.54 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 93.1 m-70 -60.52 -36.9 79.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 110.84 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.2 t80 -78.82 -30.2 45.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.56 -9.25 56.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 177' ' ' ARG . 13.3 mtp-105 -104.82 -28.43 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.98 -52.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 28.8 mt -85.2 21.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -71.65 -60.08 2.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 0.0 110.881 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.73 -49.65 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.383 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.5 t80 -45.07 -54.12 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -77.21 -37.93 52.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 40.9 tp -62.14 -19.59 63.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -98.0 -50.59 4.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -48.34 -45.12 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.545 HG22 HD11 ' A' ' 101' ' ' LEU . 19.6 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 12.9 ttp-105 -45.74 -59.09 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.41 -34.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HA ' ' CE2' ' A' ' 131' ' ' PHE . 53.1 mtpt -82.86 -58.82 2.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 97' ' ' THR . 34.0 mt -45.56 -36.98 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -50.5 -57.44 8.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 6.2 t80 -58.27 -58.91 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.9 mt -46.71 -37.95 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.32 -57.5 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -48.32 -56.0 9.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.598 HD12 ' CD1' ' A' ' 182' ' ' TYR . 1.7 tp -55.59 -40.1 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.18 91.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.01 -36.81 30.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -63.4 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.729 ' HD1' HD12 ' A' ' 118' ' ' LEU . 27.0 m95 -83.34 -59.24 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -38.31 -36.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.447 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 33.4 mt -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.47 -36.36 82.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.86 39.94 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -132.7 118.08 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.8 m -64.88 129.62 40.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.8 tt -79.97 122.15 26.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -116.15 141.66 47.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 mm -85.52 127.38 63.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.621 0.724 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HG2' HD23 ' A' ' 128' ' ' LEU . 54.1 Cg_endo -69.71 168.01 22.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.362 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -127.61 125.49 40.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 56.0 t -113.41 131.78 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 51.06 37.61 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? 64.16 54.5 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -164.37 164.02 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -73.45 127.56 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.598 HD23 ' HG2' ' A' ' 121' ' ' PRO . 15.3 tp -102.02 98.69 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 129' ' ' ASP . 43.0 t0 -70.8 117.12 11.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.4 mt -72.36 -63.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 100' ' ' LYS . 16.2 t80 -38.68 -61.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -57.46 -58.42 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 171' ' ' ILE . 6.7 tp -41.23 -67.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -50.59 -49.28 56.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -46.17 -54.35 8.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.64 -43.3 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.798 HG22 HD13 ' A' ' 155' ' ' ILE . 64.6 t -51.17 -48.81 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.48 91.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.26 -41.14 88.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.01 -22.35 58.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.561 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 161.63 -57.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.15 177.47 20.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.45 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 11.1 t80 -66.61 -36.63 83.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.61 -66.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.561 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -50.6 -51.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 142' ' ' GLY . 98.4 t -59.04 -68.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 35.5 t -44.73 -38.09 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -66.59 -45.42 79.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.2 m-20 -93.34 24.07 4.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 149' ' ' ASP . 3.0 mpt_? 35.02 45.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 146' ' ' VAL . 59.4 mttt -93.36 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.694 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 30.6 m95 -84.8 -48.67 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 152' ' ' TRP . 38.7 m -37.04 -53.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -46.43 -68.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.798 HD13 HG22 ' A' ' 137' ' ' VAL . 24.0 mt -45.31 -65.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.91 -50.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.8 m -54.3 -53.31 55.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.47 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -47.47 -49.57 25.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.4 mmm -50.12 -28.15 6.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.24 -4.04 10.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 36.7 m-85 -81.07 167.69 19.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 143.29 60.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 104.49 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.62 -159.48 9.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -101.0 -36.85 8.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.321 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -52.82 -58.48 6.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.52 -36.97 78.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.6 90.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 t -77.22 -28.76 53.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -58.34 -50.77 72.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.694 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 50.6 mm -40.4 -60.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -56.51 -53.58 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.38 -43.27 34.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -55.85 -39.86 72.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 2.6 t80 -67.77 -39.17 84.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -80.96 -9.21 59.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -97.2 -33.35 11.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.01 -51.39 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.47 ' HB2' ' CD1' ' A' ' 175' ' ' TYR . 12.6 mt -84.53 28.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.28 -60.4 2.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.875 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.75 -33.7 16.1 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.369 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.598 ' CD1' HD12 ' A' ' 107' ' ' ILE . 4.4 t80 -47.89 -60.91 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -72.4 -34.85 68.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.5 tm? -54.08 -48.8 70.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -73.67 -58.55 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.7 mt -41.83 -43.56 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.959 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -69.6 -42.28 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.2 p -62.2 -34.41 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.88 -53.55 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.1 mt -60.36 -46.01 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -46.64 -59.47 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 104' ' ' LEU . 71.7 t80 -49.25 -68.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 70.7 mt -37.03 -37.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.37 -57.92 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -52.29 -51.46 58.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.452 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.7 tt -58.05 -36.78 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -60.85 -50.99 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -47.71 -38.77 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -58.57 -38.58 78.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.417 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 13.8 m95 -82.06 -53.49 6.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -41.58 -50.13 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.33 -44.31 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -73.31 -36.81 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.18 40.71 0.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.9 m -131.88 126.68 34.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -74.51 128.28 35.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 119' ' ' LYS . 4.1 tt -91.22 118.32 30.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 118' ' ' LEU . 46.5 tttm -128.59 136.84 51.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.944 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.422 HD11 HD22 ' A' ' 104' ' ' LEU . 25.7 mm -67.47 124.5 89.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 111.108 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.725 ' HG2' HD23 ' A' ' 128' ' ' LEU . 53.9 Cg_endo -69.76 167.17 25.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.696 2.264 . . . . 0.0 112.311 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -123.89 119.92 31.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.583 ' CG2' HD22 ' A' ' 128' ' ' LEU . 43.1 t -108.67 136.51 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 45.17 39.84 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 61.48 44.82 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -155.04 142.33 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.06 118.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 121' ' ' PRO . 22.1 tp -94.8 103.9 15.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.938 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.1 104.03 5.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.9 mt -64.67 -46.64 81.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 58.6 t80 -48.12 -61.06 2.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 136' ' ' LEU . 7.1 mm100 -65.7 -39.5 91.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.935 HD11 HG23 ' A' ' 171' ' ' ILE . 11.6 tp -52.66 -71.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -53.57 -62.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -42.31 -50.81 4.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 132' ' ' GLN . 24.8 mt -56.1 -42.87 77.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 155' ' ' ILE . 72.8 t -57.8 -48.04 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.73 75.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.9 -44.9 94.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.35 -27.57 67.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 165.65 -54.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 142.49 163.48 9.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -57.17 -29.29 63.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.34 -66.3 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.069 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 141' ' ' GLY . 3.6 p -55.01 -39.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.4 t -68.04 -56.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.0 t -56.29 -41.95 76.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -55.61 -49.77 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.34 4.12 53.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.73 40.43 31.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -89.38 46.79 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -89.08 -41.65 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.4 m -42.9 -52.72 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -54.01 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 137' ' ' VAL . 15.4 mt -60.35 -60.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -43.72 -47.6 7.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.6 m -62.51 -46.21 89.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -51.78 -52.77 46.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 30.5 mtp -46.6 -28.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.33 -3.99 10.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.481 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.36 172.03 13.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.08 142.09 51.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 90.02 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.324 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.01 178.97 21.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -83.0 -32.38 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.58 55.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.9 p -63.59 -38.57 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -53.33 -45.96 64.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.1 m -75.43 -32.87 60.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -56.25 -49.71 73.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 133' ' ' LEU . 9.7 mm -44.23 -55.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.8 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.53 -56.69 9.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -49.32 -35.6 18.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.6 OUTLIER -75.99 -44.54 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.0 -9.9 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -105.27 -28.62 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.488 HG22 HD13 ' A' ' 179' ' ' LEU . 34.4 mt -116.72 -52.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.488 HD13 HG22 ' A' ' 178' ' ' ILE . 1.9 mm? -91.45 33.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.507 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.63 -63.88 0.52 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.39 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.7 t80 -37.74 -36.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -82.55 -53.8 5.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -55.7 -20.36 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -90.6 -52.08 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -47.98 -46.03 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.745 0.307 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -71.26 -59.01 3.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' A' ' 131' ' ' PHE . 7.6 p -56.87 -39.07 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.551 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 31.0 mttm -65.56 -54.37 28.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.47 -56.75 18.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.963 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -38.42 -58.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 12.1 t80 -50.17 -57.36 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 41.0 mt -52.18 -27.98 16.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.2 -53.71 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -56.32 -49.87 73.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 4.8 tt -57.49 -42.07 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.72 82.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -48.87 -37.36 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.502 ' OH ' ' CE1' ' A' ' 185' ' ' PHE . 5.6 m-85 -59.18 -43.98 92.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.751 ' HD1' HD12 ' A' ' 118' ' ' LEU . 73.2 m95 -68.97 -51.7 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -42.09 -50.3 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.3 mt -47.96 -42.0 26.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.92 -36.21 64.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.3 30.05 2.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.44 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.3 m -128.83 138.07 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.811 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -86.96 132.85 33.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.751 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.3 tt -85.31 118.75 25.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -112.54 125.0 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.79 119.61 75.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 154.47 67.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.2 123.36 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.59 121.47 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.07 48.57 6.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 126' ' ' LYS . 12.1 mpt_? 54.14 46.8 24.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 125' ' ' ARG . 34.8 mtmm -164.52 142.18 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -56.88 144.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -109.07 120.09 41.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.43 95.37 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 131' ' ' PHE . 55.9 mt -57.3 -63.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE2' HG22 ' A' ' 99' ' ' VAL . 10.5 t80 -34.76 -58.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 133' ' ' LEU . 10.8 tp60 -62.41 -62.61 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -35.08 -66.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -45.86 -56.22 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.45 -52.51 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.28 -41.97 66.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 155' ' ' ILE . 77.5 t -57.14 -45.89 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.73 -34.99 79.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -68.01 -31.59 71.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -82.93 -16.1 48.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.434 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 155.15 -60.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 153.43 172.76 21.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.72 -40.42 95.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.16 -66.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.434 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.2 p -48.61 -43.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 137' ' ' VAL . 44.8 t -62.83 -62.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 8.7 m -49.89 -46.02 51.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 148' ' ' LYS . 4.7 tmtt? -53.5 -60.15 3.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 150' ' ' ARG . 18.1 m-20 -84.47 25.87 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 149' ' ' ASP . 21.2 mmt180 34.49 38.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 41.1 mtpt -76.9 47.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.607 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 13.6 m95 -91.03 -48.73 6.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.5 m -39.07 -51.25 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -48.55 -64.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 137' ' ' VAL . 18.8 mt -52.92 -62.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.43 -49.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.6 m -65.23 -38.67 91.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 155' ' ' ILE . 24.3 mmtt -53.64 -47.14 70.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.0 mtp -65.13 -19.97 66.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.44 3.56 25.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.455 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.414 ' CB ' HG21 ' A' ' 167' ' ' VAL . 27.8 m-85 -83.56 128.17 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -47.4 143.87 5.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.545 0.688 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.08 4.86 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 171.35 41.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -79.17 -14.66 58.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.21 -56.84 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 161' ' ' PHE . 7.5 p -64.69 -37.34 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.98 -46.73 83.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.9 t -76.0 -28.31 57.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -58.33 -49.21 77.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 133' ' ' LEU . 5.7 mm -44.5 -60.09 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -57.05 -55.9 28.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.41 -44.87 16.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -49.14 -46.73 45.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -62.78 -38.54 91.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -80.56 -9.18 59.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -99.91 -31.73 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.0 mt -119.74 -50.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 18.9 mt -83.66 22.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -72.48 -60.62 2.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -48.03 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.99 -44.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.01 -58.07 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -42.09 -35.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CE1' ' OH ' ' A' ' 110' ' ' TYR . 12.1 t80 -73.2 -49.5 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.1 mt -56.65 -35.68 68.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.832 0.349 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -41.35 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.4 p -64.54 -30.56 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -79.0 -51.51 9.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.89 -47.75 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -42.78 -53.2 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.731 ' O ' HG22 ' A' ' 107' ' ' ILE . 35.1 t80 -51.84 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 23.0 mt -42.75 -36.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 29.7 t70 -67.59 -59.19 3.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -52.87 -54.14 38.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.9 tt -59.1 -33.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -58.55 -54.37 47.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HE2' ' N ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -42.84 -54.85 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -42.76 -38.12 2.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.655 ' HD1' HD12 ' A' ' 118' ' ' LEU . 66.7 m95 -83.56 -47.82 10.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -46.52 -44.38 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 109' ' ' LYS . 8.1 mp -58.82 -42.59 89.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -68.43 -37.67 80.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.8 40.46 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.9 p -142.8 106.15 4.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.912 0.387 . . . . 0.0 110.818 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.7 p -50.58 147.11 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.655 HD12 ' HD1' ' A' ' 111' ' ' TRP . 7.0 tt -101.51 111.95 24.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -110.03 140.6 43.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 121' ' ' PRO . 47.2 mm -85.91 131.89 45.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 120' ' ' ILE . 54.1 Cg_endo -69.75 170.97 15.33 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -127.62 111.13 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.6 t -104.47 123.55 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 60.74 41.86 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 57.64 40.89 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -153.69 149.31 27.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.38 135.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.513 HD11 HD22 ' A' ' 133' ' ' LEU . 40.0 tp -103.47 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.91 97.71 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' PHE . 51.7 mt -55.43 -62.84 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 88.7 t80 -34.79 -54.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 133' ' ' LEU . 4.7 tp60 -64.94 -62.91 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 171' ' ' ILE . 14.4 tp -34.39 -69.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -50.33 -51.27 46.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -46.27 -51.55 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.01 -50.17 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 146' ' ' VAL . 70.5 t -47.64 -50.7 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.26 -45.86 83.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.55 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -76.56 -22.7 53.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.2 -58.55 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 151.93 170.76 18.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.518 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -60.52 -40.79 92.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.89 -66.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.424 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.3 p -49.13 -43.37 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.2 t -67.62 -66.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 52.7 t -44.57 -48.1 10.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -56.79 -57.82 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.99 19.56 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 38.86 48.67 1.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.558 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -84.51 38.49 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.404 ' CZ2' ' HG2' ' A' ' 172' ' ' ARG . 80.7 m95 -84.01 -44.97 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -41.28 -50.71 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -49.38 -55.15 13.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.6 mp -60.3 -64.49 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.48 -49.97 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.4 m -61.41 -47.55 85.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -50.09 -41.88 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 31.6 mtp -68.15 -28.0 66.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -1.67 10.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CB ' HG21 ' A' ' 167' ' ' VAL . 19.6 m-85 -81.37 128.02 33.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -46.4 141.61 4.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.56 0.695 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.39 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 0.0 112.37 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.637 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -140.17 132.32 5.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -37.36 -33.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -53.2 -58.75 5.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 164' ' ' GLY . 8.6 p -64.77 -32.57 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.24 -45.0 89.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.9 m -77.49 -35.3 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -51.89 -48.09 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.636 HG23 HD11 ' A' ' 133' ' ' LEU . 5.0 mm -45.89 -55.72 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' C ' ' OE1' ' A' ' 176' ' ' GLU . 41.2 mtp180 -55.38 -57.88 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.81 -42.29 7.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -59.6 -39.95 85.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -72.2 -39.12 68.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.408 ' OE1' ' C ' ' A' ' 172' ' ' ARG . 10.1 mp0 -81.89 -9.24 59.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.76 -30.84 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.98 -50.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 175' ' ' TYR . 11.2 mt -84.04 23.36 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.61 -60.34 2.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.564 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.8 Cg_endo -69.74 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.28 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 186' ' ' LEU . 5.8 t80 -42.08 -54.4 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -77.25 -42.16 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 55.1 tp -55.28 -27.01 43.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -97.1 -54.16 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 182' ' ' TYR . 28.0 mt -41.95 -44.36 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.6 m -88.84 100.34 13.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 t -116.21 114.23 24.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.76 59.75 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.474 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 83.1 p -109.92 161.61 15.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 0.0 110.847 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.8 t -171.35 144.75 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.29 42.01 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.81 155.83 15.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 149.59 45.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -128.96 -58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -82.25 -36.43 27.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -70.71 -50.39 36.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -44.67 -35.98 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -80.28 -46.97 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.3 mt -55.0 -39.15 68.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -44.74 -65.59 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 74.1 t80 -49.66 -68.04 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.436 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 72.5 mt -37.05 -52.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CD ' ' A' ' 109' ' ' LYS . 22.1 t70 -49.77 -53.41 25.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -56.1 -59.64 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.436 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.0 tt -57.06 -25.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -74.2 -41.82 60.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -56.3 -34.08 66.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.37 -31.12 72.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' LEU . 14.5 m95 -88.13 -54.3 4.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -26.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 111' ' ' TRP . 54.7 mt -69.81 -48.82 57.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.443 ' OE1' ' C ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -68.08 -36.71 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 115.41 33.45 1.6 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -120.05 145.33 46.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.846 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 m -89.31 128.84 35.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -86.2 120.31 27.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 118' ' ' LEU . 16.3 tptp -142.33 124.29 15.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.0 mm -81.1 138.46 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.9 Cg_endo -69.77 179.48 3.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 127' ' ' ILE . 56.9 m80 -115.8 107.02 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.505 HG12 ' CE1' ' A' ' 161' ' ' PHE . 53.3 t -93.14 110.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 57.65 48.29 14.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 60.21 31.59 20.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -148.42 123.36 10.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 122' ' ' HIS . 19.9 mm -54.75 131.68 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.618 ' O ' HG21 ' A' ' 120' ' ' ILE . 58.8 tp -92.39 103.62 16.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.14 91.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 131' ' ' PHE . 64.4 mt -43.17 -59.5 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' LEU . 45.9 t80 -35.31 -69.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 133' ' ' LEU . 40.8 mt-30 -54.89 -57.27 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.996 HD11 HG23 ' A' ' 171' ' ' ILE . 16.6 tp -34.09 -71.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -51.2 -45.91 62.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -49.17 -58.64 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.94 -46.26 60.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.8 t -49.07 -55.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.85 75.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.0 -38.04 89.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.91 -19.79 60.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 157.38 -59.44 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.76 171.32 17.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.07 -46.0 91.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.84 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.52 -66.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.6 p -49.9 -54.47 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 142' ' ' GLY . 57.4 t -51.43 -49.09 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.2 m -58.25 -45.41 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -57.49 -49.04 77.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.9 m-20 -97.36 18.4 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 35.36 51.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -86.47 41.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.85 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 43.4 m95 -84.26 -36.36 22.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 m -49.7 -43.7 47.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -54.45 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.583 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.7 mp -55.23 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -38.7 -53.51 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 92.4 m -57.83 -43.79 86.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -61.07 -22.83 64.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 93.3 mmm -82.45 9.24 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.82 -10.11 74.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.543 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.505 ' CE1' HG12 ' A' ' 123' ' ' VAL . 13.6 m-85 -72.26 157.11 38.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.0 61.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 85.64 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.677 2.252 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.34 -130.49 3.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.44 -46.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.61 -58.98 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.534 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.2 p -54.9 -31.08 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.16 19.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 t -70.13 -25.65 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -58.49 -48.09 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.996 HG23 HD11 ' A' ' 133' ' ' LEU . 34.7 mm -47.1 -52.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -59.63 -57.47 12.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.14 -57.69 7.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -40.34 -37.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.6 OUTLIER -77.07 -42.31 38.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -76.81 -9.23 58.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -101.46 -32.23 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.29 -51.1 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 19.5 mt -83.93 21.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.45 -60.25 2.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 0.0 110.888 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.1 Cg_endo -69.72 -50.68 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -40.78 -47.9 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.26 -27.21 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 184' ' ' LEU . 2.2 tt -61.52 -29.45 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -95.3 -45.59 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.1 mt -48.94 -39.97 28.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 79.7 p -62.84 -49.55 74.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.52 -49.67 0.85 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.15 101.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.5 t -50.39 -35.94 30.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.428 ' HA ' HD13 ' A' ' 191' ' ' LEU . 1.9 mm? -47.41 -55.78 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -45.2 101.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.82 164.02 32.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 194' ' ' LEU . 6.2 tt -70.55 119.41 14.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -66.41 120.12 12.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.472 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 14.1 ttpp -86.83 139.96 33.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.569 0.7 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 54.1 Cg_endo -69.74 -179.69 3.08 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 0.0 112.325 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 199' ' ' LEU . 88.4 m-20 -122.77 99.53 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 199' ' ' LEU . 4.6 pp -34.39 142.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 85.2 m -99.84 132.42 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.4 m -107.58 158.7 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -136.82 146.28 45.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 97.8 m -130.8 138.57 49.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -117.96 152.24 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.83 131.13 16.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 207' ' ' GLU . 2.5 pptp? -110.46 175.71 5.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.42 ' N ' ' HD2' ' A' ' 206' ' ' LYS . 2.3 pm0 -147.4 156.64 43.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 6.7 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.82 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -48.33 160.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 110.833 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -81.32 162.11 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.843 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.53 -99.1 1.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -105.06 168.67 8.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.873 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -134.14 -51.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 46.17 49.71 13.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -104.04 172.71 6.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 -33.79 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 14.9 tt0 -71.75 -29.46 64.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -59.15 -29.24 67.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.118 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -65.57 -62.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' A' ' 131' ' ' PHE . 9.7 p -63.24 -20.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 96' ' ' GLN . 22.4 mmtt -75.02 -49.06 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 104' ' ' LEU . 71.7 mt -77.99 -37.44 47.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -39.96 -62.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.66 ' O ' HG22 ' A' ' 107' ' ' ILE . 46.0 t80 -53.31 -57.69 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 101' ' ' LEU . 43.5 mt -44.07 -31.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.8 -40.78 22.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -68.0 -26.17 65.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.6 tp -92.88 -31.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.54 -45.33 46.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 113' ' ' LEU . 29.5 pttt -48.72 -39.78 26.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 6.2 m-85 -56.67 -38.04 71.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 66.4 m95 -72.32 -49.48 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -43.57 -56.05 3.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.0 mp -47.39 -42.33 21.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -68.15 -31.91 71.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.16 33.86 3.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -138.55 138.26 37.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.971 0.415 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -86.18 137.31 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 7.0 tt -89.79 128.88 36.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.3 tptm -114.99 120.48 40.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.03 129.73 93.95 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.62 0.724 . . . . 0.0 111.11 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.15 57.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.267 . . . . 0.0 112.301 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 1.6 m80 -123.61 108.86 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 72.2 t -96.55 140.29 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 41.63 43.24 2.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 60.16 41.82 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -152.99 156.41 38.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.513 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 15.3 mm -69.75 137.34 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.75 HD11 HD22 ' A' ' 133' ' ' LEU . 15.8 tp -107.47 98.78 8.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -72.29 105.09 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.2 -57.35 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CE2' HG22 ' A' ' 99' ' ' VAL . 7.6 t80 -38.78 -48.37 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -73.44 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.75 HD22 HD11 ' A' ' 128' ' ' LEU . 24.6 tp -38.12 -67.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -47.46 -57.49 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -41.51 -56.67 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.0 mt -51.61 -44.34 62.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 133' ' ' LEU . 59.2 t -52.26 -51.3 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.21 85.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.67 -42.89 97.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -73.07 -22.01 60.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 158.76 -58.21 0.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 141.67 170.11 12.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CE2' ' HG2' ' A' ' 172' ' ' ARG . 30.3 t80 -57.31 -41.76 80.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.847 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.15 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.8 p -55.54 -52.01 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 142' ' ' GLY . 95.3 t -56.72 -66.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 14.2 t -51.25 -36.24 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -58.8 -50.99 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.09 25.62 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 38.38 39.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -85.46 46.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.865 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 45.4 m95 -88.96 -42.68 11.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.2 m -40.92 -50.73 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -50.69 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.2 mt -45.16 -62.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.5 -56.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.7 m -55.29 -41.46 72.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -53.65 -44.99 70.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.0 mmm -59.43 -18.82 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.28 -14.53 12.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 19.4 m-85 -66.5 164.63 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 144.14 75.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 111.069 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 96.19 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.2 13.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -36.65 10.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.741 0.305 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -55.97 10.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.44 -38.18 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.2 -47.56 41.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -76.7 -33.52 58.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.67 -51.98 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.865 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 6.8 mm -40.98 -55.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HG2' ' CE2' ' A' ' 143' ' ' PHE . 21.2 mtm105 -57.38 -56.09 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.04 -44.96 26.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.425 ' CD2' HD22 ' A' ' 128' ' ' LEU . 60.9 m-70 -53.39 -38.42 63.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -76.8 -32.27 57.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -86.33 -9.34 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -101.69 -29.59 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.92 -52.28 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 13.1 mt -84.15 24.16 0.98 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.53 -60.25 2.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.65 0.738 . . . . 0.0 110.912 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.73 -50.0 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.665 2.243 . . . . 0.0 112.397 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.0 t80 -42.61 -56.12 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.49 -52.49 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.95 -33.5 4.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -75.11 -55.55 5.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.84 -46.33 64.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 188' ' ' GLY . 25.4 p -88.02 -0.88 57.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' SER . . . -34.45 114.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -111.45 113.92 26.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.0 p -51.42 -43.25 61.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.73 -46.23 40.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.28 92.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.8 t -81.11 168.13 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.47 120.48 14.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -88.5 114.08 24.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 149.07 53.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 159.92 51.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.656 2.238 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.51 45.06 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 13.3 mt -132.71 119.86 20.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.1 m -117.24 94.57 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.1 m -91.22 134.95 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -93.81 153.04 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -116.2 123.45 47.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -57.24 165.69 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 206' ' ' LYS . 2.9 p30 -131.3 147.06 52.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.869 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 205' ' ' ASP . 30.9 tttt -36.34 141.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -127.71 172.72 10.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.3 t -115.67 103.45 10.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 t -119.27 157.7 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.09 -107.2 0.86 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 84.8 p -123.27 40.16 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 110.869 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.3 m -139.31 154.65 47.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.83 129.35 18.59 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -96.17 34.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.17 82.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -69.7 -20.49 63.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -87.94 -36.02 17.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.142 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -64.19 -52.44 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 100' ' ' LYS . 8.7 p -55.64 -44.88 78.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 99' ' ' VAL . 81.0 mttt -60.57 -46.78 88.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ASN . 35.2 mt -57.21 -50.25 73.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' LEU . 57.3 t-20 -37.56 -61.95 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 105' ' ' ASP . 31.4 t80 -57.97 -65.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 58.1 mt -38.23 -27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.9 t70 -80.77 -48.95 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 103' ' ' PHE . 12.3 mm100 -64.13 -21.33 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.4 tt -91.55 -39.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -67.16 -41.6 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 55.4 pttt -56.93 -44.24 82.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 5.5 m-85 -50.04 -33.06 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.52 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 60.7 m95 -79.16 -49.47 12.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -45.4 -40.14 7.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.37 -45.25 88.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -65.44 -33.06 75.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.56 40.83 1.69 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -144.06 147.49 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -87.45 146.6 25.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -96.29 115.98 28.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 118' ' ' LEU . 22.7 ttpt -107.27 124.08 49.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.72 125.44 90.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 160.75 48.55 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -125.37 109.12 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.15 121.64 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 56.11 45.6 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' NH1' ' A' ' 125' ' ' ARG . 6.3 mtp-105 58.37 41.29 23.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -145.78 153.36 40.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -76.95 113.57 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.24 108.6 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.944 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.63 88.86 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' PHE . 41.3 mt -39.19 -64.6 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.4 t80 -37.32 -66.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 38.1 tt0 -50.42 -60.65 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -36.45 -70.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.2 -47.49 46.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -49.5 -54.4 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -52.38 -49.31 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 155' ' ' ILE . 97.4 t -48.24 -48.84 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.99 90.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.19 -32.12 69.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.05 -12.85 58.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.08 -61.7 0.38 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.92 170.58 18.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 34.2 t80 -60.13 -35.83 76.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 0.0 110.926 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.44 -66.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.7 p -49.95 -49.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 145' ' ' VAL . 53.2 t -61.89 -62.63 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 52.2 t -46.34 -46.13 18.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -63.35 -55.46 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 14.93 2.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.4 OUTLIER 39.64 52.12 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 9.0 mtpm? -94.22 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.496 ' CE3' HG21 ' A' ' 171' ' ' ILE . 89.7 m95 -81.81 -40.67 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 98.9 m -42.31 -51.25 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -49.59 -68.28 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -43.13 -65.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.11 -51.29 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.6 m -54.66 -53.02 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -54.08 -27.4 32.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -78.72 10.27 3.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.3 75.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -70.5 157.03 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.65 80.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.521 0.677 . . . . 0.0 111.142 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.224 . . . . 0.0 112.324 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -141.74 -169.18 11.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -93.93 -47.66 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.72 -58.22 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HA ' ' CD2' ' A' ' 170' ' ' HIS . 11.5 p -60.23 -31.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.25 -49.84 62.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.9 t -74.31 -34.08 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.446 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 3.8 m-70 -50.74 -53.78 28.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.684 HG23 HD11 ' A' ' 133' ' ' LEU . 32.4 mm -38.78 -48.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -65.14 -52.84 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 176' ' ' GLU . . . -53.16 -57.31 15.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -43.38 -30.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.599 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -79.47 -37.99 35.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' GLY . 7.3 mt-10 -77.97 -10.3 59.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 177' ' ' ARG . 1.2 mpt_? -98.16 -34.03 10.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.1 mt -119.52 -48.34 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 175' ' ' TYR . 7.7 mt -83.47 21.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -70.98 -60.1 3.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.52 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.76 -49.08 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.32 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 6.1 t80 -44.61 -56.65 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.98 -38.84 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.424 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 52.0 tp -58.13 -23.19 54.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -98.13 -43.1 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -53.16 -44.6 67.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 m -69.18 -47.17 65.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.06 142.11 3.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -126.24 160.32 30.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.0 m -92.51 -44.91 8.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 191' ' ' LEU . 4.9 mp -51.98 -46.64 64.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -50.7 140.53 14.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.7 p -69.21 174.14 4.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.08 136.94 50.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.962 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -110.93 149.42 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -52.66 146.33 18.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.541 0.686 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -4.28 13.7 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.322 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.87 134.69 57.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -146.46 125.63 12.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 106.4 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.9 p -124.03 128.48 49.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -72.39 82.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.5 m -131.74 104.93 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -72.08 162.97 28.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.895 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.46 127.34 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -118.92 162.84 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 208' ' ' TYR . 12.0 tt0 -58.94 159.01 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 207' ' ' GLU . 77.9 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.3 m -83.88 172.26 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.2 t -125.68 -42.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.39 -104.51 0.73 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 90.4 p -153.32 168.75 24.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.924 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -137.11 145.95 44.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.835 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -130.4 -110.37 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -123.77 149.28 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.96 133.46 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 97' ' ' THR . 22.9 mp0 -69.1 -60.18 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 96' ' ' GLN . 3.7 t -34.16 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 96' ' ' GLN . 28.4 mmt180 -56.54 -57.84 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 96' ' ' GLN . 9.8 p -71.17 -31.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -54.8 -49.67 70.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 102' ' ' ASN . 81.5 mt -77.31 -48.16 18.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 101' ' ' LEU . 5.4 t-20 -37.33 -63.25 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.25 -64.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.453 ' HA ' HG22 ' A' ' 107' ' ' ILE . 28.3 mt -45.08 -26.07 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.17 -40.34 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -74.69 -24.38 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 182' ' ' TYR . 9.1 tp -87.39 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -65.69 -46.15 80.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.651 ' O ' HD12 ' A' ' 113' ' ' LEU . 61.0 pttt -49.05 -45.0 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.446 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 56.5 t80 -52.49 -41.63 63.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.864 ' CD1' HD12 ' A' ' 118' ' ' LEU . 53.6 m95 -68.09 -48.25 66.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.19 -45.39 16.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.5 mp -51.44 -37.06 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -78.26 -23.16 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 27.36 9.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -129.91 136.43 49.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.79 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -82.11 145.22 30.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.6 tt -90.79 117.15 29.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -109.57 114.65 28.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mm -70.47 126.56 92.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.56 10.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.38 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -122.58 121.0 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 128' ' ' LEU . 97.4 t -110.22 127.96 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 54.17 42.48 31.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 58.87 45.15 15.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -157.07 153.86 28.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.12 105.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.533 ' CD2' ' CD2' ' A' ' 174' ' ' HIS . 49.4 tp -65.6 116.6 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -80.41 108.21 13.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.07 -52.19 51.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CD2' ' N ' ' A' ' 132' ' ' GLN . 6.8 t80 -48.27 -66.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 59.3 tt0 -54.77 -47.96 73.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 171' ' ' ILE . 5.8 tp -50.08 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -48.98 -43.6 40.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -51.03 -53.38 34.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 66.1 mt -56.14 -46.29 79.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.1 t -48.57 -49.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.87 79.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.23 -42.59 79.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -72.97 -14.58 61.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.97 -61.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.82 168.79 14.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.26 -42.15 81.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.28 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.447 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -52.49 -40.96 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.6 t -69.9 -26.38 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.9 m -78.82 -32.64 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 8.1 pttp -81.35 -45.3 16.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 150' ' ' ARG . 5.8 m-20 -89.43 20.15 4.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 31.41 47.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -87.97 37.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 24.6 m95 -85.36 -42.27 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m -52.02 -53.27 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -46.71 -53.89 10.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 156' ' ' ALA . 28.4 mt -58.9 -68.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.116 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -34.32 -49.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -58.88 -49.22 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -50.17 -49.13 53.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 22.9 mtp -47.93 -27.19 2.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.5 -7.55 10.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -77.43 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.32 145.11 55.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.542 0.686 . . . . 0.0 111.142 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 93.32 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -146.91 135.32 5.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.455 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -43.78 -23.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.401 ' N ' ' C ' ' A' ' 164' ' ' GLY . . . -61.01 -59.09 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.53 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.3 p -67.57 -40.68 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.94 -41.44 45.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.3 m -83.33 -31.6 26.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.1 m-70 -54.69 -40.0 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.791 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 49.9 mm -50.51 -61.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.081 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.69 -52.68 63.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.69 -43.02 37.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.533 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 60.9 m-70 -56.83 -39.81 74.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.8 OUTLIER -75.23 -39.98 59.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -76.29 -9.44 58.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -104.04 -29.72 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.1 mt -119.25 -52.47 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 29.2 mt -82.94 18.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -69.95 -60.22 3.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.632 0.73 . . . . 0.0 110.909 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -41.78 4.01 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.576 ' CD1' HD12 ' A' ' 107' ' ' ILE . 16.5 t80 -45.31 -51.68 10.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.72 -42.85 21.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 47.4 tp -50.82 -31.28 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -90.53 -54.08 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -42.18 -51.82 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.8 m -63.99 -40.6 96.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -43.4 -82.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.498 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -123.65 115.19 21.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 5.3 p -95.33 -21.9 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.17 2.2 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -134.42 84.55 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.7 m -146.47 179.61 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.41 160.11 41.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -132.96 130.55 39.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -89.17 141.99 29.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 129.36 17.5 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.342 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.9 125.14 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.59 108.15 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.7 p -115.2 163.48 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.0 m -129.72 122.33 28.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 98' ' ' ARG . 2.2 p-10 -120.23 114.76 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.7 p -109.53 -29.69 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 108.77 20.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.5 -24.92 66.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -149.75 116.95 6.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.9 -25.42 42.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 36.9 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.1 p -170.34 145.14 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.896 0.379 . . . . 0.0 110.834 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.1 t -131.32 176.28 8.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.89 -114.55 4.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' SER . 77.6 p -131.85 40.92 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 91' ' ' SER . 1.3 t -37.06 120.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.67 -156.33 23.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.45 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -56.86 169.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.35 156.31 38.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.6 -35.04 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 t -85.26 -38.34 19.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -60.9 -56.18 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.614 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.1 p -44.34 -35.6 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 60.9 mttt -78.44 -54.88 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 102' ' ' ASN . 72.9 mt -46.06 -48.42 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 101' ' ' LEU . 25.6 t-20 -36.41 -65.55 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 106' ' ' GLN . 55.5 t80 -55.05 -68.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.468 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 36.6 mt -36.68 -30.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' PHE . 10.1 t70 -79.48 -45.78 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.3 mm-40 -67.04 -17.98 65.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.6 tt -96.86 -34.98 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.83 -42.32 81.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.092 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' O ' HD23 ' A' ' 113' ' ' LEU . 49.4 pttt -54.44 -46.37 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' N ' ' CG ' ' A' ' 109' ' ' LYS . 7.5 m-85 -47.97 -36.48 12.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.848 ' CD1' HD12 ' A' ' 118' ' ' LEU . 80.6 m95 -74.63 -49.33 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -43.21 -54.0 4.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 109' ' ' LYS . 2.7 mm? -45.64 -40.69 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.21 -44.54 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 35.87 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -138.14 120.12 15.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.936 0.398 . . . . 0.0 110.883 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 t -65.16 147.46 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.848 HD12 ' CD1' ' A' ' 111' ' ' TRP . 4.0 tt -110.37 110.28 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -103.91 140.38 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.29 122.99 73.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.13 11.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -122.22 125.27 45.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.7 t -112.94 134.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 46.76 42.32 11.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 57.75 45.6 18.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -163.89 130.71 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mm -46.5 133.05 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 133' ' ' LEU . 25.8 tp -94.98 104.6 16.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -72.5 98.62 2.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.81 -57.06 14.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.614 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 44.7 t80 -42.26 -65.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -56.01 -53.67 54.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 128' ' ' LEU . 20.7 tp -46.94 -70.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -42.91 -48.66 5.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -48.6 -56.17 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.59 -40.26 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 155' ' ' ILE . 46.6 t -55.04 -54.74 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.99 70.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -63.86 -37.66 88.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -81.14 -19.12 44.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.458 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.55 -57.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.508 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.75 160.5 9.11 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 175' ' ' TYR . 2.4 t80 -53.69 -33.62 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.23 -66.26 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.7 p -52.11 -31.07 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.5 t -76.1 -54.58 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 38.6 t -57.88 -49.8 75.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 9.3 ptmt -51.76 -42.95 62.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 148' ' ' LYS . 16.3 t0 -90.42 0.89 57.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 52.22 50.79 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -102.84 35.41 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -71.73 -31.76 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.3 m -53.75 -62.67 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.154 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -39.32 -58.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 137' ' ' VAL . 22.2 mt -55.43 -64.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.441 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -39.19 -44.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.1 m -62.42 -47.69 83.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -51.8 -45.9 64.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.1 -27.21 52.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.07 -7.69 9.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -73.29 135.67 44.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.56 142.7 21.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.538 0.685 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 125.69 12.45 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.4 -144.78 4.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -121.36 -29.72 4.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.27 -57.96 10.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 168' ' ' GLY . 9.2 p -58.72 -44.88 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -49.48 -40.38 31.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.49 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -79.75 -28.72 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.1 m-70 -57.83 -51.64 68.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 133' ' ' LEU . 4.5 mm -46.77 -58.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -50.69 -54.04 26.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -53.62 -52.08 44.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 90.8 m-70 -44.46 -33.96 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CD1' ' CE2' ' A' ' 143' ' ' PHE . 1.0 OUTLIER -79.4 -36.1 39.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -83.57 -9.07 59.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -101.94 -31.45 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.13 -50.35 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 175' ' ' TYR . 15.8 mt -83.22 18.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.517 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.82 -58.85 4.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.71 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.57 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 54.2 Cg_endo -69.74 -50.83 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.377 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -42.75 -41.64 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.37 -64.55 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 180' ' ' ASN . 6.9 mp -40.35 -36.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -70.57 -51.96 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.9 mt -46.9 -44.81 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 m -66.07 -43.19 88.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.15 144.18 3.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.49 173.36 6.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.879 0.371 . . . . 0.0 110.837 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.2 p -83.14 -6.04 59.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.73 -27.85 20.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.24 -46.23 62.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.1 m -104.99 167.29 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.84 114.39 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -147.36 151.63 36.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -127.17 143.38 46.86 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.903 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 112.62 3.14 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.527 ' C ' HD12 ' A' ' 199' ' ' LEU . 18.9 p30 -66.73 169.19 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 198' ' ' ASN . 7.3 mp -127.14 140.01 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 76.4 p -125.09 142.83 51.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 7.9 t -83.46 137.37 33.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -114.73 122.87 47.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.2 m -74.15 124.08 25.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.27 148.55 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -120.83 -20.17 7.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -93.24 110.65 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -66.37 96.45 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.824 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p 37.85 41.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -67.62 151.48 47.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.76 65.75 0.26 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -66.15 123.11 19.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.4 t 61.15 43.22 11.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.37 -47.99 3.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.46 139.14 40.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.343 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.97 152.85 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -104.74 -36.38 7.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 p -86.05 -54.19 4.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -47.36 -51.58 19.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.8 p -47.08 -35.84 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.553 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 7.3 mtmp? -73.09 -49.2 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.76 -38.26 81.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.26 -53.63 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 107' ' ' ILE . 50.1 t80 -58.61 -48.39 81.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.46 -36.72 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.5 -42.02 68.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -65.82 -52.74 48.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 103' ' ' PHE . 2.8 tp -55.16 -49.35 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -54.26 -49.17 70.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -43.71 -52.34 6.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.98 -42.96 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.455 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 51.6 m95 -71.72 -48.64 45.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -44.53 -50.59 9.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mt -54.39 -43.86 71.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.13 -38.44 88.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.86 34.8 1.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -140.64 130.08 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 p -67.18 140.16 57.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -111.76 149.02 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.915 ' H ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -169.98 141.2 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 128' ' ' LEU . 10.1 mm -75.26 131.51 78.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.602 0.715 . . . . 0.0 111.17 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.31 24.85 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.541 ' CE1' HD11 ' A' ' 127' ' ' ILE . 32.8 m80 -100.46 116.74 33.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 128' ' ' LEU . 88.2 t -108.41 120.54 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 61.82 43.73 9.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 58.11 42.16 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -170.25 133.19 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.541 HD11 ' CE1' ' A' ' 122' ' ' HIS . 17.0 mm -46.99 148.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.66 ' O ' HG21 ' A' ' 120' ' ' ILE . 9.4 tp -116.86 111.41 19.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.8 106.31 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.36 -50.63 72.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 54.3 t80 -44.38 -56.5 4.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -63.2 -56.03 20.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 171' ' ' ILE . 6.6 tp -40.79 -70.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -43.54 -48.39 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -50.53 -50.43 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' HB3' HG23 ' A' ' 155' ' ' ILE . 4.1 mm? -57.11 -38.15 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.707 HG22 HD13 ' A' ' 155' ' ' ILE . 46.4 t -58.53 -59.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.54 60.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -60.77 -37.24 81.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -79.49 -13.4 59.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 151.55 -62.71 0.39 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 162.17 169.22 25.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -61.25 -37.05 81.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.72 -66.34 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 2.5 p -43.15 -30.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 150' ' ' ARG . 20.2 t -80.43 -50.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.5 p -57.78 -38.43 75.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -78.01 -28.27 49.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.16 2.2 45.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmm180 53.69 31.04 12.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 146' ' ' VAL . 40.9 mtmt -83.53 43.11 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -86.4 -44.97 11.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 m -47.85 -49.62 28.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -49.15 -55.36 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.707 HD13 HG22 ' A' ' 137' ' ' VAL . 14.9 mt -57.34 -60.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.429 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -41.64 -48.13 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -50.76 -43.7 58.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.9 mtp -58.31 -21.0 47.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.68 2.11 24.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -78.97 177.46 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.88 142.91 34.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.595 0.712 . . . . 0.0 111.095 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 122.98 9.64 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.39 -166.63 32.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -104.7 -20.87 13.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.72 -59.1 4.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.429 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.1 p -61.79 -30.75 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.63 -49.29 78.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.8 m -75.43 -27.38 58.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.6 m-70 -58.22 -54.22 49.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.856 HG23 HD21 ' A' ' 133' ' ' LEU . 5.4 mm -37.97 -64.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -52.04 -50.61 61.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -52.55 -44.38 59.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.75 -31.53 70.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -84.17 -22.87 30.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -90.63 -10.77 42.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.15 -25.21 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.7 mt -119.35 -52.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.26 28.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.499 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.26 -62.73 0.79 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.67 0.748 . . . . 0.0 110.905 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.76 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 107' ' ' ILE . 7.3 t80 -40.56 -44.22 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 175' ' ' TYR . 8.3 m120 -72.06 -43.38 64.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 181' ' ' PRO . 43.3 mt -56.78 -54.96 40.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 189' ' ' ASP . 27.0 t80 -59.46 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.5 mt -50.11 -48.11 53.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.1 t -55.5 -46.89 76.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.31 124.17 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.401 ' HB2' ' CD1' ' A' ' 185' ' ' PHE . 11.9 t70 -106.85 80.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.331 . . . . 0.0 110.903 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.4 t -84.45 -46.97 11.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 192' ' ' ARG . 1.7 pt? -43.34 -34.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.444 ' N ' ' HG ' ' A' ' 191' ' ' LEU . 1.8 mpt_? -140.22 132.66 28.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 88.2 m -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.9 107.9 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -97.07 94.18 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -127.26 142.66 44.56 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 102.08 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -89.09 163.09 15.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 199' ' ' LEU . 0.9 OUTLIER -146.08 175.31 10.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 86.7 m -144.21 127.62 16.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 t -116.65 154.38 30.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -129.3 164.7 22.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 t -149.24 156.98 42.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 134.03 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.88 172.1 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.65 136.13 33.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -105.06 -48.25 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.846 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -114.04 120.08 39.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.7 t -108.36 108.4 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.2 119.49 1.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -80.24 158.19 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -142.16 159.46 42.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.67 -123.83 1.05 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.52 167.32 17.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.01 -43.6 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -81.13 46.14 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.0 m -83.95 -40.67 18.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.6 -40.08 94.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.95 -26.29 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 50.8 mtpt -80.05 -37.49 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.7 -44.85 69.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -39.32 -58.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 107' ' ' ILE . 79.2 t80 -55.85 -62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 37.4 mt -42.15 -37.75 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.49 -54.84 30.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -57.03 -54.55 45.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 103' ' ' PHE . 7.9 tt -60.91 -35.27 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -65.79 -41.81 91.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' O ' HD12 ' A' ' 113' ' ' LEU . 47.0 mttt -56.66 -29.09 61.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 181' ' ' PRO . 42.2 t80 -71.22 -32.83 69.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.668 ' HD1' HD12 ' A' ' 118' ' ' LEU . 56.7 m95 -85.26 -53.24 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -42.44 -39.42 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 109' ' ' LYS . 15.9 mt -62.09 -47.74 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -60.45 -39.74 88.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.36 35.49 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.438 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.5 m -141.26 119.29 11.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 110.885 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.6 m -62.78 128.7 37.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.0 tt -78.11 128.55 33.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.647 ' N ' HD23 ' A' ' 118' ' ' LEU . 10.8 ttmm -126.17 142.24 51.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -84.17 130.43 54.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.68 0.753 . . . . 0.0 111.109 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 159.21 54.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -119.1 118.08 30.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' LYS . 90.2 t -110.67 143.95 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' VAL . 77.0 mm-40 37.79 42.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? 59.06 42.81 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 123' ' ' VAL . 40.7 mttm -147.96 141.87 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.76 100.66 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 133' ' ' LEU . 53.5 tp -67.31 94.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.33 100.67 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.28 -52.32 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 4.2 t80 -41.92 -59.14 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.4 tp60 -67.51 -54.05 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.938 HD11 ' CG2' ' A' ' 171' ' ' ILE . 9.9 tp -37.93 -72.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 134' ' ' ASN . 3.3 t-20 -48.61 -47.08 40.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -47.73 -48.12 29.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 132' ' ' GLN . 11.2 mp -63.24 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.23 -48.85 54.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.05 85.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.81 -36.94 80.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.71 -18.89 50.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 158.34 -59.04 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 154.71 173.86 24.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.787 ' CZ ' ' CD1' ' A' ' 175' ' ' TYR . 48.0 t80 -64.63 -37.26 86.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.62 -66.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.7 p -45.99 -44.85 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' GLY . 50.3 t -65.54 -68.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 51.7 t -42.26 -45.72 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -57.67 -55.43 34.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 151' ' ' LYS . 17.3 m-20 -84.46 24.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 149' ' ' ASP . 29.2 mmt180 34.38 37.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 25.2 mtpp -79.74 44.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.766 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -90.04 -49.76 6.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.9 m -37.0 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -57.61 -69.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.2 mt -45.43 -58.75 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.82 -56.23 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.3 m -51.31 -50.07 60.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.462 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -55.83 -27.86 53.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.0 mmm -79.69 12.23 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.75 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CB ' HG21 ' A' ' 167' ' ' VAL . 24.2 m-85 -65.07 171.61 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.94 144.09 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 86.7 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.82 -158.78 7.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -103.71 -39.46 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -48.26 -59.15 3.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.124 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 161' ' ' PHE . 13.0 p -63.89 -37.43 79.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.25 -58.38 13.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.1 m -65.19 -31.51 72.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 3.5 m-70 -52.73 -57.57 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 133' ' ' LEU . 26.0 mm -41.69 -46.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.461 ' HB2' ' NE1' ' A' ' 152' ' ' TRP . 1.3 tmt_? -59.64 -51.27 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.62 -44.2 97.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.9 -22.64 10.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.787 ' CD1' ' CZ ' ' A' ' 143' ' ' PHE . 0.5 OUTLIER -91.46 -21.35 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -90.98 -11.41 39.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -105.01 -25.44 12.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 mt -119.82 -52.52 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.0 mt -83.21 19.11 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.55 -60.12 2.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.897 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.558 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.2 Cg_endo -69.8 -46.48 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.345 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.9 t80 -38.55 -56.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -75.18 -34.57 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.99 -28.23 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -88.28 -54.99 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.9 mt -44.37 -44.64 8.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.9 p -68.15 -46.17 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.61 42.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -88.97 46.18 1.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 m -46.26 -32.56 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.797 ' H ' HD12 ' A' ' 191' ' ' LEU . 3.9 mp -47.71 -53.04 16.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -36.91 113.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 m -148.41 175.11 11.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.68 98.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -60.85 103.81 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 140.97 23.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.609 0.718 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 175.64 7.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.249 . . . . 0.0 112.362 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -138.27 176.56 8.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 199' ' ' LEU . 3.4 pp -107.51 165.14 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t -127.04 165.11 20.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 88.6 p -95.93 173.07 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.04 178.93 4.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -132.79 132.99 42.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.434 ' N ' ' HE3' ' A' ' 204' ' ' LYS . 0.3 OUTLIER -72.4 -176.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -131.18 175.52 9.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -86.14 143.11 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -107.93 -37.41 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.426 ' N ' ' HG2' ' A' ' 207' ' ' GLU . 2.2 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -119.42 118.94 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 t -125.46 143.98 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.08 168.57 53.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -154.33 129.01 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.9 p -78.79 119.93 22.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.38 -137.21 6.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.78 126.15 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.83 108.16 8.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' VAL . 37.0 tt0 -118.39 -41.44 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -90.92 -30.74 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -61.95 -44.0 97.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.582 HG13 ' HD2' ' A' ' 100' ' ' LYS . 9.7 p -52.1 -37.96 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.099 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.582 ' HD2' HG13 ' A' ' 99' ' ' VAL . 1.4 mptt -71.72 -58.45 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.5 mt -50.67 -39.84 51.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.74 -63.69 0.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -51.33 -67.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 39.6 mt -38.21 -40.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.66 -53.06 61.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -56.68 -51.69 67.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.9 tt -59.63 -45.49 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -55.76 -48.2 75.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -40.6 -57.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -43.56 -48.94 7.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.516 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 35.8 m95 -66.6 -53.46 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -40.93 -51.23 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.02 -48.27 67.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -64.54 -37.66 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.65 37.99 1.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.8 p -131.8 141.2 49.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 m -85.76 134.45 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.5 tt -94.38 111.18 22.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' N ' HD23 ' A' ' 118' ' ' LEU . 4.4 tppp? -118.79 115.3 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 mm -62.72 129.7 93.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.63 0.729 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 157.32 60.72 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.48 HG21 HD22 ' A' ' 128' ' ' LEU . 45.0 t -98.85 120.85 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 55.3 46.47 23.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 56.52 32.54 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -141.91 134.26 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.68 99.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 123' ' ' VAL . 14.7 tp -66.36 104.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.35 116.74 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.7 mt -66.94 -57.0 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 135' ' ' LYS . 2.7 t80 -50.88 -54.57 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.69 -44.48 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -47.91 -72.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.21 -39.15 43.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -54.04 -55.04 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.48 ' CG2' HG21 ' A' ' 155' ' ' ILE . 69.6 t -53.52 -50.04 51.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.36 92.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.56 -42.09 98.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -67.57 -17.89 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.537 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 156.58 -56.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.48 166.59 12.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.45 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 143' ' ' PHE . 2.7 t80 -59.63 -42.48 92.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.11 -64.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.3 p -48.64 -44.9 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 151' ' ' LYS . 28.9 t -63.8 -64.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 20.3 m -49.11 -36.64 19.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -66.35 -51.09 60.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -95.37 18.32 12.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 146' ' ' VAL . 13.5 mmt85 45.38 51.86 9.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.621 ' HB2' HG22 ' A' ' 146' ' ' VAL . 4.2 mmmm -86.55 24.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.671 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -68.46 -40.04 81.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.5 m -54.73 -39.44 68.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.468 ' N ' ' HE3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -63.8 -33.6 76.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.526 ' N ' HD13 ' A' ' 155' ' ' ILE . 1.9 mm -73.37 -61.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -44.87 -51.95 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 m -59.98 -51.15 70.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -52.97 -45.08 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.424 ' SD ' HD13 ' A' ' 133' ' ' LEU . 32.4 mtp -58.41 -15.92 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.09 -7.62 27.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 171.24 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.1 31.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.593 0.711 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 109.65 2.38 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.4 -147.48 4.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -115.7 -37.0 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -59.48 -58.22 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.2 p -57.96 -41.34 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -48.69 -52.65 19.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -77.85 -27.02 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 2.8 m-70 -53.47 -46.93 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 133' ' ' LEU . 46.7 mm -46.3 -43.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.407 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 23.1 mmm-85 -71.35 -63.25 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.51 -51.62 7.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -46.68 -40.44 13.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.542 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -67.33 -45.33 76.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -76.41 -9.34 58.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -97.25 -35.55 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.6 mt -119.87 -48.32 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 175' ' ' TYR . 10.8 mt -83.5 21.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.73 -60.24 2.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.516 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 53.7 Cg_endo -69.75 -50.68 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.709 2.273 . . . . 0.0 112.353 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 4.1 t80 -44.63 -52.71 7.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.19 -51.24 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -49.32 -44.18 44.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 188' ' ' GLY . 8.7 t80 -69.61 -57.42 5.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.6 mt -38.28 -50.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 m -66.18 -38.84 89.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 129.39 177.53 14.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -139.65 152.08 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 110.818 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.7 p -97.97 -61.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.826 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.712 ' H ' HD23 ' A' ' 191' ' ' LEU . 1.3 pt? -49.26 -20.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.3 p -71.4 168.61 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 117.5 11.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 165.11 13.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -75.48 143.94 76.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 133.88 26.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.698 2.266 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.15 115.68 30.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.5 mt -62.03 102.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 90.3 m -126.16 128.81 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.0 p -49.33 165.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.76 175.1 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 97.3 m -120.9 149.28 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -124.89 128.7 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -90.91 162.91 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -143.79 111.83 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.27 -178.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 58.0 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.932 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -72.49 165.24 25.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -123.22 172.19 8.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.87 156.82 23.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -101.39 106.32 17.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -44.49 143.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.19 -141.21 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.31 117.31 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 131.32 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -121.05 43.23 2.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -90.23 -32.01 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.121 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -69.56 -34.51 74.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 131' ' ' PHE . 7.1 p -73.84 -33.78 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 40.5 mtmt -68.54 -52.42 32.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.47 -40.69 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -48.36 -52.35 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 104' ' ' LEU . 3.9 t80 -58.95 -61.3 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 16.5 mt -49.37 -20.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.69 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 107' ' ' ILE . 7.1 pt20 -53.13 -31.91 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.48 HD12 ' CD2' ' A' ' 182' ' ' TYR . 5.5 tt -81.59 -39.23 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.56 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -42.55 -58.01 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -38.89 -42.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.472 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 43.0 m95 -73.97 -49.1 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -42.75 -43.44 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -61.48 -47.54 85.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -64.9 -28.2 69.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.92 40.68 3.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -136.66 127.24 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 110.853 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.6 m -77.81 128.37 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.2 tt -89.92 108.0 19.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -106.09 128.23 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.6 mm -63.58 127.29 91.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 174' ' ' HIS . 53.1 Cg_endo -69.82 161.97 43.91 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.313 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -118.1 115.44 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.816 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 77.1 t -102.4 124.29 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 51.52 51.16 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 55.62 35.27 24.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -144.83 142.89 30.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.53 107.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.044 HD11 HD22 ' A' ' 133' ' ' LEU . 19.4 tp -71.55 114.77 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.74 89.06 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' PHE . 23.1 mt -44.28 -63.47 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 99' ' ' VAL . 17.0 t80 -34.91 -67.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.456 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 17.1 tt0 -53.97 -56.8 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 128' ' ' LEU . 22.6 tp -43.93 -71.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -45.6 -57.46 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -41.56 -47.55 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.928 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -46.65 87.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -50.71 -46.79 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.16 95.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.6 -45.04 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -67.56 -18.16 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.458 ' CA ' HG11 ' A' ' 145' ' ' VAL . . . 155.28 -60.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 149.36 165.36 12.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.492 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -55.85 -35.12 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.884 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -66.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' CA ' ' A' ' 141' ' ' GLY . 2.6 p -51.88 -37.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 151' ' ' LYS . 51.0 t -72.06 -64.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 9.8 t -52.24 -32.22 35.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -73.55 -49.42 26.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -91.54 15.22 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 45.81 55.03 7.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -96.16 36.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.509 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 42.4 m95 -84.69 -46.89 11.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.8 m -43.96 -54.57 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -48.58 -63.05 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ALA . 20.4 mt -54.27 -63.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.22 -47.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.6 m -62.75 -45.43 92.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -51.28 -51.12 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.2 mmm -50.08 -25.08 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.87 -8.14 10.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 26.0 m-85 -72.27 146.55 47.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.45 142.99 98.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 122.8 9.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.716 2.277 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.67 -134.89 1.78 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -127.81 -34.8 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.68 -58.65 7.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.17 -30.93 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -58.91 12.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -67.16 -25.97 66.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.2 m-70 -58.32 -59.54 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 133' ' ' LEU . 24.8 mm -37.83 -63.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -52.21 -56.86 11.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.14 -52.99 9.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 70.9 m-70 -49.27 -35.65 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -82.27 -22.72 35.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.67 -13.06 40.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -105.25 -22.79 12.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.7 mt -119.98 -52.61 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 175' ' ' TYR . 5.4 mp -87.01 25.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.5 -63.64 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -48.28 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.694 2.262 . . . . 0.0 112.356 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 107' ' ' ILE . 6.1 t80 -40.12 -48.21 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.34 -34.2 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 184' ' ' LEU . 4.0 tt -56.57 -40.66 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -84.8 -56.65 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.9 mt -40.61 -36.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 m -89.29 -45.48 9.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.12 124.63 2.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.04 136.85 41.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.3 t -98.56 -18.43 18.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.9 OUTLIER -92.76 -38.04 12.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.908 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -63.51 112.45 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 76.4 m -43.4 91.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 194' ' ' LEU . 1.1 pp -150.12 116.66 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.5 135.07 54.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -87.49 143.14 33.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.486 ' HG2' HD12 ' A' ' 199' ' ' LEU . 53.8 Cg_endo -69.74 147.84 63.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.664 2.243 . . . . 0.0 112.366 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 198' ' ' ASN . 11.2 p-10 -53.39 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.486 HD12 ' HG2' ' A' ' 197' ' ' PRO . 15.4 mt -133.25 169.35 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 46.1 p -68.81 106.97 2.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -136.92 167.18 21.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -119.45 151.02 39.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.9 p -124.19 175.13 7.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -146.39 105.31 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.03 169.62 11.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 207' ' ' GLU . 7.1 tmtt? -135.05 145.57 48.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.441 ' N ' ' HD3' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -132.47 175.68 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 207' ' ' GLU . 21.4 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 m -143.75 139.89 29.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -139.71 169.65 17.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.0 -137.67 5.52 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.5 m -76.29 121.47 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.893 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -93.27 81.57 4.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.88 -47.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -148.49 114.37 5.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.13 40.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -115.04 38.91 3.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.4 m -83.54 -42.33 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -55.21 -46.31 75.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.47 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 6.0 p -58.54 -31.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 45.1 mtmt -73.41 -47.15 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -66.6 -44.08 83.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -42.7 -44.52 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.8 t80 -68.18 -44.74 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.476 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.9 mt -63.27 -26.94 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -76.91 -51.04 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -62.02 -32.82 73.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 103' ' ' PHE . 5.8 tt -79.68 -42.43 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -66.83 -47.51 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -28.15 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -70.21 -30.39 67.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.781 ' HD1' HD12 ' A' ' 118' ' ' LEU . 79.0 m95 -87.07 -49.4 7.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -47.6 -21.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.57 -45.22 46.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -70.07 -37.98 75.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.97 36.49 1.23 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.455 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.4 t -137.9 111.26 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.789 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 p -58.05 147.12 30.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.781 HD12 ' HD1' ' A' ' 111' ' ' TRP . 5.6 tt -98.07 108.03 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -96.34 132.82 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -87.06 121.02 71.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.62 0.724 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 149.73 67.43 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.94 111.59 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 167' ' ' VAL . 96.8 t -97.42 124.95 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 51.43 44.79 28.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.3 30.37 19.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -139.33 150.23 45.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.1 mm -75.01 129.95 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.6 tp -91.59 107.97 19.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.79 82.44 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 131' ' ' PHE . 60.1 mt -40.05 -59.9 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 31.1 t80 -34.91 -67.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.63 ' OE1' HD12 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -58.81 -54.83 42.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.927 HD11 ' CG2' ' A' ' 171' ' ' ILE . 4.3 tp -35.47 -71.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -49.37 -53.81 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -40.06 -56.9 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.63 HD12 ' OE1' ' A' ' 132' ' ' GLN . 12.4 mt -54.6 -48.11 72.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 HD13 ' A' ' 155' ' ' ILE . 93.3 t -46.54 -49.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.07 86.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.48 -37.26 86.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -79.89 -14.35 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.48 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.18 -62.73 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 154.54 165.28 13.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 3.1 t80 -55.47 -38.83 69.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.6 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.48 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.1 p -48.37 -46.0 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 151' ' ' LYS . 54.3 t -67.05 -69.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 47.1 t -40.32 -42.45 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.32 -51.34 63.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' ARG . 12.3 m-20 -84.81 25.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 34.49 41.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 146' ' ' VAL . 29.6 mtpt -86.07 40.59 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.584 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 23.3 m95 -86.11 -46.91 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -38.88 -44.72 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -63.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 137' ' ' VAL . 20.0 mt -52.31 -57.87 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -45.45 -50.04 12.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 m -64.25 -37.9 89.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -65.35 -27.5 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.47 ' HG2' HE22 ' A' ' 132' ' ' GLN . 17.7 mtp -75.36 -3.24 32.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.81 54.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.73 166.85 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.93 144.62 79.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.558 0.694 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 85.73 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.729 2.286 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.38 169.76 26.3 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.03 -34.55 64.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.78 0.324 . . . . 0.0 110.882 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.66 -58.83 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 168' ' ' GLY . 12.7 p -67.06 -44.12 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -45.5 -48.89 11.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 m -75.49 -36.08 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.834 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -49.18 -39.0 27.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.927 ' CG2' HD11 ' A' ' 133' ' ' LEU . 37.0 mm -57.33 -59.42 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -50.83 -61.19 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -44.91 -48.67 9.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -50.55 -44.83 56.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -43.54 90.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -80.01 -9.03 59.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 173' ' ' GLY . 23.1 mmt180 -99.1 -30.37 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.36 -51.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.16 26.58 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.54 -60.05 2.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.892 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.724 ' HA ' HD12 ' A' ' 184' ' ' LEU . 53.6 Cg_endo -69.74 -48.18 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 186' ' ' LEU . 6.2 t80 -44.25 -41.41 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -71.28 -38.52 71.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 181' ' ' PRO . 69.4 mt -57.57 -36.31 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.86 -41.72 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.465 HD11 ' CE2' ' A' ' 182' ' ' TYR . 79.2 mt -61.87 -32.62 73.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.9 t -81.63 9.25 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.58 -132.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.57 74.57 10.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 97.2 p -97.86 -22.97 16.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -87.48 -0.66 57.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.407 ' N ' HD13 ' A' ' 191' ' ' LEU . 7.0 mmm180 -77.85 109.22 11.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.0 -40.1 65.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.729 ' H ' HD13 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.01 22.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -46.4 173.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -51.43 145.29 14.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.598 0.713 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 141.55 45.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.27 157.05 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 1.6 mm? -84.75 90.48 7.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.7 p -131.59 111.1 11.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 t -113.59 107.08 15.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.52 113.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.3 p -92.78 85.27 5.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -105.75 142.24 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.54 138.38 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -93.53 120.62 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -120.84 120.81 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -38.93 109.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.0 t -131.15 127.06 37.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.55 -148.66 5.66 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 m -127.9 159.66 34.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 p -50.89 173.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.33 -162.78 22.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.56 -23.51 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.487 ' HB3' ' HD3' ' A' ' 98' ' ' ARG . . . -112.8 141.75 46.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 98' ' ' ARG . 15.3 pt20 -119.63 -46.53 2.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 96' ' ' GLN . 98.9 m -33.79 -34.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.487 ' HD3' ' HB3' ' A' ' 95' ' ' ALA . 6.7 ptm180 -66.04 -57.55 7.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.76 -39.78 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -53.38 -54.78 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.66 -39.27 84.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -50.64 -50.71 53.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 107' ' ' ILE . 52.3 t80 -60.01 -64.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 58.6 mt -41.17 -35.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -70.13 -57.99 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -55.13 -50.65 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.3 tt -63.73 -37.03 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -59.64 -49.72 76.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' HD13 ' A' ' 113' ' ' LEU . 37.6 mttp -45.76 -56.07 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -39.58 -40.67 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -76.4 -50.66 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -41.87 -38.12 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 109' ' ' LYS . 10.4 mp -57.24 -44.45 83.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -73.72 -36.68 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 111.55 30.1 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -116.97 139.57 50.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 m -84.9 129.4 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 119' ' ' LYS . 2.3 tt -93.62 119.5 32.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.699 ' N ' HD23 ' A' ' 118' ' ' LEU . 25.7 tptt -133.19 142.99 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.55 122.45 82.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -177.21 1.78 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.679 2.252 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CE1' HD13 ' A' ' 127' ' ' ILE . 25.1 m80 -126.21 126.04 43.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 128' ' ' LEU . 93.1 t -112.67 128.53 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.8 42.39 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 61.06 27.88 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -145.03 128.49 16.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 122' ' ' HIS . 4.8 mm -40.92 146.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 133' ' ' LEU . 16.3 tp -120.27 89.71 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -56.22 103.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 178' ' ' ILE . 81.3 mt -58.13 -63.09 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' LEU . 5.7 t80 -37.79 -62.21 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -54.82 -59.15 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.964 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -38.15 -72.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -47.28 -46.36 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -58.48 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.62 -42.42 62.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.493 HG22 HD13 ' A' ' 155' ' ' ILE . 60.9 t -52.49 -50.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.49 75.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.41 -41.76 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -72.69 -12.03 60.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 150.97 -59.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.88 176.11 20.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.21 -36.7 84.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.7 -66.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.068 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.3 p -50.75 -47.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.9 t -60.14 -43.72 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.4 m -67.7 -33.46 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -70.97 -49.85 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.03 10.84 39.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmt85 46.41 52.25 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -81.92 40.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -87.04 -45.22 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.1 m -41.43 -49.21 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -56.81 -59.28 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 137' ' ' VAL . 14.2 mt -51.8 -72.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.621 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.15 -51.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.0 m -60.35 -41.98 94.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 155' ' ' ILE . 37.7 mttp -62.56 -22.65 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.4 mmm -81.67 7.31 12.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.19 -15.45 62.37 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -69.62 162.29 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -80.13 143.95 57.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.726 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 84.42 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.12 -138.63 4.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -124.21 -48.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.85 -57.56 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.127 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.621 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 5.4 p -58.39 -39.17 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.0 -48.21 52.54 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.1 m -72.86 -32.04 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.443 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 6.4 m-70 -54.66 -53.9 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.964 HG23 HD11 ' A' ' 133' ' ' LEU . 45.0 mm -43.25 -51.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 28.3 mtm180 -56.91 -62.32 1.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -43.8 -51.87 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.467 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 96.6 m-70 -50.58 -41.38 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.3 OUTLIER -71.22 -45.74 62.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.61 -9.15 58.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 173' ' ' GLY . 38.1 mtm180 -105.12 -28.94 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.619 HG22 HD13 ' A' ' 179' ' ' LEU . 39.9 mt -116.43 -52.63 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.619 HD13 HG22 ' A' ' 178' ' ' ILE . 1.5 mm? -92.84 35.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.488 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.39 -62.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.859 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.82 -49.23 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.322 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.4 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 5.0 t80 -42.11 -55.83 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.46 -46.68 75.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt -51.67 -37.08 49.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.1 -54.09 12.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 42.3 mt -49.83 -36.47 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.5 t -78.26 -48.02 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -171.48 -140.35 3.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.44 163.67 14.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.353 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.0 t -99.06 -45.51 5.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 192' ' ' ARG . 3.1 pp -49.96 -44.23 50.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.909 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.784 ' N ' HD12 ' A' ' 191' ' ' LEU . 0.8 OUTLIER -35.3 117.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.8 t -50.57 166.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.64 149.11 44.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -86.53 156.48 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -37.37 141.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -177.34 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -120.78 160.65 22.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -61.88 152.33 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.7 p -53.91 144.24 19.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 67.2 m -99.38 101.94 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.0 120.07 34.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.0 m -114.02 95.82 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -61.84 172.1 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 205' ' ' ASP . 7.0 p-10 -89.01 98.2 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 207' ' ' GLU . 72.1 tttt -75.13 126.69 31.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 206' ' ' LYS . 6.7 tp10 -37.22 114.3 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.827 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 m -64.7 -48.87 73.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.0 p -173.6 150.33 1.75 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.38 72.1 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.521 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 p -43.05 116.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -170.14 155.1 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.51 160.38 8.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.518 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -91.33 124.49 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.75 149.94 10.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.43 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.1 pp0? -124.12 -21.03 5.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.8 m -87.79 -44.61 10.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -57.78 -51.62 68.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.6 p -53.45 -24.99 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 47.6 mttp -81.01 -53.02 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.91 -44.92 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -39.0 -64.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -51.73 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.874 HD22 HD11 ' A' ' 120' ' ' ILE . 38.5 mt -39.72 -39.52 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.5 -53.87 50.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -54.26 -59.97 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 104' ' ' LEU . 2.9 tt -48.8 -45.36 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.93 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' TRP . 4.5 mmmm -55.97 -60.26 3.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -38.54 -26.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.56 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 88.7 m95 -87.97 -45.72 9.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' A' ' 113' ' ' LEU . 5.6 pt-20 -49.61 -18.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.441 HD12 ' HG2' ' A' ' 112' ' ' GLU . 6.5 mp -78.9 -35.34 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -81.25 -28.74 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.32 34.55 3.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 m -135.17 112.25 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.849 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -58.39 143.38 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.96 HD13 ' N ' ' A' ' 119' ' ' LYS . 2.0 tm? -105.92 157.87 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 118' ' ' LEU . 14.7 ttmm -171.99 155.51 3.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.874 HD11 HD22 ' A' ' 104' ' ' LEU . 28.6 mm -89.26 129.69 46.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.694 0.759 . . . . 0.0 111.121 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HG3' ' CD2' ' A' ' 174' ' ' HIS . 53.1 Cg_endo -69.81 -179.29 2.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 39.4 m80 -119.77 129.28 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 128' ' ' LEU . 93.0 t -115.09 109.08 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 61.65 51.25 4.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 56.71 31.64 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -148.77 126.1 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 32.4 mm -48.16 145.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 HD22 ' A' ' 133' ' ' LEU . 22.6 tp -110.31 91.85 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.7 83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 mt -40.12 -57.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 23.9 t80 -39.72 -52.28 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 133' ' ' LEU . 32.0 tp60 -70.35 -58.36 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.978 HD22 HD11 ' A' ' 128' ' ' LEU . 7.4 tp -35.68 -71.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -47.34 -57.44 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -42.09 -55.46 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.97 -45.09 60.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.782 HG22 HD13 ' A' ' 155' ' ' ILE . 64.8 t -52.82 -55.08 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.03 -41.04 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.94 -37.69 88.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.09 -27.5 63.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 169.1 -52.0 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 131.41 150.45 6.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -41.7 -36.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.15 -66.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.0 p -61.81 -54.99 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.199 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 142' ' ' GLY . 72.3 t -46.77 -57.93 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.1 t -57.62 -43.76 84.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -54.52 -53.73 50.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 150' ' ' ARG . 2.2 m-20 -90.02 18.39 5.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 149' ' ' ASP . 1.1 mpp_? 37.62 48.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -86.87 40.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 34.1 m95 -81.21 -50.54 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.8 m -39.03 -50.73 1.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -50.72 -61.03 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.782 HD13 HG22 ' A' ' 137' ' ' VAL . 19.0 mt -49.14 -67.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -40.14 -49.73 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.4 m -63.17 -36.91 85.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.63 -22.04 65.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 75.5 mmm -83.67 5.3 25.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.55 -1.36 66.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.26 156.93 26.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.57 143.72 85.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.2 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.92 -168.58 11.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -97.73 -32.11 11.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 110.955 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.65 -59.09 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.493 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 11.6 p -59.19 -32.1 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.54 95.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -82.22 -23.65 35.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.5 -47.27 84.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 133' ' ' LEU . 30.0 mm -43.62 -50.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -63.88 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.44 -45.3 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.411 ' CD2' ' HG3' ' A' ' 121' ' ' PRO . 4.5 m170 -52.44 -46.44 66.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -69.18 -23.71 63.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -90.28 -9.33 48.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -104.96 -28.58 11.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.1 -51.4 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 175' ' ' TYR . 12.5 mt -83.32 15.57 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.514 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.56 -58.85 4.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.723 . . . . 0.0 110.874 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.56 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 54.0 Cg_endo -69.72 -50.87 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.379 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.461 ' CE2' HD11 ' A' ' 186' ' ' LEU . 8.0 t80 -48.34 -49.61 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 185' ' ' PHE . 1.1 t30 -65.5 -68.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.2 mp -39.06 -27.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 183' ' ' ASN . 82.1 t80 -82.08 -63.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 182' ' ' TYR . 71.8 mt -43.81 -48.03 8.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 t -79.23 -44.35 21.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -51.72 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -47.01 109.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.9 m -98.07 -58.46 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -77.34 -0.06 24.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.515 ' N ' HD13 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -119.81 86.66 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.25 157.74 46.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 194' ' ' LEU . 2.5 pt? -47.02 147.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -82.79 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 148.61 45.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 137.73 36.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -48.27 159.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.01 175.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 31.0 p -131.2 164.44 25.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.4 m -131.56 177.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -108.29 174.29 5.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.887 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 75.9 p -125.37 164.47 20.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -127.83 177.91 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.04 154.57 45.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -136.29 172.19 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -110.32 172.43 6.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 20.7 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -76.86 118.13 19.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 135.79 36.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.23 115.17 4.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -70.77 -22.13 62.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.884 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.2 p -91.73 125.97 36.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.55 47.52 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -99.92 86.35 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.16 145.98 26.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -78.67 -42.71 27.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.5 p -60.4 -38.1 82.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.4 mtt-85 -64.69 -61.68 2.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.88 -35.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.573 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 46.3 mtpt -70.59 -53.73 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 mt -53.74 -39.16 65.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -46.36 -51.9 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' ILE . 38.0 t80 -58.67 -65.76 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.474 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.5 mt -45.24 -24.94 0.31 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -82.69 -48.11 11.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -67.22 -26.0 66.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.0 tt -85.08 -42.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -70.19 -41.57 73.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -55.67 -28.49 55.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 3.7 t80 -69.8 -29.41 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.809 ' CD1' HD12 ' A' ' 118' ' ' LEU . 77.0 m95 -81.56 -49.52 10.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -44.28 -40.94 5.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.67 -40.05 68.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -76.58 -39.62 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.29 32.69 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 m -134.82 103.89 5.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 p -53.64 141.3 26.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.1 tt -86.32 125.43 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -118.94 125.06 48.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.02 129.44 61.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.722 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.34 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.42 ' NE2' ' CD1' ' A' ' 127' ' ' ILE . 26.3 m80 -120.61 114.51 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.8 t -100.12 119.11 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 56.35 51.13 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 52.64 35.59 18.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -150.28 140.4 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' ' NE2' ' A' ' 122' ' ' HIS . 15.9 mm -60.81 144.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 133' ' ' LEU . 22.1 tp -106.91 104.21 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' HE1' ' A' ' 159' ' ' MET . 5.8 t70 -71.93 113.32 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.39 -61.06 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 100' ' ' LYS . 33.8 t80 -39.97 -55.32 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.87 -51.06 59.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 128' ' ' LEU . 34.9 tp -50.65 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -49.26 -46.35 46.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -49.52 -52.13 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.69 -49.05 74.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 146' ' ' VAL . 98.2 t -47.35 -54.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.66 70.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -54.92 -39.28 68.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.99 -14.77 61.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.407 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 152.85 -61.92 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 160.04 173.51 28.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.475 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.94 -46.19 90.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.38 -66.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 5.7 p -44.32 -37.04 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 142' ' ' GLY . 37.5 t -72.89 -49.34 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 148' ' ' LYS . 5.8 p -58.15 -45.87 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 147' ' ' CYS . 31.3 tttm -68.27 -33.4 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.54 4.45 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 146' ' ' VAL . 15.6 mmm180 47.12 37.88 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 19.3 mtpp -83.42 36.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 51.9 m95 -81.5 -44.21 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.1 m -43.39 -47.16 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -51.89 -61.63 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -55.73 -55.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.87 -53.61 2.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -47.4 86.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -45.19 -49.23 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.419 ' HE1' ' O ' ' A' ' 129' ' ' ASP . 92.0 mmm -60.78 -25.81 66.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.97 -2.93 14.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -74.54 138.61 43.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.27 144.14 16.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.545 0.688 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 85.03 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.353 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.22 169.13 24.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.489 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -74.6 -38.28 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.73 -59.11 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.32 -37.25 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.4 -49.33 57.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.4 t -73.67 -31.11 63.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.442 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.7 m-70 -54.7 -47.23 73.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 20.7 mm -46.2 -49.75 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.574 ' NH2' ' CD1' ' A' ' 152' ' ' TRP . 16.9 ttm105 -61.86 -61.66 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.31 -46.56 11.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 80.1 m-70 -49.34 -43.26 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.0 t80 -68.01 -41.45 82.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.65 -9.26 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -100.13 -32.12 11.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.0 mt -119.75 -49.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.169 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 11.8 mt -82.52 18.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.08 -60.24 2.93 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.739 . . . . 0.0 110.885 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.526 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.9 Cg_endo -69.75 -47.54 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -49.41 -49.41 45.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -80.69 -38.0 29.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 14.9 tp -55.62 -26.23 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.12 -51.89 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.3 mt -45.37 -53.72 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t -60.68 -46.02 91.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.07 75.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -117.1 82.83 1.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -93.01 -50.22 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 191' ' ' LEU . 1.9 pt? -46.73 -41.25 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 130.18 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.8 p -69.78 152.69 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -57.72 142.65 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -149.33 140.93 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.36 131.45 23.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 0.0 110.908 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 138.87 38.91 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 0.0 112.35 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -107.96 112.33 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 199' ' ' LEU . 5.7 tt -125.1 154.28 41.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 199' ' ' LEU . 82.2 p -120.11 146.65 45.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.1 m -135.96 130.47 33.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -111.11 42.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 75.2 p -87.8 116.24 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -39.35 114.64 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -48.63 163.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 206' ' ' LYS . 6.5 tmtm? -95.31 134.72 37.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -140.86 168.7 19.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.855 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.9 p -122.13 166.0 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -43.7 -58.49 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.2 -152.28 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.457 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 m -163.69 121.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 110.86 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.1 p -44.69 109.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.7 64.02 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.472 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -63.43 -48.79 76.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.868 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.95 91.42 3.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 99' ' ' VAL . 9.6 tt0 -82.49 -60.8 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 p -40.64 -30.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 102' ' ' ASN . 5.0 tpt85 -66.59 -57.68 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 96' ' ' GLN . 12.7 p -68.29 -22.99 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -77.88 -60.66 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HA ' HD12 ' A' ' 104' ' ' LEU . 73.4 mt -63.75 -34.8 78.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 30.9 m-20 -44.22 -58.26 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -55.21 -59.97 4.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 101' ' ' LEU . 27.8 mt -42.5 -43.11 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.86 -40.54 95.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -64.9 -51.38 62.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.714 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.1 tp -61.46 -37.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.12 88.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -53.06 -36.63 60.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.13 -37.35 87.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.578 ' HD1' HD12 ' A' ' 118' ' ' LEU . 39.1 m95 -80.17 -59.87 2.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -38.99 -40.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -59.12 -53.03 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -61.36 -35.37 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.84 39.87 1.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -136.21 123.08 21.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.1 m -70.41 129.45 39.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.578 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.9 tt -84.39 125.22 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.46 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.1 ttmm -121.81 125.37 46.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.6 mm -70.9 131.65 87.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.162 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.6 Cg_endo -69.75 158.69 56.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -115.69 126.37 54.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.18 112.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 57.8 49.91 11.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 125' ' ' ARG . 26.2 mtm105 54.48 35.97 24.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.82 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -145.32 125.11 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.24 127.43 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.092 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.1 115.04 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.51 102.63 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.49 -51.94 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -43.53 -53.27 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 133' ' ' LEU . 43.3 tt0 -70.4 -60.51 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 171' ' ' ILE . 13.3 tp -35.19 -69.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -47.93 -47.61 32.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 139' ' ' GLU . 22.8 tptt -47.67 -54.21 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 132' ' ' GLN . 9.3 mp -56.28 -40.87 74.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 155' ' ' ILE . 63.9 t -53.27 -47.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.77 81.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 2.3 mp0 -66.59 -38.02 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -75.19 -21.41 58.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.34 -58.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 152.55 169.63 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.503 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -61.03 -39.09 88.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.69 -66.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.437 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.0 p -48.05 -42.99 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 142' ' ' GLY . 54.5 t -65.03 -70.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.3 t -44.61 -50.04 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -48.87 -55.41 11.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.81 14.78 5.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 42.85 54.34 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -98.25 41.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -79.75 -40.84 27.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -46.35 -56.51 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -45.07 -53.34 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 137' ' ' VAL . 19.9 mt -64.09 -62.8 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -38.09 -49.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 m -63.27 -47.75 81.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -48.35 -41.15 27.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.4 mtp -67.45 -28.52 67.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -2.06 10.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.576 ' CB ' HG21 ' A' ' 167' ' ' VAL . 21.2 m-85 -80.52 129.64 34.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -44.58 143.04 2.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.558 0.694 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -152.11 137.04 5.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -44.61 -26.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.23 -59.11 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 161' ' ' PHE . 10.8 p -67.82 -36.35 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.51 -44.95 85.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -78.64 -32.37 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -53.18 -50.57 64.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.641 HG23 HD21 ' A' ' 133' ' ' LEU . 21.8 mm -40.31 -61.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -54.39 -54.96 33.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -47.9 -47.0 25.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -51.21 -42.89 61.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.5 t80 -68.08 -40.75 82.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -78.04 -9.24 59.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -103.7 -28.18 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mt -120.11 -52.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 8.4 mt -88.58 28.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.58 -60.37 2.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.668 0.747 . . . . 0.0 110.864 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 184' ' ' LEU . 54.3 Cg_endo -69.66 -48.12 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.676 2.251 . . . . 0.0 112.383 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.714 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.3 t80 -39.25 -46.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.38 -51.78 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 181' ' ' PRO . 83.8 mt -45.35 -37.47 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.32 -55.31 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.2 mt -47.32 -46.51 25.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.5 m -59.63 -46.78 87.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -58.91 92.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.8 119.23 9.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 97.7 p -88.77 -27.98 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.774 ' H ' HD23 ' A' ' 191' ' ' LEU . 1.3 pt? -80.65 -38.69 28.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 192' ' ' ARG . 1.1 mmp_? -62.72 134.16 55.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.18 148.93 41.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 tp -55.96 125.3 20.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -135.15 137.54 42.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.441 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -142.46 137.73 15.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.943 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.441 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 53.5 Cg_endo -69.76 160.26 50.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -133.69 106.91 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -87.51 166.69 14.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 23.4 m -131.38 103.61 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.7 p -64.08 107.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -54.82 107.71 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.9 p -52.33 166.19 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -73.85 96.73 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 170.2 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.38 138.59 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -42.99 -46.13 5.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 32.0 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.843 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.6 t -86.05 151.95 23.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.803 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 p -84.31 -45.19 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.86 138.86 6.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 t -47.46 137.49 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -100.25 87.1 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 53.51 -171.07 0.77 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.48 165.28 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.98 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.825 ' O ' HG12 ' A' ' 99' ' ' VAL . 68.4 mt-30 -111.6 -44.98 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.487 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 42.5 p -45.3 -21.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' GLN . 23.4 ttt180 -67.47 -45.59 75.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 96' ' ' GLN . 11.5 p -65.63 -24.98 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CE ' ' HA ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.46 -41.77 21.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.18 -44.52 88.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -43.83 -60.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 106' ' ' GLN . 45.9 t80 -61.17 -63.64 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 98.7 mt -38.4 -32.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 103' ' ' PHE . 7.5 t70 -77.63 -46.35 22.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 103' ' ' PHE . 91.9 mt-30 -64.17 -23.52 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.2 tp -92.02 -36.6 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.07 62.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 13.6 ptmt -57.76 -43.67 85.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 33.1 t80 -55.41 -28.19 52.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 68.5 m95 -81.08 -48.81 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.97 -57.09 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -47.36 -36.37 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -73.62 -32.92 64.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.63 34.46 3.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.3 t -139.02 123.24 18.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 110.865 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -68.85 148.95 49.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.8 tt -105.79 143.75 33.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.79 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.3 ttmt -156.42 120.46 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 178' ' ' ILE . 34.6 mm -84.18 131.94 49.34 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.3 Cg_endo -69.84 153.77 68.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 0.0 112.294 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -86.36 109.68 19.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.9 t -96.69 123.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 49.6 53.75 12.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 54.8 27.85 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -154.38 123.85 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.15 127.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.743 HD21 HD22 ' A' ' 133' ' ' LEU . 10.7 tp -82.35 107.76 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.72 117.2 17.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 120' ' ' ILE . 17.5 mt -65.16 -49.59 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CD2' ' HG3' ' A' ' 100' ' ' LYS . 35.7 t80 -42.62 -57.34 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -72.99 -48.14 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.991 HD11 HG23 ' A' ' 171' ' ' ILE . 32.0 tp -44.43 -71.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' VAL . 57.5 t-20 -47.99 -66.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 134' ' ' ASN . 35.9 tttp -35.65 -54.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.51 -41.67 63.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 155' ' ' ILE . 94.6 t -58.07 -48.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.3 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -73.69 -35.11 65.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -77.92 -16.64 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.413 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.75 -57.53 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 150.31 175.81 22.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.443 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.79 -33.17 73.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.78 -65.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.413 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.1 p -48.05 -42.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 151' ' ' LYS . 67.5 t -70.51 -67.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 48.6 t -45.51 -34.2 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -77.02 -49.23 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 150' ' ' ARG . 37.6 m-20 -89.22 21.18 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 149' ' ' ASP . 2.5 mmp_? 35.72 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 146' ' ' VAL . 15.6 mmmt -89.37 17.4 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 62.6 m95 -63.69 -45.99 87.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.2 m -41.69 -58.49 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -47.54 -58.43 4.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.699 HD13 HG22 ' A' ' 137' ' ' VAL . 17.8 mt -51.2 -66.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.1 m -54.9 -46.37 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -60.57 -26.8 67.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 82.1 mmm -78.56 2.19 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.99 63.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.15 166.71 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.12 145.16 52.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.602 0.715 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 85.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.98 -176.54 14.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.37 -25.26 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.778 0.323 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.17 -58.39 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.1 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.5 -38.65 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.82 -41.61 76.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.4 t -79.22 -29.57 42.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -57.99 -47.68 82.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.991 HG23 HD11 ' A' ' 133' ' ' LEU . 6.3 mm -45.05 -55.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -59.29 -63.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.92 -47.69 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -66.76 -30.85 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -85.04 -9.23 58.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -101.7 -31.31 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.463 HD13 ' CD1' ' A' ' 120' ' ' ILE . 23.9 mt -120.09 -51.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 175' ' ' TYR . 16.4 mt -83.12 20.03 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.83 -60.26 2.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.82 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 107' ' ' ILE . 10.0 t80 -40.05 -51.1 2.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.02 -41.29 95.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 184' ' ' LEU . 6.7 tt -56.4 -43.95 79.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -71.31 -59.19 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 182' ' ' TYR . 67.7 mt -38.4 -49.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -43.91 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.92 66.93 1.54 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -139.04 128.18 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.363 . . . . 0.0 110.82 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -81.28 -52.77 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 192' ' ' ARG . 4.1 pp -48.35 -36.7 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.56 ' N ' HD12 ' A' ' 191' ' ' LEU . 8.8 tpt180 -46.67 -33.56 4.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.81 157.9 5.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.06 144.56 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -102.54 169.9 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -128.78 136.8 29.71 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.538 0.685 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -171.2 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.338 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -116.18 179.42 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.911 HD22 ' N ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -150.48 159.56 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.911 ' N ' HD22 ' A' ' 199' ' ' LEU . 12.9 t -148.62 169.3 20.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.0 t -72.26 152.15 42.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.49 115.16 17.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 65.8 p -136.07 167.76 20.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -43.44 122.42 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -116.47 179.99 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -50.98 122.01 6.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.13 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.858 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.7 p -75.14 -45.9 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -116.44 121.71 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.13 -128.28 5.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.53 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 t -139.3 176.84 8.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 m -148.81 173.73 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.48 175.6 14.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.461 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -62.67 103.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.65 -176.58 3.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.97 -25.11 15.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.8 t -62.34 -33.97 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -67.05 -62.41 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.38 -35.38 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 62.6 mttm -71.26 -61.28 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.08 -40.46 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -51.76 -53.52 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -57.98 -65.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 44.2 mt -44.47 -35.38 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.67 -52.82 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -56.73 -52.59 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.571 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 3.8 tt -63.23 -32.14 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.43 93.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 111' ' ' TRP . 3.0 mmmm -54.46 -58.62 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -38.79 -25.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 109' ' ' LYS . 63.5 m95 -90.86 -51.11 5.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.556 ' HG3' HD22 ' A' ' 113' ' ' LEU . 5.4 pt-20 -46.63 -20.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.556 HD22 ' HG3' ' A' ' 112' ' ' GLU . 1.5 mm? -79.17 -46.62 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -69.21 -1.66 8.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.12 43.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.7 p -128.98 129.04 44.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 110.802 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.4 114.74 25.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.13 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.767 HD23 ' N ' ' A' ' 119' ' ' LYS . 5.2 tt -50.31 137.12 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.767 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.65 115.14 61.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 165.66 30.19 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 1.5 m80 -117.66 132.5 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 128' ' ' LEU . 55.0 t -123.09 124.99 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 59.72 39.25 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 6.7 mmp_? 63.38 35.17 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -145.32 162.93 36.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.557 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 44.7 mm -82.69 102.99 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.615 HD11 HD22 ' A' ' 133' ' ' LEU . 47.2 tp -66.8 93.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.47 106.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.9 -46.43 90.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 131' ' ' PHE . 4.3 t80 -53.5 -56.12 19.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.462 ' O ' HD23 ' A' ' 136' ' ' LEU . 10.1 tt0 -65.19 -41.27 94.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 171' ' ' ILE . 4.1 tp -49.63 -72.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -51.63 -32.23 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -62.07 -50.79 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 155' ' ' ILE . 3.6 mm? -59.2 -41.6 88.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 146' ' ' VAL . 63.2 t -56.18 -55.51 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -54.04 -41.59 68.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.55 -40.99 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.45 -17.06 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.639 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 157.1 -59.09 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.632 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 144.18 170.33 13.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.472 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.58 -36.68 72.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -65.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.639 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.0 p -56.62 -54.92 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 142' ' ' GLY . 85.2 t -51.4 -62.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.3 t -53.92 -40.86 67.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.2 tptp -53.88 -48.92 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.32 11.87 37.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 49.4 44.9 23.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' ILE . 55.9 mttm -84.98 50.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.459 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 81.4 m95 -86.85 -51.23 6.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.0 m -39.4 -67.36 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -37.74 -53.94 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 151' ' ' LYS . 23.3 mt -58.78 -65.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.62 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.72 -46.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 m -68.08 -45.35 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -57.14 -29.44 63.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mmm -70.3 -17.22 63.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.65 1.71 11.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -90.02 172.38 8.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.21 145.92 43.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 88.46 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.266 . . . . 0.0 112.366 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -144.98 131.08 4.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.485 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -42.74 -25.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.26 -59.18 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.62 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.5 p -64.85 -32.99 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.68 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -77.05 -32.4 56.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -51.71 -51.07 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mm -42.16 -62.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -51.88 -53.43 40.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.41 -42.69 34.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.54 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 93.1 m-70 -60.52 -36.9 79.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 110.84 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.2 t80 -78.82 -30.2 45.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.56 -9.25 56.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 177' ' ' ARG . 13.3 mtp-105 -104.82 -28.43 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.98 -52.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 28.8 mt -85.2 21.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -71.65 -60.08 2.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 0.0 110.881 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.73 -49.65 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.383 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.5 t80 -45.07 -54.12 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -77.21 -37.93 52.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 40.9 tp -62.14 -19.59 63.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -98.0 -50.59 4.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -48.34 -45.12 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m -56.58 -45.7 81.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 175.55 177.07 44.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -97.6 74.33 2.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.1 p -96.62 -17.68 20.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -80.55 3.25 22.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.405 ' N ' HD13 ' A' ' 191' ' ' LEU . 28.3 mmt180 -69.01 96.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 17.2 p -40.22 154.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.1 tp -38.74 119.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -78.39 163.07 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -43.89 156.09 0.31 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.588 0.708 . . . . 0.0 110.894 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 86.72 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 0.0 112.312 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.92 170.48 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.51 76.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.5 p -137.63 154.96 49.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.0 t -68.19 78.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -104.89 103.31 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.2 m -67.83 146.47 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 204' ' ' LYS . 0.0 OUTLIER -128.04 102.81 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.35 102.62 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -71.79 158.14 36.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -91.99 -44.24 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 39.4 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.1 m -65.78 168.59 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -149.73 156.74 42.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.3 112.12 4.02 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 m -57.09 -61.17 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.7 m -104.8 169.83 8.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.24 117.15 5.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -106.97 41.29 1.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.842 0.353 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.53 -45.88 12.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -121.7 62.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.545 HG22 HD11 ' A' ' 101' ' ' LEU . 19.6 m -92.2 -67.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 12.9 ttp-105 -45.74 -59.09 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.41 -34.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HA ' ' CE2' ' A' ' 131' ' ' PHE . 53.1 mtpt -82.86 -58.82 2.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 97' ' ' THR . 34.0 mt -45.56 -36.98 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -50.5 -57.44 8.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 6.2 t80 -58.27 -58.91 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.9 mt -46.71 -37.95 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.32 -57.5 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -48.32 -56.0 9.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.598 HD12 ' CD1' ' A' ' 182' ' ' TYR . 1.7 tp -55.59 -40.1 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.18 91.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.01 -36.81 30.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -63.4 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.729 ' HD1' HD12 ' A' ' 118' ' ' LEU . 27.0 m95 -83.34 -59.24 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -38.31 -36.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.447 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 33.4 mt -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.47 -36.36 82.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.86 39.94 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -132.7 118.08 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.8 m -64.88 129.62 40.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.8 tt -79.97 122.15 26.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -116.15 141.66 47.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 mm -85.52 127.38 63.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.621 0.724 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HG2' HD23 ' A' ' 128' ' ' LEU . 54.1 Cg_endo -69.71 168.01 22.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.362 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -127.61 125.49 40.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 56.0 t -113.41 131.78 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 51.06 37.61 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? 64.16 54.5 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -164.37 164.02 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -73.45 127.56 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.598 HD23 ' HG2' ' A' ' 121' ' ' PRO . 15.3 tp -102.02 98.69 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 129' ' ' ASP . 43.0 t0 -70.8 117.12 11.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.4 mt -72.36 -63.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 100' ' ' LYS . 16.2 t80 -38.68 -61.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -57.46 -58.42 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 171' ' ' ILE . 6.7 tp -41.23 -67.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -50.59 -49.28 56.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -46.17 -54.35 8.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.64 -43.3 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.798 HG22 HD13 ' A' ' 155' ' ' ILE . 64.6 t -51.17 -48.81 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.48 91.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.26 -41.14 88.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.01 -22.35 58.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.561 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 161.63 -57.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.15 177.47 20.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.45 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 11.1 t80 -66.61 -36.63 83.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.61 -66.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.561 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -50.6 -51.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 142' ' ' GLY . 98.4 t -59.04 -68.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 35.5 t -44.73 -38.09 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -66.59 -45.42 79.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.2 m-20 -93.34 24.07 4.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 149' ' ' ASP . 3.0 mpt_? 35.02 45.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 146' ' ' VAL . 59.4 mttt -93.36 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.694 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 30.6 m95 -84.8 -48.67 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 152' ' ' TRP . 38.7 m -37.04 -53.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -46.43 -68.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.798 HD13 HG22 ' A' ' 137' ' ' VAL . 24.0 mt -45.31 -65.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.91 -50.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.8 m -54.3 -53.31 55.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.47 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -47.47 -49.57 25.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.4 mmm -50.12 -28.15 6.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.24 -4.04 10.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 36.7 m-85 -81.07 167.69 19.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 143.29 60.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 104.49 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.62 -159.48 9.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -101.0 -36.85 8.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.321 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -52.82 -58.48 6.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.52 -36.97 78.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.6 90.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 t -77.22 -28.76 53.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -58.34 -50.77 72.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.694 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 50.6 mm -40.4 -60.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -56.51 -53.58 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.38 -43.27 34.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -55.85 -39.86 72.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 2.6 t80 -67.77 -39.17 84.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -80.96 -9.21 59.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -97.2 -33.35 11.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.01 -51.39 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.47 ' HB2' ' CD1' ' A' ' 175' ' ' TYR . 12.6 mt -84.53 28.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.28 -60.4 2.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.875 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.75 -33.7 16.1 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.369 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.598 ' CD1' HD12 ' A' ' 107' ' ' ILE . 4.4 t80 -47.89 -60.91 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -72.4 -34.85 68.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.5 tm? -54.08 -48.8 70.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -73.67 -58.55 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.7 mt -41.83 -43.56 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 t -60.54 -46.63 89.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.86 123.56 0.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.74 133.41 8.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.9 m -45.36 -30.02 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 28.3 mt -50.47 -51.51 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -53.77 152.71 5.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 192' ' ' ARG . 4.2 m -109.93 149.15 30.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.77 125.37 24.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -116.03 41.28 2.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.54 132.15 13.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 115.05 3.91 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 0.0 112.347 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -150.02 157.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 198' ' ' ASN . 23.1 tp -36.31 119.61 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 40.2 p -46.72 142.03 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 7.7 t -50.9 158.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -83.39 150.41 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.2 t -114.59 156.91 23.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -95.7 130.59 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -134.71 152.27 51.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -105.55 130.38 53.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.3 154.67 17.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 57.6 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -109.24 127.79 54.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.84 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -159.68 152.31 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.22 -99.43 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -129.17 152.11 49.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.873 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -54.47 -48.85 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.01 136.31 6.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -86.96 39.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.92 176.82 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -110.68 42.2 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.3 t -88.82 -34.0 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -69.6 -42.28 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.2 p -62.2 -34.41 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.88 -53.55 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.1 mt -60.36 -46.01 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -46.64 -59.47 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 104' ' ' LEU . 71.7 t80 -49.25 -68.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 70.7 mt -37.03 -37.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.37 -57.92 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -52.29 -51.46 58.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.452 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.7 tt -58.05 -36.78 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -60.85 -50.99 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -47.71 -38.77 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -58.57 -38.58 78.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.417 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 13.8 m95 -82.06 -53.49 6.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -41.58 -50.13 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.33 -44.31 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -73.31 -36.81 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.18 40.71 0.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.9 m -131.88 126.68 34.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -74.51 128.28 35.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 119' ' ' LYS . 4.1 tt -91.22 118.32 30.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 118' ' ' LEU . 46.5 tttm -128.59 136.84 51.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.944 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.422 HD11 HD22 ' A' ' 104' ' ' LEU . 25.7 mm -67.47 124.5 89.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 111.108 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.725 ' HG2' HD23 ' A' ' 128' ' ' LEU . 53.9 Cg_endo -69.76 167.17 25.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.696 2.264 . . . . 0.0 112.311 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -123.89 119.92 31.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.583 ' CG2' HD22 ' A' ' 128' ' ' LEU . 43.1 t -108.67 136.51 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 45.17 39.84 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 61.48 44.82 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -155.04 142.33 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.06 118.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 121' ' ' PRO . 22.1 tp -94.8 103.9 15.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.938 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.1 104.03 5.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.9 mt -64.67 -46.64 81.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 58.6 t80 -48.12 -61.06 2.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 136' ' ' LEU . 7.1 mm100 -65.7 -39.5 91.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.935 HD11 HG23 ' A' ' 171' ' ' ILE . 11.6 tp -52.66 -71.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -53.57 -62.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -42.31 -50.81 4.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 132' ' ' GLN . 24.8 mt -56.1 -42.87 77.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 155' ' ' ILE . 72.8 t -57.8 -48.04 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.73 75.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.9 -44.9 94.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.35 -27.57 67.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 165.65 -54.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 142.49 163.48 9.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -57.17 -29.29 63.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.34 -66.3 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.069 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 141' ' ' GLY . 3.6 p -55.01 -39.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.4 t -68.04 -56.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.0 t -56.29 -41.95 76.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -55.61 -49.77 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.34 4.12 53.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.73 40.43 31.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -89.38 46.79 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -89.08 -41.65 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.4 m -42.9 -52.72 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -54.01 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 137' ' ' VAL . 15.4 mt -60.35 -60.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -43.72 -47.6 7.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.6 m -62.51 -46.21 89.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -51.78 -52.77 46.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 30.5 mtp -46.6 -28.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.33 -3.99 10.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.481 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.36 172.03 13.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.08 142.09 51.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 90.02 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.324 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.01 178.97 21.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -83.0 -32.38 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.58 55.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.9 p -63.59 -38.57 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -53.33 -45.96 64.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.1 m -75.43 -32.87 60.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -56.25 -49.71 73.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 133' ' ' LEU . 9.7 mm -44.23 -55.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.8 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.53 -56.69 9.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -49.32 -35.6 18.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.6 OUTLIER -75.99 -44.54 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.0 -9.9 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -105.27 -28.62 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.488 HG22 HD13 ' A' ' 179' ' ' LEU . 34.4 mt -116.72 -52.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.488 HD13 HG22 ' A' ' 178' ' ' ILE . 1.9 mm? -91.45 33.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.507 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.63 -63.88 0.52 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.39 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.7 t80 -37.74 -36.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -82.55 -53.8 5.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -55.7 -20.36 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -90.6 -52.08 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -47.98 -46.03 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 m -76.93 -48.47 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.92 64.3 3.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.452 ' HB2' ' CG ' ' A' ' 192' ' ' ARG . 15.9 p-10 -105.74 107.13 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.0 m -97.83 -52.13 3.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.54 -18.56 1.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.452 ' CG ' ' HB2' ' A' ' 189' ' ' ASP . 36.5 ptt180 -133.39 169.04 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.99 157.87 16.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.56 ' C ' HD13 ' A' ' 194' ' ' LEU . 0.9 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.441 ' N ' HD13 ' A' ' 194' ' ' LEU . 7.2 mm100 -111.63 108.17 17.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -79.47 143.46 59.65 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.57 0.7 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 89.06 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.69 2.26 . . . . 0.0 112.301 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -71.44 72.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.813 ' C ' HD22 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -79.39 166.77 21.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.692 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.3 p -142.36 148.78 38.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 36.0 p -110.33 88.92 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.846 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.61 106.01 11.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -96.9 132.83 42.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 204' ' ' LYS . 0.0 OUTLIER -98.46 143.14 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -145.36 151.07 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -111.23 139.08 46.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.66 127.42 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -129.89 149.71 51.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.857 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 t -138.74 119.81 14.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.57 57.8 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -61.16 161.35 8.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -107.68 178.38 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.09 -111.06 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.13 137.53 37.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 126.25 30.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -108.31 -45.49 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 p -59.73 -30.54 68.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -71.26 -59.01 3.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' A' ' 131' ' ' PHE . 7.6 p -56.87 -39.07 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.551 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 31.0 mttm -65.56 -54.37 28.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.47 -56.75 18.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.963 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -38.42 -58.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 12.1 t80 -50.17 -57.36 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 41.0 mt -52.18 -27.98 16.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.2 -53.71 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -56.32 -49.87 73.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 4.8 tt -57.49 -42.07 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.72 82.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -48.87 -37.36 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.502 ' OH ' ' CE1' ' A' ' 185' ' ' PHE . 5.6 m-85 -59.18 -43.98 92.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.751 ' HD1' HD12 ' A' ' 118' ' ' LEU . 73.2 m95 -68.97 -51.7 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -42.09 -50.3 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.3 mt -47.96 -42.0 26.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.92 -36.21 64.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.3 30.05 2.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.44 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.3 m -128.83 138.07 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.811 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -86.96 132.85 33.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.751 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.3 tt -85.31 118.75 25.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -112.54 125.0 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.79 119.61 75.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 154.47 67.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.2 123.36 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.59 121.47 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.07 48.57 6.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 126' ' ' LYS . 12.1 mpt_? 54.14 46.8 24.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 125' ' ' ARG . 34.8 mtmm -164.52 142.18 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -56.88 144.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -109.07 120.09 41.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.43 95.37 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 131' ' ' PHE . 55.9 mt -57.3 -63.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE2' HG22 ' A' ' 99' ' ' VAL . 10.5 t80 -34.76 -58.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 133' ' ' LEU . 10.8 tp60 -62.41 -62.61 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -35.08 -66.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -45.86 -56.22 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.45 -52.51 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.28 -41.97 66.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 155' ' ' ILE . 77.5 t -57.14 -45.89 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.73 -34.99 79.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -68.01 -31.59 71.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -82.93 -16.1 48.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.434 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 155.15 -60.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 153.43 172.76 21.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.72 -40.42 95.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.16 -66.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.434 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.2 p -48.61 -43.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 137' ' ' VAL . 44.8 t -62.83 -62.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 8.7 m -49.89 -46.02 51.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 148' ' ' LYS . 4.7 tmtt? -53.5 -60.15 3.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 150' ' ' ARG . 18.1 m-20 -84.47 25.87 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 149' ' ' ASP . 21.2 mmt180 34.49 38.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 41.1 mtpt -76.9 47.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.607 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 13.6 m95 -91.03 -48.73 6.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.5 m -39.07 -51.25 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -48.55 -64.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 137' ' ' VAL . 18.8 mt -52.92 -62.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.43 -49.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.6 m -65.23 -38.67 91.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 155' ' ' ILE . 24.3 mmtt -53.64 -47.14 70.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.0 mtp -65.13 -19.97 66.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.44 3.56 25.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.455 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' CB ' HG21 ' A' ' 167' ' ' VAL . 27.8 m-85 -83.56 128.17 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -47.4 143.87 5.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.545 0.688 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.08 4.86 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 171.35 41.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -79.17 -14.66 58.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.21 -56.84 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 161' ' ' PHE . 7.5 p -64.69 -37.34 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.98 -46.73 83.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.9 t -76.0 -28.31 57.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -58.33 -49.21 77.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 133' ' ' LEU . 5.7 mm -44.5 -60.09 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -57.05 -55.9 28.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.41 -44.87 16.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -49.14 -46.73 45.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -62.78 -38.54 91.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -80.56 -9.18 59.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -99.91 -31.73 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.0 mt -119.74 -50.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 18.9 mt -83.66 22.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -72.48 -60.62 2.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -48.03 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.99 -44.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.01 -58.07 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -42.09 -35.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CE1' ' OH ' ' A' ' 110' ' ' TYR . 12.1 t80 -73.2 -49.5 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.1 mt -56.65 -35.68 68.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.0 t -79.47 -45.41 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.63 -145.28 4.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.521 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -124.86 151.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.1 m -48.98 -42.27 37.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 192' ' ' ARG . 4.6 mm? -45.07 -43.35 9.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -35.91 141.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.7 m -132.66 161.4 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.04 122.64 48.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -43.97 105.4 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.47 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -41.24 137.06 1.66 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.925 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.47 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 53.6 Cg_endo -69.76 138.17 37.2 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -76.44 156.49 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.411 ' HG ' ' N ' ' A' ' 200' ' ' THR . 4.3 tp -69.27 145.99 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.411 ' N ' ' HG ' ' A' ' 199' ' ' LEU . 70.3 p -97.73 164.88 12.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.0 p -111.58 87.54 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.81 149.51 43.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 73.1 m -132.23 103.31 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.16 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -42.9 132.19 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.61 132.8 38.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -97.67 85.09 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -98.52 152.78 19.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.823 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.4 m -86.2 131.59 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t -72.02 171.96 10.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.63 57.71 4.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -130.4 93.86 3.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -53.3 146.69 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.26 74.32 0.87 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.08 132.35 56.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.78 -53.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.32 45.08 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.0 t -90.01 -26.7 20.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -41.35 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.4 p -64.54 -30.56 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -79.0 -51.51 9.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.89 -47.75 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -42.78 -53.2 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.731 ' O ' HG22 ' A' ' 107' ' ' ILE . 35.1 t80 -51.84 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 23.0 mt -42.75 -36.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 29.7 t70 -67.59 -59.19 3.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -52.87 -54.14 38.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.9 tt -59.1 -33.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -58.55 -54.37 47.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HE2' ' N ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -42.84 -54.85 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -42.76 -38.12 2.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.655 ' HD1' HD12 ' A' ' 118' ' ' LEU . 66.7 m95 -83.56 -47.82 10.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -46.52 -44.38 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 109' ' ' LYS . 8.1 mp -58.82 -42.59 89.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -68.43 -37.67 80.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.8 40.46 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.9 p -142.8 106.15 4.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.912 0.387 . . . . 0.0 110.818 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.7 p -50.58 147.11 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.655 HD12 ' HD1' ' A' ' 111' ' ' TRP . 7.0 tt -101.51 111.95 24.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -110.03 140.6 43.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 121' ' ' PRO . 47.2 mm -85.91 131.89 45.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 120' ' ' ILE . 54.1 Cg_endo -69.75 170.97 15.33 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -127.62 111.13 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.6 t -104.47 123.55 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 60.74 41.86 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 57.64 40.89 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -153.69 149.31 27.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.38 135.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.513 HD11 HD22 ' A' ' 133' ' ' LEU . 40.0 tp -103.47 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.91 97.71 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' PHE . 51.7 mt -55.43 -62.84 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 88.7 t80 -34.79 -54.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 133' ' ' LEU . 4.7 tp60 -64.94 -62.91 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 171' ' ' ILE . 14.4 tp -34.39 -69.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -50.33 -51.27 46.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -46.27 -51.55 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.01 -50.17 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 146' ' ' VAL . 70.5 t -47.64 -50.7 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.26 -45.86 83.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.55 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -76.56 -22.7 53.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.2 -58.55 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 151.93 170.76 18.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.518 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -60.52 -40.79 92.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.89 -66.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.424 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.3 p -49.13 -43.37 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.2 t -67.62 -66.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 52.7 t -44.57 -48.1 10.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -56.79 -57.82 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.99 19.56 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 38.86 48.67 1.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.558 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -84.51 38.49 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.404 ' CZ2' ' HG2' ' A' ' 172' ' ' ARG . 80.7 m95 -84.01 -44.97 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -41.28 -50.71 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -49.38 -55.15 13.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.6 mp -60.3 -64.49 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.48 -49.97 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.4 m -61.41 -47.55 85.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -50.09 -41.88 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 31.6 mtp -68.15 -28.0 66.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -1.67 10.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CB ' HG21 ' A' ' 167' ' ' VAL . 19.6 m-85 -81.37 128.02 33.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -46.4 141.61 4.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.56 0.695 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.39 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 0.0 112.37 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.637 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -140.17 132.32 5.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -37.36 -33.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -53.2 -58.75 5.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 164' ' ' GLY . 8.6 p -64.77 -32.57 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.24 -45.0 89.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.9 m -77.49 -35.3 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -51.89 -48.09 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.636 HG23 HD11 ' A' ' 133' ' ' LEU . 5.0 mm -45.89 -55.72 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' C ' ' OE1' ' A' ' 176' ' ' GLU . 41.2 mtp180 -55.38 -57.88 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.81 -42.29 7.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -59.6 -39.95 85.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -72.2 -39.12 68.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.408 ' OE1' ' C ' ' A' ' 172' ' ' ARG . 10.1 mp0 -81.89 -9.24 59.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.76 -30.84 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.98 -50.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 175' ' ' TYR . 11.2 mt -84.04 23.36 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.61 -60.34 2.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.564 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.8 Cg_endo -69.74 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.28 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 186' ' ' LEU . 5.8 t80 -42.08 -54.4 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -77.25 -42.16 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 55.1 tp -55.28 -27.01 43.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -97.1 -54.16 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 182' ' ' TYR . 28.0 mt -41.95 -44.36 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.4 t -54.16 -47.29 72.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 189' ' ' ASP . . . -71.04 102.09 1.03 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 188' ' ' GLY . 1.1 m-20 -34.44 109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.848 0.356 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 87.8 p -46.07 -34.42 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.87 -43.49 38.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -47.4 -27.62 1.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 10.5 t -134.87 53.48 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.9 tp -133.04 100.36 4.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.15 34.19 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -125.37 122.36 25.05 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.602 0.715 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 136.04 31.99 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.4 176.18 5.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.44 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 55.3 m -69.85 144.18 52.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.5 m -142.78 169.33 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -82.02 125.56 30.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.5 p -101.95 128.58 48.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -57.24 143.35 39.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -120.48 143.55 48.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.05 126.31 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -123.83 -44.79 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.78 0.324 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -70.71 -50.39 36.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -44.67 -35.98 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -80.28 -46.97 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.3 mt -55.0 -39.15 68.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -44.74 -65.59 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 74.1 t80 -49.66 -68.04 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.436 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 72.5 mt -37.05 -52.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CD ' ' A' ' 109' ' ' LYS . 22.1 t70 -49.77 -53.41 25.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -56.1 -59.64 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.436 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.0 tt -57.06 -25.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -74.2 -41.82 60.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -56.3 -34.08 66.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.37 -31.12 72.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' LEU . 14.5 m95 -88.13 -54.3 4.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -26.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 111' ' ' TRP . 54.7 mt -69.81 -48.82 57.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.443 ' OE1' ' C ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -68.08 -36.71 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 115.41 33.45 1.6 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -120.05 145.33 46.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.846 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 m -89.31 128.84 35.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -86.2 120.31 27.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 118' ' ' LEU . 16.3 tptp -142.33 124.29 15.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.0 mm -81.1 138.46 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.9 Cg_endo -69.77 179.48 3.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 127' ' ' ILE . 56.9 m80 -115.8 107.02 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.505 HG12 ' CE1' ' A' ' 161' ' ' PHE . 53.3 t -93.14 110.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 57.65 48.29 14.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 60.21 31.59 20.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -148.42 123.36 10.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 122' ' ' HIS . 19.9 mm -54.75 131.68 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.618 ' O ' HG21 ' A' ' 120' ' ' ILE . 58.8 tp -92.39 103.62 16.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.14 91.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 131' ' ' PHE . 64.4 mt -43.17 -59.5 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' LEU . 45.9 t80 -35.31 -69.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 133' ' ' LEU . 40.8 mt-30 -54.89 -57.27 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.996 HD11 HG23 ' A' ' 171' ' ' ILE . 16.6 tp -34.09 -71.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -51.2 -45.91 62.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -49.17 -58.64 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.94 -46.26 60.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.8 t -49.07 -55.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.85 75.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.0 -38.04 89.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.91 -19.79 60.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 157.38 -59.44 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.76 171.32 17.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.07 -46.0 91.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.84 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.52 -66.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.6 p -49.9 -54.47 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 142' ' ' GLY . 57.4 t -51.43 -49.09 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.2 m -58.25 -45.41 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -57.49 -49.04 77.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.9 m-20 -97.36 18.4 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 35.36 51.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -86.47 41.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.85 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 43.4 m95 -84.26 -36.36 22.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 m -49.7 -43.7 47.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -54.45 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.583 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.7 mp -55.23 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -38.7 -53.51 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 92.4 m -57.83 -43.79 86.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -61.07 -22.83 64.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 93.3 mmm -82.45 9.24 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.82 -10.11 74.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.543 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.505 ' CE1' HG12 ' A' ' 123' ' ' VAL . 13.6 m-85 -72.26 157.11 38.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.0 61.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 85.64 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.677 2.252 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.34 -130.49 3.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.44 -46.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.61 -58.98 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.534 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.2 p -54.9 -31.08 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.16 19.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 t -70.13 -25.65 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -58.49 -48.09 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.996 HG23 HD11 ' A' ' 133' ' ' LEU . 34.7 mm -47.1 -52.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -59.63 -57.47 12.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.14 -57.69 7.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.437 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 82.1 m-70 -40.34 -37.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.6 OUTLIER -77.07 -42.31 38.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -76.81 -9.23 58.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -101.46 -32.23 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.29 -51.1 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 19.5 mt -83.93 21.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.45 -60.25 2.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 0.0 110.888 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.1 Cg_endo -69.72 -50.68 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -40.78 -47.9 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.26 -27.21 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 184' ' ' LEU . 2.2 tt -61.52 -29.45 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -95.3 -45.59 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.1 mt -48.94 -39.97 28.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.795 0.331 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -65.57 -62.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' A' ' 131' ' ' PHE . 9.7 p -63.24 -20.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -75.02 -49.06 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 104' ' ' LEU . 71.7 mt -77.99 -37.44 47.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -39.96 -62.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.66 ' O ' HG22 ' A' ' 107' ' ' ILE . 46.0 t80 -53.31 -57.69 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 101' ' ' LEU . 43.5 mt -44.07 -31.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.8 -40.78 22.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -68.0 -26.17 65.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.6 tp -92.88 -31.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.54 -45.33 46.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 113' ' ' LEU . 29.5 pttt -48.72 -39.78 26.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 6.2 m-85 -56.67 -38.04 71.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 66.4 m95 -72.32 -49.48 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -43.57 -56.05 3.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.0 mp -47.39 -42.33 21.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -68.15 -31.91 71.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.16 33.86 3.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -138.55 138.26 37.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.971 0.415 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -86.18 137.31 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 7.0 tt -89.79 128.88 36.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.3 tptm -114.99 120.48 40.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.03 129.73 93.95 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.62 0.724 . . . . 0.0 111.11 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.15 57.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.267 . . . . 0.0 112.301 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.455 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 11.1 m170 -123.61 108.86 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 72.2 t -96.55 140.29 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 41.63 43.24 2.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 60.16 41.82 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -152.99 156.41 38.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 15.3 mm -69.75 137.34 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.75 HD11 HD22 ' A' ' 133' ' ' LEU . 15.8 tp -107.47 98.78 8.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -72.29 105.09 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.2 -57.35 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CE2' HG22 ' A' ' 99' ' ' VAL . 7.6 t80 -38.78 -48.37 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -73.44 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.75 HD22 HD11 ' A' ' 128' ' ' LEU . 24.6 tp -38.12 -67.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -47.46 -57.49 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -41.51 -56.67 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.0 mt -51.61 -44.34 62.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 133' ' ' LEU . 59.2 t -52.26 -51.3 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.21 85.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.67 -42.89 97.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -73.07 -22.01 60.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 158.76 -58.21 0.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 141.67 170.11 12.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CE2' ' HG2' ' A' ' 172' ' ' ARG . 30.3 t80 -57.31 -41.76 80.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.847 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.15 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.8 p -55.54 -52.01 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 142' ' ' GLY . 95.3 t -56.72 -66.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 14.2 t -51.25 -36.24 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -58.8 -50.99 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.09 25.62 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 38.38 39.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -85.46 46.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.865 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 45.4 m95 -88.96 -42.68 11.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.2 m -40.92 -50.73 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -50.69 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.2 mt -45.16 -62.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.5 -56.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.7 m -55.29 -41.46 72.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -53.65 -44.99 70.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.0 mmm -59.43 -18.82 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.28 -14.53 12.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 19.4 m-85 -66.5 164.63 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 144.14 75.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 111.069 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 96.19 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.2 13.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -36.65 10.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.741 0.305 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -55.97 10.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.44 -38.18 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.2 -47.56 41.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -76.7 -33.52 58.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.67 -51.98 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.865 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 6.8 mm -40.98 -55.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HG2' ' CE2' ' A' ' 143' ' ' PHE . 21.2 mtm105 -57.38 -56.09 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.04 -44.96 26.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.425 ' CD2' HD22 ' A' ' 128' ' ' LEU . 60.9 m-70 -53.39 -38.42 63.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -76.8 -32.27 57.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -86.33 -9.34 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -101.69 -29.59 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.92 -52.28 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 13.1 mt -84.15 24.16 0.98 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.53 -60.25 2.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.65 0.738 . . . . 0.0 110.912 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.73 -50.0 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.665 2.243 . . . . 0.0 112.397 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.0 t80 -42.61 -56.12 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.49 -52.49 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.95 -33.5 4.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -75.11 -55.55 5.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.84 -46.33 64.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.4 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.744 0.307 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -64.19 -52.44 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 100' ' ' LYS . 8.7 p -55.64 -44.88 78.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 99' ' ' VAL . 81.0 mttt -60.57 -46.78 88.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ASN . 35.2 mt -57.21 -50.25 73.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' LEU . 57.3 t-20 -37.56 -61.95 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 105' ' ' ASP . 31.4 t80 -57.97 -65.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 58.1 mt -38.23 -27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.9 t70 -80.77 -48.95 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 103' ' ' PHE . 12.3 mm100 -64.13 -21.33 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.4 tt -91.55 -39.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -67.16 -41.6 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 55.4 pttt -56.93 -44.24 82.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 5.5 m-85 -50.04 -33.06 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.52 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 60.7 m95 -79.16 -49.47 12.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -45.4 -40.14 7.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.37 -45.25 88.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -65.44 -33.06 75.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.56 40.83 1.69 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -144.06 147.49 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -87.45 146.6 25.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -96.29 115.98 28.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 118' ' ' LEU . 22.7 ttpt -107.27 124.08 49.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.72 125.44 90.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 160.75 48.55 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -125.37 109.12 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.15 121.64 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 56.11 45.6 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' NH1' ' A' ' 125' ' ' ARG . 6.3 mtp-105 58.37 41.29 23.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -145.78 153.36 40.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -76.95 113.57 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.24 108.6 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.944 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.63 88.86 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' PHE . 41.3 mt -39.19 -64.6 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.4 t80 -37.32 -66.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 38.1 tt0 -50.42 -60.65 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -36.45 -70.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.2 -47.49 46.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -49.5 -54.4 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -52.38 -49.31 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 155' ' ' ILE . 97.4 t -48.24 -48.84 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.99 90.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.19 -32.12 69.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.05 -12.85 58.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.08 -61.7 0.38 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.92 170.58 18.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 34.2 t80 -60.13 -35.83 76.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 0.0 110.926 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.44 -66.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.7 p -49.95 -49.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 145' ' ' VAL . 53.2 t -61.89 -62.63 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 52.2 t -46.34 -46.13 18.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -63.35 -55.46 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 14.93 2.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.4 OUTLIER 39.64 52.12 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 9.0 mtpm? -94.22 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.496 ' CE3' HG21 ' A' ' 171' ' ' ILE . 89.7 m95 -81.81 -40.67 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 98.9 m -42.31 -51.25 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -49.59 -68.28 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -43.13 -65.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.11 -51.29 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.6 m -54.66 -53.02 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -54.08 -27.4 32.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -78.72 10.27 3.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.3 75.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -70.5 157.03 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.65 80.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.521 0.677 . . . . 0.0 111.142 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.224 . . . . 0.0 112.324 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -141.74 -169.18 11.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -93.93 -47.66 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.72 -58.22 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HA ' ' CD2' ' A' ' 170' ' ' HIS . 11.5 p -60.23 -31.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.25 -49.84 62.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.9 t -74.31 -34.08 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.446 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 3.8 m-70 -50.74 -53.78 28.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.684 HG23 HD11 ' A' ' 133' ' ' LEU . 32.4 mm -38.78 -48.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -65.14 -52.84 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 176' ' ' GLU . . . -53.16 -57.31 15.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -43.38 -30.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.599 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -79.47 -37.99 35.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' GLY . 7.3 mt-10 -77.97 -10.3 59.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 177' ' ' ARG . 1.2 mpt_? -98.16 -34.03 10.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.1 mt -119.52 -48.34 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 175' ' ' TYR . 7.7 mt -83.47 21.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -70.98 -60.1 3.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.52 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.76 -49.08 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.32 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 6.1 t80 -44.61 -56.65 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.98 -38.84 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.424 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 52.0 tp -58.13 -23.19 54.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -98.13 -43.1 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -53.16 -44.6 67.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.332 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -56.54 -57.84 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.17 -31.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -54.8 -49.67 70.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 102' ' ' ASN . 81.5 mt -77.31 -48.16 18.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 101' ' ' LEU . 5.4 t-20 -37.33 -63.25 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.25 -64.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.453 ' HA ' HG22 ' A' ' 107' ' ' ILE . 28.3 mt -45.08 -26.07 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.17 -40.34 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -74.69 -24.38 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 182' ' ' TYR . 9.1 tp -87.39 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -65.69 -46.15 80.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.651 ' O ' HD12 ' A' ' 113' ' ' LEU . 61.0 pttt -49.05 -45.0 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.446 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 56.5 t80 -52.49 -41.63 63.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.864 ' CD1' HD12 ' A' ' 118' ' ' LEU . 53.6 m95 -68.09 -48.25 66.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.19 -45.39 16.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.5 mp -51.44 -37.06 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -78.26 -23.16 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 27.36 9.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -129.91 136.43 49.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.79 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -82.11 145.22 30.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.6 tt -90.79 117.15 29.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -109.57 114.65 28.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mm -70.47 126.56 92.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.56 10.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.38 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -122.58 121.0 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 128' ' ' LEU . 97.4 t -110.22 127.96 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 54.17 42.48 31.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 58.87 45.15 15.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -157.07 153.86 28.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.12 105.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.533 ' CD2' ' CD2' ' A' ' 174' ' ' HIS . 49.4 tp -65.6 116.6 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -80.41 108.21 13.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.07 -52.19 51.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CD2' ' N ' ' A' ' 132' ' ' GLN . 6.8 t80 -48.27 -66.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 59.3 tt0 -54.77 -47.96 73.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 171' ' ' ILE . 5.8 tp -50.08 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -48.98 -43.6 40.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -51.03 -53.38 34.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 66.1 mt -56.14 -46.29 79.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.1 t -48.57 -49.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.87 79.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.23 -42.59 79.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -72.97 -14.58 61.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.97 -61.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.82 168.79 14.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.26 -42.15 81.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.28 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.447 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -52.49 -40.96 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.6 t -69.9 -26.38 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.9 m -78.82 -32.64 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 8.1 pttp -81.35 -45.3 16.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 150' ' ' ARG . 5.8 m-20 -89.43 20.15 4.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.474 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 31.41 47.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -87.97 37.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 24.6 m95 -85.36 -42.27 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m -52.02 -53.27 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -46.71 -53.89 10.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 156' ' ' ALA . 28.4 mt -58.9 -68.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.116 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -34.32 -49.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -58.88 -49.22 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -50.17 -49.13 53.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 22.9 mtp -47.93 -27.19 2.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.5 -7.55 10.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -77.43 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.32 145.11 55.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.542 0.686 . . . . 0.0 111.142 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 93.32 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -146.91 135.32 5.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.455 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -43.78 -23.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.401 ' N ' ' C ' ' A' ' 164' ' ' GLY . . . -61.01 -59.09 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.53 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.3 p -67.57 -40.68 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.94 -41.44 45.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.3 m -83.33 -31.6 26.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.1 m-70 -54.69 -40.0 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.791 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 49.9 mm -50.51 -61.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.081 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.69 -52.68 63.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.69 -43.02 37.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.533 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 60.9 m-70 -56.83 -39.81 74.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.8 OUTLIER -75.23 -39.98 59.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -76.29 -9.44 58.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -104.04 -29.72 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.1 mt -119.25 -52.47 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 29.2 mt -82.94 18.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -69.95 -60.22 3.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.632 0.73 . . . . 0.0 110.909 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -41.78 4.01 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.576 ' CD1' HD12 ' A' ' 107' ' ' ILE . 16.5 t80 -45.31 -51.68 10.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.72 -42.85 21.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 47.4 tp -50.82 -31.28 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -90.53 -54.08 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -42.18 -51.82 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.889 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -60.9 -56.18 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.614 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.1 p -44.34 -35.6 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 60.9 mttt -78.44 -54.88 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 102' ' ' ASN . 72.9 mt -46.06 -48.42 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 101' ' ' LEU . 25.6 t-20 -36.41 -65.55 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 106' ' ' GLN . 55.5 t80 -55.05 -68.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.468 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 36.6 mt -36.68 -30.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' PHE . 10.1 t70 -79.48 -45.78 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.3 mm-40 -67.04 -17.98 65.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.6 tt -96.86 -34.98 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.83 -42.32 81.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.092 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' O ' HD23 ' A' ' 113' ' ' LEU . 49.4 pttt -54.44 -46.37 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' N ' ' CG ' ' A' ' 109' ' ' LYS . 7.5 m-85 -47.97 -36.48 12.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.848 ' CD1' HD12 ' A' ' 118' ' ' LEU . 80.6 m95 -74.63 -49.33 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -43.21 -54.0 4.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 109' ' ' LYS . 2.7 mm? -45.64 -40.69 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.21 -44.54 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 35.87 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -138.14 120.12 15.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.936 0.398 . . . . 0.0 110.883 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 t -65.16 147.46 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.848 HD12 ' CD1' ' A' ' 111' ' ' TRP . 4.0 tt -110.37 110.28 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -103.91 140.38 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.29 122.99 73.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.13 11.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -122.22 125.27 45.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.7 t -112.94 134.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 46.76 42.32 11.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 57.75 45.6 18.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -163.89 130.71 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mm -46.5 133.05 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 133' ' ' LEU . 25.8 tp -94.98 104.6 16.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -72.5 98.62 2.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.81 -57.06 14.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.614 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 44.7 t80 -42.26 -65.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -56.01 -53.67 54.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 128' ' ' LEU . 20.7 tp -46.94 -70.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -42.91 -48.66 5.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -48.6 -56.17 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.59 -40.26 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 155' ' ' ILE . 46.6 t -55.04 -54.74 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.99 70.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -63.86 -37.66 88.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -81.14 -19.12 44.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.458 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.55 -57.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.508 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.75 160.5 9.11 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 175' ' ' TYR . 2.4 t80 -53.69 -33.62 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.23 -66.26 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.7 p -52.11 -31.07 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.5 t -76.1 -54.58 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 38.6 t -57.88 -49.8 75.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 9.3 ptmt -51.76 -42.95 62.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 148' ' ' LYS . 16.3 t0 -90.42 0.89 57.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 52.22 50.79 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -102.84 35.41 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -71.73 -31.76 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.3 m -53.75 -62.67 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.154 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -39.32 -58.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 137' ' ' VAL . 22.2 mt -55.43 -64.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.441 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -39.19 -44.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.1 m -62.42 -47.69 83.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -51.8 -45.9 64.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.1 -27.21 52.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.07 -7.69 9.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -73.29 135.67 44.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.56 142.7 21.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.538 0.685 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 125.69 12.45 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.4 -144.78 4.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -121.36 -29.72 4.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.27 -57.96 10.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 168' ' ' GLY . 9.2 p -58.72 -44.88 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -49.48 -40.38 31.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.49 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -79.75 -28.72 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.1 m-70 -57.83 -51.64 68.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 133' ' ' LEU . 4.5 mm -46.77 -58.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -50.69 -54.04 26.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -53.62 -52.08 44.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 90.8 m-70 -44.46 -33.96 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CD1' ' CE2' ' A' ' 143' ' ' PHE . 1.0 OUTLIER -79.4 -36.1 39.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -83.57 -9.07 59.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -101.94 -31.45 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.13 -50.35 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 175' ' ' TYR . 15.8 mt -83.22 18.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.517 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.82 -58.85 4.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.71 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.57 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 54.2 Cg_endo -69.74 -50.83 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.377 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -42.75 -41.64 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.37 -64.55 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 180' ' ' ASN . 6.9 mp -40.35 -36.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -70.57 -51.96 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.9 mt -46.9 -44.81 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -47.36 -51.58 19.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.8 p -47.08 -35.84 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.553 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 7.3 mtmp? -73.09 -49.2 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.76 -38.26 81.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.26 -53.63 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 107' ' ' ILE . 50.1 t80 -58.61 -48.39 81.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.46 -36.72 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.5 -42.02 68.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -65.82 -52.74 48.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 103' ' ' PHE . 2.8 tp -55.16 -49.35 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -54.26 -49.17 70.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -43.71 -52.34 6.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.98 -42.96 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.455 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 51.6 m95 -71.72 -48.64 45.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -44.53 -50.59 9.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mt -54.39 -43.86 71.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.13 -38.44 88.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.86 34.8 1.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -140.64 130.08 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 p -67.18 140.16 57.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -111.76 149.02 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.915 ' H ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -169.98 141.2 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 128' ' ' LEU . 10.1 mm -75.26 131.51 78.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.602 0.715 . . . . 0.0 111.17 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.31 24.85 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.541 ' CE1' HD11 ' A' ' 127' ' ' ILE . 32.8 m80 -100.46 116.74 33.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 128' ' ' LEU . 88.2 t -108.41 120.54 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 61.82 43.73 9.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 58.11 42.16 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -170.25 133.19 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.541 HD11 ' CE1' ' A' ' 122' ' ' HIS . 17.0 mm -46.99 148.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.66 ' O ' HG21 ' A' ' 120' ' ' ILE . 9.4 tp -116.86 111.41 19.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.8 106.31 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.36 -50.63 72.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 54.3 t80 -44.38 -56.5 4.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -63.2 -56.03 20.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 171' ' ' ILE . 6.6 tp -40.79 -70.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -43.54 -48.39 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -50.53 -50.43 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.448 ' HB3' HG23 ' A' ' 155' ' ' ILE . 4.1 mm? -57.11 -38.15 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.707 HG22 HD13 ' A' ' 155' ' ' ILE . 46.4 t -58.53 -59.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.54 60.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -60.77 -37.24 81.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -79.49 -13.4 59.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 151.55 -62.71 0.39 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 162.17 169.22 25.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -61.25 -37.05 81.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.72 -66.34 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 2.5 p -43.15 -30.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 150' ' ' ARG . 20.2 t -80.43 -50.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.5 p -57.78 -38.43 75.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -78.01 -28.27 49.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.16 2.2 45.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmm180 53.69 31.04 12.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 146' ' ' VAL . 40.9 mtmt -83.53 43.11 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -86.4 -44.97 11.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 m -47.85 -49.62 28.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -49.15 -55.36 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.707 HD13 HG22 ' A' ' 137' ' ' VAL . 14.9 mt -57.34 -60.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.429 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -41.64 -48.13 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -50.76 -43.7 58.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.9 mtp -58.31 -21.0 47.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.68 2.11 24.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -78.97 177.46 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.88 142.91 34.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.595 0.712 . . . . 0.0 111.095 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 122.98 9.64 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.39 -166.63 32.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -104.7 -20.87 13.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.72 -59.1 4.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.429 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.1 p -61.79 -30.75 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.63 -49.29 78.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.8 m -75.43 -27.38 58.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.6 m-70 -58.22 -54.22 49.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.856 HG23 HD21 ' A' ' 133' ' ' LEU . 5.4 mm -37.97 -64.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -52.04 -50.61 61.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -52.55 -44.38 59.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.75 -31.53 70.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -84.17 -22.87 30.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -90.63 -10.77 42.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.15 -25.21 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.7 mt -119.35 -52.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.26 28.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.499 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.26 -62.73 0.79 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.67 0.748 . . . . 0.0 110.905 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.76 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 107' ' ' ILE . 7.3 t80 -40.56 -44.22 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 175' ' ' TYR . 8.3 m120 -72.06 -43.38 64.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 181' ' ' PRO . 43.3 mt -56.78 -54.96 40.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.46 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.5 mt -50.11 -48.11 53.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.795 0.331 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.6 -40.08 94.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.95 -26.29 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 50.8 mtpt -80.05 -37.49 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.7 -44.85 69.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -39.32 -58.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 107' ' ' ILE . 79.2 t80 -55.85 -62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 37.4 mt -42.15 -37.75 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.49 -54.84 30.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -57.03 -54.55 45.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 103' ' ' PHE . 7.9 tt -60.91 -35.27 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -65.79 -41.81 91.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' O ' HD12 ' A' ' 113' ' ' LEU . 47.0 mttt -56.66 -29.09 61.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 181' ' ' PRO . 42.2 t80 -71.22 -32.83 69.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.668 ' HD1' HD12 ' A' ' 118' ' ' LEU . 56.7 m95 -85.26 -53.24 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -42.44 -39.42 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 109' ' ' LYS . 15.9 mt -62.09 -47.74 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -60.45 -39.74 88.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.36 35.49 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.438 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.5 m -141.26 119.29 11.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 110.885 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.6 m -62.78 128.7 37.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.0 tt -78.11 128.55 33.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.647 ' N ' HD23 ' A' ' 118' ' ' LEU . 10.8 ttmm -126.17 142.24 51.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -84.17 130.43 54.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.68 0.753 . . . . 0.0 111.109 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 159.21 54.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -119.1 118.08 30.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' LYS . 90.2 t -110.67 143.95 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' VAL . 77.0 mm-40 37.79 42.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? 59.06 42.81 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 123' ' ' VAL . 40.7 mttm -147.96 141.87 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.76 100.66 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 133' ' ' LEU . 53.5 tp -67.31 94.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.33 100.67 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.28 -52.32 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 4.2 t80 -41.92 -59.14 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.4 tp60 -67.51 -54.05 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.938 HD11 ' CG2' ' A' ' 171' ' ' ILE . 9.9 tp -37.93 -72.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 134' ' ' ASN . 3.3 t-20 -48.61 -47.08 40.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -47.73 -48.12 29.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 132' ' ' GLN . 11.2 mp -63.24 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.23 -48.85 54.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.05 85.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.81 -36.94 80.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.71 -18.89 50.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 158.34 -59.04 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 154.71 173.86 24.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.787 ' CZ ' ' CD1' ' A' ' 175' ' ' TYR . 48.0 t80 -64.63 -37.26 86.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.62 -66.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.7 p -45.99 -44.85 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' GLY . 50.3 t -65.54 -68.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 51.7 t -42.26 -45.72 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -57.67 -55.43 34.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 151' ' ' LYS . 17.3 m-20 -84.46 24.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 149' ' ' ASP . 29.2 mmt180 34.38 37.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 25.2 mtpp -79.74 44.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.766 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -90.04 -49.76 6.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.9 m -37.0 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -57.61 -69.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.2 mt -45.43 -58.75 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.82 -56.23 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.3 m -51.31 -50.07 60.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.462 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -55.83 -27.86 53.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.0 mmm -79.69 12.23 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.75 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CB ' HG21 ' A' ' 167' ' ' VAL . 24.2 m-85 -65.07 171.61 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.94 144.09 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 86.7 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.82 -158.78 7.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -103.71 -39.46 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -48.26 -59.15 3.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.124 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 161' ' ' PHE . 13.0 p -63.89 -37.43 79.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.25 -58.38 13.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.1 m -65.19 -31.51 72.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 3.5 m-70 -52.73 -57.57 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 133' ' ' LEU . 26.0 mm -41.69 -46.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.461 ' HB2' ' NE1' ' A' ' 152' ' ' TRP . 1.3 tmt_? -59.64 -51.27 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.62 -44.2 97.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.9 -22.64 10.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.787 ' CD1' ' CZ ' ' A' ' 143' ' ' PHE . 0.5 OUTLIER -91.46 -21.35 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -90.98 -11.41 39.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -105.01 -25.44 12.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 mt -119.82 -52.52 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.0 mt -83.21 19.11 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.55 -60.12 2.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.897 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.558 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.2 Cg_endo -69.8 -46.48 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.345 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.9 t80 -38.55 -56.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -75.18 -34.57 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.99 -28.23 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -88.28 -54.99 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.9 mt -44.37 -44.64 8.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.801 0.334 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -61.95 -44.0 97.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.582 HG13 ' HD2' ' A' ' 100' ' ' LYS . 9.7 p -52.1 -37.96 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.099 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.582 ' HD2' HG13 ' A' ' 99' ' ' VAL . 1.4 mptt -71.72 -58.45 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.5 mt -50.67 -39.84 51.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.74 -63.69 0.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -51.33 -67.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 39.6 mt -38.21 -40.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.66 -53.06 61.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -56.68 -51.69 67.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.9 tt -59.63 -45.49 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -55.76 -48.2 75.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -40.6 -57.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -43.56 -48.94 7.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.516 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 35.8 m95 -66.6 -53.46 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -40.93 -51.23 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.02 -48.27 67.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -64.54 -37.66 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.65 37.99 1.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.8 p -131.8 141.2 49.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 m -85.76 134.45 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.5 tt -94.38 111.18 22.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.419 ' N ' HD23 ' A' ' 118' ' ' LEU . 4.4 tppp? -118.79 115.3 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 mm -62.72 129.7 93.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.63 0.729 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 157.32 60.72 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.48 HG21 HD22 ' A' ' 128' ' ' LEU . 45.0 t -98.85 120.85 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 55.3 46.47 23.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 56.52 32.54 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -141.91 134.26 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.68 99.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 123' ' ' VAL . 14.7 tp -66.36 104.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.35 116.74 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.7 mt -66.94 -57.0 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 135' ' ' LYS . 2.7 t80 -50.88 -54.57 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.69 -44.48 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -47.91 -72.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.561 HD21 HD13 ' A' ' 179' ' ' LEU . 93.8 m-20 -50.21 -39.15 43.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -54.04 -55.04 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.48 ' CG2' HG21 ' A' ' 155' ' ' ILE . 69.6 t -53.52 -50.04 51.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.36 92.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.56 -42.09 98.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -67.57 -17.89 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.537 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 156.58 -56.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.48 166.59 12.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.45 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 143' ' ' PHE . 2.7 t80 -59.63 -42.48 92.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.11 -64.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.3 p -48.64 -44.9 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 151' ' ' LYS . 28.9 t -63.8 -64.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 20.3 m -49.11 -36.64 19.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -66.35 -51.09 60.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -95.37 18.32 12.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 146' ' ' VAL . 13.5 mmt85 45.38 51.86 9.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.621 ' HB2' HG22 ' A' ' 146' ' ' VAL . 4.2 mmmm -86.55 24.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.671 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -68.46 -40.04 81.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.5 m -54.73 -39.44 68.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.468 ' N ' ' HE3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -63.8 -33.6 76.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.526 ' N ' HD13 ' A' ' 155' ' ' ILE . 1.9 mm -73.37 -61.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -44.87 -51.95 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 m -59.98 -51.15 70.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -52.97 -45.08 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.424 ' SD ' HD13 ' A' ' 133' ' ' LEU . 32.4 mtp -58.41 -15.92 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.09 -7.62 27.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 171.24 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.1 31.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.593 0.711 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 109.65 2.38 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.4 -147.48 4.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -115.7 -37.0 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -59.48 -58.22 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.2 p -57.96 -41.34 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -48.69 -52.65 19.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -77.85 -27.02 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 2.8 m-70 -53.47 -46.93 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 133' ' ' LEU . 46.7 mm -46.3 -43.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.407 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 23.1 mmm-85 -71.35 -63.25 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.51 -51.62 7.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -46.68 -40.44 13.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.542 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -67.33 -45.33 76.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -76.41 -9.34 58.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -97.25 -35.55 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.6 mt -119.87 -48.32 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.561 HD13 HD21 ' A' ' 134' ' ' ASN . 10.8 mt -83.5 21.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.513 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -71.73 -60.24 2.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.516 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 53.7 Cg_endo -69.75 -50.68 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.709 2.273 . . . . 0.0 112.353 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 4.1 t80 -44.63 -52.71 7.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.19 -51.24 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -49.32 -44.18 44.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.61 -57.42 5.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.6 mt -38.28 -50.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.807 0.337 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -69.56 -34.51 74.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 131' ' ' PHE . 7.1 p -73.84 -33.78 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 40.5 mtmt -68.54 -52.42 32.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.47 -40.69 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -48.36 -52.35 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 104' ' ' LEU . 3.9 t80 -58.95 -61.3 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 16.5 mt -49.37 -20.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.69 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 107' ' ' ILE . 7.1 pt20 -53.13 -31.91 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.48 HD12 ' CD2' ' A' ' 182' ' ' TYR . 5.5 tt -81.59 -39.23 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.56 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -42.55 -58.01 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -38.89 -42.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.472 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 43.0 m95 -73.97 -49.1 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -42.75 -43.44 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -61.48 -47.54 85.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -64.9 -28.2 69.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.92 40.68 3.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -136.66 127.24 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 110.853 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.6 m -77.81 128.37 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.2 tt -89.92 108.0 19.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -106.09 128.23 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.6 mm -63.58 127.29 91.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 174' ' ' HIS . 53.1 Cg_endo -69.82 161.97 43.91 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.313 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -118.1 115.44 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.816 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 77.1 t -102.4 124.29 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 51.52 51.16 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 55.62 35.27 24.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -144.83 142.89 30.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.53 107.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 1.044 HD11 HD22 ' A' ' 133' ' ' LEU . 19.4 tp -71.55 114.77 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.74 89.06 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' PHE . 23.1 mt -44.28 -63.47 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 99' ' ' VAL . 17.0 t80 -34.91 -67.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.456 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 17.1 tt0 -53.97 -56.8 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 128' ' ' LEU . 22.6 tp -43.93 -71.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -45.6 -57.46 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -41.56 -47.55 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.928 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -46.65 87.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -50.71 -46.79 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.16 95.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.6 -45.04 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -67.56 -18.16 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.458 ' CA ' HG11 ' A' ' 145' ' ' VAL . . . 155.28 -60.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 149.36 165.36 12.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.492 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -55.85 -35.12 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.884 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -66.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' CA ' ' A' ' 141' ' ' GLY . 2.6 p -51.88 -37.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 151' ' ' LYS . 51.0 t -72.06 -64.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 9.8 t -52.24 -32.22 35.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -73.55 -49.42 26.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -91.54 15.22 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 45.81 55.03 7.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -96.16 36.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.509 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 42.4 m95 -84.69 -46.89 11.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.8 m -43.96 -54.57 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -48.58 -63.05 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ALA . 20.4 mt -54.27 -63.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.22 -47.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.6 m -62.75 -45.43 92.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -51.28 -51.12 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.2 mmm -50.08 -25.08 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.87 -8.14 10.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 26.0 m-85 -72.27 146.55 47.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.45 142.99 98.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 122.8 9.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.716 2.277 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.67 -134.89 1.78 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -127.81 -34.8 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.68 -58.65 7.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.17 -30.93 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -58.91 12.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -67.16 -25.97 66.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.2 m-70 -58.32 -59.54 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 133' ' ' LEU . 24.8 mm -37.83 -63.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -52.21 -56.86 11.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.14 -52.99 9.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 70.9 m-70 -49.27 -35.65 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -82.27 -22.72 35.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.67 -13.06 40.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -105.25 -22.79 12.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.7 mt -119.98 -52.61 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 175' ' ' TYR . 5.4 mp -87.01 25.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -76.5 -63.64 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -48.28 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.694 2.262 . . . . 0.0 112.356 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 107' ' ' ILE . 6.1 t80 -40.12 -48.21 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.34 -34.2 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 184' ' ' LEU . 4.0 tt -56.57 -40.66 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -84.8 -56.65 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.9 mt -40.61 -36.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.733 0.301 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -55.21 -46.31 75.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.47 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 6.0 p -58.54 -31.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 45.1 mtmt -73.41 -47.15 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -66.6 -44.08 83.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -42.7 -44.52 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.8 t80 -68.18 -44.74 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.476 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.9 mt -63.27 -26.94 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -76.91 -51.04 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -62.02 -32.82 73.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 103' ' ' PHE . 5.8 tt -79.68 -42.43 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -66.83 -47.51 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -28.15 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -70.21 -30.39 67.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.781 ' HD1' HD12 ' A' ' 118' ' ' LEU . 79.0 m95 -87.07 -49.4 7.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -47.6 -21.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.57 -45.22 46.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -70.07 -37.98 75.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.97 36.49 1.23 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.455 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.4 t -137.9 111.26 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.789 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 p -58.05 147.12 30.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.781 HD12 ' HD1' ' A' ' 111' ' ' TRP . 5.6 tt -98.07 108.03 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -96.34 132.82 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -87.06 121.02 71.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.62 0.724 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 149.73 67.43 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.94 111.59 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 167' ' ' VAL . 96.8 t -97.42 124.95 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 51.43 44.79 28.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.3 30.37 19.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -139.33 150.23 45.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.1 mm -75.01 129.95 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.454 HD22 ' CD2' ' A' ' 174' ' ' HIS . 32.6 tp -91.59 107.97 19.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.79 82.44 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 131' ' ' PHE . 60.1 mt -40.05 -59.9 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 31.1 t80 -34.91 -67.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.78 ' NE2' HD12 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -58.81 -54.83 42.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.927 HD11 ' CG2' ' A' ' 171' ' ' ILE . 4.3 tp -35.47 -71.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -49.37 -53.81 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -40.06 -56.9 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.78 HD12 ' NE2' ' A' ' 132' ' ' GLN . 12.4 mt -54.6 -48.11 72.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 HD13 ' A' ' 155' ' ' ILE . 93.3 t -46.54 -49.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.07 86.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.48 -37.26 86.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -79.89 -14.35 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.48 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.18 -62.73 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 154.54 165.28 13.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 3.1 t80 -55.47 -38.83 69.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.6 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.48 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.1 p -48.37 -46.0 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 151' ' ' LYS . 54.3 t -67.05 -69.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 47.1 t -40.32 -42.45 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.32 -51.34 63.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' ARG . 12.3 m-20 -84.81 25.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 34.49 41.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 146' ' ' VAL . 29.6 mtpt -86.07 40.59 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.584 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 23.3 m95 -86.11 -46.91 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -38.88 -44.72 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -63.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 137' ' ' VAL . 20.0 mt -52.31 -57.87 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -45.45 -50.04 12.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 m -64.25 -37.9 89.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -65.35 -27.5 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 mtp -75.36 -3.24 32.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.81 54.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.73 166.85 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.93 144.62 79.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.558 0.694 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 85.73 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.729 2.286 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.38 169.76 26.3 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.03 -34.55 64.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.78 0.324 . . . . 0.0 110.882 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.66 -58.83 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 168' ' ' GLY . 12.7 p -67.06 -44.12 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -45.5 -48.89 11.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 m -75.49 -36.08 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.834 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.4 m-70 -49.18 -39.0 27.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.927 ' CG2' HD11 ' A' ' 133' ' ' LEU . 37.0 mm -57.33 -59.42 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -50.83 -61.19 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -44.91 -48.67 9.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 32.1 m-70 -50.55 -44.83 56.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -43.54 90.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -80.01 -9.03 59.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 173' ' ' GLY . 23.1 mmt180 -99.1 -30.37 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.36 -51.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.16 26.58 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.54 -60.05 2.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.892 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.724 ' HA ' HD12 ' A' ' 184' ' ' LEU . 53.6 Cg_endo -69.74 -48.18 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 186' ' ' LEU . 6.2 t80 -44.25 -41.41 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -71.28 -38.52 71.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 181' ' ' PRO . 69.4 mt -57.57 -36.31 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.86 -41.72 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.465 HD11 ' CE2' ' A' ' 182' ' ' TYR . 79.2 mt -61.87 -32.62 73.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -66.04 -57.55 7.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.76 -39.78 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -53.38 -54.78 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.66 -39.27 84.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -50.64 -50.71 53.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 107' ' ' ILE . 52.3 t80 -60.01 -64.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 58.6 mt -41.17 -35.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -70.13 -57.99 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -55.13 -50.65 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.3 tt -63.73 -37.03 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -59.64 -49.72 76.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' HD13 ' A' ' 113' ' ' LEU . 37.6 mttp -45.76 -56.07 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -39.58 -40.67 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -76.4 -50.66 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -41.87 -38.12 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 109' ' ' LYS . 10.4 mp -57.24 -44.45 83.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -73.72 -36.68 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 111.55 30.1 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -116.97 139.57 50.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 m -84.9 129.4 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 119' ' ' LYS . 2.3 tt -93.62 119.5 32.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.699 ' N ' HD23 ' A' ' 118' ' ' LEU . 25.7 tptt -133.19 142.99 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.55 122.45 82.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -177.21 1.78 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.679 2.252 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CE1' HD13 ' A' ' 127' ' ' ILE . 25.1 m80 -126.21 126.04 43.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 128' ' ' LEU . 93.1 t -112.67 128.53 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.8 42.39 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 61.06 27.88 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -145.03 128.49 16.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 122' ' ' HIS . 4.8 mm -40.92 146.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 133' ' ' LEU . 16.3 tp -120.27 89.71 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -56.22 103.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 178' ' ' ILE . 81.3 mt -58.13 -63.09 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' LEU . 5.7 t80 -37.79 -62.21 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -54.82 -59.15 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.964 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -38.15 -72.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -47.28 -46.36 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -58.48 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.62 -42.42 62.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.493 HG22 HD13 ' A' ' 155' ' ' ILE . 60.9 t -52.49 -50.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.49 75.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.41 -41.76 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -72.69 -12.03 60.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 150.97 -59.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.88 176.11 20.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.21 -36.7 84.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.7 -66.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.068 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.3 p -50.75 -47.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.9 t -60.14 -43.72 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.4 m -67.7 -33.46 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -70.97 -49.85 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.03 10.84 39.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmt85 46.41 52.25 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -81.92 40.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -87.04 -45.22 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.1 m -41.43 -49.21 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -56.81 -59.28 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 137' ' ' VAL . 14.2 mt -51.8 -72.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.621 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.15 -51.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.0 m -60.35 -41.98 94.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 155' ' ' ILE . 37.7 mttp -62.56 -22.65 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.4 mmm -81.67 7.31 12.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.19 -15.45 62.37 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -69.62 162.29 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -80.13 143.95 57.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.726 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 84.42 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.12 -138.63 4.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -124.21 -48.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.85 -57.56 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.127 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.621 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 5.4 p -58.39 -39.17 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.0 -48.21 52.54 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.1 m -72.86 -32.04 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.443 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 6.4 m-70 -54.66 -53.9 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.964 HG23 HD11 ' A' ' 133' ' ' LEU . 45.0 mm -43.25 -51.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 28.3 mtm180 -56.91 -62.32 1.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -43.8 -51.87 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.467 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 96.6 m-70 -50.58 -41.38 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.3 OUTLIER -71.22 -45.74 62.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.61 -9.15 58.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 173' ' ' GLY . 38.1 mtm180 -105.12 -28.94 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.619 HG22 HD13 ' A' ' 179' ' ' LEU . 39.9 mt -116.43 -52.63 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.619 HD13 HG22 ' A' ' 178' ' ' ILE . 1.5 mm? -92.84 35.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.546 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -75.39 -62.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.859 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.82 -49.23 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.322 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.4 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 5.0 t80 -42.11 -55.83 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.46 -46.68 75.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt -51.67 -37.08 49.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.1 -54.09 12.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 42.3 mt -49.83 -36.47 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -57.78 -51.62 68.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.6 p -53.45 -24.99 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 47.6 mttp -81.01 -53.02 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.91 -44.92 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -39.0 -64.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -51.73 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.874 HD22 HD11 ' A' ' 120' ' ' ILE . 38.5 mt -39.72 -39.52 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.5 -53.87 50.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -54.26 -59.97 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 104' ' ' LEU . 2.9 tt -48.8 -45.36 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.93 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' TRP . 4.5 mmmm -55.97 -60.26 3.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -38.54 -26.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.56 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 88.7 m95 -87.97 -45.72 9.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' A' ' 113' ' ' LEU . 5.6 pt-20 -49.61 -18.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.441 HD12 ' HG2' ' A' ' 112' ' ' GLU . 6.5 mp -78.9 -35.34 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -81.25 -28.74 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.32 34.55 3.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 m -135.17 112.25 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.849 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -58.39 143.38 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.96 HD13 ' N ' ' A' ' 119' ' ' LYS . 2.0 tm? -105.92 157.87 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 118' ' ' LEU . 14.7 ttmm -171.99 155.51 3.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.874 HD11 HD22 ' A' ' 104' ' ' LEU . 28.6 mm -89.26 129.69 46.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.694 0.759 . . . . 0.0 111.121 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -179.29 2.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 39.4 m80 -119.77 129.28 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 128' ' ' LEU . 93.0 t -115.09 109.08 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 61.65 51.25 4.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 56.71 31.64 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -148.77 126.1 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 32.4 mm -48.16 145.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 HD22 ' A' ' 133' ' ' LEU . 22.6 tp -110.31 91.85 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.7 83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 mt -40.12 -57.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 23.9 t80 -39.72 -52.28 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 133' ' ' LEU . 32.0 tp60 -70.35 -58.36 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.978 HD22 HD11 ' A' ' 128' ' ' LEU . 7.4 tp -35.68 -71.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -47.34 -57.44 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -42.09 -55.46 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.97 -45.09 60.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.782 HG22 HD13 ' A' ' 155' ' ' ILE . 64.8 t -52.82 -55.08 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.03 -41.04 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.94 -37.69 88.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.09 -27.5 63.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 169.1 -52.0 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 131.41 150.45 6.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -41.7 -36.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.15 -66.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.0 p -61.81 -54.99 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.199 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 142' ' ' GLY . 72.3 t -46.77 -57.93 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.1 t -57.62 -43.76 84.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -54.52 -53.73 50.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 150' ' ' ARG . 2.2 m-20 -90.02 18.39 5.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 149' ' ' ASP . 1.1 mpp_? 37.62 48.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -86.87 40.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 34.1 m95 -81.21 -50.54 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.8 m -39.03 -50.73 1.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -50.72 -61.03 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.782 HD13 HG22 ' A' ' 137' ' ' VAL . 19.0 mt -49.14 -67.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -40.14 -49.73 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.4 m -63.17 -36.91 85.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.63 -22.04 65.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 75.5 mmm -83.67 5.3 25.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.55 -1.36 66.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.26 156.93 26.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.57 143.72 85.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.2 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.92 -168.58 11.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -97.73 -32.11 11.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 110.955 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.65 -59.09 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.493 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 11.6 p -59.19 -32.1 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.54 95.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -82.22 -23.65 35.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.5 -47.27 84.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 133' ' ' LEU . 30.0 mm -43.62 -50.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -63.88 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.44 -45.3 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.49 ' CD2' HD22 ' A' ' 128' ' ' LEU . 4.9 m-70 -52.44 -46.44 66.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -69.18 -23.71 63.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -90.28 -9.33 48.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -104.96 -28.58 11.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.1 -51.4 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 175' ' ' TYR . 12.5 mt -83.32 15.57 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.514 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.56 -58.85 4.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.723 . . . . 0.0 110.874 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.56 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 54.0 Cg_endo -69.72 -50.87 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.379 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.461 ' CE2' HD11 ' A' ' 186' ' ' LEU . 8.0 t80 -48.34 -49.61 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 185' ' ' PHE . 7.9 t-20 -65.5 -68.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.2 mp -39.06 -27.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 183' ' ' ASN . 82.1 t80 -82.08 -63.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 182' ' ' TYR . 71.8 mt -43.81 -48.03 8.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.4 mtt-85 -64.69 -61.68 2.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.88 -35.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.573 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 46.3 mtpt -70.59 -53.73 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 mt -53.74 -39.16 65.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -46.36 -51.9 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' ILE . 38.0 t80 -58.67 -65.76 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.474 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.5 mt -45.24 -24.94 0.31 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -82.69 -48.11 11.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -67.22 -26.0 66.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.0 tt -85.08 -42.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -70.19 -41.57 73.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -55.67 -28.49 55.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 3.7 t80 -69.8 -29.41 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.809 ' CD1' HD12 ' A' ' 118' ' ' LEU . 77.0 m95 -81.56 -49.52 10.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -44.28 -40.94 5.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.67 -40.05 68.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -76.58 -39.62 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.29 32.69 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 m -134.82 103.89 5.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 p -53.64 141.3 26.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.1 tt -86.32 125.43 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -118.94 125.06 48.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.02 129.44 61.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.722 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.34 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.42 ' NE2' ' CD1' ' A' ' 127' ' ' ILE . 26.3 m80 -120.61 114.51 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.8 t -100.12 119.11 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 56.35 51.13 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 52.64 35.59 18.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -150.28 140.4 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' ' NE2' ' A' ' 122' ' ' HIS . 15.9 mm -60.81 144.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 133' ' ' LEU . 22.1 tp -106.91 104.21 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' HE1' ' A' ' 159' ' ' MET . 5.8 t70 -71.93 113.32 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.39 -61.06 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 100' ' ' LYS . 33.8 t80 -39.97 -55.32 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -66.87 -51.06 59.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 128' ' ' LEU . 34.9 tp -50.65 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -49.26 -46.35 46.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -49.52 -52.13 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.69 -49.05 74.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 146' ' ' VAL . 98.2 t -47.35 -54.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.66 70.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -54.92 -39.28 68.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.99 -14.77 61.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.407 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 152.85 -61.92 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 160.04 173.51 28.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.475 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.94 -46.19 90.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.38 -66.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 5.7 p -44.32 -37.04 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 142' ' ' GLY . 37.5 t -72.89 -49.34 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 148' ' ' LYS . 5.8 p -58.15 -45.87 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 147' ' ' CYS . 31.3 tttm -68.27 -33.4 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.54 4.45 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 146' ' ' VAL . 15.6 mmm180 47.12 37.88 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 19.3 mtpp -83.42 36.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 51.9 m95 -81.5 -44.21 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.1 m -43.39 -47.16 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -51.89 -61.63 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -55.73 -55.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.87 -53.61 2.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -47.4 86.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -45.19 -49.23 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.419 ' HE1' ' O ' ' A' ' 129' ' ' ASP . 92.0 mmm -60.78 -25.81 66.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.97 -2.93 14.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -74.54 138.61 43.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.27 144.14 16.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.545 0.688 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 85.03 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.353 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.22 169.13 24.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.489 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -74.6 -38.28 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.73 -59.11 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.32 -37.25 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.4 -49.33 57.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.4 t -73.67 -31.11 63.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.442 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.7 m-70 -54.7 -47.23 73.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 20.7 mm -46.2 -49.75 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.574 ' NH2' ' CD1' ' A' ' 152' ' ' TRP . 16.9 ttm105 -61.86 -61.66 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.31 -46.56 11.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 80.1 m-70 -49.34 -43.26 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.0 t80 -68.01 -41.45 82.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.65 -9.26 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -100.13 -32.12 11.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.0 mt -119.75 -49.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.169 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 11.8 mt -82.52 18.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.08 -60.24 2.93 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.739 . . . . 0.0 110.885 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.526 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.9 Cg_endo -69.75 -47.54 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -49.41 -49.41 45.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -80.69 -38.0 29.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 14.9 tp -55.62 -26.23 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.12 -51.89 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.3 mt -45.37 -53.72 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 102' ' ' ASN . 5.0 tpt85 -66.59 -57.68 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.29 -22.99 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -77.88 -60.66 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HA ' HD12 ' A' ' 104' ' ' LEU . 73.4 mt -63.75 -34.8 78.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 30.9 m-20 -44.22 -58.26 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -55.21 -59.97 4.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 101' ' ' LEU . 27.8 mt -42.5 -43.11 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.86 -40.54 95.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -64.9 -51.38 62.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.714 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.1 tp -61.46 -37.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.12 88.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -53.06 -36.63 60.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.13 -37.35 87.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.578 ' HD1' HD12 ' A' ' 118' ' ' LEU . 39.1 m95 -80.17 -59.87 2.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -38.99 -40.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -59.12 -53.03 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -61.36 -35.37 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.84 39.87 1.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -136.21 123.08 21.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.1 m -70.41 129.45 39.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.578 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.9 tt -84.39 125.22 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.46 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.1 ttmm -121.81 125.37 46.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.6 mm -70.9 131.65 87.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.162 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.6 Cg_endo -69.75 158.69 56.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -115.69 126.37 54.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.18 112.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 57.8 49.91 11.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 125' ' ' ARG . 26.2 mtm105 54.48 35.97 24.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.82 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -145.32 125.11 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.24 127.43 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.092 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.1 115.04 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.51 102.63 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.49 -51.94 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -43.53 -53.27 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 133' ' ' LEU . 43.3 tt0 -70.4 -60.51 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 171' ' ' ILE . 13.3 tp -35.19 -69.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -47.93 -47.61 32.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 139' ' ' GLU . 22.8 tptt -47.67 -54.21 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 132' ' ' GLN . 9.3 mp -56.28 -40.87 74.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 155' ' ' ILE . 63.9 t -53.27 -47.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.77 81.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 2.3 mp0 -66.59 -38.02 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -75.19 -21.41 58.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.34 -58.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 152.55 169.63 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.503 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -61.03 -39.09 88.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.69 -66.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.437 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.0 p -48.05 -42.99 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 142' ' ' GLY . 54.5 t -65.03 -70.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.3 t -44.61 -50.04 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -48.87 -55.41 11.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.81 14.78 5.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 42.85 54.34 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -98.25 41.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -79.75 -40.84 27.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -46.35 -56.51 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -45.07 -53.34 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 137' ' ' VAL . 19.9 mt -64.09 -62.8 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -38.09 -49.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 m -63.27 -47.75 81.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -48.35 -41.15 27.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.4 mtp -67.45 -28.52 67.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -2.06 10.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.576 ' CB ' HG21 ' A' ' 167' ' ' VAL . 21.2 m-85 -80.52 129.64 34.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -44.58 143.04 2.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.558 0.694 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -152.11 137.04 5.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -44.61 -26.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.23 -59.11 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 161' ' ' PHE . 10.8 p -67.82 -36.35 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.51 -44.95 85.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -78.64 -32.37 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -53.18 -50.57 64.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.641 HG23 HD21 ' A' ' 133' ' ' LEU . 21.8 mm -40.31 -61.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -54.39 -54.96 33.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -47.9 -47.0 25.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -51.21 -42.89 61.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.5 t80 -68.08 -40.75 82.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -78.04 -9.24 59.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -103.7 -28.18 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mt -120.11 -52.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 8.4 mt -88.58 28.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.58 -60.37 2.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.668 0.747 . . . . 0.0 110.864 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 184' ' ' LEU . 54.3 Cg_endo -69.66 -48.12 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.676 2.251 . . . . 0.0 112.383 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.714 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.3 t80 -39.25 -46.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.38 -51.78 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 181' ' ' PRO . 83.8 mt -45.35 -37.47 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.32 -55.31 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.2 mt -47.32 -46.51 25.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.487 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 42.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.781 0.324 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -67.47 -45.59 75.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.63 -24.98 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CE ' ' HA ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.46 -41.77 21.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.18 -44.52 88.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -43.83 -60.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 106' ' ' GLN . 45.9 t80 -61.17 -63.64 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 98.7 mt -38.4 -32.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 103' ' ' PHE . 7.5 t70 -77.63 -46.35 22.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 103' ' ' PHE . 91.9 mt-30 -64.17 -23.52 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.2 tp -92.02 -36.6 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.07 62.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 13.6 ptmt -57.76 -43.67 85.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.438 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 33.1 t80 -55.41 -28.19 52.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 68.5 m95 -81.08 -48.81 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.97 -57.09 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -47.36 -36.37 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -73.62 -32.92 64.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.63 34.46 3.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.3 t -139.02 123.24 18.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 110.865 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -68.85 148.95 49.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.8 tt -105.79 143.75 33.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.79 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.3 ttmt -156.42 120.46 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 178' ' ' ILE . 34.6 mm -84.18 131.94 49.34 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.449 ' HG2' ' CE1' ' A' ' 174' ' ' HIS . 53.3 Cg_endo -69.84 153.77 68.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 0.0 112.294 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -86.36 109.68 19.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.9 t -96.69 123.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 49.6 53.75 12.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 54.8 27.85 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -154.38 123.85 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.15 127.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.743 HD21 HD22 ' A' ' 133' ' ' LEU . 10.7 tp -82.35 107.76 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.72 117.2 17.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 120' ' ' ILE . 17.5 mt -65.16 -49.59 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CD2' ' HG3' ' A' ' 100' ' ' LYS . 35.7 t80 -42.62 -57.34 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -72.99 -48.14 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.991 HD11 HG23 ' A' ' 171' ' ' ILE . 32.0 tp -44.43 -71.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' VAL . 57.5 t-20 -47.99 -66.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 134' ' ' ASN . 35.9 tttp -35.65 -54.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.51 -41.67 63.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 155' ' ' ILE . 94.6 t -58.07 -48.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.3 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -73.69 -35.11 65.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -77.92 -16.64 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.413 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.75 -57.53 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 150.31 175.81 22.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.443 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.79 -33.17 73.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.78 -65.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.413 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.1 p -48.05 -42.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 151' ' ' LYS . 67.5 t -70.51 -67.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 48.6 t -45.51 -34.2 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -77.02 -49.23 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 150' ' ' ARG . 37.6 m-20 -89.22 21.18 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 149' ' ' ASP . 2.5 mmp_? 35.72 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 146' ' ' VAL . 15.6 mmmt -89.37 17.4 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 62.6 m95 -63.69 -45.99 87.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.2 m -41.69 -58.49 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -47.54 -58.43 4.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.699 HD13 HG22 ' A' ' 137' ' ' VAL . 17.8 mt -51.2 -66.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.1 m -54.9 -46.37 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -60.57 -26.8 67.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 82.1 mmm -78.56 2.19 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.99 63.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.15 166.71 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.12 145.16 52.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.602 0.715 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 85.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.98 -176.54 14.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.37 -25.26 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.778 0.323 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.17 -58.39 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.1 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.5 -38.65 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.82 -41.61 76.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.4 t -79.22 -29.57 42.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -57.99 -47.68 82.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.991 HG23 HD11 ' A' ' 133' ' ' LEU . 6.3 mm -45.05 -55.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -59.29 -63.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.92 -47.69 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.449 ' CE1' ' HG2' ' A' ' 121' ' ' PRO . 57.7 m-70 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -66.76 -30.85 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -85.04 -9.23 58.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -101.7 -31.31 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.463 HD13 ' CD1' ' A' ' 120' ' ' ILE . 23.9 mt -120.09 -51.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 175' ' ' TYR . 16.4 mt -83.12 20.03 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.83 -60.26 2.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.82 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 107' ' ' ILE . 10.0 t80 -40.05 -51.1 2.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.02 -41.29 95.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 184' ' ' LEU . 6.7 tt -56.4 -43.95 79.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -71.31 -59.19 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 182' ' ' TYR . 67.7 mt -38.4 -49.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.743 0.306 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -67.05 -62.41 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.38 -35.38 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 62.6 mttm -71.26 -61.28 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.08 -40.46 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -51.76 -53.52 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -57.98 -65.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 44.2 mt -44.47 -35.38 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.67 -52.82 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -56.73 -52.59 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.571 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 3.8 tt -63.23 -32.14 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.43 93.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 111' ' ' TRP . 3.0 mmmm -54.46 -58.62 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -38.79 -25.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 109' ' ' LYS . 63.5 m95 -90.86 -51.11 5.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.556 ' HG3' HD22 ' A' ' 113' ' ' LEU . 5.4 pt-20 -46.63 -20.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.556 HD22 ' HG3' ' A' ' 112' ' ' GLU . 1.5 mm? -79.17 -46.62 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -69.21 -1.66 8.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.12 43.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.7 p -128.98 129.04 44.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 110.802 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.4 114.74 25.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.13 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.767 HD23 ' N ' ' A' ' 119' ' ' LYS . 5.2 tt -50.31 137.12 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.767 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.65 115.14 61.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 165.66 30.19 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 12.0 m170 -117.66 132.5 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 128' ' ' LEU . 55.0 t -123.09 124.99 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 59.72 39.25 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 6.7 mmp_? 63.38 35.17 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -145.32 162.93 36.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.54 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 44.7 mm -82.69 102.99 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.615 HD11 HD22 ' A' ' 133' ' ' LEU . 47.2 tp -66.8 93.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.47 106.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.9 -46.43 90.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 131' ' ' PHE . 4.3 t80 -53.5 -56.12 19.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.462 ' O ' HD23 ' A' ' 136' ' ' LEU . 10.1 tt0 -65.19 -41.27 94.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 171' ' ' ILE . 4.1 tp -49.63 -72.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -51.63 -32.23 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -62.07 -50.79 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 155' ' ' ILE . 3.6 mm? -59.2 -41.6 88.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 146' ' ' VAL . 63.2 t -56.18 -55.51 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -54.04 -41.59 68.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.55 -40.99 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.45 -17.06 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.639 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 157.1 -59.09 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.632 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 144.18 170.33 13.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.472 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.58 -36.68 72.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -65.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.639 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.0 p -56.62 -54.92 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 142' ' ' GLY . 85.2 t -51.4 -62.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.3 t -53.92 -40.86 67.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.2 tptp -53.88 -48.92 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.32 11.87 37.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 49.4 44.9 23.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' ILE . 55.9 mttm -84.98 50.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.459 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 81.4 m95 -86.85 -51.23 6.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.0 m -39.4 -67.36 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -37.74 -53.94 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 151' ' ' LYS . 23.3 mt -58.78 -65.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.62 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.72 -46.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 m -68.08 -45.35 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -57.14 -29.44 63.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mmm -70.3 -17.22 63.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.65 1.71 11.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -90.02 172.38 8.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.21 145.92 43.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 88.46 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.266 . . . . 0.0 112.366 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -144.98 131.08 4.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.485 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -42.74 -25.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.26 -59.18 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.62 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.5 p -64.85 -32.99 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.68 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -77.05 -32.4 56.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 6.1 m-70 -51.71 -51.07 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mm -42.16 -62.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -51.88 -53.43 40.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.41 -42.69 34.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.54 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 93.1 m-70 -60.52 -36.9 79.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 110.84 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.2 t80 -78.82 -30.2 45.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.56 -9.25 56.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 177' ' ' ARG . 13.3 mtp-105 -104.82 -28.43 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.98 -52.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 28.8 mt -85.2 21.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -71.65 -60.08 2.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 0.0 110.881 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.73 -49.65 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.383 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.5 t80 -45.07 -54.12 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -77.21 -37.93 52.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 40.9 tp -62.14 -19.59 63.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -98.0 -50.59 4.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -48.34 -45.12 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.545 HG22 HD11 ' A' ' 101' ' ' LEU . 19.6 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.81 0.338 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 12.9 ttp-105 -45.74 -59.09 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.41 -34.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HA ' ' CE2' ' A' ' 131' ' ' PHE . 53.1 mtpt -82.86 -58.82 2.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 97' ' ' THR . 34.0 mt -45.56 -36.98 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -50.5 -57.44 8.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 6.2 t80 -58.27 -58.91 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.9 mt -46.71 -37.95 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.32 -57.5 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -48.32 -56.0 9.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.598 HD12 ' CD1' ' A' ' 182' ' ' TYR . 1.7 tp -55.59 -40.1 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.18 91.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.01 -36.81 30.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -63.4 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.729 ' HD1' HD12 ' A' ' 118' ' ' LEU . 27.0 m95 -83.34 -59.24 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -38.31 -36.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.447 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 33.4 mt -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.47 -36.36 82.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.86 39.94 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -132.7 118.08 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.8 m -64.88 129.62 40.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.8 tt -79.97 122.15 26.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -116.15 141.66 47.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 mm -85.52 127.38 63.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.621 0.724 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HG2' HD23 ' A' ' 128' ' ' LEU . 54.1 Cg_endo -69.71 168.01 22.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.362 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -127.61 125.49 40.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 56.0 t -113.41 131.78 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 51.06 37.61 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? 64.16 54.5 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -164.37 164.02 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -73.45 127.56 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.598 HD23 ' HG2' ' A' ' 121' ' ' PRO . 15.3 tp -102.02 98.69 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 129' ' ' ASP . 43.0 t0 -70.8 117.12 11.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.4 mt -72.36 -63.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 100' ' ' LYS . 16.2 t80 -38.68 -61.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -57.46 -58.42 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 171' ' ' ILE . 6.7 tp -41.23 -67.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -50.59 -49.28 56.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -46.17 -54.35 8.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.64 -43.3 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.798 HG22 HD13 ' A' ' 155' ' ' ILE . 64.6 t -51.17 -48.81 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.48 91.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.26 -41.14 88.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.01 -22.35 58.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.561 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 161.63 -57.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.15 177.47 20.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.45 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 11.1 t80 -66.61 -36.63 83.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.61 -66.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.561 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -50.6 -51.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 142' ' ' GLY . 98.4 t -59.04 -68.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 35.5 t -44.73 -38.09 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -66.59 -45.42 79.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.2 m-20 -93.34 24.07 4.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 149' ' ' ASP . 3.0 mpt_? 35.02 45.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 146' ' ' VAL . 59.4 mttt -93.36 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.694 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 30.6 m95 -84.8 -48.67 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 152' ' ' TRP . 38.7 m -37.04 -53.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -46.43 -68.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.798 HD13 HG22 ' A' ' 137' ' ' VAL . 24.0 mt -45.31 -65.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.91 -50.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.8 m -54.3 -53.31 55.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.47 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -47.47 -49.57 25.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.4 mmm -50.12 -28.15 6.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.24 -4.04 10.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 36.7 m-85 -81.07 167.69 19.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 143.29 60.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 104.49 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.62 -159.48 9.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -101.0 -36.85 8.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.321 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -52.82 -58.48 6.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.52 -36.97 78.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.6 90.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 t -77.22 -28.76 53.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -58.34 -50.77 72.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.694 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 50.6 mm -40.4 -60.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -56.51 -53.58 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.38 -43.27 34.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -55.85 -39.86 72.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 2.6 t80 -67.77 -39.17 84.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -80.96 -9.21 59.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -97.2 -33.35 11.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.01 -51.39 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.47 ' HB2' ' CD1' ' A' ' 175' ' ' TYR . 12.6 mt -84.53 28.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.53 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -72.28 -60.4 2.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.875 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.75 -33.7 16.1 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.369 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.598 ' CD1' HD12 ' A' ' 107' ' ' ILE . 4.4 t80 -47.89 -60.91 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -72.4 -34.85 68.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.5 tm? -54.08 -48.8 70.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -73.67 -58.55 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.7 mt -41.83 -43.56 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.959 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -69.6 -42.28 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.2 p -62.2 -34.41 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.88 -53.55 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.1 mt -60.36 -46.01 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -46.64 -59.47 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 104' ' ' LEU . 71.7 t80 -49.25 -68.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 70.7 mt -37.03 -37.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.37 -57.92 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -52.29 -51.46 58.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.452 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.7 tt -58.05 -36.78 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -60.85 -50.99 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -47.71 -38.77 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -58.57 -38.58 78.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.417 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 13.8 m95 -82.06 -53.49 6.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -41.58 -50.13 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.33 -44.31 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -73.31 -36.81 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.18 40.71 0.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.9 m -131.88 126.68 34.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -74.51 128.28 35.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 119' ' ' LYS . 4.1 tt -91.22 118.32 30.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 118' ' ' LEU . 46.5 tttm -128.59 136.84 51.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.944 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.422 HD11 HD22 ' A' ' 104' ' ' LEU . 25.7 mm -67.47 124.5 89.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 111.108 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.725 ' HG2' HD23 ' A' ' 128' ' ' LEU . 53.9 Cg_endo -69.76 167.17 25.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.696 2.264 . . . . 0.0 112.311 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -123.89 119.92 31.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.583 ' CG2' HD22 ' A' ' 128' ' ' LEU . 43.1 t -108.67 136.51 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 45.17 39.84 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 61.48 44.82 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -155.04 142.33 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.06 118.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 121' ' ' PRO . 22.1 tp -94.8 103.9 15.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.938 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.1 104.03 5.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.9 mt -64.67 -46.64 81.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 58.6 t80 -48.12 -61.06 2.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 136' ' ' LEU . 7.1 mm100 -65.7 -39.5 91.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.935 HD11 HG23 ' A' ' 171' ' ' ILE . 11.6 tp -52.66 -71.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -53.57 -62.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -42.31 -50.81 4.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 132' ' ' GLN . 24.8 mt -56.1 -42.87 77.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 155' ' ' ILE . 72.8 t -57.8 -48.04 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.73 75.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.9 -44.9 94.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.35 -27.57 67.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 165.65 -54.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 142.49 163.48 9.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -57.17 -29.29 63.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.34 -66.3 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.069 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 141' ' ' GLY . 3.6 p -55.01 -39.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.4 t -68.04 -56.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.0 t -56.29 -41.95 76.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -55.61 -49.77 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.34 4.12 53.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.73 40.43 31.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -89.38 46.79 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -89.08 -41.65 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.4 m -42.9 -52.72 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -54.01 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 137' ' ' VAL . 15.4 mt -60.35 -60.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -43.72 -47.6 7.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.6 m -62.51 -46.21 89.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -51.78 -52.77 46.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 30.5 mtp -46.6 -28.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.33 -3.99 10.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.481 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.36 172.03 13.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.08 142.09 51.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 90.02 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.324 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.01 178.97 21.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -83.0 -32.38 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.58 55.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.9 p -63.59 -38.57 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -53.33 -45.96 64.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.1 m -75.43 -32.87 60.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -56.25 -49.71 73.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 133' ' ' LEU . 9.7 mm -44.23 -55.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.8 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.53 -56.69 9.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 25.3 m-70 -49.32 -35.6 18.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.6 OUTLIER -75.99 -44.54 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.0 -9.9 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -105.27 -28.62 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.488 HG22 HD13 ' A' ' 179' ' ' LEU . 34.4 mt -116.72 -52.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.488 HD13 HG22 ' A' ' 178' ' ' ILE . 1.9 mm? -91.45 33.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.507 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.63 -63.88 0.52 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.39 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.7 t80 -37.74 -36.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -82.55 -53.8 5.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -55.7 -20.36 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -90.6 -52.08 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -47.98 -46.03 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.745 0.307 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -71.26 -59.01 3.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' A' ' 131' ' ' PHE . 7.6 p -56.87 -39.07 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.551 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 31.0 mttm -65.56 -54.37 28.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.47 -56.75 18.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.963 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -38.42 -58.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 12.1 t80 -50.17 -57.36 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 41.0 mt -52.18 -27.98 16.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.2 -53.71 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -56.32 -49.87 73.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 4.8 tt -57.49 -42.07 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.72 82.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -48.87 -37.36 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.502 ' OH ' ' CE1' ' A' ' 185' ' ' PHE . 5.6 m-85 -59.18 -43.98 92.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.751 ' HD1' HD12 ' A' ' 118' ' ' LEU . 73.2 m95 -68.97 -51.7 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -42.09 -50.3 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.3 mt -47.96 -42.0 26.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.92 -36.21 64.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.3 30.05 2.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.44 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.3 m -128.83 138.07 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.811 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -86.96 132.85 33.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.751 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.3 tt -85.31 118.75 25.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -112.54 125.0 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.79 119.61 75.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 154.47 67.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 122' ' ' HIS . 5.5 m170 -111.2 123.36 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.59 121.47 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.07 48.57 6.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 126' ' ' LYS . 12.1 mpt_? 54.14 46.8 24.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 125' ' ' ARG . 34.8 mtmm -164.52 142.18 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -56.88 144.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -109.07 120.09 41.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.43 95.37 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 131' ' ' PHE . 55.9 mt -57.3 -63.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE2' HG22 ' A' ' 99' ' ' VAL . 10.5 t80 -34.76 -58.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 133' ' ' LEU . 10.8 tp60 -62.41 -62.61 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -35.08 -66.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -45.86 -56.22 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.45 -52.51 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.28 -41.97 66.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 155' ' ' ILE . 77.5 t -57.14 -45.89 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.73 -34.99 79.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -68.01 -31.59 71.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -82.93 -16.1 48.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.434 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 155.15 -60.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 153.43 172.76 21.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.72 -40.42 95.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.16 -66.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.434 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.2 p -48.61 -43.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 137' ' ' VAL . 44.8 t -62.83 -62.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 8.7 m -49.89 -46.02 51.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 148' ' ' LYS . 4.7 tmtt? -53.5 -60.15 3.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 150' ' ' ARG . 18.1 m-20 -84.47 25.87 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 149' ' ' ASP . 21.2 mmt180 34.49 38.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 41.1 mtpt -76.9 47.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.607 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 13.6 m95 -91.03 -48.73 6.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.5 m -39.07 -51.25 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -48.55 -64.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 137' ' ' VAL . 18.8 mt -52.92 -62.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.43 -49.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.6 m -65.23 -38.67 91.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 155' ' ' ILE . 24.3 mmtt -53.64 -47.14 70.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.0 mtp -65.13 -19.97 66.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.44 3.56 25.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.455 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.414 ' CB ' HG21 ' A' ' 167' ' ' VAL . 27.8 m-85 -83.56 128.17 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -47.4 143.87 5.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.545 0.688 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.08 4.86 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 171.35 41.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -79.17 -14.66 58.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.21 -56.84 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 161' ' ' PHE . 7.5 p -64.69 -37.34 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.98 -46.73 83.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.9 t -76.0 -28.31 57.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -58.33 -49.21 77.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 133' ' ' LEU . 5.7 mm -44.5 -60.09 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -57.05 -55.9 28.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.41 -44.87 16.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -49.14 -46.73 45.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -62.78 -38.54 91.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -80.56 -9.18 59.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -99.91 -31.73 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.0 mt -119.74 -50.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 18.9 mt -83.66 22.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -72.48 -60.62 2.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -48.03 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.99 -44.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.01 -58.07 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -42.09 -35.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CE1' ' OH ' ' A' ' 110' ' ' TYR . 12.1 t80 -73.2 -49.5 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.1 mt -56.65 -35.68 68.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.832 0.349 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -41.35 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.4 p -64.54 -30.56 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -79.0 -51.51 9.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.89 -47.75 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -42.78 -53.2 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.731 ' O ' HG22 ' A' ' 107' ' ' ILE . 35.1 t80 -51.84 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 23.0 mt -42.75 -36.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 29.7 t70 -67.59 -59.19 3.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -52.87 -54.14 38.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.9 tt -59.1 -33.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -58.55 -54.37 47.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HE2' ' N ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -42.84 -54.85 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -42.76 -38.12 2.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.655 ' HD1' HD12 ' A' ' 118' ' ' LEU . 66.7 m95 -83.56 -47.82 10.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -46.52 -44.38 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 109' ' ' LYS . 8.1 mp -58.82 -42.59 89.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -68.43 -37.67 80.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.8 40.46 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.9 p -142.8 106.15 4.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.912 0.387 . . . . 0.0 110.818 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.7 p -50.58 147.11 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.655 HD12 ' HD1' ' A' ' 111' ' ' TRP . 7.0 tt -101.51 111.95 24.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -110.03 140.6 43.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 121' ' ' PRO . 47.2 mm -85.91 131.89 45.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 120' ' ' ILE . 54.1 Cg_endo -69.75 170.97 15.33 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -127.62 111.13 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.6 t -104.47 123.55 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 60.74 41.86 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 57.64 40.89 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -153.69 149.31 27.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.38 135.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.513 HD11 HD22 ' A' ' 133' ' ' LEU . 40.0 tp -103.47 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.91 97.71 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' PHE . 51.7 mt -55.43 -62.84 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 88.7 t80 -34.79 -54.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 133' ' ' LEU . 4.7 tp60 -64.94 -62.91 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 171' ' ' ILE . 14.4 tp -34.39 -69.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -50.33 -51.27 46.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -46.27 -51.55 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.01 -50.17 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 146' ' ' VAL . 70.5 t -47.64 -50.7 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.26 -45.86 83.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.55 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -76.56 -22.7 53.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.2 -58.55 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 151.93 170.76 18.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.518 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -60.52 -40.79 92.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.89 -66.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.424 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.3 p -49.13 -43.37 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.2 t -67.62 -66.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 52.7 t -44.57 -48.1 10.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -56.79 -57.82 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.99 19.56 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 38.86 48.67 1.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.558 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -84.51 38.49 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.404 ' CZ2' ' HG2' ' A' ' 172' ' ' ARG . 80.7 m95 -84.01 -44.97 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -41.28 -50.71 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -49.38 -55.15 13.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.6 mp -60.3 -64.49 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.48 -49.97 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.4 m -61.41 -47.55 85.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -50.09 -41.88 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 31.6 mtp -68.15 -28.0 66.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -1.67 10.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CB ' HG21 ' A' ' 167' ' ' VAL . 19.6 m-85 -81.37 128.02 33.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -46.4 141.61 4.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.56 0.695 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.39 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 0.0 112.37 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.637 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -140.17 132.32 5.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -37.36 -33.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -53.2 -58.75 5.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 164' ' ' GLY . 8.6 p -64.77 -32.57 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.24 -45.0 89.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.9 m -77.49 -35.3 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -51.89 -48.09 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.636 HG23 HD11 ' A' ' 133' ' ' LEU . 5.0 mm -45.89 -55.72 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' C ' ' OE1' ' A' ' 176' ' ' GLU . 41.2 mtp180 -55.38 -57.88 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.81 -42.29 7.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -59.6 -39.95 85.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -72.2 -39.12 68.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.408 ' OE1' ' C ' ' A' ' 172' ' ' ARG . 10.1 mp0 -81.89 -9.24 59.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.76 -30.84 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.98 -50.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 175' ' ' TYR . 11.2 mt -84.04 23.36 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.61 -60.34 2.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.564 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.8 Cg_endo -69.74 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.28 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 186' ' ' LEU . 5.8 t80 -42.08 -54.4 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -77.25 -42.16 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 55.1 tp -55.28 -27.01 43.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -97.1 -54.16 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 182' ' ' TYR . 28.0 mt -41.95 -44.36 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.6 m -88.84 100.34 13.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 t -116.21 114.23 24.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.76 59.75 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.474 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 83.1 p -109.92 161.61 15.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 0.0 110.847 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.8 t -171.35 144.75 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.29 42.01 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.81 155.83 15.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 149.59 45.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -128.96 -58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.5 m -82.25 -36.43 27.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -70.71 -50.39 36.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -44.67 -35.98 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -80.28 -46.97 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.3 mt -55.0 -39.15 68.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -44.74 -65.59 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 74.1 t80 -49.66 -68.04 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.436 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 72.5 mt -37.05 -52.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CD ' ' A' ' 109' ' ' LYS . 22.1 t70 -49.77 -53.41 25.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -56.1 -59.64 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.436 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.0 tt -57.06 -25.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -74.2 -41.82 60.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -56.3 -34.08 66.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.37 -31.12 72.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' LEU . 14.5 m95 -88.13 -54.3 4.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -26.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 111' ' ' TRP . 54.7 mt -69.81 -48.82 57.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.443 ' OE1' ' C ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -68.08 -36.71 80.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 115.41 33.45 1.6 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -120.05 145.33 46.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.846 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 m -89.31 128.84 35.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -86.2 120.31 27.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 118' ' ' LEU . 16.3 tptp -142.33 124.29 15.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.0 mm -81.1 138.46 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.9 Cg_endo -69.77 179.48 3.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 127' ' ' ILE . 56.9 m80 -115.8 107.02 14.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.505 HG12 ' CE1' ' A' ' 161' ' ' PHE . 53.3 t -93.14 110.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 57.65 48.29 14.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 60.21 31.59 20.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -148.42 123.36 10.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 122' ' ' HIS . 19.9 mm -54.75 131.68 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.618 ' O ' HG21 ' A' ' 120' ' ' ILE . 58.8 tp -92.39 103.62 16.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.14 91.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 131' ' ' PHE . 64.4 mt -43.17 -59.5 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' LEU . 45.9 t80 -35.31 -69.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 133' ' ' LEU . 40.8 mt-30 -54.89 -57.27 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.996 HD11 HG23 ' A' ' 171' ' ' ILE . 16.6 tp -34.09 -71.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -51.2 -45.91 62.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -49.17 -58.64 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.94 -46.26 60.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.8 t -49.07 -55.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.85 75.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.0 -38.04 89.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.91 -19.79 60.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 157.38 -59.44 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.76 171.32 17.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.07 -46.0 91.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.84 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.52 -66.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.6 p -49.9 -54.47 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 142' ' ' GLY . 57.4 t -51.43 -49.09 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.2 m -58.25 -45.41 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -57.49 -49.04 77.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.9 m-20 -97.36 18.4 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 35.36 51.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -86.47 41.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.85 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 43.4 m95 -84.26 -36.36 22.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 m -49.7 -43.7 47.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -54.45 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.583 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.7 mp -55.23 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -38.7 -53.51 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 92.4 m -57.83 -43.79 86.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -61.07 -22.83 64.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 93.3 mmm -82.45 9.24 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.82 -10.11 74.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.543 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.505 ' CE1' HG12 ' A' ' 123' ' ' VAL . 13.6 m-85 -72.26 157.11 38.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.0 61.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 85.64 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.677 2.252 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.34 -130.49 3.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.44 -46.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.61 -58.98 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.534 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.2 p -54.9 -31.08 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.16 19.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 t -70.13 -25.65 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -58.49 -48.09 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.996 HG23 HD11 ' A' ' 133' ' ' LEU . 34.7 mm -47.1 -52.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -59.63 -57.47 12.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.14 -57.69 7.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.437 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 82.1 m-70 -40.34 -37.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.6 OUTLIER -77.07 -42.31 38.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -76.81 -9.23 58.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -101.46 -32.23 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.29 -51.1 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 19.5 mt -83.93 21.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.45 -60.25 2.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 0.0 110.888 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 54.1 Cg_endo -69.72 -50.68 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -40.78 -47.9 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.26 -27.21 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 184' ' ' LEU . 2.2 tt -61.52 -29.45 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -95.3 -45.59 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.1 mt -48.94 -39.97 28.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 79.7 p -62.84 -49.55 74.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 107.52 -49.67 0.85 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.15 101.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.5 t -50.39 -35.94 30.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.428 ' HA ' HD13 ' A' ' 191' ' ' LEU . 1.9 mm? -47.41 -55.78 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -45.2 101.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.82 164.02 32.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 194' ' ' LEU . 6.2 tt -70.55 119.41 14.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -66.41 120.12 12.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.472 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 14.1 ttpp -86.83 139.96 33.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.569 0.7 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 54.1 Cg_endo -69.74 -179.69 3.08 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 0.0 112.325 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 199' ' ' LEU . 88.4 m-20 -122.77 99.53 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 199' ' ' LEU . 4.6 pp -34.39 142.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 85.2 m -99.84 132.42 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.4 m -107.58 158.7 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -136.82 146.28 45.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 97.8 m -130.8 138.57 49.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -117.96 152.24 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.83 131.13 16.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 207' ' ' GLU . 2.5 pptp? -110.46 175.71 5.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.42 ' N ' ' HD2' ' A' ' 206' ' ' LYS . 2.3 pm0 -147.4 156.64 43.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 6.7 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -48.33 160.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 110.833 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -81.32 162.11 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.843 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.53 -99.1 1.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -105.06 168.67 8.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.873 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.3 t -134.14 -51.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 46.17 49.71 13.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -104.04 172.71 6.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 -33.79 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 16.4 tt0 -71.75 -29.46 64.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -59.15 -29.24 67.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.118 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -65.57 -62.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' A' ' 131' ' ' PHE . 9.7 p -63.24 -20.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 96' ' ' GLN . 22.4 mmtt -75.02 -49.06 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 104' ' ' LEU . 71.7 mt -77.99 -37.44 47.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -39.96 -62.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.66 ' O ' HG22 ' A' ' 107' ' ' ILE . 46.0 t80 -53.31 -57.69 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 101' ' ' LEU . 43.5 mt -44.07 -31.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.8 -40.78 22.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -68.0 -26.17 65.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.6 tp -92.88 -31.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.54 -45.33 46.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 113' ' ' LEU . 29.5 pttt -48.72 -39.78 26.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 6.2 m-85 -56.67 -38.04 71.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 66.4 m95 -72.32 -49.48 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -43.57 -56.05 3.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.0 mp -47.39 -42.33 21.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -68.15 -31.91 71.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.16 33.86 3.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.7 m -138.55 138.26 37.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.971 0.415 . . . . 0.0 110.836 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.0 p -86.18 137.31 32.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 7.0 tt -89.79 128.88 36.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.3 tptm -114.99 120.48 40.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.03 129.73 93.95 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.62 0.724 . . . . 0.0 111.11 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.15 57.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.267 . . . . 0.0 112.301 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.455 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 11.1 m170 -123.61 108.86 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 72.2 t -96.55 140.29 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 41.63 43.24 2.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 60.16 41.82 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -152.99 156.41 38.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 15.3 mm -69.75 137.34 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.75 HD11 HD22 ' A' ' 133' ' ' LEU . 15.8 tp -107.47 98.78 8.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -72.29 105.09 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.7 mt -61.2 -57.35 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.571 ' CE2' HG22 ' A' ' 99' ' ' VAL . 7.6 t80 -38.78 -48.37 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -73.44 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.75 HD22 HD11 ' A' ' 128' ' ' LEU . 24.6 tp -38.12 -67.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -47.46 -57.49 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -41.51 -56.67 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.0 mt -51.61 -44.34 62.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 133' ' ' LEU . 59.2 t -52.26 -51.3 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.21 85.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.67 -42.89 97.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -73.07 -22.01 60.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 158.76 -58.21 0.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 141.67 170.11 12.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CE2' ' HG2' ' A' ' 172' ' ' ARG . 30.3 t80 -57.31 -41.76 80.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.847 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.15 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.8 p -55.54 -52.01 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 142' ' ' GLY . 95.3 t -56.72 -66.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 14.2 t -51.25 -36.24 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -58.8 -50.99 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.09 25.62 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 38.38 39.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -85.46 46.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.865 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 45.4 m95 -88.96 -42.68 11.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.2 m -40.92 -50.73 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -50.69 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 17.2 mt -45.16 -62.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -38.5 -56.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.7 m -55.29 -41.46 72.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -53.65 -44.99 70.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.0 mmm -59.43 -18.82 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.28 -14.53 12.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 19.4 m-85 -66.5 164.63 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 144.14 75.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 111.069 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 96.19 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.2 13.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.95 -36.65 10.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.741 0.305 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -55.97 10.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.44 -38.18 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.2 -47.56 41.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -76.7 -33.52 58.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -51.67 -51.98 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.865 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 6.8 mm -40.98 -55.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HG2' ' CE2' ' A' ' 143' ' ' PHE . 21.2 mtm105 -57.38 -56.09 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.04 -44.96 26.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.425 ' CD2' HD22 ' A' ' 128' ' ' LEU . 60.9 m-70 -53.39 -38.42 63.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -76.8 -32.27 57.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -86.33 -9.34 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -101.69 -29.59 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.92 -52.28 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 13.1 mt -84.15 24.16 0.98 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.53 -60.25 2.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.65 0.738 . . . . 0.0 110.912 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.73 -50.0 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.665 2.243 . . . . 0.0 112.397 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.0 t80 -42.61 -56.12 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.49 -52.49 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.95 -33.5 4.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -75.11 -55.55 5.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.84 -46.33 64.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 188' ' ' GLY . 25.4 p -88.02 -0.88 57.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' SER . . . -34.45 114.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -111.45 113.92 26.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.0 p -51.42 -43.25 61.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.73 -46.23 40.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.28 92.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.8 t -81.11 168.13 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.47 120.48 14.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -88.5 114.08 24.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 149.07 53.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 159.92 51.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.656 2.238 . . . . 0.0 112.365 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.51 45.06 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 13.3 mt -132.71 119.86 20.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.1 m -117.24 94.57 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.1 m -91.22 134.95 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -93.81 153.04 18.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.4 m -116.2 123.45 47.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -57.24 165.69 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 206' ' ' LYS . 2.9 p30 -131.3 147.06 52.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.869 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 205' ' ' ASP . 30.9 tttt -36.34 141.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -127.71 172.72 10.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.3 t -115.67 103.45 10.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 t -119.27 157.7 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.09 -107.2 0.86 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 84.8 p -123.27 40.16 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 110.869 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.3 m -139.31 154.65 47.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.83 129.35 18.59 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -96.17 34.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.17 82.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -69.7 -20.49 63.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -87.94 -36.02 17.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.142 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -64.19 -52.44 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 100' ' ' LYS . 8.7 p -55.64 -44.88 78.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 99' ' ' VAL . 81.0 mttt -60.57 -46.78 88.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ASN . 35.2 mt -57.21 -50.25 73.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' LEU . 57.3 t-20 -37.56 -61.95 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 105' ' ' ASP . 31.4 t80 -57.97 -65.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 58.1 mt -38.23 -27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.9 t70 -80.77 -48.95 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 103' ' ' PHE . 12.3 mm100 -64.13 -21.33 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.4 tt -91.55 -39.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -67.16 -41.6 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 55.4 pttt -56.93 -44.24 82.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 5.5 m-85 -50.04 -33.06 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.52 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 60.7 m95 -79.16 -49.47 12.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -45.4 -40.14 7.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.37 -45.25 88.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -65.44 -33.06 75.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.56 40.83 1.69 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -144.06 147.49 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -87.45 146.6 25.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 108' ' ' ALA . 5.3 tt -96.29 115.98 28.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 118' ' ' LEU . 22.7 ttpt -107.27 124.08 49.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.72 125.44 90.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 160.75 48.55 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -125.37 109.12 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.15 121.64 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 56.11 45.6 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' NH1' ' A' ' 125' ' ' ARG . 6.3 mtp-105 58.37 41.29 23.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -145.78 153.36 40.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -76.95 113.57 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.24 108.6 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.944 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.63 88.86 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' PHE . 41.3 mt -39.19 -64.6 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LEU . 21.4 t80 -37.32 -66.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 133' ' ' LEU . 38.1 tt0 -50.42 -60.65 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -36.45 -70.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.2 -47.49 46.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -49.5 -54.4 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 mt -52.38 -49.31 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 155' ' ' ILE . 97.4 t -48.24 -48.84 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.99 90.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.19 -32.12 69.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.05 -12.85 58.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.08 -61.7 0.38 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.92 170.58 18.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 34.2 t80 -60.13 -35.83 76.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.889 0.376 . . . . 0.0 110.926 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.44 -66.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.7 p -49.95 -49.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 145' ' ' VAL . 53.2 t -61.89 -62.63 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 52.2 t -46.34 -46.13 18.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -63.35 -55.46 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.32 14.93 2.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.4 OUTLIER 39.64 52.12 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 9.0 mtpm? -94.22 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.496 ' CE3' HG21 ' A' ' 171' ' ' ILE . 89.7 m95 -81.81 -40.67 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 98.9 m -42.31 -51.25 4.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -49.59 -68.28 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -43.13 -65.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.11 -51.29 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.6 m -54.66 -53.02 60.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -54.08 -27.4 32.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 92.0 mmm -78.72 10.27 3.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.3 75.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -70.5 157.03 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.65 80.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.521 0.677 . . . . 0.0 111.142 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.224 . . . . 0.0 112.324 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -141.74 -169.18 11.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -93.93 -47.66 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.72 -58.22 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HA ' ' CD2' ' A' ' 170' ' ' HIS . 11.5 p -60.23 -31.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.25 -49.84 62.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.9 t -74.31 -34.08 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.343 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.446 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 3.8 m-70 -50.74 -53.78 28.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.684 HG23 HD11 ' A' ' 133' ' ' LEU . 32.4 mm -38.78 -48.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -65.14 -52.84 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 176' ' ' GLU . . . -53.16 -57.31 15.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -43.38 -30.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.599 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -79.47 -37.99 35.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' GLY . 7.3 mt-10 -77.97 -10.3 59.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 177' ' ' ARG . 1.2 mpt_? -98.16 -34.03 10.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.1 mt -119.52 -48.34 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 175' ' ' TYR . 7.7 mt -83.47 21.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -70.98 -60.1 3.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.52 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.6 Cg_endo -69.76 -49.08 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.32 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 6.1 t80 -44.61 -56.65 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.98 -38.84 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.424 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 52.0 tp -58.13 -23.19 54.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -98.13 -43.1 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -53.16 -44.6 67.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 m -69.18 -47.17 65.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.06 142.11 3.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -126.24 160.32 30.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.0 m -92.51 -44.91 8.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 191' ' ' LEU . 4.9 mp -51.98 -46.64 64.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -50.7 140.53 14.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 20.7 p -69.21 174.14 4.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.08 136.94 50.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.962 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -110.93 149.42 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -52.66 146.33 18.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.541 0.686 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -4.28 13.7 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.322 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.87 134.69 57.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -146.46 125.63 12.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 106.4 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.9 p -124.03 128.48 49.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -72.39 82.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.5 m -131.74 104.93 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -72.08 162.97 28.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.895 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.46 127.34 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -118.92 162.84 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 208' ' ' TYR . 12.0 tt0 -58.94 159.01 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 207' ' ' GLU . 77.9 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.3 m -83.88 172.26 12.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.2 t -125.68 -42.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.39 -104.51 0.73 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 90.4 p -153.32 168.75 24.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.924 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -137.11 145.95 44.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.835 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -130.4 -110.37 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -123.77 149.28 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.96 133.46 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 97' ' ' THR . 22.9 mp0 -69.1 -60.18 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 96' ' ' GLN . 3.7 t -34.16 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 96' ' ' GLN . 28.4 mmt180 -56.54 -57.84 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 96' ' ' GLN . 9.8 p -71.17 -31.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -54.8 -49.67 70.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 102' ' ' ASN . 81.5 mt -77.31 -48.16 18.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 101' ' ' LEU . 5.4 t-20 -37.33 -63.25 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.25 -64.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.453 ' HA ' HG22 ' A' ' 107' ' ' ILE . 28.3 mt -45.08 -26.07 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.17 -40.34 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -74.69 -24.38 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 182' ' ' TYR . 9.1 tp -87.39 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -65.69 -46.15 80.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.651 ' O ' HD12 ' A' ' 113' ' ' LEU . 61.0 pttt -49.05 -45.0 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.446 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 56.5 t80 -52.49 -41.63 63.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.864 ' CD1' HD12 ' A' ' 118' ' ' LEU . 53.6 m95 -68.09 -48.25 66.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.19 -45.39 16.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 109' ' ' LYS . 5.5 mp -51.44 -37.06 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -78.26 -23.16 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.84 27.36 9.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.1 t -129.91 136.43 49.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.79 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.0 t -82.11 145.22 30.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.6 tt -90.79 117.15 29.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -109.57 114.65 28.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.3 mm -70.47 126.56 92.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.56 10.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.38 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -122.58 121.0 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 128' ' ' LEU . 97.4 t -110.22 127.96 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 54.17 42.48 31.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 58.87 45.15 15.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -157.07 153.86 28.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.12 105.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.533 ' CD2' ' CD2' ' A' ' 174' ' ' HIS . 49.4 tp -65.6 116.6 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -80.41 108.21 13.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.07 -52.19 51.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CD2' ' N ' ' A' ' 132' ' ' GLN . 6.8 t80 -48.27 -66.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 59.3 tt0 -54.77 -47.96 73.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 171' ' ' ILE . 5.8 tp -50.08 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -48.98 -43.6 40.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -51.03 -53.38 34.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 66.1 mt -56.14 -46.29 79.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.1 t -48.57 -49.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.87 79.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.23 -42.59 79.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -72.97 -14.58 61.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.97 -61.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 148.82 168.79 14.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.26 -42.15 81.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.28 -66.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.447 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -52.49 -40.96 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.6 t -69.9 -26.38 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.9 m -78.82 -32.64 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 8.1 pttp -81.35 -45.3 16.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 150' ' ' ARG . 5.8 m-20 -89.43 20.15 4.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 31.41 47.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -87.97 37.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 24.6 m95 -85.36 -42.27 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m -52.02 -53.27 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -46.71 -53.89 10.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 156' ' ' ALA . 28.4 mt -58.9 -68.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.116 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -34.32 -49.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -58.88 -49.22 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -50.17 -49.13 53.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 22.9 mtp -47.93 -27.19 2.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.5 -7.55 10.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -77.43 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.32 145.11 55.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.542 0.686 . . . . 0.0 111.142 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 93.32 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -146.91 135.32 5.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.455 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -43.78 -23.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.401 ' N ' ' C ' ' A' ' 164' ' ' GLY . . . -61.01 -59.09 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.53 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.3 p -67.57 -40.68 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.94 -41.44 45.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.3 m -83.33 -31.6 26.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.1 m-70 -54.69 -40.0 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.791 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 49.9 mm -50.51 -61.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.081 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.69 -52.68 63.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.69 -43.02 37.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.533 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 60.9 m-70 -56.83 -39.81 74.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 0.8 OUTLIER -75.23 -39.98 59.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -76.29 -9.44 58.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -104.04 -29.72 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.1 mt -119.25 -52.47 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 29.2 mt -82.94 18.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -69.95 -60.22 3.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.632 0.73 . . . . 0.0 110.909 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -41.78 4.01 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.576 ' CD1' HD12 ' A' ' 107' ' ' ILE . 16.5 t80 -45.31 -51.68 10.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.72 -42.85 21.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 47.4 tp -50.82 -31.28 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -90.53 -54.08 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -42.18 -51.82 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.8 m -63.99 -40.6 96.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -43.4 -82.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.498 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -123.65 115.19 21.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 5.3 p -95.33 -21.9 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.17 2.2 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -134.42 84.55 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 35.7 m -146.47 179.61 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.41 160.11 41.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -132.96 130.55 39.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -89.17 141.99 29.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 129.36 17.5 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.342 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.9 125.14 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.59 108.15 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.7 p -115.2 163.48 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.0 m -129.72 122.33 28.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' NH2' ' A' ' 98' ' ' ARG . 2.2 p-10 -120.23 114.76 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.7 p -109.53 -29.69 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.08 108.77 20.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -61.5 -24.92 66.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -149.75 116.95 6.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.9 -25.42 42.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 36.9 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.1 p -170.34 145.14 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.896 0.379 . . . . 0.0 110.834 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.1 t -131.32 176.28 8.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.89 -114.55 4.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' SER . 77.6 p -131.85 40.92 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 91' ' ' SER . 1.3 t -37.06 120.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.67 -156.33 23.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.45 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -56.86 169.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.35 156.31 38.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.6 -35.04 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 t -85.26 -38.34 19.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -60.9 -56.18 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.614 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.1 p -44.34 -35.6 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 60.9 mttt -78.44 -54.88 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 102' ' ' ASN . 72.9 mt -46.06 -48.42 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 101' ' ' LEU . 25.6 t-20 -36.41 -65.55 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 106' ' ' GLN . 55.5 t80 -55.05 -68.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.468 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 36.6 mt -36.68 -30.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' PHE . 10.1 t70 -79.48 -45.78 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.3 mm-40 -67.04 -17.98 65.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 5.6 tt -96.86 -34.98 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.83 -42.32 81.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.092 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' O ' HD23 ' A' ' 113' ' ' LEU . 49.4 pttt -54.44 -46.37 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' N ' ' CG ' ' A' ' 109' ' ' LYS . 7.5 m-85 -47.97 -36.48 12.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.848 ' CD1' HD12 ' A' ' 118' ' ' LEU . 80.6 m95 -74.63 -49.33 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -43.21 -54.0 4.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 109' ' ' LYS . 2.7 mm? -45.64 -40.69 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.21 -44.54 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 35.87 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -138.14 120.12 15.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.936 0.398 . . . . 0.0 110.883 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 t -65.16 147.46 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.848 HD12 ' CD1' ' A' ' 111' ' ' TRP . 4.0 tt -110.37 110.28 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -103.91 140.38 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.29 122.99 73.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.13 11.41 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -122.22 125.27 45.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.7 t -112.94 134.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 46.76 42.32 11.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 57.75 45.6 18.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -163.89 130.71 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mm -46.5 133.05 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 133' ' ' LEU . 25.8 tp -94.98 104.6 16.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -72.5 98.62 2.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.81 -57.06 14.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.614 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 44.7 t80 -42.26 -65.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -56.01 -53.67 54.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 128' ' ' LEU . 20.7 tp -46.94 -70.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -42.91 -48.66 5.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -48.6 -56.17 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.59 -40.26 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 155' ' ' ILE . 46.6 t -55.04 -54.74 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.99 70.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -63.86 -37.66 88.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -81.14 -19.12 44.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.458 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.55 -57.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.508 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.75 160.5 9.11 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 175' ' ' TYR . 2.4 t80 -53.69 -33.62 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.23 -66.26 0.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.7 p -52.11 -31.07 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.5 t -76.1 -54.58 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 38.6 t -57.88 -49.8 75.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 149' ' ' ASP . 9.3 ptmt -51.76 -42.95 62.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 148' ' ' LYS . 16.3 t0 -90.42 0.89 57.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 52.22 50.79 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -102.84 35.41 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -71.73 -31.76 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.3 m -53.75 -62.67 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.154 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -39.32 -58.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 137' ' ' VAL . 22.2 mt -55.43 -64.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.441 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -39.19 -44.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.1 m -62.42 -47.69 83.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -51.8 -45.9 64.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.1 -27.21 52.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.07 -7.69 9.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -73.29 135.67 44.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.56 142.7 21.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.538 0.685 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 125.69 12.45 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.4 -144.78 4.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -121.36 -29.72 4.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.27 -57.96 10.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 168' ' ' GLY . 9.2 p -58.72 -44.88 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -49.48 -40.38 31.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.49 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -79.75 -28.72 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.1 m-70 -57.83 -51.64 68.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 133' ' ' LEU . 4.5 mm -46.77 -58.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -50.69 -54.04 26.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -53.62 -52.08 44.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 90.8 m-70 -44.46 -33.96 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CD1' ' CE2' ' A' ' 143' ' ' PHE . 1.0 OUTLIER -79.4 -36.1 39.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -83.57 -9.07 59.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -101.94 -31.45 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.13 -50.35 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 175' ' ' TYR . 15.8 mt -83.22 18.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.517 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.82 -58.85 4.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.71 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.57 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 54.2 Cg_endo -69.74 -50.83 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.731 2.287 . . . . 0.0 112.377 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -42.75 -41.64 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.37 -64.55 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 180' ' ' ASN . 6.9 mp -40.35 -36.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -70.57 -51.96 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.9 mt -46.9 -44.81 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 m -66.07 -43.19 88.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.15 144.18 3.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.49 173.36 6.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.879 0.371 . . . . 0.0 110.837 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.2 p -83.14 -6.04 59.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.73 -27.85 20.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.24 -46.23 62.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.1 m -104.99 167.29 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.84 114.39 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -147.36 151.63 36.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -127.17 143.38 46.86 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.903 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 112.62 3.14 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.527 ' C ' HD12 ' A' ' 199' ' ' LEU . 18.9 p30 -66.73 169.19 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 198' ' ' ASN . 7.3 mp -127.14 140.01 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 76.4 p -125.09 142.83 51.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 7.9 t -83.46 137.37 33.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -114.73 122.87 47.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.2 m -74.15 124.08 25.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.137 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.27 148.55 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -120.83 -20.17 7.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -93.24 110.65 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -66.37 96.45 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.824 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p 37.85 41.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -67.62 151.48 47.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.76 65.75 0.26 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -66.15 123.11 19.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.4 t 61.15 43.22 11.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.37 -47.99 3.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.46 139.14 40.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.343 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.97 152.85 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -104.74 -36.38 7.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 p -86.05 -54.19 4.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -47.36 -51.58 19.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.8 p -47.08 -35.84 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.553 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 7.3 mtmp? -73.09 -49.2 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.76 -38.26 81.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.26 -53.63 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 107' ' ' ILE . 50.1 t80 -58.61 -48.39 81.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.7 mt -57.46 -36.72 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.5 -42.02 68.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -65.82 -52.74 48.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 103' ' ' PHE . 2.8 tp -55.16 -49.35 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -54.26 -49.17 70.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -43.71 -52.34 6.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.98 -42.96 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.455 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 51.6 m95 -71.72 -48.64 45.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -44.53 -50.59 9.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mt -54.39 -43.86 71.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.13 -38.44 88.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.86 34.8 1.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.7 m -140.64 130.08 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 p -67.18 140.16 57.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -111.76 149.02 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.915 ' H ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -169.98 141.2 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 128' ' ' LEU . 10.1 mm -75.26 131.51 78.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.602 0.715 . . . . 0.0 111.17 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.31 24.85 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.541 ' CE1' HD11 ' A' ' 127' ' ' ILE . 32.8 m80 -100.46 116.74 33.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 128' ' ' LEU . 88.2 t -108.41 120.54 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 61.82 43.73 9.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 58.11 42.16 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -170.25 133.19 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.541 HD11 ' CE1' ' A' ' 122' ' ' HIS . 17.0 mm -46.99 148.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.66 ' O ' HG21 ' A' ' 120' ' ' ILE . 9.4 tp -116.86 111.41 19.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.8 106.31 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.36 -50.63 72.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 54.3 t80 -44.38 -56.5 4.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -63.2 -56.03 20.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 171' ' ' ILE . 6.6 tp -40.79 -70.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -43.54 -48.39 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -50.53 -50.43 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' HB3' HG23 ' A' ' 155' ' ' ILE . 4.1 mm? -57.11 -38.15 72.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.707 HG22 HD13 ' A' ' 155' ' ' ILE . 46.4 t -58.53 -59.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.54 60.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -60.77 -37.24 81.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -79.49 -13.4 59.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 151.55 -62.71 0.39 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 162.17 169.22 25.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -61.25 -37.05 81.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.72 -66.34 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 2.5 p -43.15 -30.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 150' ' ' ARG . 20.2 t -80.43 -50.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.5 p -57.78 -38.43 75.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -78.01 -28.27 49.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.16 2.2 45.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmm180 53.69 31.04 12.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 146' ' ' VAL . 40.9 mtmt -83.53 43.11 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -86.4 -44.97 11.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 m -47.85 -49.62 28.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -49.15 -55.36 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.707 HD13 HG22 ' A' ' 137' ' ' VAL . 14.9 mt -57.34 -60.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.429 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -41.64 -48.13 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -50.76 -43.7 58.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.9 mtp -58.31 -21.0 47.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.68 2.11 24.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -78.97 177.46 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.88 142.91 34.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.595 0.712 . . . . 0.0 111.095 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 122.98 9.64 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.39 -166.63 32.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -104.7 -20.87 13.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.72 -59.1 4.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.429 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 7.1 p -61.79 -30.75 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.63 -49.29 78.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.8 m -75.43 -27.38 58.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.6 m-70 -58.22 -54.22 49.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.856 HG23 HD21 ' A' ' 133' ' ' LEU . 5.4 mm -37.97 -64.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -52.04 -50.61 61.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -52.55 -44.38 59.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.75 -31.53 70.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -84.17 -22.87 30.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -90.63 -10.77 42.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.15 -25.21 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.7 mt -119.35 -52.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.26 28.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.499 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -75.26 -62.73 0.79 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.67 0.748 . . . . 0.0 110.905 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.9 Cg_endo -69.76 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 107' ' ' ILE . 7.3 t80 -40.56 -44.22 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 175' ' ' TYR . 8.3 m120 -72.06 -43.38 64.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 181' ' ' PRO . 43.3 mt -56.78 -54.96 40.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 189' ' ' ASP . 27.0 t80 -59.46 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.5 mt -50.11 -48.11 53.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.1 t -55.5 -46.89 76.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.31 124.17 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.401 ' HB2' ' CD1' ' A' ' 185' ' ' PHE . 11.9 t70 -106.85 80.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.331 . . . . 0.0 110.903 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.4 t -84.45 -46.97 11.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 192' ' ' ARG . 1.7 pt? -43.34 -34.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.444 ' N ' ' HG ' ' A' ' 191' ' ' LEU . 1.8 mpt_? -140.22 132.66 28.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 88.2 m -122.45 142.5 50.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.9 107.9 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -97.07 94.18 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -127.26 142.66 44.56 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 102.08 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -89.09 163.09 15.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 199' ' ' LEU . 0.9 OUTLIER -146.08 175.31 10.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 86.7 m -144.21 127.62 16.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 t -116.65 154.38 30.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -129.3 164.7 22.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 t -149.24 156.98 42.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 134.03 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.88 172.1 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.65 136.13 33.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -105.06 -48.25 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.846 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -114.04 120.08 39.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.7 t -108.36 108.4 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.2 119.49 1.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -80.24 158.19 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -142.16 159.46 42.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.67 -123.83 1.05 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.52 167.32 17.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.01 -43.6 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -81.13 46.14 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.0 m -83.95 -40.67 18.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.6 -40.08 94.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.95 -26.29 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 50.8 mtpt -80.05 -37.49 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.7 -44.85 69.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -39.32 -58.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 107' ' ' ILE . 79.2 t80 -55.85 -62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 37.4 mt -42.15 -37.75 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.49 -54.84 30.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -57.03 -54.55 45.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 103' ' ' PHE . 7.9 tt -60.91 -35.27 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -65.79 -41.81 91.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' O ' HD12 ' A' ' 113' ' ' LEU . 47.0 mttt -56.66 -29.09 61.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 181' ' ' PRO . 42.2 t80 -71.22 -32.83 69.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.668 ' HD1' HD12 ' A' ' 118' ' ' LEU . 56.7 m95 -85.26 -53.24 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -42.44 -39.42 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 109' ' ' LYS . 15.9 mt -62.09 -47.74 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -60.45 -39.74 88.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.36 35.49 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.438 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.5 m -141.26 119.29 11.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 110.885 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.6 m -62.78 128.7 37.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.0 tt -78.11 128.55 33.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.647 ' N ' HD23 ' A' ' 118' ' ' LEU . 10.8 ttmm -126.17 142.24 51.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.6 mm -84.17 130.43 54.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.68 0.753 . . . . 0.0 111.109 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 159.21 54.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -119.1 118.08 30.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' LYS . 90.2 t -110.67 143.95 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' VAL . 77.0 mm-40 37.79 42.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? 59.06 42.81 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 123' ' ' VAL . 40.7 mttm -147.96 141.87 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.76 100.66 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 133' ' ' LEU . 53.5 tp -67.31 94.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.33 100.67 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.28 -52.32 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 4.2 t80 -41.92 -59.14 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 20.4 tp60 -67.51 -54.05 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.938 HD11 ' CG2' ' A' ' 171' ' ' ILE . 9.9 tp -37.93 -72.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 134' ' ' ASN . 3.3 t-20 -48.61 -47.08 40.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -47.73 -48.12 29.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 132' ' ' GLN . 11.2 mp -63.24 -39.14 93.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.23 -48.85 54.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.05 85.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.81 -36.94 80.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.71 -18.89 50.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.428 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 158.34 -59.04 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 154.71 173.86 24.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.787 ' CZ ' ' CD1' ' A' ' 175' ' ' TYR . 48.0 t80 -64.63 -37.26 86.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.62 -66.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 146' ' ' VAL . 4.7 p -45.99 -44.85 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 142' ' ' GLY . 50.3 t -65.54 -68.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 51.7 t -42.26 -45.72 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -57.67 -55.43 34.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 151' ' ' LYS . 17.3 m-20 -84.46 24.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 149' ' ' ASP . 29.2 mmt180 34.38 37.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 25.2 mtpp -79.74 44.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.766 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -90.04 -49.76 6.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.9 m -37.0 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -57.61 -69.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.2 mt -45.43 -58.75 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -41.82 -56.23 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.3 m -51.31 -50.07 60.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.462 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -55.83 -27.86 53.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.0 mmm -79.69 12.23 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.75 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CB ' HG21 ' A' ' 167' ' ' VAL . 24.2 m-85 -65.07 171.61 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.94 144.09 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 86.7 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.82 -158.78 7.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -103.71 -39.46 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -48.26 -59.15 3.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.124 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 161' ' ' PHE . 13.0 p -63.89 -37.43 79.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.25 -58.38 13.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.1 m -65.19 -31.51 72.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.539 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 3.5 m-70 -52.73 -57.57 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 133' ' ' LEU . 26.0 mm -41.69 -46.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.461 ' HB2' ' NE1' ' A' ' 152' ' ' TRP . 1.3 tmt_? -59.64 -51.27 70.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.62 -44.2 97.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.9 -22.64 10.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.787 ' CD1' ' CZ ' ' A' ' 143' ' ' PHE . 0.5 OUTLIER -91.46 -21.35 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -90.98 -11.41 39.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -105.01 -25.44 12.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 mt -119.82 -52.52 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.0 mt -83.21 19.11 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.55 -60.12 2.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.897 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.558 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.2 Cg_endo -69.8 -46.48 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.345 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.9 t80 -38.55 -56.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -75.18 -34.57 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.99 -28.23 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -88.28 -54.99 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.9 mt -44.37 -44.64 8.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.9 p -68.15 -46.17 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.61 42.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -88.97 46.18 1.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 m -46.26 -32.56 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.797 ' H ' HD12 ' A' ' 191' ' ' LEU . 3.9 mp -47.71 -53.04 16.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -36.91 113.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 27.4 m -148.41 175.11 11.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.68 98.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -60.85 103.81 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 140.97 23.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.609 0.718 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 175.64 7.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.249 . . . . 0.0 112.362 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -138.27 176.56 8.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 199' ' ' LEU . 3.4 pp -107.51 165.14 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t -127.04 165.11 20.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 88.6 p -95.93 173.07 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.04 178.93 4.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.4 m -132.79 132.99 42.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.434 ' N ' ' HE3' ' A' ' 204' ' ' LYS . 0.3 OUTLIER -72.4 -176.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -131.18 175.52 9.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -86.14 143.11 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -107.93 -37.41 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.426 ' N ' ' HG2' ' A' ' 207' ' ' GLU . 2.2 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -119.42 118.94 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.869 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 t -125.46 143.98 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.08 168.57 53.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -154.33 129.01 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.9 p -78.79 119.93 22.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.831 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.38 -137.21 6.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.78 126.15 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.83 108.16 8.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' VAL . 37.0 tt0 -118.39 -41.44 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -90.92 -30.74 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -61.95 -44.0 97.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.582 HG13 ' HD2' ' A' ' 100' ' ' LYS . 9.7 p -52.1 -37.96 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.099 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.582 ' HD2' HG13 ' A' ' 99' ' ' VAL . 1.4 mptt -71.72 -58.45 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.5 mt -50.67 -39.84 51.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.74 -63.69 0.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -51.33 -67.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 39.6 mt -38.21 -40.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.66 -53.06 61.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -56.68 -51.69 67.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.9 tt -59.63 -45.49 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -55.76 -48.2 75.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -40.6 -57.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -43.56 -48.94 7.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.516 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 35.8 m95 -66.6 -53.46 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -40.93 -51.23 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.02 -48.27 67.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -64.54 -37.66 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.65 37.99 1.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.8 p -131.8 141.2 49.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.1 m -85.76 134.45 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.5 tt -94.38 111.18 22.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' N ' HD23 ' A' ' 118' ' ' LEU . 4.4 tppp? -118.79 115.3 24.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 mm -62.72 129.7 93.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.63 0.729 . . . . 0.0 111.121 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 157.32 60.72 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.48 HG21 HD22 ' A' ' 128' ' ' LEU . 45.0 t -98.85 120.85 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 55.3 46.47 23.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 56.52 32.54 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -141.91 134.26 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.68 99.14 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 123' ' ' VAL . 14.7 tp -66.36 104.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -73.35 116.74 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.7 mt -66.94 -57.0 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 135' ' ' LYS . 2.7 t80 -50.88 -54.57 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -60.69 -44.48 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -47.91 -72.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.561 HD21 HD13 ' A' ' 179' ' ' LEU . 93.8 m-20 -50.21 -39.15 43.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -54.04 -55.04 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.48 ' CG2' HG21 ' A' ' 155' ' ' ILE . 69.6 t -53.52 -50.04 51.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.36 92.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.56 -42.09 98.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -67.57 -17.89 64.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.537 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 156.58 -56.19 0.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.48 166.59 12.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.45 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 143' ' ' PHE . 2.7 t80 -59.63 -42.48 92.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.11 -64.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.3 p -48.64 -44.9 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 151' ' ' LYS . 28.9 t -63.8 -64.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 20.3 m -49.11 -36.64 19.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -66.35 -51.09 60.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -95.37 18.32 12.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 146' ' ' VAL . 13.5 mmt85 45.38 51.86 9.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.621 ' HB2' HG22 ' A' ' 146' ' ' VAL . 4.2 mmmm -86.55 24.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.671 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 10.3 m95 -68.46 -40.04 81.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 49.5 m -54.73 -39.44 68.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.468 ' N ' ' HE3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -63.8 -33.6 76.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.526 ' N ' HD13 ' A' ' 155' ' ' ILE . 1.9 mm -73.37 -61.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -44.87 -51.95 9.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 m -59.98 -51.15 70.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -52.97 -45.08 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.424 ' SD ' HD13 ' A' ' 133' ' ' LEU . 32.4 mtp -58.41 -15.92 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.09 -7.62 27.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 171.24 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.1 31.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.593 0.711 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 109.65 2.38 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.4 -147.48 4.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -115.7 -37.0 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 170' ' ' HIS . . . -59.48 -58.22 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.2 p -57.96 -41.34 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -48.69 -52.65 19.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -77.85 -27.02 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 166' ' ' ALA . 2.8 m-70 -53.47 -46.93 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 133' ' ' LEU . 46.7 mm -46.3 -43.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.407 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 23.1 mmm-85 -71.35 -63.25 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.51 -51.62 7.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -46.68 -40.44 13.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.542 ' HA ' HD12 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -67.33 -45.33 76.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -76.41 -9.34 58.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -97.25 -35.55 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.6 mt -119.87 -48.32 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.561 HD13 HD21 ' A' ' 134' ' ' ASN . 10.8 mt -83.5 21.37 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.513 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -71.73 -60.24 2.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.516 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 53.7 Cg_endo -69.75 -50.68 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.709 2.273 . . . . 0.0 112.353 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 4.1 t80 -44.63 -52.71 7.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.19 -51.24 69.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -49.32 -44.18 44.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 188' ' ' GLY . 8.7 t80 -69.61 -57.42 5.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 34.6 mt -38.28 -50.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 m -66.18 -38.84 89.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 129.39 177.53 14.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -139.65 152.08 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 110.818 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.7 p -97.97 -61.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.826 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.712 ' H ' HD23 ' A' ' 191' ' ' LEU . 1.3 pt? -49.26 -20.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 31.3 p -71.4 168.61 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 117.5 11.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 165.11 13.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -75.48 143.94 76.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 133.88 26.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.698 2.266 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.15 115.68 30.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.5 mt -62.03 102.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 90.3 m -126.16 128.81 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.0 p -49.33 165.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.76 175.1 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 97.3 m -120.9 149.28 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -124.89 128.7 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -90.91 162.91 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -143.79 111.83 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.27 -178.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 58.0 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.932 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -72.49 165.24 25.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -123.22 172.19 8.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.87 156.82 23.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -101.39 106.32 17.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -44.49 143.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.19 -141.21 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.31 117.31 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.887 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 131.32 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -121.05 43.23 2.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -90.23 -32.01 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.121 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -69.56 -34.51 74.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 131' ' ' PHE . 7.1 p -73.84 -33.78 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 40.5 mtmt -68.54 -52.42 32.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.47 -40.69 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -48.36 -52.35 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 104' ' ' LEU . 3.9 t80 -58.95 -61.3 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 16.5 mt -49.37 -20.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.69 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 107' ' ' ILE . 7.1 pt20 -53.13 -31.91 44.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.48 HD12 ' CD2' ' A' ' 182' ' ' TYR . 5.5 tt -81.59 -39.23 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.56 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -42.55 -58.01 2.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -38.89 -42.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.472 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 43.0 m95 -73.97 -49.1 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -42.75 -43.44 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -61.48 -47.54 85.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -64.9 -28.2 69.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.92 40.68 3.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -136.66 127.24 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 110.853 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.6 m -77.81 128.37 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.2 tt -89.92 108.0 19.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -106.09 128.23 53.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.6 mm -63.58 127.29 91.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 174' ' ' HIS . 53.1 Cg_endo -69.82 161.97 43.91 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.313 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -118.1 115.44 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.816 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 77.1 t -102.4 124.29 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 51.52 51.16 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 55.62 35.27 24.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -144.83 142.89 30.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.53 107.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.044 HD11 HD22 ' A' ' 133' ' ' LEU . 19.4 tp -71.55 114.77 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.74 89.06 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' PHE . 23.1 mt -44.28 -63.47 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 99' ' ' VAL . 17.0 t80 -34.91 -67.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.456 ' N ' ' CD2' ' A' ' 131' ' ' PHE . 17.1 tt0 -53.97 -56.8 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 128' ' ' LEU . 22.6 tp -43.93 -71.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -45.6 -57.46 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.9 tttp -41.56 -47.55 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.928 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -46.65 87.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -50.71 -46.79 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.16 95.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.6 -45.04 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -67.56 -18.16 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.458 ' CA ' HG11 ' A' ' 145' ' ' VAL . . . 155.28 -60.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 149.36 165.36 12.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.492 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -55.85 -35.12 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.884 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.24 -66.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.458 HG11 ' CA ' ' A' ' 141' ' ' GLY . 2.6 p -51.88 -37.46 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 151' ' ' LYS . 51.0 t -72.06 -64.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 9.8 t -52.24 -32.22 35.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -73.55 -49.42 26.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -91.54 15.22 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER 45.81 55.03 7.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -96.16 36.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.509 ' CZ3' ' CG2' ' A' ' 171' ' ' ILE . 42.4 m95 -84.69 -46.89 11.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.8 m -43.96 -54.57 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -48.58 -63.05 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 156' ' ' ALA . 20.4 mt -54.27 -63.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.22 -47.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.6 m -62.75 -45.43 92.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -51.28 -51.12 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.2 mmm -50.08 -25.08 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.87 -8.14 10.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 26.0 m-85 -72.27 146.55 47.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.45 142.99 98.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 122.8 9.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.716 2.277 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.67 -134.89 1.78 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -127.81 -34.8 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.68 -58.65 7.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.17 -30.93 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -58.91 12.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -67.16 -25.97 66.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' ILE . 2.2 m-70 -58.32 -59.54 5.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.605 HG23 HD11 ' A' ' 133' ' ' LEU . 24.8 mm -37.83 -63.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -52.21 -56.86 11.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.14 -52.99 9.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 70.9 m-70 -49.27 -35.65 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -82.27 -22.72 35.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.67 -13.06 40.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -105.25 -22.79 12.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.7 mt -119.98 -52.61 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 175' ' ' TYR . 5.4 mp -87.01 25.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -76.5 -63.64 0.55 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.8 Cg_endo -69.73 -48.28 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.694 2.262 . . . . 0.0 112.356 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 107' ' ' ILE . 6.1 t80 -40.12 -48.21 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.34 -34.2 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 184' ' ' LEU . 4.0 tt -56.57 -40.66 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -84.8 -56.65 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 55.9 mt -40.61 -36.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 m -89.29 -45.48 9.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.12 124.63 2.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.04 136.85 41.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.3 t -98.56 -18.43 18.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 191' ' ' LEU . 0.9 OUTLIER -92.76 -38.04 12.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.908 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -63.51 112.45 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 76.4 m -43.4 91.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 194' ' ' LEU . 1.1 pp -150.12 116.66 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.5 135.07 54.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -87.49 143.14 33.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.588 0.708 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.486 ' HG2' HD12 ' A' ' 199' ' ' LEU . 53.8 Cg_endo -69.74 147.84 63.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.664 2.243 . . . . 0.0 112.366 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.407 ' O ' ' CG ' ' A' ' 198' ' ' ASN . 11.2 p-10 -53.39 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.486 HD12 ' HG2' ' A' ' 197' ' ' PRO . 15.4 mt -133.25 169.35 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 46.1 p -68.81 106.97 2.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -136.92 167.18 21.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -119.45 151.02 39.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.9 p -124.19 175.13 7.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -146.39 105.31 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.03 169.62 11.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 207' ' ' GLU . 7.1 tmtt? -135.05 145.57 48.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.441 ' N ' ' HD3' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -132.47 175.68 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 207' ' ' GLU . 21.4 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.9 m -143.75 139.89 29.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -139.71 169.65 17.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.0 -137.67 5.52 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.5 m -76.29 121.47 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.893 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -93.27 81.57 4.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.88 -47.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -148.49 114.37 5.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.13 40.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -115.04 38.91 3.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.4 m -83.54 -42.33 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -55.21 -46.31 75.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.47 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 6.0 p -58.54 -31.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 131' ' ' PHE . 45.1 mtmt -73.41 -47.15 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -66.6 -44.08 83.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -42.7 -44.52 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.8 t80 -68.18 -44.74 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.476 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.9 mt -63.27 -26.94 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -76.91 -51.04 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -62.02 -32.82 73.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 103' ' ' PHE . 5.8 tt -79.68 -42.43 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -66.83 -47.51 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.19 -28.15 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -70.21 -30.39 67.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.781 ' HD1' HD12 ' A' ' 118' ' ' LEU . 79.0 m95 -87.07 -49.4 7.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -47.6 -21.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.57 -45.22 46.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -70.07 -37.98 75.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.97 36.49 1.23 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.455 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.4 t -137.9 111.26 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.789 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 p -58.05 147.12 30.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.109 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.781 HD12 ' HD1' ' A' ' 111' ' ' TRP . 5.6 tt -98.07 108.03 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -96.34 132.82 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -87.06 121.02 71.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.62 0.724 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 149.73 67.43 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -107.94 111.59 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 167' ' ' VAL . 96.8 t -97.42 124.95 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 51.43 44.79 28.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.3 30.37 19.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -139.33 150.23 45.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.1 mm -75.01 129.95 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.454 HD22 ' CD2' ' A' ' 174' ' ' HIS . 32.6 tp -91.59 107.97 19.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.79 82.44 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 131' ' ' PHE . 60.1 mt -40.05 -59.9 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 31.1 t80 -34.91 -67.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.78 ' NE2' HD12 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -58.81 -54.83 42.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.927 HD11 ' CG2' ' A' ' 171' ' ' ILE . 4.3 tp -35.47 -71.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -49.37 -53.81 20.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -40.06 -56.9 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.78 HD12 ' NE2' ' A' ' 132' ' ' GLN . 12.4 mt -54.6 -48.11 72.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 HD13 ' A' ' 155' ' ' ILE . 93.3 t -46.54 -49.88 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.07 86.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.48 -37.26 86.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -79.89 -14.35 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.48 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 153.18 -62.73 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 145' ' ' VAL . . . 154.54 165.28 13.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 3.1 t80 -55.47 -38.83 69.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.6 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.48 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.1 p -48.37 -46.0 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 151' ' ' LYS . 54.3 t -67.05 -69.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 47.1 t -40.32 -42.45 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -64.32 -51.34 63.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' ARG . 12.3 m-20 -84.81 25.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 34.49 41.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 146' ' ' VAL . 29.6 mtpt -86.07 40.59 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.584 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 23.3 m95 -86.11 -46.91 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.8 m -38.88 -44.72 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -63.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.684 HD13 HG22 ' A' ' 137' ' ' VAL . 20.0 mt -52.31 -57.87 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -45.45 -50.04 12.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 m -64.25 -37.9 89.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -65.35 -27.5 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 mtp -75.36 -3.24 32.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.81 54.38 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -79.73 166.85 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.93 144.62 79.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.558 0.694 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 85.73 0.61 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.729 2.286 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.38 169.76 26.3 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -74.03 -34.55 64.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.78 0.324 . . . . 0.0 110.882 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.66 -58.83 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 168' ' ' GLY . 12.7 p -67.06 -44.12 88.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -45.5 -48.89 11.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 m -75.49 -36.08 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.834 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 3.4 m-70 -49.18 -39.0 27.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.927 ' CG2' HD11 ' A' ' 133' ' ' LEU . 37.0 mm -57.33 -59.42 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -50.83 -61.19 2.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -44.91 -48.67 9.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 32.1 m-70 -50.55 -44.83 56.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -43.54 90.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -80.01 -9.03 59.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.83 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 173' ' ' GLY . 23.1 mmt180 -99.1 -30.37 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.36 -51.9 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.16 26.58 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -72.54 -60.05 2.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.892 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.724 ' HA ' HD12 ' A' ' 184' ' ' LEU . 53.6 Cg_endo -69.74 -48.18 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 186' ' ' LEU . 6.2 t80 -44.25 -41.41 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -71.28 -38.52 71.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 181' ' ' PRO . 69.4 mt -57.57 -36.31 71.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.86 -41.72 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.465 HD11 ' CE2' ' A' ' 182' ' ' TYR . 79.2 mt -61.87 -32.62 73.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.9 t -81.63 9.25 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.58 -132.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.57 74.57 10.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 97.2 p -97.86 -22.97 16.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -87.48 -0.66 57.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.407 ' N ' HD13 ' A' ' 191' ' ' LEU . 7.0 mmm180 -77.85 109.22 11.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.0 -40.1 65.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.729 ' H ' HD13 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.01 22.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -46.4 173.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -51.43 145.29 14.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.598 0.713 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 141.55 45.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.35 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.27 157.05 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 1.6 mm? -84.75 90.48 7.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.7 p -131.59 111.1 11.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 t -113.59 107.08 15.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.52 113.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.3 p -92.78 85.27 5.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -105.75 142.24 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.54 138.38 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -93.53 120.62 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -120.84 120.81 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -38.93 109.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.0 t -131.15 127.06 37.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.55 -148.66 5.66 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 m -127.9 159.66 34.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 p -50.89 173.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.33 -162.78 22.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.56 -23.51 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.487 ' HB3' ' HD3' ' A' ' 98' ' ' ARG . . . -112.8 141.75 46.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 98' ' ' ARG . 15.3 pt20 -119.63 -46.53 2.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 96' ' ' GLN . 98.9 m -33.79 -34.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.487 ' HD3' ' HB3' ' A' ' 95' ' ' ALA . 6.7 ptm180 -66.04 -57.55 7.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.76 -39.78 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -53.38 -54.78 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.66 -39.27 84.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -50.64 -50.71 53.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 107' ' ' ILE . 52.3 t80 -60.01 -64.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 58.6 mt -41.17 -35.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -70.13 -57.99 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -55.13 -50.65 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.3 tt -63.73 -37.03 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -59.64 -49.72 76.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' HD13 ' A' ' 113' ' ' LEU . 37.6 mttp -45.76 -56.07 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -39.58 -40.67 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -76.4 -50.66 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -41.87 -38.12 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 109' ' ' LYS . 10.4 mp -57.24 -44.45 83.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -73.72 -36.68 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 114' ' ' GLN . . . 111.55 30.1 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -116.97 139.57 50.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 m -84.9 129.4 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 119' ' ' LYS . 2.3 tt -93.62 119.5 32.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.699 ' N ' HD23 ' A' ' 118' ' ' LEU . 25.7 tptt -133.19 142.99 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.55 122.45 82.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -177.21 1.78 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.679 2.252 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CE1' HD13 ' A' ' 127' ' ' ILE . 25.1 m80 -126.21 126.04 43.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 128' ' ' LEU . 93.1 t -112.67 128.53 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.8 42.39 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 61.06 27.88 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -145.03 128.49 16.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 122' ' ' HIS . 4.8 mm -40.92 146.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 133' ' ' LEU . 16.3 tp -120.27 89.71 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -56.22 103.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 178' ' ' ILE . 81.3 mt -58.13 -63.09 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' LEU . 5.7 t80 -37.79 -62.21 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -54.82 -59.15 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.964 HD11 HG23 ' A' ' 171' ' ' ILE . 13.7 tp -38.15 -72.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -47.28 -46.36 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -58.48 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.62 -42.42 62.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.493 HG22 HD13 ' A' ' 155' ' ' ILE . 60.9 t -52.49 -50.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.39 -33.49 75.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.41 -41.76 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -72.69 -12.03 60.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 150.97 -59.72 0.42 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.88 176.11 20.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.21 -36.7 84.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.7 -66.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.068 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 141' ' ' GLY . 2.3 p -50.75 -47.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 142' ' ' GLY . 72.9 t -60.14 -43.72 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.4 m -67.7 -33.46 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -70.97 -49.85 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.03 10.84 39.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 146' ' ' VAL . 17.5 mmt85 46.41 52.25 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -81.92 40.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -87.04 -45.22 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.1 m -41.43 -49.21 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -56.81 -59.28 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 137' ' ' VAL . 14.2 mt -51.8 -72.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.621 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.15 -51.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.0 m -60.35 -41.98 94.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 155' ' ' ILE . 37.7 mttp -62.56 -22.65 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 80.4 mmm -81.67 7.31 12.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.19 -15.45 62.37 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -69.62 162.29 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -80.13 143.95 57.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.726 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 84.42 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.12 -138.63 4.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -124.21 -48.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.85 -57.56 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.127 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.621 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 5.4 p -58.39 -39.17 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.0 -48.21 52.54 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.1 m -72.86 -32.04 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.443 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 6.4 m-70 -54.66 -53.9 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.964 HG23 HD11 ' A' ' 133' ' ' LEU . 45.0 mm -43.25 -51.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HG2' ' CZ2' ' A' ' 152' ' ' TRP . 28.3 mtm180 -56.91 -62.32 1.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 177' ' ' ARG . . . -43.8 -51.87 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.467 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 96.6 m-70 -50.58 -41.38 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.3 OUTLIER -71.22 -45.74 62.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.61 -9.15 58.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 173' ' ' GLY . 38.1 mtm180 -105.12 -28.94 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.619 HG22 HD13 ' A' ' 179' ' ' LEU . 39.9 mt -116.43 -52.63 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.619 HD13 HG22 ' A' ' 178' ' ' ILE . 1.5 mm? -92.84 35.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.546 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -75.39 -62.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.859 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.82 -49.23 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.322 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.4 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 5.0 t80 -42.11 -55.83 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.46 -46.68 75.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt -51.67 -37.08 49.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.1 -54.09 12.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 42.3 mt -49.83 -36.47 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.5 t -78.26 -48.02 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -171.48 -140.35 3.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.44 163.67 14.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.353 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.0 t -99.06 -45.51 5.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 192' ' ' ARG . 3.1 pp -49.96 -44.23 50.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.909 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.784 ' N ' HD12 ' A' ' 191' ' ' LEU . 0.8 OUTLIER -35.3 117.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.8 t -50.57 166.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.64 149.11 44.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -86.53 156.48 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -37.37 141.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -177.34 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -120.78 160.65 22.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -61.88 152.33 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.7 p -53.91 144.24 19.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 67.2 m -99.38 101.94 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.0 120.07 34.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.0 m -114.02 95.82 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -61.84 172.1 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 205' ' ' ASP . 7.0 p-10 -89.01 98.2 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 207' ' ' GLU . 72.1 tttt -75.13 126.69 31.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 206' ' ' LYS . 6.7 tp10 -37.22 114.3 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.827 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 m -64.7 -48.87 73.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.0 p -173.6 150.33 1.75 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.38 72.1 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.521 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 p -43.05 116.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -170.14 155.1 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.51 160.38 8.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.518 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -91.33 124.49 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.75 149.94 10.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.43 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.1 pp0? -124.12 -21.03 5.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.8 m -87.79 -44.61 10.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -57.78 -51.62 68.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.6 p -53.45 -24.99 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 47.6 mttp -81.01 -53.02 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.91 -44.92 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -39.0 -64.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -51.73 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.874 HD22 HD11 ' A' ' 120' ' ' ILE . 38.5 mt -39.72 -39.52 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.5 -53.87 50.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -54.26 -59.97 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 104' ' ' LEU . 2.9 tt -48.8 -45.36 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.93 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' TRP . 4.5 mmmm -55.97 -60.26 3.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -38.54 -26.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.56 ' CZ2' ' HG3' ' A' ' 181' ' ' PRO . 88.7 m95 -87.97 -45.72 9.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' A' ' 113' ' ' LEU . 5.6 pt-20 -49.61 -18.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.441 HD12 ' HG2' ' A' ' 112' ' ' GLU . 6.5 mp -78.9 -35.34 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -81.25 -28.74 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 106.32 34.55 3.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.8 m -135.17 112.25 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.849 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -58.39 143.38 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.164 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.96 HD13 ' N ' ' A' ' 119' ' ' LYS . 2.0 tm? -105.92 157.87 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 118' ' ' LEU . 14.7 ttmm -171.99 155.51 3.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.874 HD11 HD22 ' A' ' 104' ' ' LEU . 28.6 mm -89.26 129.69 46.76 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.694 0.759 . . . . 0.0 111.121 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -179.29 2.84 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 39.4 m80 -119.77 129.28 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 128' ' ' LEU . 93.0 t -115.09 109.08 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 61.65 51.25 4.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 56.71 31.64 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -148.77 126.1 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.422 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 32.4 mm -48.16 145.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 HD22 ' A' ' 133' ' ' LEU . 22.6 tp -110.31 91.85 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.7 83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 mt -40.12 -57.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.51 ' CD1' ' HG2' ' A' ' 100' ' ' LYS . 23.9 t80 -39.72 -52.28 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 133' ' ' LEU . 32.0 tp60 -70.35 -58.36 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.978 HD22 HD11 ' A' ' 128' ' ' LEU . 7.4 tp -35.68 -71.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -47.34 -57.44 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -42.09 -55.46 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.97 -45.09 60.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.782 HG22 HD13 ' A' ' 155' ' ' ILE . 64.8 t -52.82 -55.08 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.03 -41.04 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.94 -37.69 88.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.09 -27.5 63.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 169.1 -52.0 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 131.41 150.45 6.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -41.7 -36.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.15 -66.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.0 p -61.81 -54.99 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.199 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 142' ' ' GLY . 72.3 t -46.77 -57.93 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.1 t -57.62 -43.76 84.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -54.52 -53.73 50.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 150' ' ' ARG . 2.2 m-20 -90.02 18.39 5.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 149' ' ' ASP . 1.1 mpp_? 37.62 48.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -86.87 40.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 34.1 m95 -81.21 -50.54 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 51.8 m -39.03 -50.73 1.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -50.72 -61.03 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.782 HD13 HG22 ' A' ' 137' ' ' VAL . 19.0 mt -49.14 -67.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -40.14 -49.73 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.4 m -63.17 -36.91 85.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.63 -22.04 65.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 75.5 mmm -83.67 5.3 25.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.55 -1.36 66.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.26 156.93 26.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.57 143.72 85.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.2 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.92 -168.58 11.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -97.73 -32.11 11.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 110.955 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.65 -59.09 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.493 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 11.6 p -59.19 -32.1 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.54 95.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.9 m -82.22 -23.65 35.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -62.5 -47.27 84.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 133' ' ' LEU . 30.0 mm -43.62 -50.67 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.37 -63.88 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.44 -45.3 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.49 ' CD2' HD22 ' A' ' 128' ' ' LEU . 4.9 m-70 -52.44 -46.44 66.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -69.18 -23.71 63.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -90.28 -9.33 48.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -104.96 -28.58 11.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.1 -51.4 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 175' ' ' TYR . 12.5 mt -83.32 15.57 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.514 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -70.56 -58.85 4.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.723 . . . . 0.0 110.874 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.56 ' HG3' ' CZ2' ' A' ' 111' ' ' TRP . 54.0 Cg_endo -69.72 -50.87 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.379 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.461 ' CE2' HD11 ' A' ' 186' ' ' LEU . 8.0 t80 -48.34 -49.61 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 185' ' ' PHE . 7.9 t-20 -65.5 -68.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.2 mp -39.06 -27.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 183' ' ' ASN . 82.1 t80 -82.08 -63.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 182' ' ' TYR . 71.8 mt -43.81 -48.03 8.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 t -79.23 -44.35 21.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -51.72 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -47.01 109.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.9 m -98.07 -58.46 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -77.34 -0.06 24.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.515 ' N ' HD13 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -119.81 86.66 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.25 157.74 46.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 194' ' ' LEU . 2.5 pt? -47.02 147.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -82.79 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 148.61 45.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.697 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 137.73 36.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -48.27 159.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.01 175.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 31.0 p -131.2 164.44 25.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.4 m -131.56 177.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -108.29 174.29 5.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.887 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 75.9 p -125.37 164.47 20.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -127.83 177.91 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.04 154.57 45.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -136.29 172.19 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -110.32 172.43 6.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 20.7 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -76.86 118.13 19.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 135.79 36.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.23 115.17 4.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -70.77 -22.13 62.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.884 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.2 p -91.73 125.97 36.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.55 47.52 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -99.92 86.35 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.16 145.98 26.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -78.67 -42.71 27.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.5 p -60.4 -38.1 82.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.4 mtt-85 -64.69 -61.68 2.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.88 -35.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.573 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 46.3 mtpt -70.59 -53.73 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 mt -53.74 -39.16 65.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -46.36 -51.9 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' ILE . 38.0 t80 -58.67 -65.76 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.474 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.5 mt -45.24 -24.94 0.31 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -82.69 -48.11 11.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -67.22 -26.0 66.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 103' ' ' PHE . 6.0 tt -85.08 -42.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -70.19 -41.57 73.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -55.67 -28.49 55.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 3.7 t80 -69.8 -29.41 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.809 ' CD1' HD12 ' A' ' 118' ' ' LEU . 77.0 m95 -81.56 -49.52 10.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -44.28 -40.94 5.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.67 -40.05 68.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -76.58 -39.62 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.29 32.69 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 m -134.82 103.89 5.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 p -53.64 141.3 26.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.1 tt -86.32 125.43 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -118.94 125.06 48.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.02 129.44 61.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.722 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.34 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.42 ' NE2' ' CD1' ' A' ' 127' ' ' ILE . 26.3 m80 -120.61 114.51 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.8 t -100.12 119.11 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 56.35 51.13 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 52.64 35.59 18.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -150.28 140.4 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' ' NE2' ' A' ' 122' ' ' HIS . 15.9 mm -60.81 144.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 133' ' ' LEU . 22.1 tp -106.91 104.21 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' O ' ' HE1' ' A' ' 159' ' ' MET . 5.8 t70 -71.93 113.32 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -67.39 -61.06 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 100' ' ' LYS . 33.8 t80 -39.97 -55.32 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -66.87 -51.06 59.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 128' ' ' LEU . 34.9 tp -50.65 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -49.26 -46.35 46.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -49.52 -52.13 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.69 -49.05 74.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 146' ' ' VAL . 98.2 t -47.35 -54.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.66 70.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -54.92 -39.28 68.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.99 -14.77 61.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.407 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 152.85 -61.92 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 160.04 173.51 28.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.475 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.94 -46.19 90.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.38 -66.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 142' ' ' GLY . 5.7 p -44.32 -37.04 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 142' ' ' GLY . 37.5 t -72.89 -49.34 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 148' ' ' LYS . 5.8 p -58.15 -45.87 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 147' ' ' CYS . 31.3 tttm -68.27 -33.4 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.54 4.45 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 146' ' ' VAL . 15.6 mmm180 47.12 37.88 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 155' ' ' ILE . 19.3 mtpp -83.42 36.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 51.9 m95 -81.5 -44.21 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.1 m -43.39 -47.16 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -51.89 -61.63 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 155' ' ' ILE . 5.3 mp -55.73 -55.86 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.87 -53.61 2.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -47.4 86.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -45.19 -49.23 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.419 ' HE1' ' O ' ' A' ' 129' ' ' ASP . 92.0 mmm -60.78 -25.81 66.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.97 -2.93 14.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -74.54 138.61 43.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -51.27 144.14 16.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.545 0.688 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 85.03 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.353 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.22 169.13 24.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.489 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -74.6 -38.28 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.73 -59.11 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.32 -37.25 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.4 -49.33 57.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.4 t -73.67 -31.11 63.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.442 ' O ' ' CD2' ' A' ' 174' ' ' HIS . 2.7 m-70 -54.7 -47.23 73.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 20.7 mm -46.2 -49.75 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.574 ' NH2' ' CD1' ' A' ' 152' ' ' TRP . 16.9 ttm105 -61.86 -61.66 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.31 -46.56 11.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 170' ' ' HIS . 80.1 m-70 -49.34 -43.26 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.0 t80 -68.01 -41.45 82.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -75.65 -9.26 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -100.13 -32.12 11.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.0 mt -119.75 -49.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.169 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 11.8 mt -82.52 18.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -71.08 -60.24 2.93 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.739 . . . . 0.0 110.885 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.526 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.9 Cg_endo -69.75 -47.54 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -49.41 -49.41 45.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -80.69 -38.0 29.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 14.9 tp -55.62 -26.23 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.12 -51.89 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 31.3 mt -45.37 -53.72 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t -60.68 -46.02 91.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.07 75.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -117.1 82.83 1.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -93.01 -50.22 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 191' ' ' LEU . 1.9 pt? -46.73 -41.25 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 130.18 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 29.8 p -69.78 152.69 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -57.72 142.65 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -149.33 140.93 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.36 131.45 23.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 0.0 110.908 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 138.87 38.91 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 0.0 112.35 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -107.96 112.33 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 199' ' ' LEU . 5.7 tt -125.1 154.28 41.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 199' ' ' LEU . 82.2 p -120.11 146.65 45.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.1 m -135.96 130.47 33.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -111.11 42.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 75.2 p -87.8 116.24 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -39.35 114.64 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -48.63 163.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 206' ' ' LYS . 6.5 tmtm? -95.31 134.72 37.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -140.86 168.7 19.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.9 p -122.13 166.0 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -43.7 -58.49 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.2 -152.28 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.457 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 m -163.69 121.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 110.86 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.1 p -44.69 109.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.7 64.02 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.472 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -63.43 -48.79 76.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.868 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.95 91.42 3.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 99' ' ' VAL . 9.6 tt0 -82.49 -60.8 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 p -40.64 -30.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 102' ' ' ASN . 5.0 tpt85 -66.59 -57.68 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 96' ' ' GLN . 12.7 p -68.29 -22.99 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -77.88 -60.66 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HA ' HD12 ' A' ' 104' ' ' LEU . 73.4 mt -63.75 -34.8 78.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 30.9 m-20 -44.22 -58.26 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -55.21 -59.97 4.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 101' ' ' LEU . 27.8 mt -42.5 -43.11 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.86 -40.54 95.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -64.9 -51.38 62.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.714 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.1 tp -61.46 -37.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.12 88.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -53.06 -36.63 60.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -65.13 -37.35 87.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.578 ' HD1' HD12 ' A' ' 118' ' ' LEU . 39.1 m95 -80.17 -59.87 2.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -38.99 -40.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -59.12 -53.03 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -61.36 -35.37 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.84 39.87 1.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -136.21 123.08 21.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.1 m -70.41 129.45 39.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.578 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.9 tt -84.39 125.22 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.46 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.1 ttmm -121.81 125.37 46.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 121' ' ' PRO . 21.6 mm -70.9 131.65 87.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.162 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 120' ' ' ILE . 53.6 Cg_endo -69.75 158.69 56.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -115.69 126.37 54.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.18 112.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 57.8 49.91 11.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 125' ' ' ARG . 26.2 mtm105 54.48 35.97 24.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.82 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -145.32 125.11 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.24 127.43 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.092 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.1 115.04 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.51 102.63 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.49 -51.94 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -43.53 -53.27 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 133' ' ' LEU . 43.3 tt0 -70.4 -60.51 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 171' ' ' ILE . 13.3 tp -35.19 -69.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -47.93 -47.61 32.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 139' ' ' GLU . 22.8 tptt -47.67 -54.21 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 132' ' ' GLN . 9.3 mp -56.28 -40.87 74.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 155' ' ' ILE . 63.9 t -53.27 -47.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.77 81.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 2.3 mp0 -66.59 -38.02 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -75.19 -21.41 58.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.34 -58.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 152.55 169.63 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.503 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -61.03 -39.09 88.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.69 -66.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.437 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.0 p -48.05 -42.99 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 142' ' ' GLY . 54.5 t -65.03 -70.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.3 t -44.61 -50.04 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -48.87 -55.41 11.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.81 14.78 5.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 42.85 54.34 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -98.25 41.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -79.75 -40.84 27.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 m -46.35 -56.51 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -45.07 -53.34 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 137' ' ' VAL . 19.9 mt -64.09 -62.8 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -38.09 -49.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 m -63.27 -47.75 81.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -48.35 -41.15 27.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.4 mtp -67.45 -28.52 67.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -2.06 10.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.576 ' CB ' HG21 ' A' ' 167' ' ' VAL . 21.2 m-85 -80.52 129.64 34.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -44.58 143.04 2.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.558 0.694 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -152.11 137.04 5.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -44.61 -26.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.23 -59.11 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 161' ' ' PHE . 10.8 p -67.82 -36.35 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.51 -44.95 85.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -78.64 -32.37 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -53.18 -50.57 64.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.641 HG23 HD21 ' A' ' 133' ' ' LEU . 21.8 mm -40.31 -61.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -54.39 -54.96 33.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -47.9 -47.0 25.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -51.21 -42.89 61.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 2.5 t80 -68.08 -40.75 82.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -78.04 -9.24 59.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -103.7 -28.18 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mt -120.11 -52.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 8.4 mt -88.58 28.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.58 -60.37 2.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.668 0.747 . . . . 0.0 110.864 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 184' ' ' LEU . 54.3 Cg_endo -69.66 -48.12 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.676 2.251 . . . . 0.0 112.383 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.714 ' CD1' HD12 ' A' ' 107' ' ' ILE . 6.3 t80 -39.25 -46.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.38 -51.78 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 181' ' ' PRO . 83.8 mt -45.35 -37.47 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.32 -55.31 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.2 mt -47.32 -46.51 25.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.5 m -59.63 -46.78 87.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -58.91 92.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.8 119.23 9.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 97.7 p -88.77 -27.98 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.774 ' H ' HD23 ' A' ' 191' ' ' LEU . 1.3 pt? -80.65 -38.69 28.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 192' ' ' ARG . 1.1 mmp_? -62.72 134.16 55.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.18 148.93 41.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.8 tp -55.96 125.3 20.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -135.15 137.54 42.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.441 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -142.46 137.73 15.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.943 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.441 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 53.5 Cg_endo -69.76 160.26 50.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -133.69 106.91 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -87.51 166.69 14.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 23.4 m -131.38 103.61 6.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.7 p -64.08 107.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -54.82 107.71 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.9 p -52.33 166.19 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -73.85 96.73 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 170.2 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.38 138.59 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -42.99 -46.13 5.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 32.0 t80 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.843 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.6 t -86.05 151.95 23.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.803 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 p -84.31 -45.19 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.86 138.86 6.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 t -47.46 137.49 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.2 t -100.25 87.1 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 53.51 -171.07 0.77 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -126.48 165.28 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.98 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.825 ' O ' HG12 ' A' ' 99' ' ' VAL . 68.4 mt-30 -111.6 -44.98 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.487 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 42.5 p -45.3 -21.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' GLN . 23.4 ttt180 -67.47 -45.59 75.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 96' ' ' GLN . 11.5 p -65.63 -24.98 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CE ' ' HA ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.46 -41.77 21.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.18 -44.52 88.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -43.83 -60.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 106' ' ' GLN . 45.9 t80 -61.17 -63.64 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 98.7 mt -38.4 -32.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 103' ' ' PHE . 7.5 t70 -77.63 -46.35 22.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 103' ' ' PHE . 91.9 mt-30 -64.17 -23.52 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 182' ' ' TYR . 2.2 tp -92.02 -36.6 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.07 62.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 110' ' ' TYR . 13.6 ptmt -57.76 -43.67 85.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 33.1 t80 -55.41 -28.19 52.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.94 ' CD1' HD12 ' A' ' 118' ' ' LEU . 68.5 m95 -81.08 -48.81 11.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.97 -57.09 6.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -47.36 -36.37 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -73.62 -32.92 64.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.63 34.46 3.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.3 t -139.02 123.24 18.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 110.865 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -68.85 148.95 49.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.94 HD12 ' CD1' ' A' ' 111' ' ' TRP . 6.8 tt -105.79 143.75 33.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.79 ' N ' HD23 ' A' ' 118' ' ' LEU . 24.3 ttmt -156.42 120.46 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 178' ' ' ILE . 34.6 mm -84.18 131.94 49.34 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.449 ' HG2' ' CE1' ' A' ' 174' ' ' HIS . 53.3 Cg_endo -69.84 153.77 68.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 0.0 112.294 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -86.36 109.68 19.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.9 t -96.69 123.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 49.6 53.75 12.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 54.8 27.85 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -154.38 123.85 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.15 127.21 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.743 HD21 HD22 ' A' ' 133' ' ' LEU . 10.7 tp -82.35 107.76 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.72 117.2 17.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 120' ' ' ILE . 17.5 mt -65.16 -49.59 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CD2' ' HG3' ' A' ' 100' ' ' LYS . 35.7 t80 -42.62 -57.34 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -72.99 -48.14 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.991 HD11 HG23 ' A' ' 171' ' ' ILE . 32.0 tp -44.43 -71.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 137' ' ' VAL . 57.5 t-20 -47.99 -66.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 134' ' ' ASN . 35.9 tttp -35.65 -54.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.51 -41.67 63.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 155' ' ' ILE . 94.6 t -58.07 -48.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.3 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -73.69 -35.11 65.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -77.92 -16.64 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.413 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.75 -57.53 0.32 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 150.31 175.81 22.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.443 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.79 -33.17 73.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.78 -65.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.413 HG11 ' C ' ' A' ' 141' ' ' GLY . 2.1 p -48.05 -42.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 151' ' ' LYS . 67.5 t -70.51 -67.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 48.6 t -45.51 -34.2 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -77.02 -49.23 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 150' ' ' ARG . 37.6 m-20 -89.22 21.18 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 149' ' ' ASP . 2.5 mmp_? 35.72 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 146' ' ' VAL . 15.6 mmmt -89.37 17.4 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 62.6 m95 -63.69 -45.99 87.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.2 m -41.69 -58.49 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -47.54 -58.43 4.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.699 HD13 HG22 ' A' ' 137' ' ' VAL . 17.8 mt -51.2 -66.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.1 m -54.9 -46.37 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -60.57 -26.8 67.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 82.1 mmm -78.56 2.19 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.99 63.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.15 166.71 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.12 145.16 52.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.602 0.715 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 85.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.98 -176.54 14.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.37 -25.26 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.778 0.323 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.17 -58.39 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.1 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.5 -38.65 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.82 -41.61 76.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.4 t -79.22 -29.57 42.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -57.99 -47.68 82.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.991 HG23 HD11 ' A' ' 133' ' ' LEU . 6.3 mm -45.05 -55.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -59.29 -63.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.92 -47.69 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.449 ' CE1' ' HG2' ' A' ' 121' ' ' PRO . 57.7 m-70 -51.05 -43.42 60.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -66.76 -30.85 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -85.04 -9.23 58.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -101.7 -31.31 10.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.463 HD13 ' CD1' ' A' ' 120' ' ' ILE . 23.9 mt -120.09 -51.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 175' ' ' TYR . 16.4 mt -83.12 20.03 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -71.83 -60.26 2.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.82 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 107' ' ' ILE . 10.0 t80 -40.05 -51.1 2.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.02 -41.29 95.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 184' ' ' LEU . 6.7 tt -56.4 -43.95 79.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -71.31 -59.19 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 182' ' ' TYR . 67.7 mt -38.4 -49.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -43.91 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.92 66.93 1.54 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -139.04 128.18 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.363 . . . . 0.0 110.82 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -81.28 -52.77 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 192' ' ' ARG . 4.1 pp -48.35 -36.7 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.56 ' N ' HD12 ' A' ' 191' ' ' LEU . 8.8 tpt180 -46.67 -33.56 4.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.8 m -56.81 157.9 5.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.06 144.56 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -102.54 169.9 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -128.78 136.8 29.71 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.538 0.685 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -171.2 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.338 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -116.18 179.42 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.911 HD22 ' N ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -150.48 159.56 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.911 ' N ' HD22 ' A' ' 199' ' ' LEU . 12.9 t -148.62 169.3 20.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.0 t -72.26 152.15 42.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -77.49 115.16 17.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 65.8 p -136.07 167.76 20.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -43.44 122.42 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -116.47 179.99 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -50.98 122.01 6.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.13 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.858 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.7 p -75.14 -45.9 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -116.44 121.71 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.13 -128.28 5.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.53 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 t -139.3 176.84 8.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 m -148.81 173.73 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.48 175.6 14.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.461 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -62.67 103.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.65 -176.58 3.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 96' ' ' GLN . 2.8 pm0 -97.97 -25.11 15.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.8 t -62.34 -33.97 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -67.05 -62.41 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.38 -35.38 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 62.6 mttm -71.26 -61.28 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.08 -40.46 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -51.76 -53.52 38.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -57.98 -65.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 44.2 mt -44.47 -35.38 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.67 -52.82 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -56.73 -52.59 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.571 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 3.8 tt -63.23 -32.14 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.43 93.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 111' ' ' TRP . 3.0 mmmm -54.46 -58.62 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -38.79 -25.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.502 ' N ' ' O ' ' A' ' 109' ' ' LYS . 63.5 m95 -90.86 -51.11 5.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.556 ' HG3' HD22 ' A' ' 113' ' ' LEU . 5.4 pt-20 -46.63 -20.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.556 HD22 ' HG3' ' A' ' 112' ' ' GLU . 1.5 mm? -79.17 -46.62 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -69.21 -1.66 8.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.12 43.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.7 p -128.98 129.04 44.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 110.802 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.4 114.74 25.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.13 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.767 HD23 ' N ' ' A' ' 119' ' ' LYS . 5.2 tt -50.31 137.12 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.767 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.65 115.14 61.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 165.66 30.19 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.695 2.264 . . . . 0.0 112.343 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CE1' ' CD1' ' A' ' 127' ' ' ILE . 12.0 m170 -117.66 132.5 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 128' ' ' LEU . 55.0 t -123.09 124.99 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 59.72 39.25 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 6.7 mmp_? 63.38 35.17 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -145.32 162.93 36.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.54 ' CD1' ' CE1' ' A' ' 122' ' ' HIS . 44.7 mm -82.69 102.99 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.615 HD11 HD22 ' A' ' 133' ' ' LEU . 47.2 tp -66.8 93.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.47 106.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.9 -46.43 90.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 131' ' ' PHE . 4.3 t80 -53.5 -56.12 19.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.462 ' O ' HD23 ' A' ' 136' ' ' LEU . 10.1 tt0 -65.19 -41.27 94.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 171' ' ' ILE . 4.1 tp -49.63 -72.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -51.63 -32.23 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -62.07 -50.79 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 155' ' ' ILE . 3.6 mm? -59.2 -41.6 88.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 146' ' ' VAL . 63.2 t -56.18 -55.51 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -54.04 -41.59 68.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.55 -40.99 89.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.45 -17.06 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.639 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 157.1 -59.09 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.632 ' H ' HG23 ' A' ' 146' ' ' VAL . . . 144.18 170.33 13.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.472 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.58 -36.68 72.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -65.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.639 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.0 p -56.62 -54.92 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 142' ' ' GLY . 85.2 t -51.4 -62.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.3 t -53.92 -40.86 67.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.2 tptp -53.88 -48.92 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.32 11.87 37.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 49.4 44.9 23.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' ILE . 55.9 mttm -84.98 50.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.459 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 81.4 m95 -86.85 -51.23 6.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.0 m -39.4 -67.36 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -37.74 -53.94 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 151' ' ' LYS . 23.3 mt -58.78 -65.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.62 ' HB1' ' CG2' ' A' ' 167' ' ' VAL . . . -37.72 -46.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.6 m -68.08 -45.35 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -57.14 -29.44 63.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mmm -70.3 -17.22 63.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.65 1.71 11.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -90.02 172.38 8.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.21 145.92 43.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 88.46 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.266 . . . . 0.0 112.366 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -144.98 131.08 4.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.485 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -42.74 -25.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.26 -59.18 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.62 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 12.5 p -64.85 -32.99 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.5 -48.3 65.68 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.9 m -77.05 -32.4 56.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 167' ' ' VAL . 6.1 m-70 -51.71 -51.07 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mm -42.16 -62.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -51.88 -53.43 40.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.41 -42.69 34.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.54 ' CD2' ' CD2' ' A' ' 128' ' ' LEU . 93.1 m-70 -60.52 -36.9 79.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 110.84 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.2 t80 -78.82 -30.2 45.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.56 -9.25 56.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 177' ' ' ARG . 13.3 mtp-105 -104.82 -28.43 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.98 -52.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 28.8 mt -85.2 21.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -71.65 -60.08 2.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 0.0 110.881 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.4 Cg_endo -69.73 -49.65 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.383 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.5 t80 -45.07 -54.12 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -77.21 -37.93 52.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 180' ' ' ASN . 40.9 tp -62.14 -19.59 63.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -98.0 -50.59 4.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 35.7 mt -48.34 -45.12 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m -56.58 -45.7 81.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 175.55 177.07 44.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -97.6 74.33 2.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.1 p -96.62 -17.68 20.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -80.55 3.25 22.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.405 ' N ' HD13 ' A' ' 191' ' ' LEU . 28.3 mmt180 -69.01 96.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 17.2 p -40.22 154.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.1 tp -38.74 119.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -78.39 163.07 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -43.89 156.09 0.31 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.588 0.708 . . . . 0.0 110.894 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 86.72 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 0.0 112.312 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.92 170.48 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.51 76.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.5 p -137.63 154.96 49.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.0 t -68.19 78.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -104.89 103.31 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.2 m -67.83 146.47 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 204' ' ' LYS . 0.0 OUTLIER -128.04 102.81 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.35 102.62 9.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -71.79 158.14 36.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -91.99 -44.24 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 39.4 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.1 m -65.78 168.59 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -149.73 156.74 42.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.3 112.12 4.02 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 m -57.09 -61.17 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.7 m -104.8 169.83 8.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.24 117.15 5.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -106.97 41.29 1.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.842 0.353 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.53 -45.88 12.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -121.7 62.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.545 HG22 HD11 ' A' ' 101' ' ' LEU . 19.6 m -92.2 -67.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 12.9 ttp-105 -45.74 -59.09 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.41 -34.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HA ' ' CE2' ' A' ' 131' ' ' PHE . 53.1 mtpt -82.86 -58.82 2.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 97' ' ' THR . 34.0 mt -45.56 -36.98 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -50.5 -57.44 8.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 6.2 t80 -58.27 -58.91 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.9 mt -46.71 -37.95 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.32 -57.5 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -48.32 -56.0 9.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.598 HD12 ' CD1' ' A' ' 182' ' ' TYR . 1.7 tp -55.59 -40.1 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.18 91.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.01 -36.81 30.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -63.4 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.729 ' HD1' HD12 ' A' ' 118' ' ' LEU . 27.0 m95 -83.34 -59.24 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -38.31 -36.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.447 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 33.4 mt -60.08 -52.03 67.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.47 -36.36 82.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.86 39.94 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -132.7 118.08 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.8 m -64.88 129.62 40.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.8 tt -79.97 122.15 26.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -116.15 141.66 47.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 mm -85.52 127.38 63.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.621 0.724 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HG2' HD23 ' A' ' 128' ' ' LEU . 54.1 Cg_endo -69.71 168.01 22.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.362 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -127.61 125.49 40.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 161' ' ' PHE . 56.0 t -113.41 131.78 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 51.06 37.61 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? 64.16 54.5 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -164.37 164.02 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -73.45 127.56 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.598 HD23 ' HG2' ' A' ' 121' ' ' PRO . 15.3 tp -102.02 98.69 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 129' ' ' ASP . 43.0 t0 -70.8 117.12 11.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.4 mt -72.36 -63.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 100' ' ' LYS . 16.2 t80 -38.68 -61.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -57.46 -58.42 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 171' ' ' ILE . 6.7 tp -41.23 -67.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -50.59 -49.28 56.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -46.17 -54.35 8.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.64 -43.3 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.798 HG22 HD13 ' A' ' 155' ' ' ILE . 64.6 t -51.17 -48.81 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.48 91.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.26 -41.14 88.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.01 -22.35 58.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.561 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 161.63 -57.16 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 146.15 177.47 20.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.45 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 147' ' ' CYS . 11.1 t80 -66.61 -36.63 83.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.61 -66.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.561 HG11 ' HA3' ' A' ' 141' ' ' GLY . 4.2 p -50.6 -51.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 142' ' ' GLY . 98.4 t -59.04 -68.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 35.5 t -44.73 -38.09 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -66.59 -45.42 79.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 150' ' ' ARG . 3.2 m-20 -93.34 24.07 4.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 149' ' ' ASP . 3.0 mpt_? 35.02 45.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 146' ' ' VAL . 59.4 mttt -93.36 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.694 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 30.6 m95 -84.8 -48.67 9.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 152' ' ' TRP . 38.7 m -37.04 -53.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -46.43 -68.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.798 HD13 HG22 ' A' ' 137' ' ' VAL . 24.0 mt -45.31 -65.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -37.91 -50.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.8 m -54.3 -53.31 55.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.47 ' HE3' ' N ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -47.47 -49.57 25.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 77.4 mmm -50.12 -28.15 6.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.24 -4.04 10.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 123' ' ' VAL . 36.7 m-85 -81.07 167.69 19.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 143.29 60.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 104.49 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.62 -159.48 9.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -101.0 -36.85 8.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.321 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -52.82 -58.48 6.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.52 -36.97 78.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.64 -45.6 90.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 t -77.22 -28.76 53.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -58.34 -50.77 72.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.694 HG21 ' CZ3' ' A' ' 152' ' ' TRP . 50.6 mm -40.4 -60.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -56.51 -53.58 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -49.38 -43.27 34.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -55.85 -39.86 72.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 2.6 t80 -67.77 -39.17 84.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -80.96 -9.21 59.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -97.2 -33.35 11.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.01 -51.39 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.47 ' HB2' ' CD1' ' A' ' 175' ' ' TYR . 12.6 mt -84.53 28.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.53 ' ND2' ' C ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -72.28 -60.4 2.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 110.875 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.75 -33.7 16.1 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.369 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.598 ' CD1' HD12 ' A' ' 107' ' ' ILE . 4.4 t80 -47.89 -60.91 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -72.4 -34.85 68.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.5 tm? -54.08 -48.8 70.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -73.67 -58.55 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 39.7 mt -41.83 -43.56 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.7 t -60.54 -46.63 89.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.86 123.56 0.7 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.466 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.74 133.41 8.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.9 m -45.36 -30.02 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 28.3 mt -50.47 -51.51 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 193' ' ' CYS . 0.0 OUTLIER -53.77 152.71 5.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 192' ' ' ARG . 4.2 m -109.93 149.15 30.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.77 125.37 24.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.439 ' CD ' ' O ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -116.03 41.28 2.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.54 132.15 13.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.587 0.708 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 115.05 3.91 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 0.0 112.347 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -150.02 157.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 198' ' ' ASN . 23.1 tp -36.31 119.61 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 40.2 p -46.72 142.03 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 7.7 t -50.9 158.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -83.39 150.41 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.2 t -114.59 156.91 23.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -95.7 130.59 42.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -134.71 152.27 51.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -105.55 130.38 53.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.3 154.67 17.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 57.6 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -109.24 127.79 54.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.84 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -159.68 152.31 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.22 -99.43 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -129.17 152.11 49.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.873 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 t -54.47 -48.85 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.01 136.31 6.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -86.96 39.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.92 176.82 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -110.68 42.2 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.3 t -88.82 -34.0 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -69.6 -42.28 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 7.2 p -62.2 -34.41 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.88 -53.55 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.1 mt -60.36 -46.01 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -46.64 -59.47 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 104' ' ' LEU . 71.7 t80 -49.25 -68.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 70.7 mt -37.03 -37.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.37 -57.92 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -52.29 -51.46 58.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.452 ' HA ' ' CE1' ' A' ' 182' ' ' TYR . 4.7 tt -58.05 -36.78 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -60.85 -50.99 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -47.71 -38.77 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -58.57 -38.58 78.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.417 ' CH2' ' HG3' ' A' ' 181' ' ' PRO . 13.8 m95 -82.06 -53.49 6.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -41.58 -50.13 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.33 -44.31 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -73.31 -36.81 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.18 40.71 0.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.9 m -131.88 126.68 34.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 m -74.51 128.28 35.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 119' ' ' LYS . 4.1 tt -91.22 118.32 30.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 118' ' ' LEU . 46.5 tttm -128.59 136.84 51.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.944 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.422 HD11 HD22 ' A' ' 104' ' ' LEU . 25.7 mm -67.47 124.5 89.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 111.108 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.725 ' HG2' HD23 ' A' ' 128' ' ' LEU . 53.9 Cg_endo -69.76 167.17 25.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.696 2.264 . . . . 0.0 112.311 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -123.89 119.92 31.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.583 ' CG2' HD22 ' A' ' 128' ' ' LEU . 43.1 t -108.67 136.51 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 45.17 39.84 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 61.48 44.82 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -155.04 142.33 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.06 118.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 121' ' ' PRO . 22.1 tp -94.8 103.9 15.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.938 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.1 104.03 5.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.9 mt -64.67 -46.64 81.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 58.6 t80 -48.12 -61.06 2.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 136' ' ' LEU . 7.1 mm100 -65.7 -39.5 91.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.935 HD11 HG23 ' A' ' 171' ' ' ILE . 11.6 tp -52.66 -71.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -53.57 -62.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -42.31 -50.81 4.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 132' ' ' GLN . 24.8 mt -56.1 -42.87 77.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 155' ' ' ILE . 72.8 t -57.8 -48.04 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.73 75.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.9 -44.9 94.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.35 -27.57 67.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 165.65 -54.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 142.49 163.48 9.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -57.17 -29.29 63.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.34 -66.3 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.069 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 141' ' ' GLY . 3.6 p -55.01 -39.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.4 t -68.04 -56.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.0 t -56.29 -41.95 76.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -55.61 -49.77 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.34 4.12 53.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.73 40.43 31.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -89.38 46.79 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 72.6 m95 -89.08 -41.65 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.4 m -42.9 -52.72 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -54.01 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 137' ' ' VAL . 15.4 mt -60.35 -60.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -43.72 -47.6 7.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.6 m -62.51 -46.21 89.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -51.78 -52.77 46.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 30.5 mtp -46.6 -28.1 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.33 -3.99 10.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.481 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.36 172.03 13.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.08 142.09 51.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 90.02 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.324 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.01 178.97 21.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -83.0 -32.38 26.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.58 55.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 168' ' ' GLY . 8.9 p -63.59 -38.57 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 167' ' ' VAL . . . -53.33 -45.96 64.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.1 m -75.43 -32.87 60.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -56.25 -49.71 73.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 133' ' ' LEU . 9.7 mm -44.23 -55.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.8 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.53 -56.69 9.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 121' ' ' PRO . 25.3 m-70 -49.32 -35.6 18.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.6 OUTLIER -75.99 -44.54 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.0 -9.9 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -105.27 -28.62 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.488 HG22 HD13 ' A' ' 179' ' ' LEU . 34.4 mt -116.72 -52.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.488 HD13 HG22 ' A' ' 178' ' ' ILE . 1.9 mm? -91.45 33.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.507 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -76.63 -63.88 0.52 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.39 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 107' ' ' ILE . 7.7 t80 -37.74 -36.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -82.55 -53.8 5.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -55.7 -20.36 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -90.6 -52.08 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 27.4 mt -47.98 -46.03 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.4 m -76.93 -48.47 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.92 64.3 3.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.452 ' HB2' ' CG ' ' A' ' 192' ' ' ARG . 15.9 p-10 -105.74 107.13 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.0 m -97.83 -52.13 3.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.54 -18.56 1.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.452 ' CG ' ' HB2' ' A' ' 189' ' ' ASP . 36.5 ptt180 -133.39 169.04 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.99 157.87 16.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.56 ' C ' HD13 ' A' ' 194' ' ' LEU . 0.9 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.441 ' N ' HD13 ' A' ' 194' ' ' LEU . 7.2 mm100 -111.63 108.17 17.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -79.47 143.46 59.65 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.57 0.7 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 89.06 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.69 2.26 . . . . 0.0 112.301 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -71.44 72.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.813 ' C ' HD22 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -79.39 166.77 21.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.692 ' N ' HD22 ' A' ' 199' ' ' LEU . 2.3 p -142.36 148.78 38.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 36.0 p -110.33 88.92 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.846 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.61 106.01 11.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.0 t -96.9 132.83 42.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 204' ' ' LYS . 0.0 OUTLIER -98.46 143.14 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -145.36 151.07 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -111.23 139.08 46.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.66 127.42 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -129.89 149.71 51.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.857 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 t -138.74 119.81 14.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.57 57.8 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -61.16 161.35 8.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -107.68 178.38 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.09 -111.06 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.13 137.53 37.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 126.25 30.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -108.31 -45.49 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 p -59.73 -30.54 68.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -71.26 -59.01 3.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' A' ' 131' ' ' PHE . 7.6 p -56.87 -39.07 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.551 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 31.0 mttm -65.56 -54.37 28.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.47 -56.75 18.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.963 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -38.42 -58.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 131' ' ' PHE . 12.1 t80 -50.17 -57.36 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 41.0 mt -52.18 -27.98 16.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.2 -53.71 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -56.32 -49.87 73.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 104' ' ' LEU . 4.8 tt -57.49 -42.07 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.72 82.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -48.87 -37.36 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.502 ' OH ' ' CE1' ' A' ' 185' ' ' PHE . 5.6 m-85 -59.18 -43.98 92.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.751 ' HD1' HD12 ' A' ' 118' ' ' LEU . 73.2 m95 -68.97 -51.7 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -42.09 -50.3 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.3 mt -47.96 -42.0 26.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.92 -36.21 64.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.3 30.05 2.8 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.44 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.3 m -128.83 138.07 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.811 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.6 p -86.96 132.85 33.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.751 HD12 ' HD1' ' A' ' 111' ' ' TRP . 6.3 tt -85.31 118.75 25.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -112.54 125.0 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.79 119.61 75.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 154.47 67.54 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 122' ' ' HIS . 5.5 m170 -111.2 123.36 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.59 121.47 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.07 48.57 6.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 126' ' ' LYS . 12.1 mpt_? 54.14 46.8 24.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 125' ' ' ARG . 34.8 mtmm -164.52 142.18 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -56.88 144.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -109.07 120.09 41.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.43 95.37 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 131' ' ' PHE . 55.9 mt -57.3 -63.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.89 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE2' HG22 ' A' ' 99' ' ' VAL . 10.5 t80 -34.76 -58.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 133' ' ' LEU . 10.8 tp60 -62.41 -62.61 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 171' ' ' ILE . 7.9 tp -35.08 -66.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -45.86 -56.22 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.45 -52.51 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.28 -41.97 66.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 155' ' ' ILE . 77.5 t -57.14 -45.89 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.73 -34.99 79.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -68.01 -31.59 71.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -82.93 -16.1 48.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.434 ' HA3' HG11 ' A' ' 145' ' ' VAL . . . 155.15 -60.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 153.43 172.76 21.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.72 -40.42 95.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.16 -66.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.434 HG11 ' HA3' ' A' ' 141' ' ' GLY . 5.2 p -48.61 -43.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 137' ' ' VAL . 44.8 t -62.83 -62.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 8.7 m -49.89 -46.02 51.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 148' ' ' LYS . 4.7 tmtt? -53.5 -60.15 3.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 150' ' ' ARG . 18.1 m-20 -84.47 25.87 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 149' ' ' ASP . 21.2 mmt180 34.49 38.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' A' ' 149' ' ' ASP . 41.1 mtpt -76.9 47.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.607 ' CZ3' HG21 ' A' ' 171' ' ' ILE . 13.6 m95 -91.03 -48.73 6.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.5 m -39.07 -51.25 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -48.55 -64.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 137' ' ' VAL . 18.8 mt -52.92 -62.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.43 -49.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.6 m -65.23 -38.67 91.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 155' ' ' ILE . 24.3 mmtt -53.64 -47.14 70.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.0 mtp -65.13 -19.97 66.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.44 3.56 25.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.455 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' CB ' HG21 ' A' ' 167' ' ' VAL . 27.8 m-85 -83.56 128.17 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -47.4 143.87 5.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.545 0.688 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.08 4.86 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 171.35 41.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -79.17 -14.66 58.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.21 -56.84 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 161' ' ' PHE . 7.5 p -64.69 -37.34 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -55.98 -46.73 83.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.9 t -76.0 -28.31 57.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -58.33 -49.21 77.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 133' ' ' LEU . 5.7 mm -44.5 -60.09 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -57.05 -55.9 28.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -46.41 -44.87 16.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -49.14 -46.73 45.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 179' ' ' LEU . 1.0 OUTLIER -62.78 -38.54 91.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -80.56 -9.18 59.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -99.91 -31.73 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.0 mt -119.74 -50.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 175' ' ' TYR . 18.9 mt -83.66 22.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -72.48 -60.62 2.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 180' ' ' ASN . 53.7 Cg_endo -69.78 -48.03 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.376 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.99 -44.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.01 -58.07 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -42.09 -35.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CE1' ' OH ' ' A' ' 110' ' ' TYR . 12.1 t80 -73.2 -49.5 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.1 mt -56.65 -35.68 68.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.0 t -79.47 -45.41 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.63 -145.28 4.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.521 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -124.86 151.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.1 m -48.98 -42.27 37.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 192' ' ' ARG . 4.6 mm? -45.07 -43.35 9.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -35.91 141.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.7 m -132.66 161.4 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.04 122.64 48.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -43.97 105.4 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.47 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -41.24 137.06 1.66 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.925 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.47 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 53.6 Cg_endo -69.76 138.17 37.2 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -76.44 156.49 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.411 ' HG ' ' N ' ' A' ' 200' ' ' THR . 4.3 tp -69.27 145.99 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.411 ' N ' ' HG ' ' A' ' 199' ' ' LEU . 70.3 p -97.73 164.88 12.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.0 p -111.58 87.54 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.81 149.51 43.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 73.1 m -132.23 103.31 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.16 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -42.9 132.19 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.61 132.8 38.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -97.67 85.09 3.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -98.52 152.78 19.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.823 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.4 m -86.2 131.59 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t -72.02 171.96 10.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.63 57.71 4.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -130.4 93.86 3.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -53.3 146.69 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.26 74.32 0.87 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.08 132.35 56.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.78 -53.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.32 45.08 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.0 t -90.01 -26.7 20.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -41.35 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' CZ ' ' A' ' 131' ' ' PHE . 8.4 p -64.54 -30.56 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -79.0 -51.51 9.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.89 -47.75 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -42.78 -53.2 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.731 ' O ' HG22 ' A' ' 107' ' ' ILE . 35.1 t80 -51.84 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 23.0 mt -42.75 -36.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 29.7 t70 -67.59 -59.19 3.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -52.87 -54.14 38.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 103' ' ' PHE . 4.9 tt -59.1 -33.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 104' ' ' LEU . . . -58.55 -54.37 47.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HE2' ' N ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -42.84 -54.85 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -42.76 -38.12 2.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.655 ' HD1' HD12 ' A' ' 118' ' ' LEU . 66.7 m95 -83.56 -47.82 10.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -46.52 -44.38 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 109' ' ' LYS . 8.1 mp -58.82 -42.59 89.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -68.43 -37.67 80.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.8 40.46 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.9 p -142.8 106.15 4.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.912 0.387 . . . . 0.0 110.818 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.7 p -50.58 147.11 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.655 HD12 ' HD1' ' A' ' 111' ' ' TRP . 7.0 tt -101.51 111.95 24.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -110.03 140.6 43.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 121' ' ' PRO . 47.2 mm -85.91 131.89 45.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 120' ' ' ILE . 54.1 Cg_endo -69.75 170.97 15.33 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -127.62 111.13 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.6 t -104.47 123.55 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 60.74 41.86 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 57.64 40.89 26.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -153.69 149.31 27.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.38 135.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.513 HD11 HD22 ' A' ' 133' ' ' LEU . 40.0 tp -103.47 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.91 97.71 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' PHE . 51.7 mt -55.43 -62.84 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 99' ' ' VAL . 88.7 t80 -34.79 -54.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 133' ' ' LEU . 4.7 tp60 -64.94 -62.91 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 171' ' ' ILE . 14.4 tp -34.39 -69.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -50.33 -51.27 46.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -46.27 -51.55 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.01 -50.17 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 146' ' ' VAL . 70.5 t -47.64 -50.7 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.26 -45.86 83.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.55 -31.54 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -76.56 -22.7 53.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' HG11 ' A' ' 145' ' ' VAL . . . 159.2 -58.55 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 146' ' ' VAL . . . 151.93 170.76 18.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.518 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -60.52 -40.79 92.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.89 -66.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.424 HG11 ' C ' ' A' ' 141' ' ' GLY . 5.3 p -49.13 -43.37 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 142' ' ' GLY . 69.2 t -67.62 -66.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 52.7 t -44.57 -48.1 10.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -56.79 -57.82 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.99 19.56 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 38.86 48.67 1.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.558 ' HB2' HG13 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -84.51 38.49 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.404 ' CZ2' ' HG2' ' A' ' 172' ' ' ARG . 80.7 m95 -84.01 -44.97 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -41.28 -50.71 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -49.38 -55.15 13.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 155' ' ' ILE . 4.6 mp -60.3 -64.49 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ILE . . . -36.48 -49.97 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.4 m -61.41 -47.55 85.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -50.09 -41.88 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 31.6 mtp -68.15 -28.0 66.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.34 -1.67 10.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CB ' HG21 ' A' ' 167' ' ' VAL . 19.6 m-85 -81.37 128.02 33.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -46.4 141.61 4.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.56 0.695 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.39 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 0.0 112.37 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.637 ' O ' HG12 ' A' ' 167' ' ' VAL . . . -140.17 132.32 5.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -37.36 -33.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -53.2 -58.75 5.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 164' ' ' GLY . 8.6 p -64.77 -32.57 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.24 -45.0 89.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.9 m -77.49 -35.3 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -51.89 -48.09 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.636 HG23 HD11 ' A' ' 133' ' ' LEU . 5.0 mm -45.89 -55.72 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' C ' ' OE1' ' A' ' 176' ' ' GLU . 41.2 mtp180 -55.38 -57.88 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.81 -42.29 7.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -59.6 -39.95 85.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -72.2 -39.12 68.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.408 ' OE1' ' C ' ' A' ' 172' ' ' ARG . 10.1 mp0 -81.89 -9.24 59.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.76 -30.84 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.98 -50.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 175' ' ' TYR . 11.2 mt -84.04 23.36 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -71.61 -60.34 2.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.564 ' HG3' ' CH2' ' A' ' 111' ' ' TRP . 53.8 Cg_endo -69.74 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.28 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 186' ' ' LEU . 5.8 t80 -42.08 -54.4 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -77.25 -42.16 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 181' ' ' PRO . 55.1 tp -55.28 -27.01 43.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -97.1 -54.16 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 182' ' ' TYR . 28.0 mt -41.95 -44.36 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.4 t -54.16 -47.29 72.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 189' ' ' ASP . . . -71.04 102.09 1.03 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 188' ' ' GLY . 1.1 m-20 -34.44 109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.848 0.356 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 87.8 p -46.07 -34.42 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.87 -43.49 38.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -47.4 -27.62 1.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 10.5 t -134.87 53.48 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 16.9 tp -133.04 100.36 4.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.15 34.19 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -125.37 122.36 25.05 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.602 0.715 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 136.04 31.99 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.4 176.18 5.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.4 mp -141.44 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 55.3 m -69.85 144.18 52.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.5 m -142.78 169.33 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -82.02 125.56 30.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 23.5 p -101.95 128.58 48.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -57.24 143.35 39.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -120.48 143.55 48.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.05 126.31 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -123.83 -44.79 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 -179.879 . . . . . . . . 0 0 . 1 stop_ save_